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PREFACE
The Occupational Safety and Health Act of 1970 (Public Law 91-596) 
states that the purpose of Congress expressed in the Act is "to assure so 
far as possible every working man and woman in the Nation safe and healthful 
working conditions and to preserve our human resources...by," among other 
things, "providing medical criteria which will assure insofar as practicable 
that no employee will suffer diminished health, functional capacity, or life 
expectancy as a result of his work experience." Later in the Act, the
National Institute for Occupational Safety and Health (NIOSH) is 
specifically authorized to "develop and establish recommended occupational 
safety and health standards" and to "conduct such research and experimental 
programs as....are necessary for the development of criteria for new and 
improved occupational safety and health standards."
The Institute responds to these mandates by means of the Criteria
Document. The essential and distinguishing feature of a Criteria Document 
is that it recommends a standard for promulgation by an appropriate
regulatory body, usually the Occupational Safety and Health Administration
or the Mine Safety and Health Administration of the U. S. Department of 
Labor.
The development of a Criteria Document entails a critical evaluation of 
all available scientific data pertinent to the subject, the writing of a 
draft Criteria Document, a systematic external review of the draft by
acknowledged experts in the field, the incorporation of their relevant
comments and suggestions, a review by the Office of the Director of NIOSH,
the printing of a final version, and the delivery of the Criteria Document 
to the appropriate regulatory body. This process is lengthy and the typical 
Criteria Document is usually two to three years in the making.
Because they encompass thorough systematic reviews of available
information, Criteria Documents generally prove to be of considerable 
interest and utility far beyond the regulatory process. Information 
contained in them is useful to both labor and management, and to official 
health agencies in reducing the hazards of work. Moreover, they have proven 
useful to voluntary agencies seeking to assist these efforts, and to 
academicians instructing students in principles of occupational safety and 
health. It is our intention that the information contained in these 
documents be disseminated as widely as possible among those with a need to 
know, in order to protect the health and safety of workers.
I am pleased to acknowledge the many contributions to this Criteria 
Document on styrene made by external consultants; representatives of the 
United Rubber Workers International Union and the Oil, Chemical, and Atomic 
Workers International Union; reviewers selected by The Society of 
Occupational and Environmental Health, the American Occupational Medical 
Association, the Society of the Plastics Industry, Inc., and the Chemical 
Manufacturers Association; representatives of other federal agencies; and, 
of course, the staff of the Institute (a list of consultants and agencies
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receiving the draft Document for review, appears on pages vi-viii). 
However, responsibility for the conclusions reached and the recommendations 
made, belongs solely to the Institute. All comments by reviewers, whether 
or not incorporated into the final version, are being sent with the Criteria 
Document to the Occupational Safety and Health Administration (OSHA) for 
consideration in standard setting.
H. (Lond.)J
Assistant Surgeon General 
Director, National Institute for 
Occupational Safety and Health
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I. RECOMMENDATIONS FOR A STYRENE STANDARD
The National Institute for Occupational Safety and Health (NIOSH) 
recommends that worker exposure to styrene in the workplace be controlled by 
compliance with the following sections. These recommendations are designed 
to protect the health and provide for the safety of workers for up to a
10-hour workshift, 40-hour workweek, over a working lifetime. Compliance 
with all sections of the recommended standard should prevent or greatly 
reduce the risk to exposed workers of adverse effects. NIOSH considers the 
recommended environmental limits for styrene to be upper boundaries of 
exposure. Thus, employers should make every effort to maintain exposure 
concentrations as low as possible. This recommended standard will be 
subject to review and revision as necessary.
Occupational injury and illness attributed to styrene results from 
inhalation of the vapor or from skin contact with the readily absorbed 
liquid. The NIOSH recommended standard is primarily based on reports of
effects on the human nervous system, and on irritation of the eyes and 
respiratory system.
Central nervous system (CNS) effects have been observed among 
experimental subjects as well as workers exposed to styrene at time-weighted 
average (TWA) concentrations of about 100 parts per million (ppm). In
addition, some investigators have reported observing these effects at
concentrations less than 100 ppm, both experimentally and clinically. 
However, the experimental studies are of limited value in establishing a 
recommended exposure limit because of the small numbers of subjects 
studied. Similarly, the clinical studies are difficult to interpret because 
the exposures occurred over a wide range of concentrations, occasionally in 
excess of 100 ppm. The most frequently reported effects of exposures at
about 100 ppm are subjective symptoms such as fatigue, dizziness, headache,
nausea, poor memory, and drowsiness. These subjective symptoms of CNS 
depression have been substantiated experimentally in human subjects and in 
clinical studies of workers exposed to styrene who demonstrated slower 
reaction times and impaired balance; abnormal EEGs have also been noted.
It has been reported in a number of clinical studies that chromosome 
changes occurred with greater frequency in the lymphocytes of workers
exposed to styrene at about 100 ppm than among workers not exposed to
styrene. Other investigators have reported an increase in the rate of
sister chromatid exchanges among styrene-exposed workers. However, the 
long-term significance of these effects is not clear and requires further 
elucida tion.
Although the evidence is not strong, exposure to styrene has also been 
implicated with other adverse health effects such as peripheral neuropathy, 
abnormal pulmonary function, liver toxicity, teratogenicity, and
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carcinogenicity. These health effects need further investigation, and would 
provide additional evidence for a reduction in the current occupational 
exposure standard if they were found to be styrene-related.
Although additional research is needed to clarify some of the reported 
effects, worker exposure to styrene should not exceed 50 ppm as a TWA 
concentration for up to a 10-hour workshift, 40-hour workweek. To prevent 
CNS depression and irritation of the eyes and respiratory tract, exposures 
should not exceed 100 ppm, determined as a ceiling concentration by a 
15-minute sample.
The "action level" for styrene is defined as one-half the TWA 
concentration limit for styrene. Due to interday variability of 
environmental levels, a worker's single TWA exposure measurement over the 
workshift that is below the recommended standard does not necessarily 
indicate that exposures on other days would also be below the recommended 
standard. If a worker's TWA exposure during a workshift is at or above 
one-half the recommended standard, a sufficient probability exists that on 
other days exposures could exceed the recommended TWA standard. As such, 
the concept of an "action level" is needed to ensure adequate protection of 
the workers. Exposure to styrene below the "action level" will require 
adherence to all sections of the recommended standard except Sections 2(b), 
8(a)(2), and the monitoring provisions of 8(b).
Section 1 - Environmental (Workplace Air)
(a) Concentration (Recommended Environmental Limits)
Exposure to styrene in the workplace shall be controlled so that workers 
are not exposed to styrene at concentrations greater than 50 parts per
million (ppm), determined as a time-weighted average (TWA) exposure 
concentration for up to a 10-hour workshift, 40-hour workweek. A ceiling 
concentration of 100 ppm, as determined during any 15-minute sampling 
period, is also recommended.
(b) Sampling and Analysis
Workroom air samples shall be collected and analyzed as described in
Appendix I, or by any other methods at least equivalent in accuracy, 
precision, and sensitivity.
Section 2 - Medical
The employer shall provide the following information to the physician
performing or responsible for the medical surveillance program: the
requirements of the applicable standard; an estimate of the worker's
potential exposure to styrene, including any available workplace sampling 
results; a description of the worker's duties as they relate to the
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workers's exposure; and a description of any protective equipment the worker 
may be required to use.
(a) Preplacement medical examinations shall include at least:
(1) Comprehensive medical and work histories with special emphasis 
on the nervous system, skin, respiratory tract, liver, and eyes.
(2) A physical examination giving special attention to the nervous 
system, skin, respiratory tract, liver, and eyes. Additional testing, such 
as clinical tests of liver function and enzymes, should be considered by the 
physician responsible for the examination.
(3) A judgment of the worker's ability to use positive and 
negative pressure respirators.
(b) Periodic medical examinations shall be made available at least 
annually to all workers occupationally exposed to styrene at airborne 
concentrations at or above the action level, or who have the potential for 
significant skin exposure (see paragraph (b)(3) of this section). These 
examinations shall include at least:
(1) An update of medical and work histories.
(2) A physical examination and tests as outlined in paragraph
(a)(2) of this section.
(3) In those instances where there is a potential for elevated or 
widely varying styrene exposures through inhalation and/or skin absorption, 
measurement of urinary mandelic acid (a styrene metabolite) may serve as a 
useful adjunct for characterization of workplace styrene exposures (see 
Appendix II). If the measurement of a worker's urinary mandelic acid
suggests possible overexposure to styrene, an effort should be made to 
ascertain the cause, such as failure of engineering controls, poor work 
practices, or nonoccupational exposures.
(c) Monitoring of urinary mandelic acid and a physical examination as 
outlined in paragraph (a)(2) of this section shall be made available to any 
worker exposed to unknown concentrations of styrene during a spill or
emergency.
(d) Workers and potential workers having medical conditions, such as 
disorders of the nervous or respiratory systems, or a liver disease that 
could be directly or indirectly aggravated by exposure to styrene, shall be 
counseled on the possibility of increased risk of impairment to their health 
from working with styrene.
(e) Following completion of the examination, the physician shall give 
to the employer a written statement about whether the worker has any 
detected medical conditions which would place the worker at increased risk
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of health impairment from exposure to styrene. The written statement shall 
include any recommended limitations upon the worker's exposure to styrene or 
upon the use of respirators. A copy of this written statement obtained by 
the employer shall not reveal specific findings or diagnoses and shall be 
provided to the worker.
(f) Pertinent medical records (i.e., the physician's written statement, 
the results of medical examinations and tests, medical complaints, etc.) for 
all workers subject to exposure to styrene in the workplace shall be 
retained for at least 30 years after termination of employment. Copies of 
environmental monitoring data applicable to a worker shall also be included 
in that worker's medical records. These records shall be made available to 
the designated medical representatives of the Secretary of Labor, the 
Secretary of Health and Human Services, the employer, and the worker or 
former worker.
(g) The relationship of styrene exposure to adverse reproductive 
effects has not been thoroughly investigated. Workers shall be made aware 
of the possibility of such adverse effects.
Section 3 - Labeling and Posting
All labels and warning signs shall be printed both in English and in the 
predominant language of non-English-reading workers. Workers unable to read 
the labels and posted signs shall be informed verbally regarding the 
hazardous areas of the plant or worksite and the instructions printed on 
labels and signs.
(a) Labeling
Containers of styrene used or stored in the workplace shall carry a 
permanently attached label that is readily visible. The label shall 
identify the presence of styrene and give information regarding its effects 
on human health. The information may be arranged as follows.
STYRENE
CAUTION!
HARMFUL IF INHALED OR IF ABSORBED THROUGH SKIN 
IRRITATING TO SKIN, EYES, NOSE, THROAT, MOUTH, AND LUNGS
FLAMMABLE
In case of eye contact, immediately flush eyes 
with large amounts of water for 15 minutes.
If irritation persists, get medical attention.
Keep containers closed when not in use.
Use only with adequate ventilation.
Keep away from heat, sparks, and open flame.
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(b) Posting
Readily visible signs containing information on the effects of styrene 
on human health and emergency measures shall be posted in work areas and at 
entrances to work areas or building enclosures where there is the likelihood 
of styrene concentrations above the action level or where the possibility of 
appreciable spills or skin contact with styrene exist. This information may 
be arranged as follows.
STYRENE
CAUTION!
HARMFUL IF INHALED OR IF ABSORBED THROUGH SKIN 
IRRITATING TO SKIN, EYES, NOSE, THROAT, MOUTH, AND LUNGS
FLAMMABLE
Place cleaning rags and soiled clothing in 
fireproof containers.
Use chemical fire extinguisher.
(c) Respirators
If respirators are needed during the installation or implementation 
of required engineering controls, the following statement shall be added in 
large letters to the sign required in paragraph (b) of this section:
RESPIRATORY PROTECTION REQUIRED IN THIS AREA
(d) Emergency Situations
In any area where there is a likelihood of emergency situations 
arising, signs required by paragraph (b) of this section shall be 
supplemented with signs giving emergency and first-aid instructions and 
procedures, the location of first-aid supplies and emergency equipment, and 
the locations of emergency showers and eyewash fountains.
Section 4 - Protective Clothing and Equipment
Engineering controls and safe work practices shall be used to keep the 
concentration of airborne styrene at or below the limits specified in 
Section 1(a) and to minimize skin and eye contact. In addition, protective 
clothing and equipment shall be provided by the employer to the workers when 
necessary.
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(a) Eye Protection
The employer shall provide safety glasses, chemical safety goggles, or 
face shields (20-cm minimum) with goggles and shall ensure that workers wear 
the protective equipment during any operation in which splashes of liquid 
styrene are likely to occur. Devices for eye and face protection shall be 
selected, used, and maintained in accordance with 29 CFR 1910.133 (U.S. 
Department of Labor, Occupational Safety and Health Administration, 
Occupational Safety and Health Standards, Eye and Face Protection).
(b) Skin Protection
(1) Workers at risk of skin contact with styrene shall be provided 
with protective clothing such as gloves, boots, overshoes, and bib-type 
aprons (at least knee-length). The clothing shall be both impervious and 
resistant to styrene. Materials made of polyvinyl alcohol or polyethylene 
afford good protection.
(2) Clothing contaminated with styrene shall be cleaned before 
reuse. Anyone who handles contaminated clothing or is responsible for its 
cleaning shall be informed of the hazards of styrene and the proper 
precautions for its safe handling and use.
(3) The employer shall ensure that all personal protective 
clothing and equipment is inspected regularly and maintained in a clean and 
satisfactory working condition.
(c) Respiratory Protection
(1) The use of a respirator to achieve compliance with the 
recommended exposure limits is permitted only during the time necessary to 
install and test required engineering controls, for nonroutine operations 
such as maintenance or repair activities causing brief exposures at 
concentrations in excess of the recommended environmental limits, during 
work in confined spaces, or during emergencies when concentrations of 
airborne styrene may exceed the recommended environmental limit.
(2) Respirators shall be provided in accordance with Table 1-1 by 
the employer when such equipment is necessary to protect the health of the 
worker. The worker shall use the provided respiratory protection in 
accordance with instructions and training received.
(3) The respiratory protective devices provided in conformance 
with Table 1-1 shall comply with the standards jointly approved by NIOSH and 
the Mine Safety and Health Administration (MSHA) as specified under the 
provisions of the U.S. Department of the Interior, Bureau of Mines 
(Respiratory Protective Devices and Tests for Permissibility, 30 CFR Part 
11).
6
(4) The employer shall ensure that respirators are properly fitted 
and that workers are instructed at least annually in the proper use and 
testing for leakage of respirators assigned to them.
(5) The employer shall be responsible for the establishment and 
maintenance of a respiratory protection program meeting or exceeding the 
requirements established by the Occupational Safety and Health 
Administration (Respiratory Protection, 29 CFR 1910.134) as summarized below:
(A) Written standard operating procedures governing use of
respirators shall be established.
(B) The worker shall be instructed and trained in the proper 
use of respirators and their limitations.
(C) Where practicable, the respirators should be assigned to 
individual workers for their exclusive use.
(D) Respirators shall be regularly cleaned and disinfected.
(E) Respirators shall be stored in a convenient, clean, and
sanitary location.
(F) Respirators used routinely shall be inspected during
cleaning. Worn or deteriorated parts shall be replaced. Respirators for 
emergency use such as self-contained devices shall be thoroughly inspected 
at least once a month and after each use.
(G) Workers should not be assigned to tasks requiring use of 
respirators unless it has been determined that they are physically able to 
perform the work and use the equipment. The respirator user's medical 
status should be reviewed periodically (for instance, annually) as 
recommended by the physician responsible for the physical examination.
(H) Appropriate surveillance of work area conditions and 
degree of worker exposure or stress shall be maintained.
(I) There shall be regular inspection and evaluation by the 
employer to determine the continued effectiveness of the program.
Section 5 - Informing Workers of the Hazards of Styrene
(a) All new and current workers in areas where airborne exposures to
styrene are at or above the action level, or who have the potential for
significant skin exposure, shall be kept informed of the hazards, relevant 
prenarcotic symptoms, effects of overexposure, and proper conditions and 
precautions for the safe use and handling of styrene.
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TABLE 1-1
RESPIRATOR SELECTION GUIDE 
FOR PROTECTION AGAINST STYRENE
Vapor Concentration Respirator Type Approved Under 
Provisions of 30 CFR 11*
400 ppa or less Any chealcal cartridge resp irato r w ith organic vapor c a r tr id g e (s ).* *  
Any supp lied -a lr re s p ira to r.**
Any self-contained breathing apparatus.**
1000 ppm or less A chealcal cartridge resp irator u ith  a f u l l  faceplece and organic vapor 
c a rtr id g e (s ).
5000 ppa or less A gas aask w ith a ch in -sty l^  or fro n t- or back-aounted organic vapor 
canls te r .
Any supp lled -a ir resp irato r w ith a f u l l  faceplece, helmet, or hood. 
Any self-contained breathing apparatus w ith  a f u l l  faceplece.
Greater than 5000 ppa 
or during entry and 
escape froa unknown 
concentra tlons.
Self-contained breathing apparatus w ith a f u l l  faceplece operated In 
pressure-demand or other positive  pressure node.
A combination resp irato r which includes a Type C supp lied -a lr resp irator  
with a f u l l  faceplece operated in pressure-deaand or other positive  
pressure or continuous-flow mode and an a u x ilia ry  self-contained breathing 
apparatus operated in pressure-demand or other positive  pressure mode.
F ire  Fighting Self-contained breathing apparatus w ith a f u l l  faceplece operated in  
pressure-deaand or other positive  pressure aode.
Escape Any gas Bask providing protection against organic vapors. 
Any escape self-contained breathing apparatus.
*Only NIOSH-approved or HSIIA-approved equipment should be used.
* * I f  eye I r r i t a t io n  occurs, fu ll-fa c e p le c e  resp iratory protective equipaent should be used.
(b) The employer shall institute a continuing education program, 
conducted by persons qualified by experience or training in occupational 
safety and health, to ensure that all workers exposed to styrene above the 
action level have current knowledge of styrene hazards, proper maintenance, 
cleanup methods, and proper use of protective clothing and equipment, 
including respirators. The instructional program shall include oral and 
written descriptions of the environmental and medical surveillance programs 
and of the advantages to the worker of participating in these surveillance 
programs. The employer shall maintain a written plan of these training and 
surveillance programs.
(c) Workers shall also be instructed on their responsibilities for 
following proper work practices and sanitation procedures to help protect 
the health and provide for the safety of themselves and their fellow workers.
(d) All new and current workers in areas where exposure to styrene may 
reasonably be expected to occur during spills or emergencies shall be 
trained in proper emergency and/or evacuation procedures.
(e) Required information shall be recorded on the "Material Safety Data 
Sheet" shown in Appendix III, or on a similar form specified by the 
Occupational Safety and Health Administration (OSHA) describing the relevant 
toxic, physical, and chemical properties of styrene and of mixtures of
styrene that are used or otherwise handled in the workplace. This 
information shall be kept on file and shall be readily available to workers 
for examination and copying.
Section 6 - Work Practices
(a) Handling and General Work Practices
(1) Operating instructions for all equipment shall be developed 
and posted where styrene is handled or used.
(2) Transportation and use of styrene shall comply with all 
applicable local, State, and Federal regulations.
(3) Styrene shall be stored in tightly closed containers in 
well-ventilated areas.
(4) Containers shall be moved only with the proper equipment and 
shall be secured to prevent loss of control or dropping during transport.
(5) Storage facilities shall be designed to contain spills 
completely within surrounding dikes and to prevent contamination of workroom 
air.
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(6) Ventilation switches and emergency respiratory equipment shall 
be located outside storage areas in readily accessible locations that will 
remain only minimally contaminated with styrene in an emergency.
(7) Process valves and pumps shall be readily accessible and shall
not be located in pits or congested areas.
(8) Styrene containers and systems shall be handled and opened
with care. Approved protective clothing and equipment as specified in
Section 4 shall be worn by workers who open, connect, and disconnect styrene 
containers and systems. Adequate ventilation shall be provided to minimize 
exposures of such workers to airborne styrene.
(9) Styrene storage equipment and systems shall be inspected daily 
for signs of leakage. All equipment, including valves, fittings, and 
connections, shall be checked for leaks immediately after styrene is 
introduced therein.
(10) When a leak is found, it shall be repaired promptly. Work 
shall resume normally only after necessary repair or replacement has been 
completed, and the area has been well ventilated.
(b) Engineering Controls
(1) Engineering controls shall be used when needed to maintain 
exposure to airborne styrene within the limits prescribed in Section 1(a). 
Complete containment of the vapor is the recommended method for control of 
styrene exposure. Local exhaust ventilation may also be effective when used 
alone or in combination with process enclosure. When a local exhaust 
ventilation system is used, it shall be designed and operated so as to 
prevent accumulation or recirculation of airborne styrene into the workplace 
environment and to effectively maintain safe levels of styrene in the
breathing zones of workers. Exhaust ventilation systems discharging to
outside air shall conform with applicable local, State, and Federal air 
pollution regulations and shall not constitute a hazard to workers or to the 
general population. Before maintenance work on control equipment begins, 
the generation of airborne styrene shall be eliminated to the extent
feasible.
Enclosures, exhaust hoods, and ductwork shall be kept in good repair so 
that designed airflows are maintained. Measurements such as capture 
velocity, duct velocity, or static pressure shall be made at least
semiannually, and preferably monthly, to demonstrate the effectiveness of 
the mechanical ventilation system. The use of continuous airflow 
indicators, such as water or oil manometers marked to indicate acceptable 
airflow, is recommended. A log shall be kept showing design airflow and the 
results of all airflow measurements. Measurements of the effectiveness of 
the system to control exposures shall also be made as soon as possible after 
any change in production, process, or control which may result in any 
increase in airborne concentrations of styrene.
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(2) Forced-draft ventilation systems shall be equipped with remote 
manual controls and should be designed to shut off automatically in the 
event of a fire in the styrene work area.
(c) Confined or Enclosed Spaces
(1) Entry into confined or enclosed spaces, such as tanks, pits, 
tank cars, and process vessels, where there is limited egress, shall be 
controlled by a permit system. Permits shall be signed by an authorized 
employer representative and shall certify that preparation of the confined 
space, precautionary measures, and personal protective equipment are 
adequate and that precautions have been taken to ensure that prescribed 
procedures will be followed.
(2) Confined spaces that have contained styrene shall be 
thoroughly ventilated, inspected, and tested for oxygen deficiency and for 
the presence of styrene and any other known or suspected contaminants.
Every effort shall be made to prevent inadvertent release of hazardous
amounts of styrene into confined spaces in which work is in progress. 
Styrene supply lines shall be disconnected or blocked off before and while 
such work is in progress.
(3) No worker shall enter any confined space that does not have an 
entryway large enough to admit a worker wearing safety harness, lifeline, 
and appropriate respiratory equipment as specified in Section 4(c).
(4) Confined spaces shall be ventilated while work is in progress 
to keep the concentration of styrene at or below the recommended limits, to 
keep the concentration of other contaminants below dangerous levels, and to 
prevent oxygen deficiency.
(5) If the concentration of styrene in the confined space exceeds
the recommended environmental limit, respiratory protective equipment is
required for entry.
(6) Anyone entering a confined space shall be kept under 
observation from the outside by another properly trained and protected 
worker. An additional supplied-air or self-contained breathing apparatus 
with safety harness and lifeline shall be located outside the confined space 
for emergency use. The person entering the confined space shall maintain 
continuous communication with the standby worker.
(d) Emergency Procedures
Emergency plans and procedures shall be developed for all work areas 
where there is a potential for exposure to styrene. They shall include 
those procedures specified below as well as any others considered 
appropriate for a specific operation or process. Workers shall be 
instructed in the effective implementation of these plans and procedures.
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(1) If styrene leaks or spills, the following steps shall be taken:
(A) All nonessential personnel shall be evacuated from the
leak or spill area.
(B) The area where the leak or spill occurs shall be 
adequately ventilated to prevent the accumulation of vapor.
(C) The styrene shall be collected for reclamation or be
absorbed on vermiculite, dry sand, earth, or similar nonreactive material
and be disposed of properly.
(2) Only personnel trained in the emergency procedures and
protected against the attendant hazards shall clean up spills, control and 
repair leaks, and fight fires in areas where styrene is present.
(3) Personnel entering the spill or leak area shall be furnished 
with appropriate personal protective clothing and equipment. Other 
personnel shall be prohibited from entering the area.
(4) Safety showers, eyewash fountains, and washroom facilities 
shall be provided, maintained in working condition, and located so as to be 
readily accessible to workers in all areas where skin or eye contact with 
styrene is likely. If styrene is splashed or spilled on a worker, 
contaminated clothing shall be removed promptly and the skin washed
thoroughly with soap and water. Eyes splashed by styrene shall be irrigated 
immediately with a copious flow of water for 15 minutes. If irritation 
persists, get medical attention.
(e) Storage
Styrene shall be stored in well-ventilated areas and kept away from
ignition sources such as heat or sparks and from oxidizing agents, 
catalysts, and strong acids. If styrene is stored more than 30 days at 32°C 
(about 90°F) or above, the inhibitor concentration shall be checked 
periodically. Large styrene storage containers should be installed with a 
temperature alarm system to signal interior temperature increases that may 
result in runaway polymerization, a special concern in hot climates. The 
rate of polymer formation in storage tanks can be reduced by cooling the
tank by means of a water spray, refrigeration, insulation, or reflective
painting. In a laboratory, samples of styrene may be stored in 
refrigerators or cold boxes.
Section 7 - Sanitation
(a) The preparation, storage, dispensing (including vending machines), 
or consumption of food shall be prohibited in areas where styrene is 
manufactured, formulated, processed, stored, or otherwise used.
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(b) Smoking shall be prohibited in areas where styrene is manufactured, 
formulated, processed, stored, or otherwise used.
(c) Workers who handle styrene or equipment contaminated with styrene 
shall be instructed to wash their hands thoroughly with soap or mild 
detergent and water before eating, smoking, or using toilet facilities.
(d) Facilities such as double lockers should be provided for workers so 
soiled clothing can be stored separately from clean clothing.
Section 8 - Exposure Monitoring and Recordkeeping Requirements 
(a) Exposure Monitoring
(1) The employer shall conduct an industrial hygiene survey to 
determine whether exposures to airborne concentrations of styrene are in 
excess of the action level (i.e., 25 ppm determined as a TWA over the 
workshift). The employer shall keep records of these surveys. If the 
employer concludes that exposures are below the action level, the records 
must show the basis for this conclusion. Surveys shall be repeated at least 
annually and within 30 days of any process change likely to result in an 
increased concentration of airborne styrene.
(2) If there is exposure to styrene at or above the action level, 
a program of personal monitoring shall be instituted to identify and 
measure, or to permit calculation of, the exposure of each worker 
occupationally exposed to airborne styrene. Source and area monitoring may 
be a useful supplement to personal monitoring. In all personal monitoring, 
samples representative of the TWA and ceiling exposures to airborne styrene 
shall be collected in the breathing zone of the worker. Procedures for 
sampling and analysis shall be in accordance with Section 1(b). For each 
determination of an occupational exposure concentration, a sufficient number 
of samples shall be collected to characterize each worker's exposure during 
each workshift. While all workers do not have to be monitored, sufficient 
samples should be collected to characterize the exposure of all workers. 
Variations in work and production schedules, as well as worker locations and 
job functions, shall be considered in decisions on sampling locations, 
times, and frequencies.
If a worker is found to be exposed to styrene at or above the action 
level but below the recommended environmental limits, the exposure of that 
worker shall be monitored at least once every 6 months or as otherwise 
indicated by a professional industrial hygienist. If a worker is found to 
be exposed to styrene in excess of the recommended environmental limits, 
controls shall be initiated, the worker shall be notified of the exposure 
and of the control measures being implemented, and the exposure of that 
worker shall be evaluated at least once a week. Such monitoring shall 
continue until two consecutive determinations, at least 1 week apart, 
indicate that the worker's exposure no longer exceeds the recommended 
limits. At that point, semiannual monitoring shall then be resumed.
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Records of the monitoring used to characterize the environmental 
exposures for each worker shall be retained for at least 30 years after the 
individual's employment has ended. These records shall include the name of 
the worker being^ monitored; Social Security number; duties performed and job 
locations within the worksite; dates and times of measurements; sampling and 
analytical methods used; number, duration, and results of samples taken; and 
the type of personal protection used, if any. Workers shall be able to 
obtain information on their own environmental exposures. Workplace 
environmental monitoring records shall be made available to designated 
representatives of the Secretary of Labor, the Secretary of Health and Human 
Services, and the worker or former worker.
Pertinent medical records (i.e., results of medical examination results, 
the physician's written opinion, medical complaints, medical and work 
histories, etc.) for all workers subject to exposure to styrene in the 
workplace shall be retained by the employer for at least 30 years after 
termination of employment. Copies of environmental monitoring data 
applicable to a worker shall be included in that worker's medical records. 
These medical records shall be made available to the designated medical 
representatives of the Secretary of Labor, the Secretary of Health and Human 
Services, the employer, and the worker or former worker.
(b) Recordkeeping
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II. INTRODUCTION
This report presents the criteria and recommended standards that have 
been prepared to meet the need for preventing impairment of health arising 
from exposure to styrene. The criteria document is developed by the 
Secretary of Health and Human Services, in response to Section 20(a)(3) of 
the Occupational Safety and Health Act of 1970, to "develop criteria dealing 
with toxic materials and harmful physical agents and substances which will 
describe...exposure levels at which no worker will suffer impaired health or 
functional capacities or diminished life expectancy as a result of his work 
experience."
NIOSH has formalized a system for the development of criteria on which 
standards could be established to protect the health and provide for the 
safety of workers from exposure to hazardous chemical and physical agents. 
The criteria and recommended standard are intended to enable management and 
labor to develop better engineering controls and more healthful work 
practices, and to comply with the recommended environmental limits should 
not be the final goal.
These criteria for a recommended standard for styrene are part of a 
continuing series of recommendations developed by NIOSH. The proposed 
standard applies only to workplace exposure arising from the processing, 
manufacturing, handling, and use of styrene. The standard is not designed 
for the population-at-large, and any extrapolation beyond the occupational 
environment is not warranted. It is intended to: (1) provide protection
against the development of systemic effects and local effects on the skin 
and eyes of workers, and (2) be measurable by techniques that are valid, 
reproducible, and available to industry and government agencies.
Styrene is used extensively in the manufacture of plastics and rubber. 
The principal acute hazards from worker exposure to styrene are central 
nervous system (CNS) depression and irritation of the skin, eyes, and upper 
respiratory tract. The possibility of styrene-related adverse health 
effects such as damage to the central and peripheral nervous systems, birth 
defects, chromosomal aberrations, sister chromatid exchanges, unscheduled 
DNA synthesis, impaired pulmonary function, liver injury, and 
carcinogenicity has also been suggested. Further study of these latter 
effects will help to elucidate their etiology.
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III. SCOPE OF THE DOCUMENT
This document assesses the hazards of occupational exposure to styrene, 
a commercially important compound. This chapter gives information on the 
physical and chemical properties of styrene, its production methods and 
uses, and the extent of worker exposure. Chapter IV discusses and 
summarizes the effects of styrene exposure on humans and animals. 
Subsequent chapters describe environmental sampling and analytical methods 
for styrene, biological monitoring techniques, existing occupational health 
standards, and a correlation of exposure and effect. In addition, methods 
for worker protection are discussed and include suggested work practices, 
engineering controls, personal protective clothing and equipment, and 
monitoring and recordkeeping.
Most of the clinical studies cited in Chapter IV. Effects of Exposure 
are based on the evaluation of workers in the reinforced plastics industry, 
along with a number of studies of workers who produce styrene and 
polystyrene. Since the formulation of styrene-butadiene rubber (SBR) 
involves numerous substances besides styrene and butadiene, and also since 
many other substances are emitted during vulcanization and curing, the 
likelihood of any effects being due to styrene alone are quite small, 
although styrene could be a contributing factor. For example, among workers 
who produce SBR, adrenocortical insufficiency [1], enlarged liver and spleen
[2], inflammation of the gall bladder [2,3], and degeneration of the 
capillaries [4], have been reported. These effects are different from those 
reported to have occurred among workers in other occupational settings where 
styrene is made or used. A detailed discussion of the SBR industry is 
beyond the scope of this document.
Physical and Chemical Properties
Styrene, also known as vinylbenzene or phenylethylene, is an aromatic 
organic compound with the chemical formula C6H5CH=CH2. Styrene is a 
volatile liquid with a low vapor pressure [5]. The odor threshold is below 
1 ppm [6,7,8]. Identifiers for styrene include the Chemical Abstracts 
Service Registry No. 100-42-5 and the Registry of Toxic Effects of Chemical 
Substances No. WL3675000. Standard specifications for styrene have been 
issued by the American Society for Testing and Materials [9], Styrene is 
soluble in many organic solvents, but only slightly soluble in water 
[10,11], Other information about styrene, including some of its chemical 
and physical properties is given in Table III-l.
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TABLE III-l
STYRENE PROPERTIES
Synonyms
Molecular formula
Formula weight
Boiling point (760 mm Hg)
Freezing point
Density
Solubility
Cinnamene, cinnamenol, cinnamol, 
ethenylbenzene, monostyrene,
phene thylene, phenylethene,
phenylethylene, stirolo (Italian),
styreen (Dutch), styren (Czech), 
styro1(German), styrole, styrolene,
styropor,
vinylbenzene,
styron, styropol,
vinylbenzen (Czech), 
vinylbenzol 
C6H5CH=CH2 
104.16
145.2°C (293.4°F)
-30.6°C (-23.1°F)
0.9018 g/cu cm (25°C)
Soluble in ethyl ether, benzene, 
methanol, toluene, ethanol, acetone, 
n-heptane, carbon tetrachloride, carbon 
disulfide; slightly soluble in 
(about 25 mg/100 g water at 25°C)
wa ter
Flammable (explosive) limits 1.1-6. 1% by volume in a i r
Flashpoint 34.4°C (94°F) Tag closed cup
36.7°C (98°F) Tag open cup
Autoignition temperature 490°C (914°F)
Vapor Pressure Tempera ture
°F °C mm Hg kPa
50 10 2.34 0.31
68 20 4.50 0.60
77 25 6.45 0.86
86 30 8.21 1.09
104 40 14.30 1.91
8,500 ppm (25°C)
1 ppm = 4.26 mg/cu m
________________________   1 mg/cu m = 0.235 ppm
Adapted from references [5,10,12,13,14,15]
Concentration in saturated air 
Conversion factors
(25°C, 760 mm Hg) ______
Discovery of Styrene, Production Methods, and Uses
Styrene was isolated and described in 1831 by Bonastre who distilled a 
fragrant natural balsamic resin called liquid amber [16]; the reaction 
forming styrene was later shown to be the decarboxylation of cinnamic acid, 
a constituent of the natural resin [17], Mention of a similar investigation 
by Neumann was made in 1795 by Nicholson [18]. A procedure for the 
synthesis of styrene was published in 1866 by Berthelot et al. [19], in 
which benzene and ethylene mixtures were passed through a heated porcelain 
tube.
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Although styrene was known for many years to polymerize, the first 
successful production of high purity styrene was begun in 1925 by I.G. 
Farbenindustrie of Germany [20]. The first successful production of styrene 
in the United States (U.S.) was begun in 1930 by the Dow Chemical Company 
[17]. Today, most styrene continues to be produced by the catalytic 
dehydrogenation of ethylbenzene [21,22,23]. Recently, styrene has also been 
produced as a coproduct with propylene oxide. In this latter process, 
ethylbenzene is first oxidized to its peroxide and is then reacted with 
propylene to yield propylene oxide and alpha-me thylphenyl carbinol; the 
carbinol is dehydrated to styrene [21,22,23]. Almost all of the 
ethylbenzene used in styrene production in the U.S. is obtained by on-site 
alkylation of benzene with ethylene [23]. A small amount (10-15 ppm) of 
p-tert-butylcatechol is added to the styrene monomer to prevent spontaneous 
polymerization [21],
The U.S. production of styrene grew from 2.4 million pounds in 1940 to 
1,745 million pounds in 1960, to a peak of 7,473 million pounds in 1979 
[23], U.S. styrene production was 6,612 million pounds in 1981 [24]; in 
1984, 62% is expected to be sonsumed in polystyrene production, 22% in
copolymers such as styrene-acrylonitrile (SAN) and acrylonitrile-butadiene- 
styrene (ABS), 7% in styrene-butadiene rubber (SBR), 7% in unsaturated 
polyester resins, and 2% in miscellaneous uses [23]. Many consumer products 
are made from styrene-containing compounds including packaging and 
insulation from polystyrene, pipes and automotive components such as 
instrument panels and consoles from ABS, drinking tumblers and battery cases 
from SAN, carpet backcoatings from styrene-butadiene latexes, passenger car 
tires and industrial hoses from SBR, and boats and open storage tanks from 
unsaturated polyester resins. Some other end-uses of styrene are shown in 
Table XIII-1.
Worker Exposure
The number of workers in the U.S. potentially exposed to styrene is 
difficult to estimate. Currently, there are 13 facilities producing styrene 
monomer [23] which is mainly used as a constituent in a variety of different 
plastic and rubber items. Polystyrene is made at over 40 locations; other 
styrene-containing polymer resins such as ABS and SAN are also produced at 
about 40 locations with some facilities producing both types of resins 
[25,26,27], About 20 facilities produce SBR and SBR latexes with 66% 
utilized in the tire and tire products industry [26,28], Many plants are 
involved with the fabrication of reinforced plastics/composites, including 
hundreds of boat producers [26,29], There are also hundreds of plastic 
fabrication facilities where polystyrene, ABS, SAN, etc., are custom molded, 
extruded, formed, or cast into thousands of finished products [26]. In 
these operations, styrene exposure is due to the unreacted residual monomer 
or the thermal degradation of the plastics. In addition, exposures to 
styrene may occur during the use of miscellaneous products containing 
styrene such as floor waxes and polishes, paints, adhesives, putty, metal 
cleaners, autobody fillers, and varnishes. NIOSH estimates that at least
30,000 workers in 1,000 plants are potentially exposed in the U.S. on a
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full-time basis to styrene [30], It is also estimated that compounds 
containing styrene are utilized in over 20,000 facilities with more than
300,000 workers potentially exposed [30], In most of these latter 
facilities, the potentially exposed workers may not work directly with 
styrene or may only periodically come in contact with it. Tables XIII-2 and 
XIII-3 summarize styrene exposure levels found during industrial hygiene 
surveys in various industries.
In the past, workers involved in the production of styrene and 
polystyrene may have been significantly exposed to styrene and other toxic 
chemicals such as benzene and ethylbenzene [31]. The current use of closed 
systems in styrene monomer and copolymer resin production (i.e., 
polystyrene, ABS, SAN, SBR, etc.) limits exposures (for the most part) to 
spills, sample collections, the cleaning of vessels, and fugitive emissions 
from valves, pump seals, etc. [32,33]; full-shift TWA styrene exposures are 
generally less than 10 ppm. Usually, styrene exposures are also less than 
10 ppm during the fabrication (i.e., molding, extruding, casting, etc.) of 
items from polystyrene or styrene copolymers which contain low residual 
levels of styrene monomer. The most substantial exposures to styrene occur 
when it is used as a solvent-reactant for unsaturated polyester products 
that have been reinforced with fibrous glass. For these reinforced plastic 
items such as boats, open storage tanks, wall panels, tub and shower units, 
and truck camper tops, The Society of the Plastics Industry, Inc. has given 
the formal designation of "reinforced plastics/composites" (RP/C) [34]. The 
very nature of many of these operations subjects workers to intimate contact 
with materials used in the process; workers may be exposed to high 
concentrations of styrene vapor and have skin contact with liquid styrene or 
resin. Average styrene exposures in RP/C plants can range from 40-100 ppm 
with individual TWA exposures often found as high as 150-300 ppm (see 
Table XIII-3). Short-term exposures (i.e., 5-15 minutes) of styrene in the 
1,000-1,500 ppm range have also been reported in some RP/C plants [35,36],
In the fabrication of RP/C, after the surface of the mold is treated
with a release agent (usually a wax) and the initial layer of resin (gel
coat) is applied, hand lay-up or spray-up is done which consists of putting
a layer of chopped fibers or woven mats of fibrous glass in place and then 
applying resin. Following disposition of fiber reinforcement and resin, it 
is necessary to roll-out or squeegee-out by hand the structure to saturate 
the fibrous glass with resin and to remove entrapped air. Other layers of 
glass fiber and resin are added and rolled out until the desired thickness 
is obtained. The styrene content in the resin is approximately 40 percent 
by weight [37,38], High exposure levels of styrene (especially in building 
large items such as boats) occur during the manual spray-up or lay-up
operations, since about 10 percent of the styrene evaporates into the 
workplace air as the resin cures [37,38]; the remainder of the styrene is 
consumed in the chemical reaction with the unsaturated polyester. The 
amount of styrene evolved is dependent on the surface area being fabricated, 
thickness of the laminate, ratio of resin to reinforcement, workshop 
temperature, and duration of each step in the process [39],
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Workers exposed to styrene are usually also exposed to other chemicals 
as well. These potential exposures are to substances utilized as raw 
materials, solvents, catalysts, accelerators, or inhibitors; exposures are 
also possible to chemical intermediates, thermal degradation products, and 
resin-curing emissions. Table XIII-4 lists other substances that have been 
found (usually at low levels) in processes utilizing styrene or 
s tyrene-deriva tives.
The Standard Industrial Classifications (SICs) of some of the industries 
with potential exposures to styrene are listed in Table XIII-5. In addition 
to occupational exposure to styrene, exposure may occur from styrene in 
community air [40,41,42], drinking water [43,44,45j, fermented grains [46], 
food [47,48], toys [49], building panels, and floor coverings [50], and in 
the domestic usage of certain floor polishes, metal cleaners, or adhesives 
containing styrene.
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IV. EFFECTS OF EXPOSURE
EFFECTS ON HUMANS
Historical Reports
As mentioned in the Scope of the Document, the first published reference 
to styrene was by Bonastre in 1831 who wrote: "Its odor is sharp,
penetrating....Its taste is bitter, burning and caustic; an unpleasant 
sensation remains after tasting [16]." In a literature review published in 
the United States in 1940, Von Oettingen [51] reported that the toxicity of 
styrene had not been studied. However, according to a 1960 report [52], 
data on the acute animal toxicity of styrene had been published in Russia in 
1936 by Larionov indicating changes in the lungs and bronchi, fat 
accumulation in the liver, and slight degenerative changes in the kidneys, 
as well as decomposition of leukocytes in the spleen, lymph nodes, and blood.
The first U.S. report of the effects of styrene was written by Spencer 
et al. [53] in 1942 who, based on animal studies, estimated that repeated 
exposure of workers to styrene at 650 ppm would produce no serious 
disturbances. However, it was noted that this concentration was definitely 
irritating to the eyes and nose and, therefore, the investigators [53] 
suggested 400 ppm as a tentative permissible limit for occupational exposure 
to styrene, a level producing a disagreeable odor but only slightly 
irritating.
Based on his experiences in the synthetic rubber industry, in 1943, 
Mallette [54] described styrene as a lung and skin irritant that produced 
light narcosis and possible liver and kidney injury. He noted that in a 
series of several hundred periodic examinations of the blood of workers in 
the rubber industry who were exposed to styrene, no traces of the "blood 
damage so characteristic of benzol" were found. Mallette [54] suggested 
that a styrene limit of 400 ppm was too high to prevent skin irritation 
among workers in synthetic rubber producing factories, and he stated that 
200 ppm, which was not irritating to the eyes or nose, was preferable.
Case Studies and Miscellaneous Reports
Few cases of styrene intoxication as such have come to the attention of 
physicians because of obscure etiologies associated with styrene exposure, 
and there have been no reports of fatalities.
In 1946, McLaughlin [55] reported that among 458 chemical burns of the 
human cornea treated by him over a three-year period, thirty cases were 
caused by styrene. In the styrene cases there were only superficial 
transient disturbances of the eye, with return to normal within 48 hours in 
all but one case in which healing took three to ten days.
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In 1952, Barsotti et al. [56] studied seven workers from a polystyrene 
manufacturing facility in Italy. The styrene concentration in the work area 
where styrene was loaded into the polymerization tower was reported as 
188 ppm. Traces of styrene were found in the pumproom air, but no styrene 
was detected in any other area of the factory. Methods of sampling and 
analysis were not given. The workers had been employed in this factory for 
18 months, and most had conjunctival and pharyngeal congestion. Two workers 
had an erythematopapular dermatitis localized on the back of the arms, with 
increasingly intense itching. Another had suffered for 3 months with a 
pruriginous dermatitis. Three workers had hyperactive deep reflexes. 
Complete blood counts and urinary hippuric acid concentrations were normal. 
None of 20 workers who handled the polymerized product had disturbances of 
any consequence. Atmospheric concentrations of polystyrene dust were not 
reported [56].
In 1964, Pratt-Johnson [57] described a case of retrobulbar neuritis in 
a 48-year-old self-employed Canadian who had worked for five years making 
reinforced plastics. The individual admitted that he had handled styrene 
carelessly, and had frequently come into contact with it with his bare 
hands. Initially, painless deterioration of vision to 20/400 and
centrocecal scotomata were noted in each eye. Upon treatment with vitamin B 
compound and nicotinic acid for six months, visual acuity and visual fields 
improved slowly, recovery being complete within a year. The author [57]
noted that circumstantial evidence alone incriminated styrene as the toxic 
agent. Kohn [58], in reviewing this study, stated "the likelihood of 
nutritional amblyopia could not be excluded."
In 1968, Matsushita et al. [59] described the case of a 35-year-old 
Japanese worker who developed symptoms of both central and peripheral 
nervous system poisoning while employed in a resin coating operation for 3.5 
years. As a result of falling at work, he was examined by a physician who 
diagnosed his condition as organic solvent poisoning on the basis of 
progressive symptoms of peripheral numbness, fatigue, and dizziness, and 
work conditions. During a subsequent neurologic examination, a slight 
decrease in the muscular strength of the legs and arms, and the grasping 
strength of the right hand were found. Most reflexes were normal except for
muscular reflexes of the upper limbs. Decreased sensation in the forearms
and lower limbs was indicated by objective pain and vibration tests. 
Abnormal electromyograms (EMGs) of the arm and leg muscles were recorded and 
interpreted as indicating peripheral neuromyogenic nervous disorders. 
However, findings of normal motor nerve conduction velocities for ulnar, 
median, peroneal, and tibial nerves may not support this hypothesis. A 
slight contraction of the visual fields and a slight expansion of Mariott's 
dark point without eye fundus changes were found during ophthalmologic 
examination. No electroencephalographic abnormalities, indications of 
impaired liver function, or blood dyscrasias were found. The man was 
removed from work, treated as an outpatient, and slowly began to recover; 
however, about 22 months after treatment had begun, he was still 
hypersensitive to cold in his arms and legs. As a result of this case, the 
investigators [59] subsequently studied other workers in the factory and
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determined that exposures were due primarily to styrene (up to 600 ppm) and 
occasionally to traces of toluene, ethyl acetate, and methanol. The results 
of this subsequent study are discussed in the Clinical Studies Section.
In 1971, a case of accidental exposure was reported by Schwarzmann and 
Kutscha [60]. In this incident a student inhaled some styrene vapor and
spilled a "small" amount on his hand. Thirty minutes later the student 
noticed central blind spots in both eyes, and, 30 minutes after this, a
headache developed. The blind spots had almost disappeared 1.5 hours after 
the initial contact, but the headache persisted and he was visibly shaking. 
He experienced hot and cold spells, had periodic sensations of numbness on 
the hand where styrene was spilled, and was extremely restless. For 7 hours 
following the accident, he felt very weak. After eating dinner he noticed 
the headache was gone. Other reports of this type of reaction to styrene 
have not been found, and many of the symptoms described could also be
explained as hysteria or anxiety on the part of the student.
In 1971, Araki et al. [61] provided information of an 11-year history of 
lacrimation, nasal irritation, muscle soreness, headache, insomnia, general 
malaise, and anxiety, which led to the hospitalization of a 55-year-old 
man. The man had worked for 14 years in a Japanese factory where polyester
resin tubs were manufactured. Although no information about airborne
concentrations of styrene was given, the authors reported that the man 
typically handled styrene with his bare hands. As a result of this work 
practice, the skin on the man's hands was generally thin and atrophic. 
Biopsy revealed thinning of the prickle cell layer, flattening of the 
papillary layer, and marked edema with mild perivascular infiltration of the 
round cells throughout the dermis.
This case also had signs of neuropathy. Although pathologic reflexes 
were not found, he did have generally exaggerated deep tendon reflexes, 
paresthesia (tingling sensation) of the extremities, and bilaterally 
decreased cold sensation of the legs and feet. An electromyogram indicated 
a reduced number of motor units during maximal voluntary effort, and larger 
polyphasic action potentials of long duration. Biopsy of the biceps humeri 
and the gastrocnemius muscles revealed degeneration of the fibers with an 
increase of the sarcolemmal nuclei in some places. Biopsy of a peripheral 
nerve, n. suralis, showed no remarkable changes. The man's visual field and 
acuity were intact and an electroencephalogram (EEG) was normal. Since 
Raynaud's syndrome was absent and the man's symptoms were not consistent 
with scleroderma, Araki et al. [61] thought that the skin, muscle, and nerve 
changes were the result of the direct action of styrene and suggested, 
without explanation, that effects on the autonomic and central nervous 
systems were due to the action of styrene on the man's brain stem.
A chest roentgenogram of the man revealed pulmonary emphysema, but it 
was noted that the man smoked about 20 cigarettes a day. Hippuric acid 
excretion and results of tests of liver competence and blood counts were all 
normal, but creatinuria (0.187 g/24 hours) was noted. Araki et al. [61] 
also reported that about the time of the onset of symptoms (11 years prior
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to hospitalization) the man was admitted to a hospital because of jaundice, 
but its cause was not established.
In 1973, Stepien [62] described the case of a 33-year-old female who 
suffered from thrombosis of the central retinal vein. She had worked over a 
year in a Polish experimental chemical laboratory and had been exposed 
mainly to styrene and solvents (not specified) in testing polyester 
laminates and epoxide films. Stepien [62] concluded that the interview, 
type of work, increased red blood cell count (RBC), toxic changes in the 
bone marrow, increased mandelic acid levels to 980 mg% ten days after last 
workplace exposure, and a lack of other reasons pointed to a toxic 
background for the disease, caused mainly by styrene.
In 1975, Hruba et al. [63] reported a study of two groups of workers 
from four Czechoslovakian plants; the styrene exposures were unspecified. 
The first group consisted of 101 workers who had been exposed to styrene for 
2 months to 6 years; the other group, called a "control" group, included 21 
workers just beginning employment. The most common subjective complaints of 
the 122 workers (95 women, 27 men, average age 35) were drowsiness (34%), 
headaches (28%), fatigue (25%), and increased irritability (14%). 
Examinations revealed signs of vegetative imbalance (64%), lowered tendon 
and periostal reflexes (19%), and slight signs of cerebellar nerve 
disturbances (14%). Normal EEGs were found in 13 of the exposed workers, 
borderline EEGs (including flat graph and conspicuous sleep activity) were 
found in 42, and mildly abnormal EEGs (including synchronous rhythms and 
centralized predominance of dispersed changes) were found in 46 of the 101 
workers. Of the 21 workers in the "control" group just starting employment, 
7 had normal EEGs, 7 had borderline readings (including mildly disturbed 
rhythm, increased beta, or flat graph), and 7 had slightly abnormal EEGs 
because of increased slow activity. After 3 years of employment, only 1 of 
the 21 "controls" had an EEG that the investigators [63] considered normal, 
12 had borderline EEGs (including flat graphs and mildly increased sleep 
rhythms), and 8 workers had abnormal EEGs (not defined).
In 1974, Axelson et al. [64] described two men who were engaged in 
plastic boat production and had chronic emotional insufficiency with 
symptoms suggesting cerebral lesions around the time they started to work 
with styrene. TWA styrene concentrations measured at some worksites at one 
of the plants about a year after the men became ill were 200-292 ppm; 
instantaneous styrene peaks were sometimes higher than 1,500 ppm. There 
were some complicating factors, such as alcohol and drug abuse by one man, 
but these did not seem to the authors [64] to be of sufficient degree to 
have been likely causes. Axelson et al. [64] thought styrene might have 
contributed to the conditions, but believed the evidence was inadequate for 
a definite conclusion.
In 1976, Dowty et al. [65] reported qualitative analyses by gas 
chromatography and mass spectrometry of 11 paired maternal blood and 
umbilical cord blood samples obtained at birth. Styrene was identified in 
blood from both sources. The mothers were all healthy and 10 of the babies
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normal. One Infant with a lumbosacral meningomyelocele had numerous
volatile organic compounds (apparently including styrene, acetone, and
butylated hydroxy toluene) identified in the cord blood. The concentrations 
in these blood samples were not reported and are apparently not known. 
There were no known occupational exposures to styrene, and its sources were 
not determined.
In 1977, Holmberg [66] described CNS birth defects in children born to 
two women who were employed in factories in Finland where reinforced 
plastics were made. These two women were in a group of 43 women who
responded to questionnaires sent to all women, without regard to their 
occupation, who had borne children with CNS defects in the previous year.
In the first case, the mother was a 19-year-old woman (first pregnancy, 
first birth). She and her 26-year-old husband, a carpenter, worked in a 
factory where reinforced plastics were made; her regular job was grinding, 
polishing, and mending reinforced plastic products. She was potentially 
exposed to styrene, polyester resin, organic peroxides, acetone, and
polishes. At one point in her pregnancy (about the 4th month), she was 
"heavily exposed" to styrene for 3 days when she cleaned a mold. Her
pregnancy was generally unremarkable, except for bronchitis during the 3rd 
month. The mother worked until 2 weeks before delivery. The baby, born in 
the 9th month, was 54 cm long and weighed 3,900 g. It had congenital 
hydrocephalus, anomaly of the right ear, and bilateral malformations of the 
thoracic vertebral column and ribs [66].
The other case involved a 24-year-old woman (first pregnancy, first 
birth) who also worked in the reinforced plastics industry. She was married 
to a 24-year-old welder-plater and gave birth to a 47-cm, 2,200-g girl. The 
child died during delivery and was anencephalic. The 7-month pregnancy was 
essentially uncomplicated although contractions that occurred in the 2nd 
month were controlled with 10 mg of isoxsuprine three times daily for 1 
week. In the 7th month, the mother was treated for slight edema with 500 mg 
of chlorothiazide once daily for 1 week [66]. In the 3rd month, the woman 
was exposed to styrene, acetone, organic peroxides, and polyester resin 
while performing a hand-rolling operation for about 3 weeks with no 
respiratory protection. Afterwards, she was assigned to needlework in the 
same shop with occasional assignments in the hand-rolling operation.
Holmberg [66] reported still another case, not involving occupational 
exposure; it involved a 20-year-old woman (first pregnancy) who gave birth 
in the 7th month to a stillborn, anencephalic child. The mother was exposed 
to styrene on six occasions when her husband did repair work with reinforced 
plastics at home. The materials used were styrene, polyester resin, and 
organic peroxides. This case was complicated by a history of juvenile 
diabetes in the mother.
Based on information from the Finnish Register of Congenital 
Malformations, Holmberg [66] reported that the combined incidence of 
hydrocephaly and anencephaly among Finnish women of child-bearing age was
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0.5/1,000 live births. He predicted 12 live births among women in the 
reinforced plastics industry during the 9-month study period, based on 
estimates of the number of women of child-bearing age employed in the 
Finnish reinforced plastics industry in 1974 (i.e., 250) and on Finnish
fertility data. Thus, the normal combined rate of anencephaly and 
hydrocephaly (0.5/1,000 live births) was exceeded more than 300-fold.
Melgaard et al. [67] described chronic CNS changes in seven Danish 
workers, all males aged 42-65 years with a mean time of exposure to styrene 
of 15 years, ranging from 6 to 28 years. Exposure concentrations were not 
known, but the workers were all employed in small workshops with what were 
described as poor hygienic conditions. Details of the examinations were not 
provided except that neuroradiologic examinations were performed either with 
pneumoencephalography or computerized tomography.
The men had often experienced acute CNS effects (symptoms of acute 
intoxication with headache, dizziness, and a sense of drunkenness toward the 
end of the workday). At the time of examination in the hospital, they had 
complaints of fatigue, memory loss, difficulty in concentrating, unstated 
emotional complaints, and headache. In one man who had for several years 
imbibed alcohol excessively, there was biochemical evidence of liver damage 
and signs of polyneuropathy. Based on undescribed neuropsychological 
examinations, there was intellectual impairment in 6 men, 5 showed a 
moderate degree, and 1 was severe. Cerebral atrophy was found in 4 men by 
computerized tomography scan and in 1 man by pneumoencephalography.
Experimental Exposures
In 1944, Carpenter et al. [68] reported the results of an experimental 
study of two men exposed to styrene in a chamber at 800 ppm for 4 hours. 
The two men experienced eye and throat irritation immediately after entering 
the chamber. Increased nasal mucous secretion, a pronounced and persistent 
metallic taste, listlessness, drowsiness, and impairment of balance also 
occurred during this exposure. After exposure, symptoms of weakness, 
unsteadiness, inertia, and depression were reported. Urine collected over a 
24-hour period from both subjects was analyzed for hippuric acid and neutral 
sulfur. In one subject, hippuric acid excretion was considerably 
increased. Neutral sulfur in the two subjects was increased by 17% and 48%, 
respectively.
In 1968, the effects of inhalation of styrene vapor at 51-376 ppm on 
human subjects were reported by Stewart et al. [69] . Nine healthy men were 
studied, some several times, in five experiments according to the design in 
Table IV-1.
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TABLE IV-1
STYRENE EXPOSURE SCHEDULE
Exper­ No. of Exposure Styrene Concentration
iment Subjects Duration (ppm)
(h) Mean Range
1 1 2 117 112-121
2 6 7* 99 95-107
3 3 1 51 50-55
4 3 1 216 203-236
5 5 1 376 368-403
*Two 3.5-hour sessions with an intervening 30-minute lunch period 
Taken from Stewart et al. [69]
The styrene was 99.6% pure as determined by infrared (IR) analysis and 
contained 2 ppm of p-tert-butylcatechol to inhibit polymerization [69]. 
Styrene concentrations in the 12.5.xl.8x2.3-ra (52.2-cu m) chamber were
measured continuously with an IR spectrometer. The minimum detectable
styrene concentration in the chamber using this method was about 11 ppm.
Breathing zone samples, collected in 50-ml glass pipets every 10 minutes in 
experiments 1, 3, 4, and 5, and every hour in experiment 2, were analyzed by 
gas chromatography with a hydrogen flame detector. The minimum detectable 
styrene concentration by their method of sampling and analysis was 0.05
ppm. Total expired air samples were collected every 15 minutes and
similarly analyzed during experiments 1, 3, 4, and 5 and every hour during 
experiment 2 by having the subjects breathe through a tube connected to a 
bag outside of the chamber. Urine samples were collected for 24 hours 
before the exposures and up to 2 days after the exposures for hippuric acid 
determination; urine samples from nine laboratory workers were used for
comparison. Venous blood was collected in experiments 1, 2, and 3 during
the final 10 minutes of exposure, and, in experiment 1, after 1 hour of
exposure. Tests administered during exposure included a modified Romberg 
test (balancing on one foot with eyes closed and hands at side), heel and 
toe, finger to nose, the Crawford manual dexterity collar and pin test, and 
the Flanagan coordination test. Subjective and objective responses were 
recorded every 15 minutes during the exposures [69].
Two of five subjects exposed to styrene for 1 hour at 376 ppm reported 
eye irritation within 3 minutes; two more reported eye irritation within 15 
minutes. All five subjects noted nasal irritation at this concentration. 
After 20 minutes, a burning sensation of the face was reported by one
subject. After 25 minutes of exposure, one subject was unable to perform
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the modified Romberg test normally. After 50 minutes of exposure to
376 ppm, two subjects exhibited decrements of 20% and 33%, respectively, in 
the Crawford manual dexterity collar and pin test, and three subjects 
dropped to a 10 percentile below their pre-exposure performance on the 
Flanagan coordination test. Nausea that occurred in one subject after 45 
minutes of exposure persisted for 1 hour after the exposure. At the end of 
the exposure, two subjects reported feeling slightly inebriated; one of
these subjects and one other individual who complained of headache performed 
the Romberg test abnormally [69].
After 20 minutes of a 1-hour exposure at 216 ppm, nasal irritation was 
noted by one of three subjects. Coordination and balance were not affected 
by this exposure [69].
During the 7-hour exposure at 99 ppm, two of six subjects noted mild eye 
irritation, and one noted mild throat irritation within 20 minutes after the 
exposure began. Eye irritation persisted for 30 minutes before subsiding, 
and the throat irritation subsided after drinking coffee. The Romberg test 
was performed eight times by each of the six subjects during this
experiment. Two subjects perceived themselves as having difficulty
performing the test on one occasion, and one subject perceived having 
difficulty on two occasions. The perceived difficulty was not reflected in 
the actual performance of the Romberg test, however, since Stewart et al. 
[69] stated there were no objective signs of impairment of balance during 
the seven hours. Performances on the Crawford dexterity and Flanagan 
coordination tests were also unaffected. Two subjects noted that the odor 
of styrene was faint, while the other four barely perceived it at the end of 
the experiment [69],
Although the odor of styrene was reported to be moderately strong by the 
subject in the 2-hour exposure at 117 ppm and by the three subjects in the
1-hour exposure at 51 ppm, no untoward subjective symptoms or objective 
signs of illness were reported [69],
Clinical laboratory test results that remained normal following each of 
the exposure sessions included complete blood count (CBC), sedimentation 
rate, reticulocyte count, serum glutamic-pyruvic transaminase (SGPT), lactic 
dehydrogenase, alkaline phosphatase, blood urea nitrogen (BUN), creatinine, 
and blood glucose. Urinary hippuric acid excretion was not significantly 
altered by the styrene exposures; pre-exposure values were 0.8-3.0 g/24
hours and the postexposure values were 1.0-2.9 g/24 hours. Styrene
concentrations in exhaled breath samples during the exposures were 25% of 
the concentration present in the exposure chamber, which indicated about 75% 
retention. Concentrations of styrene found in the blood and postexposure 
alveolar air at the end of various periods are presented in Table IV-2. 
Percentages of absorbed styrene exhaled during various periods after removal 
from exposure are also given. After the exposure, only small amounts of 
styrene were eliminated in the breath; for example, 1.2% of the absorbed 
styrene was eliminated during the 4 hours after the end of exposure at 117 
ppm [69].
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TABLE IV-2
CONCENTRATIONS OF STYRENE IN CHAMBER AIR, POSTEXPOSURE VENOUS BLOOD,
AND ALVEOLAR AIR
Styrene Concentration
Exposure
(h)
Chamber
air
(ppm
Blood
(mg/liter)
Alveolar
Air
(ppm)
Absorbed Styrene 
Exhaled in 
Postexposure Periods
1 51 0.2-0.7 1.0 0.7% in 7 h
7 99 0.9-1.4 1.3 0.7% in 2 h
1 117 1.7 - -
2 117 2.7 1.8 1.2% in 4 h
Taken from Stewart et al. (69)
Hake et al. [70] exposed 10 men in groups of 2-4 for 1, 3, or 7.5 hours
a day to 0, 20, 100, or 125 ppm styrene vapor. Eight women in groups of 1-4
were exposed at 0 or 100 ppm. Each subject was part of more then one group, 
but nonexposure weekends or control exposures (i.e., 0 ppm) were
interspersed with the styrene exposures. For the men there were 3 days of 
exposure at 20 ppm, 4 days at 100 ppm, 4 days at 100 ppm with the 
concentration fluctuating between 75 and 125 to simulate workroom exposures, 
5 days at 125 ppm, and 7 days at 0 ppm. The women were exposed to 100 ppm 
on 4 days and to 0 ppm on 2 days. The exposure chamber for control
exposures was initially odorized by the introduction of styrene vapor at 10 
ppm upon entry of the subjects, then reduced within 10 minutes to 0 ppm.
Daily check of the temperature and blood pressure, urinalysis, and 
continual medical surveillance during the study by a physician revealed no 
unusual abnormalities that could be attributed to exposures to styrene 
vapor; neither did the weekly battery of clinical chemistry tests. The
weekly CBC did reveal that eight of the ten male subjects, after three 
consecutive days of exposure to 125 ppm, had elevated basophils in the 
differential analysis of blood samples drawn on the morning of the fourth 
day. The abnormal values ranged from 3 to 5%, the normal laboratory value 
being 0 to 1% [70].
No deleterious effect on equilibrium was found as measured by modified 
Romberg and heel-to-toe tests. There were some changes in 3 of 6 subjects 
in both visual evoked response and EEG amplitude over the course of the 
study deemed by the investigators [70] as consistent with CNS depression. 
However, the changes were neither uniform in all subjects identically 
exposed to styrene, nor were they consistent in magnitude within subjects.
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Pulmonary ventilation (VE) values, forced vital capacity (FVC), fraction 
of FVC exhaled in one second (FEV^/FVC), peak expiratory flow-rate (PEFR), 
and maximal mid-expiratory flow-rate (MMEF) in general showed no effects of 
styrene exposure. The investigators [70] stated that decrements in maximal 
expiration values, found in subjects repeatedly exposed for 7 1/2 hours to 
100 ppm styrene, indicated a potential effect on pulmonary mechanics that 
needed further study.
There was no significant variance in cognitive testing scores because of 
styrene exposures. Electrically evoked electromyogram (EMG) configuration 
and latency between stimulus and response were found to be consistent 
throughout the period of study. The subjects were also asked to note on a 
checklist subjective symptoms during the experiment. The overall data 
indicated a dose-response relationship between two subjective symptoms, eye, 
nose, and throat (EyNT) irritation and headache. For the men, the incidence 
of EyNT irritation was 13% at 0 ppm, 17% at 20 ppm, 20% at 100 ppm, 33% at 
exposures fluctuating between 75 and 125 ppm that averaged 100 ppm, and 45% 
at 125 ppm; the incidence of headache was 3% at 0 and 10 ppm, 0% at 100 ppm, 
13% at 100 ppm (fluctuating exposures), and 12% at 125 ppm [70]. There was 
no specific Indication as to which exposure time (i.e., 1, 3, or 7 1/2
hours) the various subjective responses were elicited at a given exposure 
concentration. For the women, the incidence of EyNT irritation was 8% at 0 
ppm and 32% at 100 ppm; the incidence of headache was 0% at 0 ppm and 35% at 
100 ppm.
In 1974, changes in psychomotor function during styrene exposure were 
examined by Gamberale and Hultengren [71]. Twelve healthy men, 21-31 years 
old, were assigned to either of two groups of six. Each group was 
sequentially exposed to styrene vapor for four consecutive 30-minute periods 
at 50, 150, 250, and 350 ppm. The subjects, while at rest, inhaled
styrene-air mixtures through a mouthpiece with very little breathing 
resistance. During the final 20 minutes of each 30-minute exposure period, 
tests of perceptual speed (numerical recognition and numerical sequence), 
simple reaction time, choice reaction time, and manual dexterity were 
given. At some point during each of the five tests, each subject's heart 
rate was recorded.
These same tasks were also performed under control conditions. To 
disguise the introduction of styrene into the exposure chamber and the 
changing concentrations of styrene, the authors [71] began the control 
experiments with a strong smell of styrene still in the mouthpiece, and 
ended with a 3-minute exposure to styrene. Upon completion of each 2-hour 
session, the volunteers evaluated their own conditions. Six pairs of 
contrasting condition descriptions were used: calm/hurried, active/passive,
relaxed/tense, well disposed/ill disposed, unaffected/affected, and 
spry/tired. These were evaluated on 7-point scales in which point 4 
described normal feelings and points 1 and 7 the extremes. At the end of 
the exposure, the subjects felt generally more tense and affected than under 
control conditions. None of the subjects believed that his performance on 
any test during exposure had been impaired [71].
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There were no significant changes from control values in the manual 
dexterity or perceptual tests. However, there were changes in results of 
the reaction time tests. The differences between experimental and control 
values for simple reaction time increased throughout the exposure and with 
the increasing of the styrene concentrations. These differences were 
statistically significant only during exposure at 350 ppm styrene after 
consecutive 30 minute exposures each to 50, 150, and 250 ppm. The
investigators did not employ an experimental design that allowed them to 
distinguish the effects of both exposure time and concentration [71],
In 1974, Oltramare et al. [72] reported their study of the toxicity of 
styrene in man. The study included experiments with six volunteers, three 
of whom had previous occupational exposure to styrene. None of the 
occupationally exposed group had worked with styrene during the 15 days 
prior to experimental exposure. Comprehensive physical examinations were 
given before the studies began.
The results of these examinations were within normal limits except for 
one case of slight anemia. The exposures were conducted in a chamber that 
was 2.6x2x3 m (15.6 cu m); styrene was introduced by blowing air from 
outside the chamber across a styrene vaporizer. The chamber was designed 
with an air intake vent in the ceiling that provided a slight air change in 
the chamber during exposure [72],
Forty-three exposure sessions (1-3 hours each) were held, using one to 
two subjects at a time. Two subjects were exposed to styrene once at 
300 ppm, all six subjects were exposed one or two times at concentrations of 
100 and 200 ppm, and most were exposed at 3-5 ppm and 50 ppm. For 
comparison, five of the six participants were exposed to toluene at 200 ppm, 
and two were each exposed to 1,1,2-trichloro-1,2,2-trifluoroethane at 300 
and 600 ppm.
Psychomotor functions of the three subjects who had been occupationally 
exposed were studied with simple visual, audiovisual, and multiple stimuli 
reaction time tests. The subjects were individually exposed in sessions 
that lasted 90 minutes. All subjects were first exposed at 3-5 ppm of 
styrene to obtain control data. In other exposure sessions at least 1 week 
apart, the subjects were exposed in random order to styrene at 50, 100, and 
200 ppm, and to toluene at 200 ppm. A final exposure session at 3-5 ppm 
styrene was conducted to obtain additional control data. One subject was 
not exposed to styrene at 50 ppm, and data from another subject were not 
obtained for toluene or the final 3-5 ppm session. At each session reaction 
times were determined before, 1 hour after start, and then 30 minutes after 
the exposures [72],
Simple visual reaction times measured during, and 30 minutes after 
exposure at 3-5 ppm were about the same as pre-exposure values. At 50, 100, 
and 200 ppm of styrene, reaction times lengthened by 12-37% during exposure 
as compared with pre-exposure values; half an hour after removal from 
exposure, reaction times in subjects exposed at 200 ppm were still increased
11-35% compared with pre-exposure values [72].
31
The audiovisual reaction time test required the subjects to push a 
button in response to either a green light or a sound. Results obtained 
during exposure were similar to those of the simple visual reaction time 
test, i.e., a drop in performance at exposures to styrene at 50, 100, and 
200 ppm.
The multiple stimulus reaction time test consisted of three visual and 
two auditory stimuli. The 50 ppm styrene concentration had no effect on
performance. The ability of the subjects to perform this diffuse attention
test improved with repeated trials, both during each session and from the
first session to the last. Thus, as the authors [72] commented, an effect
of styrene at 50 ppm, if present, might have been masked by learning 
effects. However, decrements of about 2% were found during and after 
exposure to styrene at 100 ppm and of about 10% during and after exposures 
to styrene at 200 ppm. The functional significance of the decreases in 
performance found in any of the three tests was not discussed [72],
The authors [72] concluded that measurement of reaction time was a more 
sensitive method than vigilance tests for revealing slight effects of 
styrene on higher nervous system functions, and that styrene inhalation 
leads to narcosis. It is not evident whether the same conclusions on the 
relative merits of the two types of tests would have been reached had the 
investigators [72] controlled for the effect of learning rate or the order 
of presentation of tasks.
Equilibrium disorders (loss of balance) during styrene exposure were 
also investigated by Oltramare et al. [72] in three of the six subjects 
using a special platform for quantitative assessment of each subject's 
movements during performance of a modified Romberg test. In each 4-minute 
period, the number of movements was recorded. Statistically significant 
differences between results obtained from 1-hour exposures at 3-5 and 200 
ppm and between 100 and 200 ppm were found, but no differences were found 
between results obtained at 3-5 ppm and those obtained at 100 ppm, 
suggesting a threshold between 100 ppm and 200 ppm at which performance of 
this test was impaired. However, due to the small sample size and the large 
dispersion of data, the authors [72] stated that the results should be 
confirmed with other experiments before drawing any definite conclusions.
Styrene in exhaled and alveolar air was measured in a series of 
experiments with a hydrogen flame ionization hydrocarbon analyzer, and the 
percentage of retained styrene was calculated. Usually two subjects were 
exposed together. To determine alveolar styrene concentrations, the 
subjects were asked to exhale normally into a plastic bag and then make a 
forced exhalation into a tube connected to a hydrocarbon analyzer. The 
average retention was about 64% of the inhaled styrene. A correlation 
coefficient of 0.88 was found between the styrene concentration in alveolar 
air during exposure and that in inspired air. Alveolar air concentrations 
were monitored for several hours after the exposures. At a given exposure 
concentration, the removal of styrene from alveolar air depended on duration 
of exposure. The fat content of the subjects was estimated from
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anthropometric measurements; persons with the greatest estimated amount of 
fat had lower styrene concentrations in alveolar air and longer retention of 
styrene [72].
Urinary mandelate/creatinine ratios were elevated by statistically 
significant amounts (p<0.05) over control values in the two subjects studied 
after 90-minute styrene exposures. However, exposures for 90 minutes at
100, 200, and 300 ppm did not produce differences in mandelic acid
concentrations that were large enough to distinguish between the exposures 
[72]. The six subjects were asked to note the occurrence of 12 symptoms 
during and after the exposures. From all of the experimental exposure 
sessions, a total of 55 reports of individual responses were available for 
analysis (Table IV-3). For each of the 12 symptoms in the table, the number 
of positive responses is presented as the numerator of a ratio. The
denominator is the total number of individual reports for the exposure 
concentration. A given subject could have been tested more than once at a 
given concentration. For example, at 100 ppm there were 13 
subject-exposures(denominator), gastralgia was experienced 3 times 
(numerator). It was not evident from the report whether one subject
experienced gastralgia on three occasions or whether three different 
subjects experienced gastralgia [72].
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TABLE IV-3
NUMBER OF TIMES SYMPTOMS REPORTED/NUMBER OF SUBJECT-EXPOSURES
S tyrene
ppm
Symptom 3-5 50 100 200 300
Irritation
Lips D 0/10 0/6 1/13 2/12 0/2
P 0/10 0/6 0/13 1/12 0/2
Eyes D 1/10 4/6 4/13 7/12 2/2
P 0/10 0/6 1/13 2/12 0/2
Nose D 4/10 3/6 7/13 5/12 1/2
P 2/10 1/6 3/13 2/12 0/2
Gastralgia D 0/10 0/6 3/13 5/12 1/2
P 0/10 0/10 1/13 2/12 0/2
Nausea D 0/10 0/6 5/13 4/12 2/2
P 0/10 0/6 1/13 2/12 0/2
Dizziness D 1/10 1/6 0/13 3/12 0/2
P 0/10 1/6 0/13 2/12 0/2
Headaches D 1/10 3/6 10/13 10/12 2/2
P 0/10 2/6 8/13 9/12 0/2
Sleepiness D 3/10 2/6 12/13 12/12 2/2
P 1/10 1/6 4/13 11/12 2/2
Poor concen­ D 1/10 4/6 9/13 11/12 2/2
tration P 0/10 2/6 4/13 9/12 2/2
Intoxication D 0/10 1/6 2/13 6/12 1/2
P 0/10 1/6 1/13 3/12 0/2
Fatigue D 2/10 4/6 10/13 9/12 2/2
P 2/10 4/6 9/13 9/12 2/2
Mal,aise D 0/10 1/6 7/13 7/12 2/2
P 0/10 0/6 1/13 0/12 0/2
D = occurrences during exposure 
P = persistence after exposure
Taken from 01 tramare et al. [72]
34
Symptoms indicative of narcosis and those referable to the digestive 
tract increased with increasing styrene concentrations. At 50 ppm, the 
investigators 172] reported that about half of the subjects experienced what 
was described as prenarcotic discomfort. The frequency of eye irritation 
generally increased with styrene concentration, but the other symptoms of 
irritation did not.
When subjects who had worked with styrene were compared with those 
without occupational exposure, it appeared that the styrene workers had 
become accustomed to some styrene effects. With the exception of symptoms 
of irritation, the symptoms noted were consistently fewer for the subjects 
with previous styrene exposures than for the other subjects. The workers 
previously exposed to styrene reported irritation at 3-5 ppm, and Oltramare 
et al. [72] considered that the greater degree of discomfort of the eyes, 
nose, and mouth may have been due to chronic inflammation from working with 
styrene. Oltramare et al. [72] also concluded that the nervous systems of 
the subjects with previous styrene exposure were either less sensitive than 
those of other subjects or that the subjects occupationally exposed to 
styrene in the past had become accustomed to the effects of styrene.
Subjects who had not been previously exposed to styrene complained of 
eye irritation, headaches, sleepiness, difficulty in concentrating, and 
fatigue when exposed at 50 ppm. When exposed at 100 ppm, they also 
complained of gastralgia, nausea, and malaise. The authors [72] cautioned 
that their studies were preliminary and based on an insufficient number of 
subjects.
In 1979, Odkvist et al. [73] reported the experimental study of five 
men, 22-34 years old, exposed to styrene at 300 ppm for 1 hour. The 
volunteers had no history that indicated disease of the nervous system, 
eyes, or ears. The exposure took place via a breathing valve during light 
exercise (50 Watts) on a bicycle ergometer with no significant 
electrocardiogram (ECG) changes recorded. The ability of the eyes to follow 
a stripe pattern (passing at a rate of 40 angular degrees per second) in an 
optokinetic test, immediately after styrene exposure, deteriorated in all 
five test subjects, although not significantly more so than in controlled 
experiments with no styrene exposure. No positional nystagmus, fixation 
nystagmus, or balance disturbance (standing on one leg with eyes closed and 
walking on a line with eyes closed) was observed in any of the test 
subjects. The mean concentration of styrene in the blood after 1 hour of 
exposure was 8.7 mg/kg. The authors [73] interpreted the deterioration of 
the eye's capability to follow an object as a styrene effect that decreased 
the inhibitory effect of the cerebellum on the motor function of the eyes.
Clinical Studies
Clinical studies of workers exposed to styrene can be classified by the 
relative extent to which effects are likely to be due to styrene. In the
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production of polystyrene, occupational exposures are almost entirely to 
styrene. In plants that produce styrene monomer, there may also be exposure 
to benzene and ethylbenzene. In plastics applications such as reinforced 
plastics/composites (RP/C) where styrene is a solvent-reactant for 
copolymerization, styrene is the major air contaminant; however, there are 
concomitant exposures to fibrous glass, catalysts, accelerators, cleaning 
solvents, and other chemicals. In many of the RP/C applications, the 
operations involve potential contact of the skin with liquid styrene. During 
SBR production, workers are exposed to numerous ingredients and emissions 
(during vulcanization and curing) besides low levels of styrene. Thus, the 
likelihood that observed toxic effects are due to styrene exposure alone is 
greatest in the production of polystyrene, less in the production of styrene 
and reinforced plastics, and even less in SBR production.
(a) The Production of Styrene and Polystyrene
In 1963, an industry-wide retrospective study of morbidity with 
temporary loss of work among 1,240 workers from five Russian factories was 
conducted by Troshina [74], Styrene, styrene-containing latex, polystyrene, 
and synthetic rubber were produced in four of the factories; styrene 
concentrations were not reported. In the fifth factory, products were made 
from polystyrene, which resulted in exposures to only "traces" of styrene. 
A comparison group consisted of workers with no styrene exposure from 
auxiliary shops in one factory. Only data from workers employed for at 
least a year were considered.
In general, liver and gall bladder illness were the main diseases 
recorded; Troshina [74] found that the morbidity rate among women was about 
twice that of the men. Details are presented in Table IV-4. Morbidity due 
to liver and gall bladder illness increased with increasing length of 
employment. However, due to the lack of exposure data, the cause of the 
reported effects is unknown.
3 6
TABLE IV-4
MORBIDITY DUE TO LIVER AND GALL BLADDER ILLNESS 
IN WORKERS WITH EXPOSURE TO STYRENE
Percentage of Workers with Illness
Factory Men Women Total
Styrene production 3.0 5.7 4.7
Production of styrene-containing 3.2 6.7 4.8
latex
Polystyrene production 5.4 11.9 10.5
Fabrication of polystyrene products 0.0 0.7 0.5
Rubber production 2.6 4.0 3.3
Auxiliary shops (control) 1.3 2.0 1.5
Taken from Troshina [74]
In 1978, several clinical studies of workers in a styrene and 
polystyrene production plant in the Federal Republic of Germany were 
published by Theiss and Friedheim [75], Fleig and Theiss [76], and Theiss 
and Fleig [77]; Frentzel-Beyme et al. [78] also reported in 1978 on a 
retrospective cohort mortality study (which will be discussed in the 
Epidemiological Studies Section) at this same facility. Operations in the 
plant began in 1931, but what were described as considerable improvements in 
equipment and safety precautions were made about 1960. Only closed systems 
were in use at the time of the report. It is assumed that these changes led 
to a significant decrease in the styrene concentration, but comparative data 
were not given. Concentrations of styrene as high as about 50 ppm were 
found around some equipment. However, workers were seldom present in these 
areas. In areas where workers were frequently present, styrene 
concentrations in excess of 1 ppm were seldom found and were always less 
than 10 ppm. Styrene concentrations were determined in 1975 and 1976 by gas 
chromatography, and the techniques used had a lower limit of detection of 
0.01 ppm styrene.
Mandelic acid concentrations in urine of the styrene-exposed workers 
were determined by the gas chromatographic method of Engstrom and Rantanen 
[79], as described by Schaller et al. [80]. Concentrations of mandelic acid 
in urine were less than 50 mg/1 in 61 of 67 styrene and polystyrene 
production workers, and greater than 100 mg/1 in 3 of the remaining 6. The 
data were presented only in bar graph form, and the maximum value was not 
reported. However, as will be discussed in a later section (see Figure V-l, 
p. 141), mandelic acid concentrations of 200 mg/1 correspond to 8-hour TWA 
exposures of about 10 ppm.
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In the morbidity study at this plant [75] there were 84 workers who had 
been engaged in styrene production for 1-36 years, 93 workers who had been 
engaged in polystyrene production for 1-38 years, and 62 control subjects 
with similar ages. In 1975-1976, the numbers of days lost through sickness 
were no greater for styrene and polystyrene workers than for all workers at 
the factory, and accident rates were no greater than for all production 
workers. There were no significant findings from examination of medical 
records or from physical examinations that included chest roentgenograms and 
measurements of vital capacity. Laboratory tests included CBC, thrombocyte
count, measurement of activities of serum glutamic-oxaloacetic transaminase
(SGOT), gamma-glutamyltranspeptidase (GGTP) (also known as 
gamma-glutamy1transferase), lactic dehydrogenase, SGPT, and alkaline
phosphatase, measurement of total bilirubin, albumin, erythrocyte
sedimentation rate, thymol turbidity, and creatinine and urea
concentrations. Although unusual values were occasionally found among the
test results, there were no statistically significant differences in the 
frequencies of their occurrence between the exposed workers and the 
unexposed controls.
Studies of chromosomes from lymphocytes of workers exposed to styrene at 
this German plant were reported in 1978 by Fleig and Thiess [76] and Theiss 
and Fleig [77]. A reference group of 20 men from the same factory, but not 
exposed to styrene, was used for comparison with each group of workers 
studied. Five workers engaged in the production of styrene had a slightly 
lower frequency of aberrant cells than the reference group (1.6% vs. 2.1%). 
Twelve workers who had spent 19-39 years in the production of polystyrene 
also had a lower rate of aberrations than the reference group (1.9% vs. 
2.1%).
There have been a number of reports [58,81,82,83,84,85,86,87] on studies 
of workers in one U.S. plant that manufactured styrene and polystyrene. 
Sixty-five personal charcoal tube samples for organic vapors were collected 
during surveys in 1973 by Maier et al. [84]. All but 10 of the styrene 
concentrations were less than 5 ppm, and all but one were less than 20 ppm. 
Six benzene samples were in the range of 10-50 ppm, two were between 5 and 
10 ppm, and 43 were less than 1 ppm with 34 of those being below the limit 
of detection. The highest concentration of ethylbenzene was 4 ppm. Except 
for 3 of 65 toluene samples being 212-262 ppm, toluene was present at less 
than 10 ppm. Acetone was present in 8 samples at 3-10 ppm. There were 
traces of pentane (used as a blowing agent) in 15 samples. The highest 
concentrations of styrene, benzene, and toluene resulted from spills and 
leaks. Of 34 detector tube samples, one indicated a high benzene 
concentration (30-60 ppm) and one indicated a high toluene concentration 
(300-400 ppm) after a spill of a benzene-toluene solution in the benzene 
building; the benzene concentration determined by a detector tube sample in
this building the next day was 15 ppm [84].
One of the five samples of respirable dust (7.6 mg/cu m) measured in the 
polystyrene screening area was above the OSHA limit of 5 mg/cu m. 
Tricalcium phosphate personal respirable dust samples taken in the
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polystyrene screening area contained 8.3 and 4.5 mg/cu m, respectively. 
Coal dust concentrations in the power house were 1.2, 1.8, 5.0, and 11.9 
mg/cu m. The highest dust concentration occurred when fly ash was loaded 
into a truck. The sample of cadmium sulfide dust collected from the 
breathing zone of a worker who weighed cadmium sulfide pigments was 0.023 
mg/cu m [84].
When the workers in this factory were studied in 1975 
[58,81,82,83,85,86,87], environmental measurements were not made. However, 
environmental samples collected in early 1976 by the company and reported by 
Wolff et al. [85] indicated that exposures of styrene polymerization workers 
were similar to those found in 1973 by Maier et al. [84], and that exposures 
to styrene during copolymer production and styrene purification may have 
increased.
Styrene was not detected by spectrophotofluorometry (lower detection 
limit of 2 ng/1) in the blood of 244 of the 364 workers; the highest
concentration found was 90 ng/ml [86]. By comparison, Stewart et al. [69]
found 910 ng styrene/ml of blood in test subjects exposed for 7 hours at 99
ppm styrene, and Astrand et al. [88] found 300 ng styrene/ml of blood in
test subjects exposed to styrene for 30 minutes at 50 ppm.
Various hydrocarbons in fat samples taken by needle aspiration were 
determined by gas-liquid chromatography and gas-liquid chromatography/mass 
spectrophotometry [87], Styrene concentrations of 0.1-1.2 yg/g of fat were 
found in 13 of 25 workers, all 13 whose last exposure to styrene was 3 days 
or less before the fat samples were taken. No styrene was found in fat
samples taken from the remaining workers whose exposure to styrene was
either low or had occurred more than 3 days before the fat sampling.
Urinary mandelic acid was determined by the gas chromatographic method 
of Buchet et al. [89]. Mandelic acid concentrations were below the limit of 
detection (10 mg/g of creatinine) in 341 of 477 urine samples [86], The
highest mandelic acid concentration was 140 mg/g of creatinine. By 
comparison, Philippe et al. [90], using the same method, found mandelic acid 
at about 250 mg/g of creatinine in urine collected at the end of the
workshift from workers exposed at 7-26 ppm. Other investigators [91,92] 
using other gas chromatographic methods found that a mandelic acid 
concentration of 140 mg/g of creatinine was associated with TWA exposures of 
workers to styrene at 7.5-15 ppm. In summary, the mandelic acid, and blood 
and fat styrene data [85,86,87] indicated that TWA exposures to styrene were 
probably less than 10 ppm.
Toluene was detected in 16 of 25 workers, but in measurable amounts of 
0.2-0.3 ug/g of fat in only 3. Benzene was detected in three workers, but 
not in measurable amounts. Ethylbenzene was found in fat samples from 21 of 
25 workers at concentrations of 0.1-0.7 yg/g. Although the workers were 
never exposed to ethylbenzene at airborne concentrations greater than 4 ppm, 
ethylbenzene was found in 84% of the fat samples, and traces were found as 
long as 90 days after exposure. A gas-liquid chromatographic peak that had
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a retention time identical to that of 1-phenylethanol, a possible metabolite 
of both styrene and ethylbenzene, was found in the analysis of fat from all 
seven polymerization workers. However, the presence of 1-phenylethanol was 
not confirmed by other methods [87],
According to Maier et al. [84], company policy required that white blood 
cell counts (WBC) and hemoglobin and hematocrit determinations be made every 
6 months for each worker in areas where benzene exposure was possible. 
Reports from the previous year were examined, and on eight occasions 
abnormal results consistent with benzene poisoning were found. However, 
when the individuals were retested, either these results were not confirmed 
or a cause other than benzene exposure was found. Based on their evaluation 
of the available medical information, Maier et al. [84] concluded that there 
was no evidence of chronic benzene effects among the workers.
Other investigators [81,82] conducted clinical studies on 494 workers 
from this plant. Styrene exposures were classified as high or low on the 
basis of job information and environmental data obtained from the employer 
[85] and environmental data reported by Maier et al. [84], Hemoglobin 
concentrations in 14% of the workers were below 14 g/100 ml of blood; 3% had 
a WBC below 4,800 [82], The low values were randomly distributed with
respect to duration and extent of exposure. Activities of serum alkaline 
phosphatase, SGPT, GGTP, and SGOT, and the concentrations of serum bilirubin 
were determined. Only GGTP activity demonstrated a significant relationship 
to styrene exposure with about 3% of the values greater than 45 
international units in low exposure workers and 7% in high exposure workers.
Lilis et al. [81] and Lorimer et al. [82] also studied effects on the 
nervous system. Prenarcotic symptoms had been experienced by about 10% of 
the workers in the low styrene exposure group and 19% of those in the high 
exposure group. Prenarcotic symptoms were reported most frequently by 
workers exposed more than 7 years. Among 412 workers who had no history of 
diabetes, back injury, or significant alcohol consumption, distal 
hypoesthesia (decreased sensitivity to touch) of the lower extremities and 
hypoactive deep tendon reflexes were found more frequently as duration of 
exposure increased. Distal hypoesthesia of the lower extremities was found 
in 4.1% of those who had worked 0.1-7.0 years, in 5.4% of those who had 
worked 7-20 years, and in 8.5% of those who had worked more than 20 years. 
Lilis et al. [81] did not differentiate between high and low exposure groups 
and did not say whether an effect of the workers' ages was considered. 
Because duration of exposure probably correlated with age, the effect might 
have been age-related rather than exposure-related.
Radial nerve conduction velocities were studied in 80 of the workers, 
and peroneal nerve conduction in 73 workers; workers with a history of 
diabetes, back injury, or significant alcohol consumption were excluded. 
Radial nerve conduction velocities of less than 55 meters per second (m/s) 
were found in 15 workers, but there was no relation to the duration or 
intensity of exposure to styrene. Peroneal nerve conduction velocities were
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less than 40 m/s in 12 of 63 workers with more than 7 years of exposure and 
in none of 10 workers with less than 7 years. The mean peroneal nerve 
conduction velocities decreased with duration of exposure, but the decreases 
were not statistically significant and were not related to the intensity of 
exposure. Lilis et al. [81] did not give data concerning normal nerve 
conduction velocities, although it appears that neither 55 m/s for the 
radial nerve nor 40 m/s for the peroneal nerve is an abnormally low value, 
at least without making adjustment for age. The mean age of those with 
slower nerve conduction velocities was greater than that of those with 
velocities described as normal, but the age difference was not statistically 
significant.
Kohn [58] reported the results of a screening ophthalmological 
examination of 345 of the styrene-exposed workers. Styrene exposures 
averaged approximately 5 ppm. No evidence of optic neuritis or retrobulbar 
neuritis was found. Several workers gave a history of having had styrene 
beads embedded in their corneas, and one worker complained of beads embedded 
in the eyelid after a valve had burst. Conjunctival irritation related to 
styrene exposure occurred in 22% of the workers. The irritation was noted 
commonly at styrene concentrations above 50 ppm.
In respiratory system studies of these workers by Lorimer et al. [82], 
it was found that 19% of the high exposure group had experienced wheezing or 
tightness of the chest, compared with 7% of those in the low exposure 
group. These symptoms occurred weekly or monthly in about 12% of the high
exposure group compared with symptoms occurring in about 5% of the low
exposure group. However, spirometric studies of airway effects did not 
suggest significant changes, nor was there any radiologic evidence of 
significant lung change observed.
In 1971, Ponomareva and Zlobina [93] reported on workers in a Russian 
factory engaged in the production of block and emulsion polystyrene and
styrene-aerylonitrile (SAN). The investigators examined 236 workers; 120 
were engaged in the production of block polystyrene, 56 in emulsion 
polystyrene production, and 60 in copolymer production. Eighty percent of 
the workers were women, and most workers were 30-49 years of age.
The 120 block polystyrene production workers were divided into three 
groups: (I) those involved with the polymerization of styrene, where
concentrations of styrene were occasionally as high as 5 ppm; (II) workers 
involved with polystyrene film and filament production, where they were 
exposed to styrene only 25-50% of the time at concentrations below 1 ppm, 
but at temperatures of 30°to 40°C; and (III) auxiliary and technical workers 
who had short, intermittent exposures to styrene (concentrations were not
specified) [93].
The 56 workers involved in the emulsion production of polystyrene were 
also divided into three groups. Because styrene concentrations were usually 
below 1 ppm but polystyrene dust concentrations of 8-12 mg/cu m were 
frequent in the drying and packaging rooms, the groupings were based on
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concentrations of polystyrene dust. The groups were: (I) workers engaged
in polymerization, sedimentation, and centrifugation; (II) drying and 
packaging workers; and (III) a group of miscellaneous workers who 
experienced only brief contact with styrene vapor and polystyrene dust. 
Workers in Group I (polymerization) were occasionally exposed to styrene 
concentrations above 1 ppm. For the other groups, styrene concentrations 
were generally less than 1 ppm [93].
The 60 workers engaged in SAN manufacture were exposed to styrene at 
concentrations below 1 ppm. In certain operations the concentration of 
acrylonitrile exceeded 0.2 ppm [93].
In each case within the individual production units, it was those 
workers in the groups engaged in the polymerization process, i.e., groups 
designated I, who were exposed at the highest styrene concentrations. No 
additional information was presented about exposures, such as sampling and 
analytical methods, frequency of sampling, number of samples taken, or the 
number of workers in each subgroup.
Upon examination of the workers who complained of frequent sore throats, 
Ponomareva and Zlobina [93] found that most workers had a history of sore 
throats before employment at the facility. However, the frequency of this 
complaint increased after employment. About 29% of the workers from Groups 
I and II of the block polystyrene production unit and 21% of the workers 
from Group I of the emulsion polystyrene unit had tonsillitis with a high 
fever 4-8 times a year.
Workers involved in block polystyrene production had a significantly 
higher incidence of upper respiratory tract complaints than those workers 
who had only intermittent contact with either styrene vapor or polystyrene 
dust. Those workers with only occasional exposure to styrene vapor and 
polystyrene dust had a frequency of respiratory complaints no different from 
that of the population of the adjacent town. However, the incidence of 
respiratory complaints among the residents of the adjacent town was not 
reported, nor was the time of year when the study was conducted [93],
In the workers engaged in block polystyrene production for more than 5 
years, there was a high frequency of dry, pale mucosa in the nose, the 
pharynx, and occasionally the larynx, which the investigators [93] thought 
might make these workers more susceptible to respiratory infection. These 
mucosal changes were found in 78% of those workers who had been exposed to 
styrene at 5 ppm periodically during their workshift (Group I), and among 
those workers exposed at less than 1 ppm for 25-50% of their workshift for 
more than 5 years (Group II). Ponomareva and Zlobina [93] speculated that
high temperatures (30°to 40°C) contributed to the effects observed in the
Group II workers. In some cases the mucosa was covered with a viscous
muco-purulent secretion, and nosebleeds were reported. Ponomareva and
Zlobina [93] diagnosed chronic inflammation of the nasal mucosa with atrophy 
of the mucous membranes in about 68% and chronic tonsillitis in about 39% of 
these workers.
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Dystrophic upper respiratory changes similar to those found in the block 
polystyrene workers were found in about 45% of the workers in Group II of 
the emulsion polystyrene unit workers. Workers in the emulsion polystyrene 
production unit were found to have the mucosa of their noses and throats 
covered with polystyrene dust. However, there were fewer complaints in the 
emulsion polystyrene department, and fewer diagnoses of upper respiratory 
disease. The exception were workers of Group I where styrene concentrations 
were occasionally above 1 ppm [93].
High concentrations of polystyrene dust and elevated environmental 
temperatures may have been responsible for some of the health effects noted 
in the workers. In addition, the absence of any description of how the 
investigators assessed the working environment makes impossible an 
evaluation of this report in terms of the effect of styrene at various 
concentrations. The investigators [93] concluded that the workers who had 
the lowest exposure to styrene, heat, and polystyrene dust had a lower
incidence of upper respiratory complaints.
In 1963, Zlobina [94] reported a study of 40 workers selected at random 
from two departments of a Russian polystyrene production facility. Styrene 
was the only contaminant present in significant amounts. In the block 
polystyrene production department, the styrene concentration (measured in
the winter and summer of 1962) ranged from 0.5-2 ppm. The second 
department, emulsion polystyrene production, had styrene concentrations of 
1-2 ppm; during the cleaning of process equipment, styrene concentrations 
frequently exceeded 12 ppm.
The morbidity rates, based on illnesses with absence from work, showed 
an increase in conditions ascribed to the liver and bile duct among workers 
in the two departments responsible for polystyrene production, compared with 
the rate for the entire factory (see Table IV-5). The lack of the
diagnostic criteria used for determining liver and bile duct morbidity or
information concerning the workers' personal habits, such as alcohol 
consumption, makes it difficult to interpret these results.
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TABLE IV-5
MORBIDITY OF POLYSTYRENE PRODUCTION WORKERS 
COMPARED WITH REST OF FACTORY
Morbidi ty*
1959
(per 100 Workers) 
1960 1961
Total factory 1.7 2.7 2.1
Block polystyrene
produc tion 6.7 9.7 7.5
Emulsion polystyrene
production 2.9 6.4 5.5
*Based on indicators of liver and bile duct disease
Taken from Zlobina [94]
The average blood pressure of twenty workers in the block polystyrene 
department was found to drop continually during the workweek from 105/65.7 
to 93/57.5 mm Hg, while workers from the emulsion polystyrene production 
department exhibited a blood pressure decrease from 104.4/64.4 mm Hg to 
92.8/57.2 mm Hg. Such changes were not seen in an undefined comparison 
group of workers similarly observed. When the workers returned to work 
after a day off, their blood pressures had returned to the initial values. 
However, the initial values were not reported, and it is not known why the 
systolic and diastolic pressures were so low. In addition, Zlobina [94] 
reported that 38% of the 40 workers had frequent headaches and subcostal 
(below a rib) pain on the right side, 44% expressed symptoms of irritation 
of the mucous membranes of the upper respiratory tract, and about 20% had 
pains in the epigastric and heart regions.
In 1975, Zlobina et al. [95] reported the results of a study of 110 
women workers at a Russian polystyrene plant where the concentrations of 
styrene were about 1 ppm. Other volatile components were present in only 
trace amounts. The sampling and analytical methods used were not given. 
The investigation included a questionnaire, in-depth gynecological 
examinations, and inspection of individual clinic cards and birth 
histories. The control group was composed of 231 female workers in the 
plant management and children's group who had no previous industrial contact 
with chemical substances. To ascertain group comparability, the 
social-domestic factor was investigated by means of a questionnaire which 
included education, income, length of holidays, number of children, use of 
pre-school nurseries, time spent on housework, and time spent traveling to 
work. There were no significant differences between thte groups of workers 
and controls on the criteria selected. Both groups were divided according 
to work experience and age.
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An analysis of extragenital disease revealed a high incidence of
gastrointestinal diseases (not specified) in the workers as compared to the
control group. Gynecological examinations were given and there were no
significant differences with respect to inflammatory diseases of the cervix 
or vagina, infertility, benign tumors, or deviation of internal sex organs. 
The styrene workers' incidence of inflammatory diseases of the uterus and 
appendages (12.7% vs. 4.7%) and the incidence of disorders in menstrual 
function (29.1% vs. 9.1%) significantly differed from the controls. Ten
women complaining of disorders in menstrual function were examined by the 
colpocytological method which showed moderate estrogen insufficiency in five 
and pronounced insufficiency in two of them. No disorders in estrogen
saturation were found in the other three women examined, although a 
hypermenstrual syndrome was observed in one of them [95].
The reproductive function of 67 female workers and 70 women in the
control group was evaluated. There were no significant differences between 
the groups in the number of pregnancies, births, or induced or spontaneous 
abortions. Toxemias were more frequent in the first half of pregnancy in the 
experimental group (49.2% vs. 18.5%). Of the toxemias, nephropathy was 
observed significantly more often in the second half of pregnancy in the
experimental group (10.4% vs. 1.4%).
In 1978, Veretinskaya et al. [96] examined hepatic function in 370
workers in three Russian polystyrene production plants. Industrial hygiene 
surveys at one of these plants 3 years after work began there showed that 
styrene concentrations varied considerably, but on the average did not
exceed 1 ppm. Other workroom air contaminants were isopentane, 
benzaldehyde, benzene peroxide, and formaldehyde; all were within
recommended concentration limits. The second plant had airborne 
concentrations of styrene stated as "not significantly exceeding 1 ppm."
There were 20 workers examined from a third plant. This plant, since
closed, had work conditions stated to be "unfavorable."
In the first plant, 22% of the workers had elevated bilirubin, caused in 
50% of the cases by the free bilirubin fraction, in 30% by the conjugated 
fraction, and in 20% by an increase in both fractions. In a few cases (8%), 
beta-lipoprotein concentrations in blood serum were elevated. Studies of 
SGPT activities were unrevealing. Workers known to have hepatobiliary 
disease or to be alcoholic were excluded from testing. In the second plant, 
there were increases in beta-lipoprotein and SGPT, but not in bilirubin. 
However, while these changes were significant in terms of comparison with 
the control group, they did not exceed the physiological limits of 
variability [96].
In one shop in the third plant, 29% of the workers had bilirubin levels 
above normal limits and there was a slight and apparently insignificant 
number of workers with elevated levels of beta-lipoproteins. Enlarged 
livers were found in 6 workers, and pain in the area of the gall bladder was 
noted in 20% of those examined. In another shop in this plant, styrene 
concentrations had at one time exceeded the maximum permissible
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concentration (MPC) of 1 ppm several hundredfold, but more recently styrene 
concentrations had been reduced in most places to less than the MPC. In 
this shop, there were elevated serum bilirubin concentrations in 20% of the 
examinees, elevated beta-lipoproteins in an unstated number (but not beyond 
physiologic limits), and an increase in SGPT in 13%. Leukopenia, stated to 
be a characteristic effect of styrene exposure, was found in 30% of these 
workers and in 18% of the controls; almost identical incidences of moderate 
leukopenia had been found in workers in the first plant and in their 
controls.
There were various effects attributed to functional changes in the 
liver. These changes did not reach pathological proportions in the majority 
of the cases; however, the changes suggested to Veretinskaya et al. [96] 
definite metabolic disturbances in the liver cells. The relationship of 
styrene to these effects is difficult to evaluate in this study because of 
the similarity in responses in areas with airborne styrene exposures 
believed almost always to be below the MPC (1 ppm) and in other areas with 
styrene exposures exceeding the MPC several hundredfold.
(b) Plastics Applications (Mainly Production of RP/C)
A clinical study of two factories in Czechoslovakia where reinforced 
plastics were made was reported in 1960 by Bardodej et al. [97], In both 
facilities the styrene polyester resin was applied to wooden molds by hand; 
in one factory, however, the resin was sometimes sprayed on. Regular 
medical examinations (not specified) were given to the workers for a 3-year 
period.
Apparently, area rather than breathing zone air samples for the 
determination of styrene were collected on numerous occasions during an 
entire workshift in various work areas and analyzed by UV spectrophotometry 
[98], spectrophotometry after nitration [98], and polarography after 
formation of alpha-nitroso-beta-nitroethylbenzene [99]. The method of 
collection was not specified. The styrene concentrations found averaged 
about 50 ppm.
The investigators [97] measured benzoic acid and phenol in urine 
collected at the end of the workshifts from 58 workers and 23 controls. 
Elevated concentrations of substances measured as benzoic acid were 
demonstrated (800 vs. 400 mg/1). In a later publication, Bardodej and
Bardodejova [100] stated that, with the analysis method used, both hippuric 
acid and mandelic acid were oxidized to benzoic acid. No increases in 
urinary phenols were found. There were no major medical findings in the 
RP/C workers except for four cases of dermatitis that were attributed to 
other agents. All but five of the workers reported developing increased 
fatigue and drowsiness toward the end of the workshift.
In 1972, Dzyuba [101] published the results of an investigation of a 
Russian reinforced plastics plant. Three groups of workers were evaluated 
over a 3-year period for neurological dysfunctions. Group I consisted of 70
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concentration (MPC) of 1 ppm several hundredfold, but more recently styrene 
concentrations had been reduced in most places to less than the MPC. In 
this shop, there were elevated serum bilirubin concentrations in 20% of the 
examinees, elevated beta-lipoproteins in an unstated number (but not beyond 
physiologic limits), and an increase in SGPT in 13%. Leukopenia, stated to 
be a characteristic effect of styrene exposure, was found in 30% of these 
workers and in 18% of the controls; almost identical incidences of moderate 
leukopenia had been found in workers in the first plant and in their 
controls.
There were various effects attributed to functional changes in the 
liver. These changes did not reach pathological proportions in the majority 
of the cases; however, the changes suggested to Veretinskaya et al. [96] 
definite metabolic disturbances in the liver cells. The relationship of 
styrene to these effects is difficult to evaluate in this study because of 
the similarity in responses in areas with airborne styrene exposures 
believed almost always to be below the MPC (1 ppm) and in other areas with 
styrene exposures exceeding the MPC several hundredfold.
(b) Plastics Applications (Mainly Production of RP/C)
A clinical study of two factories in Czechoslovakia where reinforced 
plastics were made was reported in 1960 by Bardodej et al. [97], In both 
facilities the styrene polyester resin was applied to wooden molds by hand; 
in one factory, however, the resin was sometimes sprayed on. Regular 
medical examinations (not specified) were given to the workers for a 3-year 
period.
Apparently, area rather than breathing zone air samples for the 
determination of styrene were collected on numerous occasions during an 
entire workshift in various work areas and analyzed by UV spectrophotometry 
[98], spectrophotometry after nitration [98], and polarography after 
formation of alpha-nitroso-beta-nitroethylbenzene [99]. The method of 
collection was not specified. The styrene concentrations found averaged 
about 50 ppm.
The investigators [97] measured benzoic acid and phenol in urine 
collected at the end of the workshifts from 58 workers and 23 controls. 
Elevated concentrations of substances measured as benzoic acid were 
demonstrated (800 vs. 400 mg/1). In a later publication, Bardodej and
Bardodejova [100] stated that, with the analysis method used, both hippuric 
acid and mandelic acid were oxidized to benzoic acid. No increases in 
urinary phenols were found. There were no major medical findings in the 
RP/C workers except for four cases of dermatitis that were attributed to 
other agents. All but five of the workers reported developing increased 
fatigue and drowsiness toward the end of the workshift.
In 1972, Dzyuba [101] published the results of an investigation of a 
Russian reinforced plastics plant. Three groups of workers were evaluated 
over a 3-year period for neurological dysfunctions. Group I consisted of 70
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workers whose primary exposure was to styrene; Group II comprised 30 workers 
exposed primarily to phenol and aniline. Occupational exposure levels were 
not given. Fifty workers from an instrument manufacturing facility served 
as a control group. Results of these neurological examinations are 
presented in Table IV-6.
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TABLE IV-6
RESULTS OF NEUROLOGIC EXAMINATION OF WORKERS EXPOSED TO STYRENE
Percent With Positive Findings
Type of Findings
Group I 
S tyrene
Group II 
Phenol/Aniline Controls
Subjective findings
Constant headache increasing 97 30 8
throughout the day with fatigue 
and sleepiness increasing after 
workshif t
Nausea, dizziness, heart pain 66 20 2
Objective findings
Emotional instability 91 60 10
Asthenia (weakness) 23 ★ 4
Cerebral nerve insufficiency 26 10 *
Unsteadiness in Romberg test 69 * *
Finger tremors of extended hand 61 20 4
Increased tendon reflexes 100 33 16
Anisoreflexia 11 * *
Sympathetic nervous system suppression 100 * *
*Data was not given 
Taken from Dzyuba [LOI]
Among Group I workers, a so-called asthenic-vegetative syndrome was 
observed in 22% in the first year, 64% in the second year, and 92% in the 
third year [101]. This neurasthenic syndrome was found in 52% of Group II 
(workers exposed to phenol and aniline) and in 5% of the controls. When the 
workers in Group I returned to work after having several days off, only a 
slight decrease in the manifestation of this condition was noticed, but it 
substantially decreased or disappeared in Group II workers.
In a factory in France where electronic filters for washing machines 
were produced, Bernard [102] in 1966 found evidence of blood abnormalities 
and CNS disturbances in workers. The filters were made by placing a 
resistor and a capacitor in a flexible plastic mold filled with a solution 
of polyester in styrene monomer. No information was presented concerning 
airborne concentrations at the time of the study, but after the introduction 
of ventilation equipment that changed the room air 50 times per hour, 
breathing zone concentrations of styrene were 40 ppm for workers who molded
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parts and 100 ppm for those who removed the mold. Sampling and analytical 
methods were not described, nor were concentrations of trichloroethylene 
used as a cleaning solvent reported [102],
The workers encountered few skin problems, but used a skin cream to 
prevent skin dryness. There were, however, frequent reports of anorexia, 
asthenia (weakness), and headache. One worker also complained of nausea, 
vomiting, gastralgia, and vertigo. Subicteric conjunctivitis, slight 
leukopenia, neutropenia, lymphocytosis, and a slight anemia were found in 
this worker. Three other workers had severe anemia (red blood cell count 
(RBC) was about 3,000,000) that disappeared rapidly after the workers were 
given jobs away from possible styrene exposure [102]. Whether these effects 
preceded or followed installation of controls was not reported, though it 
seems likely that they were the motivation for the changes. Because of the 
absence of precise information concerning this sequence of events, this 
study cannot be used to help establish a recommended exposure limit.
Studies of four workshops in Sweden where reinforced plastics were 
produced were reported in 1972 by Gotell et al. [35] and by Axelson and 
Gustavson [103] in 1978. The 17 male workers studied had a median age of 28 
years (range, 21-57 years) and duration of styrene exposure ranging from a 
few days to 12 years. Procedures used to manufacture reinforced plastic 
products involved coating wooden molds with wax, covering the molds with 
fibrous glass, and applying the styrene-modified polyester resin by either 
hand rolling or a combination of spraying and hand rolling. Based on their 
observations, Gotell et al. [35] judged the skin absorption of styrene under 
these conditions to be fairly low. The studies were conducted in the spring 
and fall so that the workers could be examined during moderate climatic 
conditions. Measurements were taken on a day in the middle of the week.
Styrene concentrations in the workers' breathing zones were determined 
by several methods. In two factories, the samples were collected for 
30-minute periods in impingers containing ethanol and analyzed by gas 
chromatography; in another factory, air was sampled simultaneously by 
absorption in ethanol and analyzed by gas chromatography, by colorimetric 
indicator tubes, and by a combustible gas indicator. In the other factory, 
samples were collected for 24-66 minutes on charcoal and analyzed by gas 
chromatography. Although Gotell et al. [35] reported that some workers were 
exposed at 500-800 ppm for certain 1-hour periods, the 8-hour TWA exposure 
concentrations calculated for each worker ranged from 17-292 ppm. However, 
due to the nature of these processes, high concentrations of styrene vapor 
were often briefly encountered; in this study, concentrations of about 1,500 
ppm were found for periods of 5-10 minutes. The workers were divided into 
three groups based on TWA exposures to styrene: (I) 235-292 ppm, (II) 89-139 
ppm, and (III) 17-32 ppm.
All workers were given a brief neurological examination that included an 
evaluation of the knee and Achilles tendon reflexes, pupillary light
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reflexes, and vibration sensibility; results of these tests were all 
normal. A modified Romberg test (one foot in front of the other) was given 
before and after work. Two workers showed a slightly unsteady Romberg test 
in the morning before work but not after exposure. A comparison group of 17 
men from a motor workshop matched in age to the study group was used for the 
reaction time test. Reaction times of workers exposed to styrene at 
concentrations greater than 235 ppm were longer than those of workers 
exposed at less than 139 ppm and those of the age-matched control subjects, 
but statistical treatment of these data was not described. Differences 
between pre- and post-shift reaction time measurements were not significant 
in any group [35],
Lung function tests consisting of forced expiratory volume in one second 
(FEV^) and vital capacity were normal in the morning and did not change 
during the day [35,103], Blood samples were taken from 35 male workers in 
one plant, who had been exposed to less than about 100 ppm styrene. When 
compared with a group of 12 healthy males in a manufacturing industry, 
elevated levels of the liver enzymes aspartate-amino-tranferase (ASAT) and 
alanine-amino-tranferase (ALAT) were found in the styrene workers [103],
Complaints of irritation of the eyes and nasopharynx were common [35]. 
The concentration of styrene giving rise to these complaints varied from 
person to person. The tolerance to the irritant effects of styrene vapor 
may increase with exposure time, because workers complained of only minor to 
moderate irritation during exposures at 500-800 ppm for several hours, while 
the investigators [35] who were in the plant only during the study could not 
tolerate such concentrations for more than 1 or 2 minutes. It was also 
mentioned that several workers had quit their jobs because of dermatosis. 
Gotell et al. [35] speculated that the agents causing the dermatosis could 
have been the peroxide or cobalt compounds used as accelerators and 
catalysts.
In 1973, Bodner et al. [104] conducted a health hazard survey of a U.S. 
factory where reinforced plastic bathtubs were manufactured. The work 
involved spraying a fibrous glass-polyester resin mixture onto molds and 
then hand-rolling, laminating, and shaping. Although local exhaust 
ventilation was used in some of the operations, the makeup air was 
insufficient; thus, some workers wore respirators. Workers were exposed to 
styrene at 45-550 ppm as determined by breathing zone samples collected on 
charcoal for unspecified periods. In one operation where a foaming agent 
was sprayed, workers were exposed to methylene bisphenyl isocyanate (MDI) at 
0.02-0.27 mg/cu m. The OSHA ceiling standard for MDI is 0.2 mg/cu m (CFR 
1910.1000). Exposure to airborne fibrous glass was not measured.
Thirty-five workers (21 women, 14 men) were interviewed; their average 
age was 34 years. The average length of employment with the company was 3.7 
years; however, this particular facility had only been operating for about 2 
years. Sixteen of the workers (46%) smoked at least 1/2 pack of cigarettes 
a day. Four of the office workers, one man and three women, were used as a 
comparison group for the investigation. Complaints of some form of eye,
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nose, or throat irritation were made by 34 of the 35 workers (97%) examined; 
17 (49%) complained of wheezing, shortness of breath, or chest tightness, 
and 14 (40%) complained of skin rashes, hives, darkening skin color, or skin 
sores. Other complaints included nose bleeds, anorexia, excessive thirst, 
numbness of extremities, frequent headaches, occasional vomiting, and upset 
stomachs. None of these complaints were made by the four office workers who 
were interviewed for comparison. Since MDI was also present and is known to 
cause irritant effects similar to those observed among these workers, a 
direct attribution to styrene cannot be made.
In 1966, Simko et al. [105] reported the effects of styrene on 128 
workers (101 women, 27 men) in three Czechoslovakian factories where 
reinforced plastics (chairs, small parts) were made. Average work 
experience was 1.8 years, with 20 of the workers having had more than 3 
years of exposure. Operations were essentially the same in all three 
factories, and no respiratory protection was used. Styrene exposures in the 
three factories ranged from 4-195 ppm; methods of sampling and analysis were 
not reported. Table IV-7 presents the environmental styrene and urinary 
mandelic acid concentrations found.
TABLE IV-7
ENVIRONMENTAL STYRENE AND URINARY MANDELIC ACID CONCENTRATIONS
Factory
Year(s) of 
Exposure
Year(s)
Measured
S tyrene 
ppm
Mandelic Acid 
mg/1
I 5 1960-65 8-195 72-2,620
II 1 1965 5-165 80-2,100
III 1 1965 4-41 36-1,215
Taken from Simko et al. [105]
Clinical and neurological examinations of the workers at the beginning 
of the study included gynecologic examinations of the women and 
determinations of SGOT, SGPT, serum cholesterol, albumin, bilirubin, and 
urinary creatinine in all the workers. In factories I and II, where worker 
exposure to styrene was the greatest, all results from measurements of blood 
serum components were within normal limits; no signs of liver or gall 
bladder injury were found. The subjective symptoms reported included 
headache (20%), tiredness (15%), and drowsiness at work (13%). Hypertension 
was found in 23% of the workers. Simko et al. [105] concluded that the 
primary health hazard of styrene exposure was development of the
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neurasthenic syndrome (a term not defined by the investigators), which was 
found in 33% of the 20 workers exposed to styrene for more than 3 years, and 
in 13% of the workers overall.
In 1962, Klimkova-Deutschova [106] reported neurological studies of 35 
styrene-exposed workers (30 women, 5 men) in two Czechoslovakian RP/C 
plants. The workers had an average age of 38.5 years and an average 
exposure duration of 1.9 years. Styrene exposures in the two facilities
were 43-131 ppm and 19-98 ppm. Dibutyl phthalate, trichloroethylene, and 
cobalt naphthenate were also present in the work environment. A catalyst, 
which was translated as being cyclohexyl peroxide, was also present.
Methods of sampling and analysis were not reported. Workers were excluded 
in which earlier diseases such as hepatitis or working with other solvents 
could have played a role [107]. Each worker was given a clinical 
examination, and 17 had EEGs recorded.
The most frequent complaints were fatigue (41% of the workers),
headaches (51%), and drowsiness with increased need for sleep (34%). 
Neurological effects reported included cranial nerve disturbances (91% of 
the workers), diminished reflexes (86%), and autonomic nervous system 
disorders (34%). Performance of a Romberg test (maintaining balance with 
eyes closed) and a Hautant test (walking with eyes closed) was impaired in 
83% of the styrene workers. Of the 18 EEGs of 17 workers, 5 EEGs were
judged to be normal [106].
A subsequent report in 1973 by Klimkova-Deutschova et al. [108]
described findings in 21 workers examined for a period of three years from 
the start of exposure. The age distribution showed a marked predominance in
the range of 40-49 years. The authors [108] found an increase in reports of
fatigue, drowsiness, headaches, symptoms indicative of autonomic nervous 
system disorders, and hyporeflexia. Also, some workers had abnormal EEGs 
after 3 years of styrene exposure, whereas no abnormal EEGs were found 
during the pre-exposure examinations [108], These effects were manifested 
in those workers with mandelic acid levels greater than 600 mg/1. Workplace 
exposure levels to styrene or other substances were not reported.
In 1967, Huzl et al. [109] reported an investigation of five separate
RP/C facilities in Czechoslovakia. The average age of the 55 workers (34
women, 21 men) was 38.4 years; average exposure duration was 1 year. In 
four of the five facilities investigated, styrene polyester resin was
applied by hand; the material was sprayed in the fifth facility. Only
"primitive" engineering controls were in use in the four areas where the 
resin was spread by hand; gloves were used only occasionally. In addition 
to styrene, the workers were also exposed to cyclohexene peroxide, a resin 
catalyst, and to cobalt naphthenate, an accelerator. Styrene concentrations 
in the four hand lay-up facilities were found to be 47-94 ppm. In the fifth 
facility (spray-up), the ventilation was much better, and styrene 
concentrations were about 6 ppm. A comparison group examined in an
outpatient clinic had previous occupational exposure to a variety of 
substances, including organic solvents, but not styrene. Medical histories
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were taken and liver function tests performed. Based on urine specimens 
collected at the end of the workweek, Huzl et al. [109] found no simple 
statistical correlation between urinary mandelic acid levels and styrene 
exposure. However, Huzl et al. [109] believed that a urinary mandelic acid 
concentration greater than 300 mg/1 indicated high occupational exposure to 
styrene. Mandelic acid values greater than 300 mg/1 were found in 24% of 
the workers examined. The subjective complaints and objective findings of 
workers from the hand lay-up sites are presented in Table IV-8.
TABLE IV-8
SUBJECTIVE COMPLAINTS AND OBJECTIVE FINDINGS IN STYRENE-EXPOSED 
RP/C WORKERS FROM FOUR HAND LAY-UP SITES
Complaint or Finding Percent of 
Workers
Percent of 
Controls
Headaches 36.4 21.8
Drowsiness, fatigue 23.6 20.0
Dyspeptic problems 10.9 *
Occupational eczema 7.3 ★
Prolonged Weltman's reaction 48.1 23.6
Hyperbilirubinemia 17.1 *
♦Data was not given
Taken from Huzl et al. [109]
Medical histories of the workers, according to Huzl et al. [109], 
revealed no cause other than styrene exposure for the prolonged Weltman's 
reactions noted, a nonspecific test which the investigators considered not 
necessarily indicative of liver disease. However, Huzl et al. [109] 
recommended that prospective workers with a history of liver disease and 
hepatitis not be allowed to work in areas with potential exposure to styrene.
In 1964, Zielhuis et al. [110] described a clinical study of workers in 
three factories in the Netherlands where reinforced plastic items (including 
boats, automobile bodies, and small objects) were manufactured. Boats were 
constructed using techniques in which layers of fibrous glass were 
impregnated by hand with a styrene-polyes ter mixture. The authors [110] 
noted that as the boats reached the final stages of construction, and the 
work area became more enclosed, the ventilation decreased. Workers had been 
exposed to styrene for 2-5 years. Breathing zone concentrations of styrene 
found during various operations in the factories, together with the authors' 
[110] classification of workers by job description, are listed in 
Table IV-9. However, precise information concerning methods of sampling was 
not provided by the investigators. Three groups of unexposed workers served 
as controls.
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TABLE IV-9
AVERAGE STYRENE CONCENTRATIONS AT THREE FACTORIES
Factory Group
Number of 
Workers Worksite
S tyrene 
ppm
A Aa 5 Pilot plant 
Boat construction 24-94
Ab 6 Pilot plant 
Laboratory worker 7
Ac 5 Pilot plant 
Maintenance Negligible
B Ba 8 S teel Works 
Boat Construction 24-94
Bb 8 Steel Works
Car body construction 24-94
Be 22 Steel Works 
Small object con­
struction 7
Bd 21 Steel Works 
Upholsterers and 
steel workers Negligible
C Ca 6 Ship Wharf 
Boat construction 24-94
Cb 5 Ship Wharf 
Carpenters Negligible
Taken from Zielhuis et al. [110]
Although physical examinations (including blood counts, organ function 
tests, and urinalysis) revealed no abnormalities that could be attributed to 
the work situation, many of the workers in factories B and C reported having 
symptoms during their work with styrene. Workers' symptoms in factories B 
and C are presented in Table IV-10. Data reported in Table IV-10 were 
obtained through the use of a questionnaire given at the end of the shift on 
the days that the air samples were taken. The number of symptoms noted by 
the workers decreased with decreasing exposure. The authors [110]
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concluded that a relationship existed between the workers' feelings of 
discomfort and styrene exposure. The most striking symptoms of discomfort 
were mucosal irritation and drowsiness. The workers reported that symptoms 
disappeared rapidly when they left the work area.
TABLE IV-10 
SYMPTOMS OF WORKERS AT TWO PLASTICS PLANTS
Symptoms Percentage* of Workers Reporting Symptoms
Factory and Group
Ba
N=8
Bb
N=8
Be
N=22
Ca
N=6
Cb
N=.
Drowsiness 90 90 70 50 0
Apa thy 70 70 50 10 0
Mental fatigue 50 90 30 0 0
Anorexia 70 30 10 50 0
Dizziness 30 70 10 50 10
Headache 70 30 50 30 30
Feeling groggy 10 50 10 30 0
Nervousness 30 10 10 10 10
Agita tion 30 30 10 0 10
Nervous tension 50 30 50 0 10
Gastric pain 10 10 10 10 0
Tearflow 90 70 50 0 10
Eye irritation 90 90 50 90 0
Sneez ing/coughing 70 30 30 70 10
♦Actual value is the range of the tabulated value +10; e.g., 90 means that 
the percentage of workers reporting symptoms was between 80 and 100.
Taken from Zielhuis et al. [110]
In 1975, Gamberale et al. [Ill] studied 106 workers in four Swedish RP/C 
boat plants. Styrene-exposed workers included plastics workers and 
mechanics. The comparison group consisted of 36 workers in the same 
locality as two of the boat plants, not exposed to styrene. Styrene 
exposures varied from 10-120 ppm for the plastics workers and from 6-60 for 
the mechanics who were exposed at levels up to 312 ppm for 24 minutes, while 
working in narrow spaces.
Reaction time was measured by having the subject rest his wrist and 
forearm on a table, with his fingertips in contact with a pressure plate. 
The time between seeing a light signal and pressing the plate with the 
fingertips was the reaction time, expressed as the mean of 160 responses 
over a 10-minute period. Workers exposed to styrene had significantly 
longer reaction times than age-matched controls. This difference
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was evident before work started in the morning, and showed a tendency to 
increase during the workday [111]. The data were not collected in a manner 
to allow inferences on concentration-response relationships to be made.
In 1977, Bergman and Lindberg [112] conducted industrial hygiene and 
medical studies at four Swedish factories where boats were made of fibrous 
glass-reinforced plastics. TWA styrene exposures ranged from 3-312 ppm for 
39 of the workers with 29 of the workers having TWA exposures less than 100 
ppm. Samples were collected with charcoal tubes or glass syringes and 
analyzed with a gas chromatograph. Interviews and medical examinations were 
given to 81 workers exposed to styrene and 32 workers with no styrene 
exposures. The 32 controls included some workers from other industries. 
Subjective symptoms elicited from the 81 styrene workers included fatigue 
that was not attributed to the heaviness or intensity of the work (60%), 
confusion or dizziness (38%), nausea (14%), headache (25%), and poor memory 
(21%). Only one of the controls mentioned any of the above subjective 
symptoms in connection with their work.
Rosensteel and Meyer [113] evaluated health hazards in a U.S. facility 
where reinforced plastic boats were manufactured. An initial survey in 1975 
demonstrated that some exposure concentrations of styrene were greater than 
100 ppm and that the workers were also exposed to acetone, methylene 
chloride, methyl ethyl ketone, naphtha, toluene, xylene, and asbestos. 
Twenty-one personal air samples in the lamination area were obtained in 1976 
by the collection on charcoal for about 7 hours. TWA styrene exposures 
averaged 69 ppm and ranged from 9-111 ppm. These same workers also had 
average TWA exposures of 56 ppm acetone and 2 ppm methylene chloride (OSHA 
standards are 1,000 ppm and 500 ppm, respectively).
During one of the surveys, 9 of 14 workers interviewed reported symptoms 
of styrene exposure on the day of the interview, and all 14 stated that they 
had, at some time in this factory, experienced symptoms of styrene exposure 
such as eye and respiratory irritation [113]. These data are presented in 
Table IV-11.
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TABLE IV-11
WORKERS WHO EXPERIENCED EFFECTS WHILE MANUFACTURING 
REINFORCED PLASTICS
Symp tom No. of Workers Percent
Eye irritation 13 93
Skin rash 8 57
Nose irritation 7 50
Headache 7 50
Throat irritation 4 29
Chest pain 4 29
Dizziness 2 14
Fatigue/drowsiness 2 14
Cracked hands 2 14
Irritability/nervousness 1 7
Cough 1 7
Adapted from Rosensteel and Meyer [113]
During the last survey in 1976, serial detector tube sampling procedures 
were used by Rosensteel and Meyer [113] to determine 5-minute peak 
concentrations of styrene in workers' breathing zones; concentrations of 
50-400 ppm were found. Analyses of samples collected during 
hull-stiffening, hull spraying, fibrous glass application, and hull roll-out 
areas, showed that styrene concentrations for 5-minute periods ranged from 
200-400 ppm.
During the medical study, 41 workers were examined; 22 workers (16 men 
and 6 women with average ages of 28.7 years and 35.2 years, respectively) 
were from the lamination area. The other 19 examined for comparison were 
from other areas of the factory with little or no styrene exposure (13 men, 
average age 29.6 years; 6 women, average age 24.0 years). Workers from the 
lamination areas were matched with the control group on the basis of age, 
sex, and smoking history. However, because of the frequency of complaints 
of upper respiratory and eye irritation expressed by this group, perhaps 
from exposure to other irritants, their use as a comparison group may have 
been inappropriate. Air samples obtained over 6-7.5 hours from 10 of the 19 
controls indicated TWA exposures to styrene below the level of detection for 
6, 9-14 ppm for 3, and 62 ppm for 1. A medical history was obtained from 
each worker, and a physical and clinical examination of each worker was 
made. All results from blood analyses were within normal limits. Although 
the lamination workers had significantly elevated concentrations (p<0.05) of 
serum uric acid with respect to the comparison group, the levels were within 
normal limits [113].
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At the time of the evaluation, all 22 lamination workers had 
work-related symptoms as did 55% of the comparison group. Subjective 
complaints that the workers reported occurring during their work with 
styrene and objective findings at the time of the study are presented in 
Table IV-12.
TABLE IV-12
SUBJECTIVE COMPLAINTS AND OBJECTIVE FINDINGS OF WORKERS WHO MADE
REINFORCED PLASTICS
Percentage
Exposed
of Workers With Complaints 
Control
Subjective complaints
Eye irritation 45 26
Nose irritation 95 37
Nasal congestion 82 37
Cough 23 21
Chest tightness 23 16
Wheezing 18 5
Shortness of breath 54 11
Nausea and vomiting 0 0
Muscle weakness 4 5
Fatigue 36 5
Headache 14 5
Objective findings
Skin rash 14 0
Conjunctival erythema 41 5
Nasal erythema 86 63
Mouth and throat erythema 45 32
Abnormal thyroid size 14 5
Rales and wheezes 9 0
Taken from Rosensteel and Meyer [113]
The average maximal mid-expiratory flow-rate (MMEF) of lamination 
workers that smoked was significantly less (p<0.05) at the end of the shift 
than at the beginning when compared with the smokers in the control group. 
Pulmonary function tests (FVC, FEV^) did not reveal any other significant 
differences between styrene-exposed workers and those used for comparison. A 
number of suggestions were made concerning improvement of work practices and 
engineering controls; one recommendation made was that the workers in the 
high exposure areas be discouraged from smoking [113].
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In 1968, Matsushita et al. [59] reported on 14 male production workers 
and 10 male office workers used as controls from a factory where plywood was 
laminated with a styrene-polyester resin. The men had been employed for 3-6 
years; their average age was 29.8 years. Concentrations of styrene 
associated with different operations in the coating process ranged from 
50-600 ppm; in other areas, no styrene was detected. Other substances 
including toluene normally were detected only in trace amounts. Toluene 
(50-550 ppm), ethyl acetate (3-160 ppm), and methanol (100-1,000 ppm) were 
present in the air when the equipment was cleaned daily during a 30-40 
minute period; the workers took turns cleaning the equipment. The method of 
sampling and the number of samples taken were not reported. However, the 
substances were analyzed by gas chromatography.
Using questionnaires and interviews, it was found that all 14 of the 
styrene-exposed workers experienced throat pain, that 12 of them (86%) tired 
easily, and that 11 (79%) caught colds easily. Eye pain, bad breath during 
work, heaviness of the head, and feeling unwell during work were each 
reported by 10 workers (71%). Nose pain, headache, dizziness, palpitation 
and an oppressive sensation of the chest, anorexia, drowsiness during work, 
loss of weight, and severe forgetfulness were reported by 6-9 of the 
styrene-exposed workers (43-64%). Heaviness of the head (three complaints) 
was the most common complaint of the comparison group of 10 office workers; 
all other complaints were reported by only 1 or 2 of this group. While 8 of 
the styrene-exposed workers (57%) complained of decreased vision, 
ophthalmologic examinations confirmed this in only 4. Contracted fields of 
vision without fundus changes were found in 7. Twelve of the styrene 
workers were examined by a neurologist; increased knee jerk reflexes were 
found in 9, hyperreflexia of the Achilles tendon in 5, hyperreflexia of the 
upper limbs in 3, and sensation disorders in 4. Four styrene workers with 
severe symptoms were given EEG examinations; there were no abnormal 
findings. Three workers with severe symptoms had EMG abnormalities.
Matsushita et al. [59] concluded that styrene had a major role in causing
the effects found in these workers [59],
A series of reports by a group of Polish investigators
[114,115,116,117,118,119,120] discussed results of studies of workers 
exposed to styrene during production of reinforced plastics. One group of 
101 workers from two factories had been exposed for about a year; their
styrene exposures in 1972 were about 25-75 ppm [115]. Twenty-one workers in
another group had been exposed to styrene for about 10 years at
concentrations that were about 75 ppm. Methods of sampling were not 
reported; analysis, however, was by colorimetric methods.
Urine samples were collected for determination of mandelic acid by the
nonspecific, colorimetric method of Ohtsuji and Ikeda [121] for the same 
period during which the air samples were collected. Mandelic acid 
concentrations of up to 150 mg/1 were considered normal, and concentrations 
greater than 400 mg/1 were considered as definite indications of exposure to 
styrene. Urinary mandelic acid concentrations of the 101 workers who had
been exposed for about 1 year (short-term workers) averaged 287 mg/1, with
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concentrations of about 150 mg/1 being found in 50 workers, 150-300 mg/1 in 
8 workers, and 300-494 mg/1 in the remaining 43 workers [114], The average 
concentration of mandelic acid in the urine of the 21 workers who had been 
exposed about 10 years (long-term workers) was 504 mg/1 (range, 325-625 
mg/l) [114,116]. Hippuric acid concentrations in the urine did not exceed 
the normal range [116].
In the 101 short-term workers, four cases of upper respiratory catarrh 
were noted by Chmielewski and Renke [114]. In 26 workers there were signs 
that the investigators classified as vegetative nervous system disturbances, 
which included skin marbleization, asymmetric body warming, prolonged blood 
vessel filling time, diaphoresis, excitability, hypoesthesia, wílitening of 
fingers, trembling of hands, weakened reactions, cat's eye pupils, and 
nystagmus [115],
Clinical studies of these workers were performed that included blood 
cell and platelet counts [117]; examination of serum proteins, lipids, 
enzymes, bilirubin, and cholesterol [119]; glucose tolerance [116,120]; and 
24-hour excretion of 17-ketosteroids [115,116,120]. Pulmonary function 
[114], blood clotting [117], and EEGs [118] were also studied in the 
long-term workers, and EEGs were studied in 43 of the short-term workers 
[118].
In the short-term workers, the significant clinical finding was that 
abnormal EEGs were noted in 31 of 43 examinations [118], The abnormal EEGs 
showed discharges of sharp waves and high-voltage slow waves in the temporal 
regions that intensified with hyperventilation. Almost all short-term 
workers complained of "neurotic troubles." Signs such as intensified or 
abated deep reflexes, vestigial nystagmus, and tremors were interpreted by 
Dolmierski et al. [118] as being minor symptoms indicating that the nervous 
system was affected.
Average blood glucose in 53 short-term workers in one of the factories 
studied was lower than in a control group of 20 individuals [115,120],
Subsequently, blood glucose concentrations were studied in 40 workers in the 
other factory and in 18 controls using 50 g of glucose taken orally,
followed by another 50 g of glucose taken orally 90 minutes later
[115,120]. The results showed a heightened glucose tolerance in persons 
exposed to styrene. There was an indication that a tendency toward 
increased glucose tolerance was greater among 20 of the workers with 
concentrations of urinary mandelic acid greater than 400 mg/l and among 27 
workers with a reduced 24-hour excretion of 17-ketosteroids (i.e., 5.78
mg/24 h on the average).
In another investigation of these same workers, Chmielewski [116] 
obtained somewhat different glucose tolerance test results from 21 long-term 
workers as compared to 40 short-term workers. The maximum concentration of 
blood glucose in the long-term workers occurred half an hour later on the 
average after administering glucose and did not rise after the second dose. 
The average response was due to three classes of blood glucose curves:
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hypoglycemic, normal, and hyperglycemic. However, only the hypoglycemic 
workers responded to the second dose of glucose or to cortisone administered 
before the test. All workers had glucose assimilation coefficients below 
control values [116].
Other aberrant clinical findings in the long-term workers included 
reduced FEV^/FVC in 4 of 21 workers examined [114], as well as reduced 
amounts of serum alpha- and beta-lipoproteins [119]. Twelve of the 
long-term workers had normal EEG patterns, two had borderline patterns, and 
four had abnormal patterns that were symmetrical in the temporal regions and 
characterized by low to medium voltage theta waves 1118], Most complaints 
by workers with abnormal EEGs were of fatigue, a sensation of weakness, and 
drowsiness. Compared with a nonexposed control group, the long-term group 
had a reduced number of blood platelets, an increased coagulation time, a 
reduction in prothrombin ratio, a shorter euglobulin fibrinolysis time, and 
an increase in blood platelet adhesion that was significantly correlated 
with beta-lipoprotein concentrations [117]. It was not mentioned whether 
the comparison group was age-matched to the exposure group, an important 
point in light of the comparison of serum lipoprotein levels between 
short-term and long-term workers; thus, the effect of age on these 
comparisons is not clear.
Occupational dermatoses were reported in 1975 by Golebiowska-Podgorczyk 
[122] among 70 workers in a Polish factory where boats were built from 
fibrous glass-reinforced plastic. The workers ranged from 20-64 years of
age and had worked at this factory for 1-15 years. The group studied was 
composed of 15 carpenters, 37 molder-artists, 13 iron workers, and 5
unskilled laborers. The workers were exposed to a variety of polyester 
resins dissolved in styrene, epoxide resins dissolved in acetone or ether, 
hardeners that included cyclohexanone hyperoxide, dibutyl phthalate, methyl 
ethyl glycol hydroxide, and triethylenetetramine, cobalt naphthenate, 
organic dyes, and various glues. No industrial hygiene monitoring was 
conducted. None of the workers had a history of, or a predisposition to, 
any allergic disease, but 18 experienced some type of dermal trauma as a
result of their employment. Three of these 18 worked with fibrous glass. 
No positive reactions to styrene or polyester resins were found by patch
testing, although positive reactions were found to the epoxide resins and 
some of the hardeners. Golebiowska-Podgorczyk [122] found four cases of
excessively dry, chapped, and cracked hands and suggested this might have 
been caused by the defatting action of styrene.
In 1978, Rosen et al. [123] reported, in what was described as a pilot 
study, the results of neurological examinations of 33 workers from 3
different worksites in Sweden. Thirteen of the workers (aged 24-66 years) 
had been employed for 1-21 years in the polyester resin boat industry (Group 
I). Exposures to styrene had been measured the previous year and averaged
125 ppm (range 74-175 ppm), but Rosen et al. [123] stated that during
previous years the exposures were significantly higher. Ten of the workers 
(aged 23-54) had been involved in the production of polyester resin cisterns 
for 2-14 years (Group II); their average exposure based on measurements
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taken 2 years earlier was 47 ppm styrene. The remaining ten workers studied 
(aged 29-65) were exposed to less than 5 ppm styrene while producing 
polystyrene for 5-15 years (Group III).
Results of the study were compared with two "control" groups. One group 
(called the "normal" group) consisted of six men from a hospital 
transportation service never significantly exposed to organic solvents; the 
other group (called the "reference" group) consisted of 17 men, many of whom 
were former painters, reported to have signs of chronic intoxication due to 
exposure to a mixture of organic solvents. All examinations of styrene 
workers were performed at least 48 hours after the last exposure, to avoid 
possible acute effects of styrene on the results. The reported incidences 
of unusual tiredness, reduced short-term memory, giddiness, headache, 
paresthesia in fingers or toes, conjunctivitis, throat irritation, and a 
minor decrease of muscle stretch reflexes were higher in the styrene-exposed 
workers than in the "normal" group. These results were roughly 
dose-dependent with the reported effects occurring most among the workers in 
the higher exposure group (I), but also frequently occurring in the medium 
exposure group (II), and occasionally among the polystyrene workers, who had 
the lowest styrene exposures (Group III).
Signs of polyneuropathy or CNS lesions were not found in the 
styrene-exposed workers. Motor conduction velocities of median, ulnar, 
fibular, and posterior tibial nerves were recorded, as well as sensory 
action potential of the median and ulnar nerves. An EEG examination was 
made while the subjects were awake, and included studies of the effects of 
arousal, hyperventilation, and intermittent light [123]. No differences in 
motor conduction velocities were found between the groups. Ten of the 33 
styrene-exposed workers had evidence of a mild sensory neuropathy with 
polyphasic sensory responses of a low amplitude; a similar pattern was found 
in many of the workers in the solvent-exposed "reference" group. The 10 
affected styrene workers were more heavily exposed than those not having 
signs of neuropathy, but they were also older and had more years of 
exposure. Based on corrections for age published by others, the
investigators [123] believed that age alone could not have accounted for the 
effects, but speculated that the effects of age and styrene exposure may 
have been synergistic. Eight of these ten workers had EEG changes
consisting of fast activity within the rostral and central parts of the 
hemispheres; similar changes were common in the solvent-exposed "reference" 
group, but were seen in only one of the other 23 styrene-exposed workers. 
Unexpectedly, the highest frequency of diffuse slow activity over both
hemispheres was seen in those workers (Group III) exposed at the lowest 
styrene concentrations. The investigators [123] suggested that the 
additional exposure of Group III to isopentane might be relevant, but no 
isopentane determinations were made.
In 1976-1978, a series of reports [124,125,126,127,128] were written by 
a group of Finnish investigators who examined the results of psychological 
and neurophysiological tests of 96 workers from 24 different factories where 
reinforced plastics were made. The workers were 16-54 years old
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(mean age, 29.6) and had been exposed to styrene for as little as 6 months 
or as long as 14 years (mean duration, 5 years). Styrene exposures of these 
workers who used their hands to spread polyester resin, were evaluated from 
urinary mandelic acid concentrations determined by the colorimetric method 
of Ohtsuji and Ikeda [121] in about half of the workers, and by the gas 
chromatographic method of Engstrom and Rantanen [77] in the remainder. 
Results from the two methods were transformed to a common scale [79,127]. 
Urine specimens from each worker were collected at the end of an 8-hour 
workday, once a week, on a different day each week for 5 weeks. The mean of 
the five determinations of mandelic acid was used as an index of exposure 
for each individual. The range of the individual means was 7-4,715 mg/1; 
the group median was 808 mg/1.
Neurophysiological findings of these workers were reported by 
Seppalainen and Harkonen [124], psychological functions and data relating to 
alcohol consumption were reported by Lindstrom et al. [127,128], and effects 
on the nervous system were reported by Harkonen [126] and Harkonen et al. 
[125], EEGs were recorded for all 96 of the workers at least 20 hours after 
the last exposure to styrene. The recording period lasted 30 minutes, and a 
3-minute hyperventilation and a photic stimulator were used as EEG pattern 
activators. All EEGs were interpreted by one investigator who had no 
knowledge of the subjects' exposure histories. The findings were normal in 
73 of the workers. Abnormal EEG patterns were found in 23 workers with 14 
having local slow activity, 8 with diffuse theta activity, and 2 with 
bilateral spike and wave discharges (1 worker had 2 abnormalities). Based on 
the available literature on EEGs, about 10% abnormal patterns were expected 
by the investigators [124] for a normal population. The incidence of 
abnormal EEGs found (24%) was significantly greater (p<0.01) than expected. 
Of the 23 workers who had abnormal EEGs, 19 had urinary mandelic acid 
concentrations greater than 700 mg/1. In a subsequent analysis of the data, 
Harkonen et al. [125] presented evidence that this concentration of mandelic 
acid corresponded on the average to an 8-hour TWA styrene exposure of 31 ppm.
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Possible peripheral nerve dysfunction in 40 of the workers (average age 
29.6 years) in the study group with the most severe complaints was also 
investigated by Seppalainen and Harkonen [124] using nerve conduction 
velocity measurements. Thirty healthy, age-matched men with no history of 
occupational exposure to toxic chemicals were used for comparison. An 
electromyograph was used to measure maximal motor conduction velocity of the 
median, ulnar, deep peroneal, and posterior tibial nerves; conduction 
velocity of slower motor fibers of the ulnar and deep peroneal nerves; and 
the sensory conduction velocity of the median and ulnar nerves. There were 
no statistically significant differences between the styrene-exposed workers 
and the comparison group in average nerve conduction velocities. However, 
slightly abnormal conduction velocities were found in 9 of the 40 workers; 
the criteria used for judgment were not stated. Five of these workers 
displayed mononeuropathy, and the other four exhibited polyneuropathy. In 
four of the workers with mononeuropathy there were possible causes other 
than styrene exposure; in the fifth worker, no other cause for the
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neuropathy could be found. In three of the workers with polyneuropathy, no 
cause other than styrene exposure could be found. There was no association 
between urinary mandelic acid concentration and nerve conduction velocity in 
the four subjects with unexplained abnormalities.
To study psychological functions in these workers, Lindstrom et al.
[127] selected a comparison group of 43 men who worked with reinforced
concrete. The comparison group was similar to the styrene-exposed group in
age distribution, educational level, and geographic location. Psychological 
functions which were measured by 30 tests included general intelligence (5 
tests), visuomotor speed (8 tests), visuomotor accuracy (3 tests), memory (5 
tests), vigilance (2 tests), psychomotor performance (3 tests), and 
personality (4 tests). Comparisons were made between averages of RP/C 
workers and the comparison group scores. When comparing these two groups, 
performances on two tests, one a measure of visuomotor accuracy and the 
other a measure of response time in Rorschach inkblot tests, were 
significantly impaired (p<0.05) in the RP/C workers. When the 19 
styrene-exposed workers with urinary mandelic acid concentrations greater 
than 1,762 mg/1 were compared with the 36 workers who had urinary mandelic 
acid concentrations less than 674 mg/1, greater visuomotor inaccuracy and 
poorer psychomotor performance were found in the workers with the higher
mandelic acid concentrations. Step-wise multiple regression analyses were 
used to study relationships of variables to urinary mandelic acid
concentrations, duration of exposures, and the combination of mandelic acid 
concentration and duration of exposure. Duration of exposure had only a 
slight relationship to disturbances in psychological functions. One measure 
of visuomotor speed and one measure of visual memory correlated with the 
duration of exposure; their joint partial correlation with duration of 
exposure, when the effect of age was eliminated, was 0.28 (p<0.05). High 
urinary mandelic acid concentration was related to visuomotor inaccuracy 
(p<0.01), and it had a slight relationship to vigilance and psychomotor 
performance (p<0.13). The product of duration of exposure and urinary 
mandelic acid concentration was related to visuomotor inaccuracy and one 
Rorschach variable, long latency time in answering.
For the study of subjective symptoms experienced by these workers, 
Harkonen [126] selected a comparison group of male postal workers and 
electricians (mean age, 29.3 years) with no reported previous exposure to 
styrene. Both the workers and the comparison group were requested to 
complete questionnaires dealing with subjective symptoms felt during the 
workday. In contrast to the comparison group, the styrene-exposed workers 
felt tired more often in the morning and excessively tired after work, and 
they also reported more difficulties in concentrating and more frequent loss 
of appetite. During the workday, the RP/C workers frequently experienced 
irritation of the eyes, nose, and skin, and many felt nauseated and 
intoxicated. No correlation was found between urinary mandelic acid 
concentrations and the magnitudes of the symptoms scored on a scale of 1-3. 
Harkonen [126] suggested that no correlation was found because acute 
symptoms may be associated with peak exposures, whereas mandelic acid 
concentrations reflect the average exposure of the day.
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In 1978, Harkonen et al. [125] summarized these studies [124,126,127] 
and extended some of the analyses. By plotting the log of the urinary 
mandelic acid concentration against the log of the 8-hour TWA styrene 
concentration, a significant correlation (r=0.92, p<0.001) was found. A
urinary mandelic acid concentration of 700 mg/1 corresponded to 31 ppm of 
styrene, 800 mg/1 to 36 ppm, 1,200 mg/1 to 55 ppm, and 1,600 mg/1 to 74 
ppm. Urinary mandelic acid concentrations were related to the percentage of 
EEG abnormalities in the group. Repeated slow wave activity and bilateral 
spike and wave discharges were used to indicate EEG abnormalities. In 38 
workers whose urinary mandelic acid concentration was less than 700 mg/1, 
the percentage with abnormal EEGs was comparable with the general population 
(about 10%). Of 58 workers with mandelic acid concentrations greater than 
700 mg/1, about a third exhibited EEG abnormalities. There was a
significant degree of visuomotor inaccuracy with the symmetry of drawing 
test in workers whose mean urinary mandelic acid concentration was 800 
mg/1. However, using the Bourdon-Wiersman test, visuomotor inaccuracy was 
statistically significant (p<0.05) only when the mean mandelic acid 
concentration was greater than 2,000 mg/1. A statistically significant
decline in psychomotor performance (Mira Test) was found at mandelic acid 
concentrations greater than 1,200 mg/1 (equivalent to about 55 ppm 
styrene). Harkonen et al. [125] concluded that although visuomotor accuracy 
and unimpaired psychomotor performance may be important in certain demanding 
operations and a prerequisite for safety at work, impairment may not 
necessarily affect a worker's performance under normal conditions, but may 
have an indirect impact by demanding more adaptation and more energy for 
compensation.
Lindstrom et al. [128] interviewed these same styrene-exposed workers 
about their alcohol consumption. A quantity of alcohol sufficient to
produce a slightly intoxicated state was consumed daily by 1 worker, twice 
weekly by 22, once or twice a month by 56, and less frequently by the other 
19 workers. Frequency of alcohol consumption for the group was about the 
same both before and after styrene exposure began. Decreased tolerance to 
alcohol was reported by 32% of the workers, about the same as in a
comparison group of painters exposed to other solvents, but greater than in 
a group of railroad workers having no reported solvent or styrene exposure.
The amount of, and changes in, alcohol consumption and decreased
tolerance to alcohol were not statistically related to the duration of 
exposure to styrene or to the concentration of urinary mandelic acid [128]. 
Overtime work, another index of styrene exposure, was related to alcohol 
consumption. The workers with high alcohol consumption were characterized 
as having straying thoughts and difficulties in staying asleep. Hand 
tremors and tiredness were related (p<0.05) to both the amount and frequency 
of alcohol consumption. Of all psychological functions, only lowered 
visuomotor speed was related to the amount of alcohol consumed [128], 
Visuomotor inaccuracy was not the function that was previously related to 
high styrene exposure by Lindstrom et al. [127]; thus, Lindstrom et al.
[128] concluded that the psychologic symptoms and signs related to alcohol 
behavioral variables were not related to styrene exposure.
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In 1977, Meretoja et al. [129] reported an Increase in the rate of 
chromosomal aberrations of the lymphocytes in peripheral blood. The ten men 
studied were 20-41 years old and from a Finnish factory where polyester 
plastic laminates were made. These workers had been exposed to styrene for 
0.6-8.5 years. Before testing began, a complete health history was taken 
from each worker, followed by clinical and psychological examinations. No 
previous or present evidence of diabetes, epilepsy, or periods of 
unconsciousness lasting more than 30 minutes was found in any worker. Five 
healthy men with no known exposure to styrene or to any agent with known 
clastogenic activity were used as a comparison group.
No industrial hygiene sampling was conducted, but urinary mandelic acid 
concentrations were determined from specimens obtained at the end of an 
8-hour shift to evaluate styrene exposure. A record was made of past 
exposures to any known clastogen, and a CBC was also performed [129]. The 
chromosomes of lymphocytes from peripheral blood of the styrene-exposed 
workers and the comparison group were studied. At the time of study all the 
workers were reported to be in good health. Results are presented in Table 
IV-13.
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TABLE IV-13
ANEUPLOIDY AND CHROMOSOMAL ABERRATIONS 
IN THE LYMPHOCYTES OF STYRENE-EXPOSED WORKERS
Subject 
No. Age 
Yrs.
Years of 
S tyrene 
Exposure
Mandelic
Acid
*
Interphase Cells
Micro- Nuclear
nuclei Bridges 
** **
Aneu-
ploidy
***
Poly­
ploidy
***
Chromosomal
Aberrations
***
1 24 0.7 833
Plant 1 
8 5 2 11
2 20 0.6 229 7 2 4 - 11
3 21 1.5 3,257
Plant 2 
14 8 2 26
4 37 8 23 9 3 3 - 25
5 41 2.5 219 12 0 5 - 13
6 27 2 1,452 6 3 7 - 15
7 21 1 422 6 4 6 1 16
8 32 8.5 75
Plant 3 
7 0 3 1 17
9 23 3 645 12 6 5 2 17
10 26 4 55 7 11 4 - 15
11 32 0 0
Comparison Group 
2 0 1 2
12 35 0 0 0 0 3 - 4
13 33 0 0 0 2 3 - 1
14 30 0 0 2 2 1 2 1
15 30 0 0 0 0 2 1
*mg/g creatinine in urine 
**Aberrations/1,000 interphase cells 
***No./100 metaphase cells 
Taken from Meretoja et al. [129]
There was a statistically greater incidence (p<0.001) of cells with 
chromosomal aberrations in lymphocytes of workers who had been exposed to 
styrene than in the comparison group (16.7 vs. 1.8 cells, on the average), 
but the biological significance of this difference is not known. An
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increase in the frequency of micronuclei and nuclear bridges between cells 
was also observed. The incidence of aberrant cells ranged from 11-26% in 
the lymphocytes of the styrene-exposed workers and was only 1-4% in the 
lymphocytes of the unexposed comparison group [129],
In a related study in 1978, Mere toja et al. [130] examined the 
lymphocytes from the peripheral blood of 16 workers (which included 8 
workers from the previous study [131]) exposed to styrene in two reinforced 
plastics factories. No data was given regarding occupational exposures. 
The subjects, all men 21-51 years of age, had been employed mainly in 
laminating work for 1-15 years. A statistically significant increase 
(p<0.001) in the incidence of chromosomal aberrations, mainly breaks, was 
found when compared to the comparison group (15.1 vs. 2.0%), and this was 
confirmed when 10 of these 16 workers were reexamined a year later and the 
incidence was 16.2%. The comparison group consisted of six men from outside 
the factory environment. However, the frequency of sister chromatid 
exchanges (SCE) was not significantly increased in these styrene workers 
(5.3 vs. 4.4 SCE/cell in the comparison group). SCE reflect intrachromosome 
rearrangements of the DNA helices, and as such are a sensitive indicator of 
damage to the DNA.
In 1979, Hogstedt et al. [131] also found an increased frequency of 
chromosomal aberrations among reinforced plastics workers in Sweden. Six 
male workers from a plant manufacturing polyester resin boats, aged 21-56 
years with a mean age of 33, were matched by age and sex with 6 workers from 
a nearby paper factory without exposure to chemicals. In the plastics 
workers, there was an average of 10.8 aberrations per 100 cells in 
chromosomes from venous lymphocytes, a statistically significant increase 
(p<0.001) over that in the reference group, 5.2/100 cells. There was also 
an excess in gaps (3.2 vs. 2.4/100 cells, not significant), isochromatid and 
chromatid breaks (6.9 vs. 2.5/100 cells, p=0.008), and hyperdiploidy (0.7 
vs. 0.3/100 cells, not significant). Airborne TWA styrene concentrations 
measured in previous years ranged from 14-73 ppm, with occasional 
concentrations as high as 188 ppm, for short periods of time. The 
investigators [131] speculated that, although styrene was the probable cause 
of the changes, exposure to other chemicals might have contributed; 
information was not given on these "other" chemicals.
In 1980, Andersson et al. [132] studied 39 men occupationally exposed to 
styrene in a plastic boat factory. The total exposures of these workers 
over a 6-year period were measured with personal TWA samples analyzed by gas 
chromatography and expressed as a concentration multiplied by the number of 
years of employment. A low-dose group (average 32 ppm-yr) and a high-dose 
group (average 283 ppm-yr) were identified. TWA styrene exposures for the 
various spraying, rolling, and casting operations ranged from 39-71 ppm (on 
the average), with exposures during assembly being about 8 ppm. TWA styrene 
exposure during spraying were sometimes as high as 158 ppm. Blood samples 
were taken from 36 of the styrene-exposed workers and from 37 age-matched 
workers (i.e., controls) in the same factory who were not exposed to 
styrene. Lymphocytes in peripheral blood were cultured and examined for
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chromosome aberrations and SCE. The styrene-exposed workers had a 
significantly higher (p<0.001) number of chromosomal aberrations compared 
with the controls (7.9 vs. 3.2 aberrations/100 cells). There was no 
significant difference between the average numbers of chromosomal 
aberrations of the highly exposed and the less exposed styrene workers. 
There was a significant increase (p<0.05) in the average frequency of SCE in 
cells originating from 20 styrene-exposed workers in comparison with 21 
controls (8.4 vs. 7.5 SCE/cell). Again there was no difference between the 
highly and less exposed groups. Interviews were performed when the blood 
samples were taken. Multiple regression analysis showed that among 9 
factors introduced into the analysis (frequency of chromosomal aberrations, 
age, duration of employment, exposure to styrene, smoking habits, alcohol 
consumption, exposure to diagnostic X-rays, other solvents, use of breathing 
mask), only exposure to styrene showed a high positive correlation to the 
frequency of chromosomal aberrations [132].
In 1978, Fleig and Thiess [76] and Thiess and Friedheim [75] studied 14 
workers employed for 2-24 years in three plants processing unsaturated 
polyester resins. At the time of the study, styrene concentrations as 
measured by colorimetric indicator tubes ranged from less than 50 to 300 ppm 
[75]. Mandelic acid concentrations in urine samples from the workers ranged 
from 100 to 1,500 mg/1 [76]. Five of the 14 workers had increased GGTP (>28 
units/ml) [75]. The investigators [76] found a significant excess (level of 
significance was not given) of chromosomal aberrations in the lymphocytes of 
peripheral blood from the styrene workers as compared to a control group of 
20 workers from the same plant not exposed to styrene (9.2 vs. 5.5%). Fleig 
and Theiss [76] suggested that the chromosomal changes in these workers were 
probably due to styrene oxide or other exposures such as methylene chloride, 
rather than to styrene. Mention was made of a finding that styrene oxide 
was generated due to the use of peroxides, but data was not given on styrene 
oxide exposures.
However, there have been studies showing no significant increases in 
chromosome aberrations among styrene-exposed workers. An investigation of 
24 styrene-exposed workers (20 men, 4 women) assigned to laboratory and 
technical service operations in a German polyester processing plant was
reported in 1979 by Theiss and Friedheim [133] and in 1980 by Theiss et al. 
[134], Their age range was 23-59 years, and they had been working with 
styrene for 4-27 years. The average styrene exposure was 6 ppm (range 1-12 
ppm) in the laboratory and 58 ppm (range 1-178 ppm) in the technical service 
operation. Samples were collected with a "Personal Air Sampler" and 
analyzed with a gas chromatograph. The workers were given thorough clinical 
examinations that included personal history, chest X-rays, and laboratory 
studies including body plethysmography, EEGs, ECGs, blood counts, and blood 
chemistry determinations [133], Findings were not relatable to styrene
exposure, and there were no patterns of disease found. Except for one
worker known to imbibe alcohol excessively, the neurological status of all 
workers was normal. One of the women, a diabetic treated with insulin, had 
given birth to a stillborn child. Another woman had aborted in the second
month of pregnancy. Chromosome analyses of lymphocytes in peripheral blood
69
were carried out for all 24 workers as well as 24 controls from the same 
plant. The control group was comprised of medical department and office 
staff, and plant maintenance workers, none of whom were exposed to radiation 
or suspected chemicals at the time of testing. Urinary mandelic acid 
excretion did not exceed 350 mg/g of creatinine in any case; 19 of 22 
workers tested had values below 80 mg/g. The investigators [133,134] 
considered 350 mg mandelic acid/g of creatinine to be a tolerable limit from 
the standpoint of occupational medicine. The mean frequency of chromosomal 
aberrations (i.e., chromatid and isochromatid gaps, breaks, fragments, 
chromatid interchanges, and dicentric chromosomes) was 5.1% in the styrene 
workers vs. 3.8% in the controls, a non-significant difference as determined 
by Theiss et al. [134], However, Norppa et al. [135], in a 1981 discussion 
of this study [134], considered the results to show an increased frequency
of cells with aberrations, when gaps were included.
In 1981, Watanabe et al. [136] examined peripheral blood lymphocytes of 
16 workers occupationally exposed to styrene in two facilities (designated
as I and II) where TWA styrene exposures were about 70 ppm and 35 ppm,
respectively, as determined by carbon felt dosimeters and gas
chromatography. Mandelic acid concentrations in the urine collected at the 
end of the work shift ranged from 90-4,300 mg/1 (mean 647 mg/1) at Facility 
I and 300-1,360 mg/1 (mean 526 mg/1) at Facility II. As compared to age- 
and sex-matched controls, the styrene-exposed workers showed no 
statistically significant increase in chromosomal aberrations (3.3% in
Facility I and 3.6% in Facility II vs. 2.9% in the controls) or SCE
frequencies (7.8% in Facility I and 6.7% in Facility II vs. 7.6%).
In 1982, Pero et al. [137] examined lymphocytes from Swedish workers 
exposed to styrene for genotoxic effects using unscheduled DNA synthesis
(UDS) as the indicator of DNA damage. Heparinized blood specimens were taken
by venous puncture from 38 male workers in a fibrous glass-reinforced
polyester plastics factory where 8-hour TWA styrene exposures, as determined 
by gas chromatography, were 1-40 ppm. The workers (average age, 38.7 years) 
had been exposed to styrene for 1-23 years (average, 8.1 years). Twenty
workers (average age, 36.2 years) were selected as a control group from a 
mechanical industry in the same town. Age distributions and smoking habits 
were similar in both the styrene-exposed and control groups.
Pero et al. [137] examined the possibility that lymphocytes isolated 
from styrene-exposed workers might have an altered level of unscheduled DNA
synthesis (UDS) when the UDS was induced ^n vitro by either
N-acetoxy-2-acetylaminofluorene (NA-AAF) or ultraviolet radiation (UV). The 
mean level of NA-AAF-induced UDS was significantly increased (p<0.001) for 
the styrene-exposed workers when compared to the mean level for the
unexposed controls. There was no significant effect on UV-induced UDS from 
the in vivo styrene exposure. These results, in addition to lymphocyte 
cultures exposed ^n vitro to styrene, indicated to the investigators [137] 
that styrene exposure did not alter the efficiency of DNA repair synthesis, 
but rather predisposed lymphocytes to an increased risk for DNA damage from
subsequent exposures to genotoxic agents that are dependent on cellular
me tabolism.
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During 1977, Brooks et al. [91] studied 152 styrene-exposed workers (82 
women and 70 men) and compared them with 34 female workers with no current 
styrene exposure. The styrene-exposed workers made reinforced plastic 
boats. Some of the workers sprayed the styrene-containing resin; others 
performed hand lay-up or other functions. Workers in the comparison group 
produced electronic circuit boards and, although they were exposed to many 
chemicals, their TWA exposures were always much lower than the respective 
OSHA limits. Table IV-14 contains information that describes the workers 
from both the study and comparison groups.
71
TABLE IV-14
DESCRIPTION OF WORKERS FROM STUDY AND COMPARISON GROUPS
Sex
Study Group 
Female Male
Comparison Group 
All Female
Number 82 70 34
Mean age, years 41 37 38
Age range, years 19-72 18-76 19-56
Smokers 38 36 17
Exsmokers 7 18 1
Nonsmokers 36* 16 16
Average time on
present job, months 77 85 62
*One woman did not respond 
Taken from Brooks et al. [91]
Information about the workers was obtained from medical histories and 
physical examinations, psychomotor tests, CBCs, and pulmonary function 
tests. Additional information included data about the environmental 
-concentrations of styrene and other contaminants from three industrial 
hygiene studies, and concentrations of mandelic and phenylglyoxylic acids in 
urine and of styrene in the blood and breath. Brooks et al. [91] combined 
the environmental data from all three surveys to characterize the styrene 
exposure for each job category; these data are presented in Table IV-15.
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TABLE IV-15
STYRENE CONCENTRATIONS IN THE AIR OF THE STUDY FACTORY
8-hour TWA
Number of Styrene Exposure, ppm
Job Category Samples Mean + SD
Préfabrication 12 2.8 + 1.4
Gel coat spraying 6 68.5 + 59.7
Hand lay-up 63 83.4 + 42.7
Hand lay-up, other areas 18 25.7 + 26.2
Woodwork/uphols tery 11 3.4 + 2.1
Final assembly 18 3.2 + 1.8
Custom molding 18 6.5 + 3.9
Small boat assembly 4 4.1 + 1.0
Miscellaneous 2 3.9 + 3.1
SD = standard deviation 
Taken from Brooks et al. [91]
Data in Table IV-15 were obtained from the gas chromatographic analysis 
of 152 charcoal tube personal samples. In addition to these TWAs, the 
investigators recorded peak styrene concentrations in the range of 
200-800 ppm. These peaks occurred during spraying operations.
To describe styrene absorption and excretion more completely, Brooks 
et al. [91] determined the concentration of styrene in the workers' blood 
and expired air. A statistically significant relationship (r=0.79, p<0.001) 
between the post-shift concentration of styrene in exhaled air and the 
styrene concentration of inspired air over the workshift was found. The 
data indicated that an 8-hour TWA exposure at 50 ppm styrene would result in 
a post-shift expired breath concentration of about 5.7 yg/liter. There 
was also an excellent correlation (r=0.74, p<0.001) between the
concentration of styrene in inspired air during a workshift and that in 
venous blood at the end of a shift.
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Brooks et al. [91] found that the styrene concentration in the expired 
air increased rapidly during the first 2 hours of exposure, remained 
relatively constant during the shift, then decreased slowly over the next 16 
hours. The concentration of styrene in blood, however, rose continuously 
throughout the exposure period. Styrene concentrations in the blood 
declined to pre-shift values during the 16 hours following exposure [91].
Because of their hand lay-up work, the 152 workers studied had 
significant skin contact with the resin mixture [91], Based on complaints, 
41% of the styrene workers had a rash during the past year, and 19% had a 
rash at the time of the study, both significantly different (p<0.05) than 
the control group. These rashes were on the forearms in 29% of the 
workers; on the back of the hands in 15%; on the trunk in 14%; and on the 
upper arms in 12%. In the comparison group, only four workers (12%) 
reported a rash during the past year and one (3%) at the time of the study. 
A dermatologist diagnosed the styrene workers' rashes as follows: 18
workers with fibrous glass dermatitis, 6 with contact dermatitis, 7 with 
nonspecific dermatitis, 10 with acne vulgaris, and 3 workers with other
inflammations.
Medical histories revealed a lower incidence of colitis, kidney or 
bladder infections, and anemia among workers of the study group than in the 
comparison group. There were no significant differences in the incidence of 
eye, nose, and throat irritation between the study and the comparison 
groups, nor were there any significant differences in the incidence of 
symptoms indicative of cardiovascular or neurological damage, nor were the 
reproductive histories of the women in the study and comparison group
different.
Brooks et al. [91] did find statistically significant differences in the 
lung function of workers in the study and control groups. Seven workers 
(4.6%) in the study plant had FVC less than 80%, 7 (4.6%) had FEV^/FVC X
100 below 70, 13 (8.6%) had FEV]^  less than 80%, and 24 (15.9%) had forced
expiratory flow between 25 and 75% of vital capacity (FEF (25-75)), less 
than 70% of predicted values. No workers in the control plant had abnormal 
pulmonary function as indicated by FEV^/FVC, FVC, or FEV^; one of the 
subjects (2.9%) in the control group had a FEF (25-75) below 70%. Brooks et 
al. [91] concluded that since some subjects with abnormal pulmonary function 
were nonsmokers, the statistical difference between the study and control 
groups could suggest an occupational origin for the abnormality.
Possible acute effects of styrene exposure were studied by examining 
pre- and post-shift psychomotor performances of the exposed and comparison 
groups. The results of the tests for choice reaction time, Flanagan 
Coordination, Neisser letter search, and digit span were significantly 
worse for the styrene-exposed group as compared to the control group. 
However, as noted by the authors [91], a bias may have been introduced since 
a pre-requisite of employment at the control plant was the passing of a 
dexterity test. Performance on each test administered showed either no 
change or slight-to-moderate improvement post-shift in both the 
styrene-exposed group and the control group when compared to their pre-shift 
performances. When the styrene-exposed workers were divided into two
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groups, one exposed at a mean TWA concentration of about 9 ppm (range, 4-120 
ppm) and the other at about 82 ppm (range, 9-244 ppm), no significant 
difference between the groups was found in terms of effects of styrene on 
pre- or post-workshift performance of psychomotor tests.
Additional analysis (correcting for workers' ages) by Brooks et al. [91] 
of the psychomotor data, revealed a significant correlation (p<0.025) 
between decreased performance on the Neisser letter search test and duration 
of employment for the group with an average TWA styrene exposure of about 
82 ppm. For the same group, impaired performance of both the Digit Span 
test and the Flanagan Coordination test was associated with duration of 
employment, although it was not statistically significant. Based on these 
results, Brooks et al. [91] concluded that exposure to styrene at an average 
concentration of about 82 ppm impaired workers' performance on the Neisser 
letter search test and, possibly, tests of coordination and memory.
Brooks et al. [91] also determined the concentrations of mandelic and 
phenylglyoxylie acids in the urine of the styrene-exposed workers. When the 
log of the sum of the mandelic acid and phenylglyoxy lie acid concentrations 
in post-shift urine was plotted against the log of the TWA styrene 
concentration for that shift, the correlation coefficient r was 0.925 
(p<0.00001); when only the concentration of mandelic acid was used, the 
correlation coefficient was 0.93 (p<0.00001). There were also excellent
correlations between the log of the post-shift urinary mandelic acid 
concentration and the log of the post-shift venous blood styrene 
concentration (r=0.899, p<0.001) and the log of the styrene concentration in 
post-shift expired breath (r=0.877, p<0.001).
In 1979, Kjellberg et al. [392] studied 7 boat-fabrication shop workers 
and compared them with 7 workers in a mechanical industry in the same 
Swedish town. The boat workers were exposed to styrene while making the 
boats and to acetone during the cleaning of equipment. TWA exposures were 
found to be 3-14 ppm of styrene and 8-60 ppm of acetone. Of the behavioral 
tests applied, namely, reaction time, Bourdon-Wiersman, and reaction time 
additions, only the reaction time test showed a significant difference 
(p<0.05) between the RP/C workers and the comparison group. This reaction 
time test involved measurement of the time between the illumination of a 
lamp and the press of a button by the subject. Kjellberg et al. [392] 
concluded that work exposure had caused the decreased reaction times, but 
were unable to determine whether styrene, acetone, or their combined effect 
was responsible.
In a 1980 study of 27 British men engaged in boat building, Cherry 
et al. [138] found effects attributable to CNS depression. The 
styrene-exposed workers were compared to a control group of workers from the 
same plant, with no styrene exposures, of almost the same average age (23 
years in exposed workers vs. 26 years in referents). Personal TWA exposures 
averaged 117 ppm styrene in the morning and 52 ppm in the afternoon, for an 
overall average of 92 ppm. Blood styrene averaged 6.9 umol/liter in the 
exposed and 0.6 ymol/liter in the control workers; urinary mandelic acid
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averaged 581 timol/mmol creatinine in the styrene-exposed workers, with no 
value being given for controls. Changes in mood were reported in both 
groups, but more so in those workers exposed to styrene; changes in mood 
were correlated with blood styrene concentrations. The reaction times of 
styrene-exposed workers were slower than the referents in the morning, but 
their reaction time increased during the day so that in the afternoon they 
were similar to those of referents. The styrene-exposed workers also fared 
worse in other behavioral tests than did the controls, but the differences 
were minor. The styrene-exposed workers reported being more fatigued than 
did the men in the comparison group, and they also reported being more tired 
on Friday evening than on Monday evening.
In 1980, Hemminki et al. [139], described finding a greater number of 
spontaneous abortions among female chemical workers than would be expected 
from the rate among all Finnish women, with part of this excess occurring 
among styrene workers. The investigators [139] obtained information on 9,000 
female workers during the period 1973-1976 from union and national Registry 
files, and found that 52 of the women had reported spontaneous abortions. 
The national Registry was based on general hospital inpatients, not 
including aborting women not treated, women treated on an outpatient basis, 
or women treated in private hospitals, which provided only about 2.2% of the 
obstetrics-gynecology beds in Finland. Abortion rates were expressed as the
ratio of spontaneous abortions to pregnancies (SA/P) and as the ratio of
spontaneous abortions to births (SA/B). Hemminki et al. [139] used both 
ratios because they believed the former index underestimated the risk,
inasmuch as some induced abortions included in total pregnancies would have 
miscarried, and the latter index overestimated the risk because induced
abortions were not included; there is a high rate of induced abortions in 
Finland. The results of the study are shown in Table IV-16.
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TABLE IV-16
SPONTANEOUS ABORTIONS OF 
FINNISH CHEMICAL WORKERS IN 1973-1976
Branch of Employment Number of 
Spontaneous 
Abortions (SA)
SA X  100 
Pregnancies 
(SA/P)
SA X  100 
Births 
(SA/B)
All women in Finland 15,482 5.52 7.98
Union of Chemical Workers 52 8.54** 15.57***
Plastics Industry 21 8.94* 17.80***
Styrene Production and Use 6 15.00** 31.59***
Viscose Rayon Industry 9 11.25* 22.50***
Laundries 7 10.14 16.67*
Pharmaceutical Industry 5 10.20 22.72*
♦significant difference from "All women in Finland," p<0.05
**significant difference from "All women in Finland," p<0.01
***significant difference from "All women in Finland," p<0.001
Taken from Hemminki et al. [139]
There were statistically significant excesses in spontaneous abortions 
among members of the Union of Chemical Workers and among several subgroups. 
There was a significant excess among plastics workers, especially among 
styrene and viscose rayon workers. There were also excesses, significant 
only in terms of the SA/B index, among workers in laundries and in the 
pharmaceutical industry. There were 6 spontaneous abortions among styrene 
workers, resulting in an SA/P index of 15.00 (p<0.01) and an SA/B index of 
31.59 (p<0.001), the highest indices of any group tabulated in the report 
[139], compared to 5.52 and 7.98, respectively, in the overall Finnish 
population. Hemminki et al. [139] stated that the styrene workplaces 
included mainly reinforced plastics workshops.
In 1982, Harkonen and Holmberg [140] studied 67 female lamination 
workers occupationally exposed to styrene to evaluate the possible 
embryotoxic effects of styrene. The average age of the workers at the 6 
Finnish factories manufacturing reinforced plastics was 30 and ranged from 
19-40 years. The duration of past styrene exposure was 0.5 to 10 years, and 
averaged 4.5 years. No styrene measurements were made in this study, but 
the investigators [140] stated that in a previous study in the Finnish 
polyester plastics industry, the median TWA exposure to styrene in 
lamination work was 66 ppm. Each of the laminators was matched by age with 
textile or food production workers of a similar social class with no 
occupational solvent exposures. A questionnaire was personnally 
administered by the same interviewer during 1979-1980. The obstetric
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histories of the subjects (laminators) were divided according to the time 
prior to styrene exposure and the period of styrene exposure. The obstetric 
histories of the controls were likewise divided to correspond to the time 
periods of their age-matched exposed subjects. Table IV-17 presents data on 
pregnancies, births, spontaneous abortions, and induced abortions.
TABLE IV-17
NUMBER OF PREGNANCIES, BIRTHS,
SPONTANEOUS ABORTIONS, AND INDUCED ABORTIONS AMONG 
67 LAMINATION WORKERS AND MATCHED CONTROLS
Before Styrene Exposure During Styrene Exposure
Lamina tors Controls Laminators Controls
Pregnancies 48 (84) 48 (80) 12 (16) 20 (22)
Births 40 (69) 39 (67) 3 (4)* 14 (14)
Spontaneous abortions 8 (8) 5 (8) 3 (4) 4 (4)
Induced abortions 6 (7) 5 (5) 8 (8) 4 (4)
Note: The number of occurrences is given in parentheses.
♦different from controls, p<0.01
Taken from Harkonen and Holmberg [140],
Prior to the period of styrene exposure, the number of women with 
pregnancies, births, spontaneous abortions, and induced abortions (or the 
number of occurrences of each) did not differ significantly for the 
styrene-exposed and control groups. During styrene exposure, the number of 
pregnancies was not significantly different but the number of births among 
the exposed subjects was significantly less than the controls (4 vs. 14, 
p<0.01). One cause leading to this difference was the higher number of 
induced abortions (8 vs. 4); this difference, however, was not significant. 
There were two birth defects reported by both the laminators and the 
controls. The two groups did not differ in the use of contraceptives or 
drugs, but smoking and the consumption of alcohol during pregnancy were more 
common in the styrene-exposed group [140].
To summarize this subsection, these studies of workers in factories 
where styrene copolymers (mainly RP/C) were produced have demonstrated 
effects that have been attributed to styrene exposure despite potential 
exposure of the workers to other chemicals. It is likely that some of the 
reported effects on worker health such as eye and respiratory tract 
irritation, dizziness, headache, nausea, and feelings of intoxication were 
due to styrene exposures at peak concentrations. Some other effects such as
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abnormal EEG patterns, increased incidence of chromosomal aberrations and 
sister chromatid exchanges, increased incidence of spontaneous abortions, 
visuomotor inaccuracy, and impaired psychomotor performance have also been 
reported.
Epidemiological Studies
A retrospective cohort mortality study of the German styrene and 
polystyrene production plant previously described in the Clinical Studies 
Section [75,76,77], was reported in 1978 by Frentzel-Beyme et al. [78]. 
Airborne styrene concentrations in production areas were about 1 ppm in 1975 
[75], In the mortality study, records of 1,960 past and present workers 
were reviewed; causes of death as listed on death certificates of 74 
workers that died during 1956-1976 were compared with age-specific mortality 
of the population of the whole country. The proportion of deaths due to 
liver and digestive organ disease was higher in the styrene-exposed workers 
than in the overall population of the country. However, the investigators 
[78] did not identify their criteria of diagnosis of liver and digestive 
organ diseases. Frentzel-Beyme et al. [78] suggested that the higher 
incidence of liver disease might be because these workers were from the 
primary wine-producing region of the country, implying a greater than 
average alcohol consumption. However, no data on the alcohol consumption of 
either the styrene-exposed or unexposed groups were given. A total of 12 
deaths from cancer were recorded among the styrene workers (3 lung, 2 
stomach, 2 pancreas, 2 colon, 1 rectum, 1 spleen, and 1 probable kidney 
cancer). The incidence of these tumors did not differ from that of the 
overall population of the country. The proportion of deaths due to
cardiovascular diseases was also less than in the country as a whole.
In 1974, Maier et al. [84] reported the results of a proportional 
mortality study of a U.S. styrene and polystyrene plant previously described 
in the Clinical Studies Section [58,81,82,83,84,85,86,87], Production of 
styrene and butadiene monomers began at this plant in 1943, with butadiene 
produced until about 1950; since 1950, the principal product had been 
polystyrene [82], Prior to 1962, benzene was used as a raw material in the 
on-site production of ethylbenzene; subsequently, ethylbenzene for styrene 
monomer production had been shipped into the plant [141], In a 1973
industrial hygiene survey, Maier et al. [84] determined that exposures to 
styrene, benzene, ethylbenzene, or toluene were each usually less than 10
ppm. Death certificates for 46 workers from this plant who had died during 
the previous 5 years were analyzed by Maier et al. [84] by a comparison to 
the mortality of males, aged 60-64 years, in the nation as a whole. Of the 
46 deaths, 1 was a suicide and 4 were accidents. Grouping the remaining 41 
death certificates into either "Coronary Disease," "All Forms of Cancer," 
"Cerebral Vascular Disease," "Respiratory Disease," "Diseases of the
Digestive System," or "All Other" revealed no significant differences from 
the expected proportion of deaths in any classification. Due to the small 
number of deaths involved, as well as the use of mortality rates from males 
aged 60-64 years for comparison, this study is difficult to interpret.
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However, these findings were verified by a more extensive mortality 
study reported in 1978 by Nicholson et al. [83]. The vital status in 1975
of 560 men who were working in this factory on May 1, 1960 and who had been
employed at least 5 years was determined. The investigators [83] expected 
about 106 deaths but 83 were found. Deaths from "Heart and Circulatory
Diseases," "Respiratory Diseases," "Cancer," and "Other Causes" categories 
were not greater than expected. Because of potential benzene exposures,
special attention was given to leukemia as a cause of death. Two cases of 
leukemia and one lymphoma were recorded on the 83 death certificates. Death
certificates provided by the company of 361 other workers who had been
employed at this factory for 6 months or more were examined, and five 
additional cases of leukemia and four additional cases involving the lymph 
system were recorded on these. Although the information available from the 
361 randomly collected death certificates was "suggestive" of an excess risk 
of death from leukemia or lymphoma in this factory, Nicholson et al. [83]
concluded that the data was not definitive.
In 1980, Ott et al. [31] studied the mortality rate of workers at four 
-different locations of a U.S. manufacturer of styrene and styrene products. 
Work activities were mainly in styrene production, polystyrene production, 
copolymerization of styrene with butadiene or aerylonitrile, color mixing, 
resin extrusion, and in support activities such as research, pilot plant 
development, and product development. Based on surveys conducted between 
1962 and 1975, estimated TWA styrene exposures were all below 10 ppm,
including one survey in which there were excursions to 50 ppm. In some
units, there were exposures to benzene which were estimated to have been 
below 15 ppm during the period 1953-1972, but much higher earlier. There 
were other exposures recorded, such as ethylbenzene (less than 10 ppm),
ammonia (about 15 ppm), acrylonitrile (less than 10 ppm), vinylidene 
chloride (less than 1 ppm), formaldehyde (about 3 ppm), cleaning solvents, 
and various pigments and dyes.
The earliest operation was 40 years old, but how many, if any, workers 
had worked with styrene that long was not stated; however, 2,904 workers had 
been employed for at least 1 year in styrene operations. Of the total
cohort, 2,360 workers (81%) were from the company's Michigan location, with 
the remaining workers from plants in Texas, Connecticut, and California. 
Verification of vital status was completed for all but 88 former workers 
[31].
During the period 1940-1975, there were 303 deaths found among styrene 
workers (professional and nonprofessional research workers, supervisors, and 
production workers), compared with 425 expected in the U.S. white male 
population; this total of 303 did not include 17 deaths among 164 former 
workers exposed to arsenic, asbestos, or high levels of vinyl chloride. 
There were 58 deaths from the "All Malignant Neoplasms" category compared 
with 76.5 expected. Except as discussed below, the number of deaths from 
specific causes did not exceed thé expected number. There was a slight 
excess of deaths from the category "Bronchitis, Emphysema, and Asthma" (10 
observed vs. 7.5 expected), "Malignant Neoplasms of the Lymphatic and
80
Hematopoietic Tissue except Leukemia" (7 observed vs. 5.3 expected), and 
"Leukemia" (6 observed vs. 3.4 expected). In addition to the 13 cases in 
which leukemia or lymphoma (malignant neoplasms of the blood forming organs) 
were reported as the cause of death, there were 2 cases where the presence 
of leukemia or lymphoma was mentioned on the death certificate but where
another cause of death was listed, and 6 cases identified as still living. 
The incidence of lymphocytic leukemia cases were significantly greater 
(p<0.05) than expected on the basis of age-specific incidence rates from the 
Third National Cancer Survey (7 observed vs. 1.6 expected). Of these cases, 
5 cases (1 of whom was still living) vs. 0.26 cases expected (p<0.05) 
occurred in workers in operations involving colorant blending and roll
compounding or extrusion of plastics, areas where polymer dusts, solvents, 
colorants, and extrusion fumes composed of vapors including styrene and 
ethylbenzene were present [31].
The production and nonprofessional research workers (2,310 men) were 
also studied separately. There were 282 deaths in this group vs. 357.8 
expected from U.S. white male data and 287.6 expected from data published in 
1954 on workers from the company's Michigan location. (There was an overlap 
between the two cohorts as 1,333 of the 8,171 workers from the 1954
comparison group were included in the later study group.) Of the 282 
deaths, 55 were due to "Malignant Neoplasms," vs. 64.2 expected in the U.S. 
population and 65 in the 1954 company comparison group. There were 6 deaths 
from "Leukemia," a significant difference (p<0.05) from the 1.6 expected in 
the company comparison group but not from the 2.9 expected in the U.S.
population [31].
In summary, mortality was less than that of the corresponding white male 
population. Deaths due to malignant neoplasms were fewer than expected, but 
an increase in lymphatic leukemia was observed among a subgroup of workers 
who had exposures to polymer extrusion fumes (including styrene), solvents, 
and colorants. However, the etiology of the lymphatic leukemia could not be 
established by Ott et al. [31],
In 1978, Ahlmark [142] described the cancer incidence and mortality 
among a group of workers in Sweden who were exposed to styrene in the
manufacture of reinforced plastics. This was a retrospective cohort study
in which entry into the cohort was defined by the date of first employment. 
From as many reinforced plastics companies as could be located and as were 
willing to participate, persons working with styrene up to the year 1970 
were identified. Sufficient information to use in the study was found on
1.114 men and 91 women. Exposure information for these workers was not
provided, but Ahlmark [142] estimated, from information on reinforced
plastics operations in Sweden, that mean styrene exposures were 250-300 ppm 
in the late 1960s and early 1970s and were probably higher earlier. The
1.114 men ranged in age from the late teens to the 70's and the 91 women 
from the 20's to the 60's. Twelve deaths from cancer were found in the 
study population from the Social Welfare Board Cancer Register for 1959-1976 
and the Central Statistical Bureau Mortality Register for 1972-1976, which 
were less than the 16.6 expected [142].
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While no excess of cancer was found in this group of workers, exposed to 
styrene at concentrations estimated to have been 250-300 ppm and higher, 
Ahlmark [142] pointed out that latency periods for many of these workers 
were not great, so, if styrene were a carcinogen, more cases would be 
expected later. The problem of varying latency was handled in the 
calculations by computing person-years of employment in each age category in 
the study cohort. However, only 472 workers (39%) in the cohort had a 
latency period of 11 years or more, so, although not given, the number of 
workers with more more than 20 years since first exposure was probably small.
Uptake, Metabolism, and Elimination
Studies were reported by Bardodej et al. [143] in 1961 and Bardodej 
[144] in 1964 on the uptake, metabolism, and elimination of inhaled styrene 
by humans. These investigations were later summarized in 1966 and 1970 by 
Bardodej and Bardodejova [100,145], Human volunteers, with no history of 
occupational styrene exposure, were experimentally exposed to styrene in a
closed chamber with no provisions for changing chamber air. To study
styrene absorption, Bardodej [144] measured each subject's minute volume 
during exposures to styrene at 21, 49, 106, and 188 ppm. The range of
minute volumes was 6-40 liters. Styrene vapor concentrations inside the 
chamber and in the breath were monitored by ultraviolet spectrophotometry. 
The percentages of styrene retained by the lungs were calculated from 
styrene concentrations in the inhaled and the exhaled air. Over the range 
of styrene concentrations studied, the subjects retained about 60% of the 
inhaled styrene regardless of minute volumes or duration of exposure. When 
the subjects were removed from the test atmosphere, styrene concentrations 
in exhaled air decreased within seconds to less than half the levels found 
immediately after removal from exposure.
To study styrene metabolism, urine was collected from subjects exposed 
at 22, 129, and 235 ppm for 8 hours and analyzed for styrene and its
metabolites. Styrene concentrations were below the detection limit of the 
photometric method used. Urine samples were subjected to paper 
chromatography, using several liquid phases and reagents for detection of
mandelic, styrene thiolic, hippuric, and phenylglyoxylie acids, 
phenylglycol, phenylglycol glucuronide, and omega-hydroxyacetophenone
[144]. The presence of phenylglycol, the glucuronide of phenylglycol, 
omega-hydroxyacetophenone, and styrene thiolic acid could not be
demonstrated in the urine of exposed subjects, nor could an increase in
hippuric acid concentration [143]. Styrene oxide could not be found in the 
urine samples by using a spectrophotometric method. Both mandelic and 
phenylglyoxylie acids were found and confirmed.
Urinary mandelic and phenylglyoxylic acids accounted for 85% and 10% of 
the absorbed styrene, respectively. Eighty percent of orally administered 
mandelic acid was excreted as such, with 15 percent excreted in the urine as 
phenylglyoxylic acid [144], Concentrations of urinary mandelic acid of
subjects at the end of 8-hour exposures to styrene at 22, 129, and 235 ppm
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averaged about 500, 1,350, and 2,700 mg/1, respectively [143,144]. After an 
8-hour exposure to 22 ppm, urinary mandelic acid, expressed as the ratio of 
mandelic acid to creatinine, was maximal at the end of exposure (i.e., 0.4) 
and declined linearly over the next 20 hours to about 0.06.
In 1965, Fiserova-Bergerova and Teisinger [146] reported the retention 
of styrene in subjects exposed at 24 ppm. Ultraviolet and polarographic 
methods (which they found equivalent) were used to analyze for styrene in 
inhaled and exhaled air during 2- and 5-hour exposures. In all experiments, 
the subjects exhaled through the mouth; they inhaled through the nose in 
some experiments and through the mouth in others. The average styrene 
retention from the very beginning of exposure was 66% following nasal
inspiration and 59% after oral inspiration, and did not change during the 2 
or 5 hours of exposure. In the analysis of a single deep breath, alveolar 
styrene concentrations were found to be about 6.2% of the inhaled 
concentration; after an expiration pause (30 seconds), alveolar
concentrations were about 5.5%. This 'indicated that transfer of styrene 
from the blood to the lungs was minor. No styrene was found in exhaled air 
one minute after removal from exposure [146],
Studies of pulmonary absorption and the elimination of styrene inhaled 
at 70, 103, 115, 200, and 206 ppm for 4 or 8 hours were reported by
Fernandez and Caperos [147] in 1977 and Caperos et al. [148] in 1979.
Pulmonary ventilation, respiratory rate, and alveolar concentrations of 
styrene were monitored frequently during the exposures. Removal of styrene 
from inhaled air by blood was practically constant throughout all of the 
exposures. The amount of styrene absorbed ranged from 90.5% during exposure
at 70 ppm for 4 hours to 86.8% during exposure at 206 ppm for 8 hours. The
styrene analytical method (gas chromatography) under their sampling
conditions had a lower limit of detection of 0.01 ppm in 25 ml of expired 
air. Some styrene was found in alveolar air for about a week after the
exposures. The calculated total amount of styrene eliminated by the lungs
accounted for 2.6% (1.5-4.4%) of that absorbed, independent of exposure 
conditions [147], On the average 54% was excreted in the urine as mandelic 
acid and 38% as phenylglyoxylic acid. Half of the urinary mandelic acid and 
one quarter of the phenylglyoxylie acid formed was excreted during the 
8-hour exposure to 103 or 206 ppm styrene with the rest being excreted 
within 3-5 days [148],
After administering styrene at 50 and 150 ppm through a mouthpiece, 
Astrand et al. [88] in 1974 measured its concentrations in the alveolar air 
and arterial and venous blood of human volunteers. These measurements, 
along with routine cardiac and respiratory tests, were conducted on 2-14 
male subjects who were 21-28 years old. Measurements were made at rest and 
after exercise on a bicycle ergometer at 50, 100, and 150 Watts (W) to study 
the effects of various workloads on styrene uptake. Mixtures of air that 
contained 4% carbon dioxide and various amounts of styrene were used to 
observe the effects of increased respiration on styrene metabolism without 
the complicating effects of an increased cardiac rate. The styrene 
concentrations found in the alveolar air and in the arterial and venous 
blood under different conditions of exposure are presented in Table IV-18.
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TABLE IV-18
AVERAGE STYRENE CONCENTRATIONS IN ALVEOLAR AIR AND BLOOD 
OF SUBJECTS EXPOSED TO STYRENE AT 50 AND 150 ppm
Exposure Conditions S tyrene Concentration (ppm)
S tyrene 
(ppm)
Workload C02
(w)
N* Alveolar
Air
Arterial
Blood
Venous
Blood
50 0 No 6 8.8 0.5 0.3
50 50 No 6 9.5 1.9 1.4
150 0 No 14 23.0 1.8 1.0
150 0 Yes 2 26.3 5.3 2.4
150 50 No 11 29.9 6.5 4.7
150 50 Yes 2 28.8 12.3 7.7
150 100 No 4 32.5 11.6 7.9
150 150 No 4 35.4 15.9 12.4
♦Number of subjects
Taken from Astrand et al. [88]
Pulmonary ventilation, heart rate, and oxygen uptake were unaffected by 
exposure to styrene. Alveolar styrene concentrations rose only slightly 
while the arterial concentrations almost tripled in response to a 50-Watt 
workload. The alveolar styrene concentration reached a plateau after only 1 
minute of exposure, but the arterial styrene concentration increased during 
the entirety of each 30-minute exposure period. Further increases in the 
arterial styrene concentrations also occurred after exposure to styrene in 
air containing 4% carbon dioxide [88].
Because of the poor relationship between alveolar and arterial styrene
concentrations, Astrand et al. [88] concluded that alveolar air was a poor
indicator of the extent of exposure to styrene vapor. Astrand et al. [88]
recommended that a fingertip blood sample be used to evaluate styrene uptake 
because styrene concentrations in arterial and capillary blood were in very 
good agreement. Urinary mandelic acid was determined colorimetrically before 
exposure and at 3-hour intervals for 24 hours after removal from exposure. 
The mandelic acid concentrations peaked 3-5 hours after exposure and fell to 
pre-exposure values 9-13 hours after concluding exposure. In one 
experiment, the concentrations of styrene in inspired and expired air were 
continuously measured in two individuals at rest during four consecutive 
30-minute styrene exposures at 50, 150, 250, and 350 ppm. More than
two-thirds of the styrene inhaled during each 30-minute period was retained 
by the subjects. The amount of styrene absorbed was 750 mg during this
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sequential 2-hour exposure that averaged 200 ppm of styrene, and it was 
determined that about 50% of the amount absorbed was excreted as mandelic 
acid. Because a nonspecific method was used for determining mandelic acid,
it is likely that not all of the mandelic acid excreted was measured.
Astrand et al. [88] concluded that measurement of urinary mandelic acid 
would not provide an accurate indication of styrene exposure because there 
was a large variation between subjects at low exposures. However, with the 
nonspecific method used to determine mandelic acid, background values were 
large and variable; consequently, slight differences in mandelic acid 
concentrations might not have been detectable.
Hake et al. [70] in an inhalation study summarized earlier in the 
Experimental Exposures Section, concluded that blood analysis, metabolite to 
creatinine ratio in 24-hour urine samples, and alveolar breath analysis 15 
minutes after exposure were all useful indicators of styrene exposure, but 
they preferred breath analysis provided analysis could be performed the same 
day as exposure occurred. Such a sample taken 15 minutes after exposure
and containing more than 2.8 ppm styrene indicated to the investigators [70]
a styrene burden injurious to health; this was associated with changes in 
EEGs, visual evoked response, and pulmonary function, and in the onset of 
such symptoms as headache, dizziness, and irritation of the eyes and upper 
respiratory tract. The experimental exposures resulting in styrene 
concentrations of 2.8 ppm in alveolar air (15 minutes after exposure) were 
100 and 125 ppm. No subject exposed at 20 ppm had more than 0.8 ppm styrene 
in his alveolar breath 15 minutes after exposure.
Gotell et al. [35], in field studies of RP/C production workers 
summarized earlier in the Clinical Studies Section, collected breath samples 
15 minutes, 2 hours, and 5 hours after the end of the workday and analyzed 
them for styrene by gas chromatography using a flame ionization detector. 
The workers were divided into three groups based on TWA exposures to 
styrene: (I) 235-292 ppm, (II) 89-139 ppm, and (III) 17-32 ppm. When the
concentrations of styrene in expired air were plotted against the time after 
exposure, there was a characteristic rate of styrene excretion for each 
group based on the level of exposure. Five hours after exposure, the 
concentration of styrene in expired air was about 0.9 ppm for group I, 
0.3 ppm for group II, and 0.2 ppm for group III [35].
Urine samples were collected immediately after work for measurement of 
mandelic and phenylglyoxylie acids by the methods of Ohtsuji and Ikeda [121] 
with the results adjusted to a urine specific gravity of 1.024. Control 
values in 27 nonexposed men were: mandelic acid, 78-434 mg/1; and
phenylglyoxylie acid, 20-196 mg/1 [35]. The overall linear correlation 
coefficients (Groups I, II, and III) with 8-hour TWA styrene exposure 
concentrations were 0.75 for mandelic acid and 0.36 for pheny lglyoxylic 
acid. However, the respective correlation coefficients for workers exposed 
at 8-hour TWA concentrations ranging from 17-139 ppm (Groups I and II) were 
0.96 and 0.85, while for the workers in Group III exposed at higher 
concentrations (i.e., 235-292 ppm), the correlation coefficients were -0.93 
and -0.95. These negative correlation coefficients found at the higher
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styrene concentrations may reflect an asymptotic curve rather than a real 
reduction in mandelic or phenylglyoxylie acid concentration. Gotell et al. 
[35] plotted three linear regression lines to explain the relationship 
between concentrations of metabolites and airborne styrene. Visual 
inspection of these plots suggests that the data might best be fitted by a 
hyperbola. If so, the negative regression would be better expressed as the 
upper end of such a curve. If these data are indeed properly described by a 
hyperbola, it appears that excretion of these metabolites approaches a 
maximum (asymptotically) with increasing dose of absorbed styrene. Whether 
the limitation is metabolic or excretory is not established, though 
metabolic limitation seems a more likely explanation.
In 1978, Gngstrom et al. [149] found styrene in subcutaneous adipose 
tissue in volunteer subjects exposed to styrene vapor. Seven male subjects, 
22 to 30 years of age, were exposed for two hours to 50 ppm of styrene 
through a breathing valve and mouthpiece with 30 minutes of rest and three 
30-minute work periods on a bicycle ergometer at intensities of 50, 100, and 
150 Watts. Average styrene uptake was 490 mg, corresponding to 63% of the 
amount inspired. Styrene uptake was 5-6 times higher during heavy work than 
at rest. The average total amount of styrene expired during the 19 hours 
following exposure was about 3% of the amount retained during exposure.
Needle biopsy of subcutaneous adipose tissue was performed on all of the 
subjects before exposure and 0.5, 2, 4, and 20-24 hours after the exposure. 
In addition, four of the men were subjected to biopsies during the 1-2 weeks 
following exposure. Styrene concentrations in the adipose tissue of the 
subjects were determined after evaporation of the solvent at 150°C into 
nitrogen which was continuously exchanged. The gas was collected in 30-ml 
glass syringes and assayed with gas chromatography. About 24 hours after 
exposure the average concentration of styrene in adipose tissue was about 
the same level as 2-4 hours after exposure, i.e., about 3.5 mg/kg. 
Retention of styrene was noticed as late as 13 days after the 2-hour 
exposure. The investigators [149] estimated the half-life of styrene in 
adipose tissue to be 2-4 days.
Also in 1978, Engstrom et al. [150] conducted a similar investigation of 
three males occupationally exposed to styrene during the processing of 
polyester tanks. The TWA exposures of the workers were 8, 15, and 20 ppm.
The average daily uptake of styrene was estimated to be 193-558 mg. On 
Monday morning styrene concentrations in adipose tissue were 2.8-8.1 mg/kg 
and on Friday afternoon were 4.7-11.6 mg/kg. The concentrations were higher 
in the two workers with the higher exposures (i.e., 15 and 20 ppm) of longer 
duration (several years) as compared to styrene adipose tissue 
concentrations in the other worker who had been employed only 2 weeks with 
an exposure of 8 ppm . Both of the workers with several years of exposure 
to styrene had a considerable amount of body fat (27 and 41 kg, 
respectively) as estimated by an anthropometric method. The half-lives of 
styrene in adipose tissue for these two workers were calculated by Engstrom 
et al. [150] to be 5.2 and 2.8 days, respectively.
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The percutaneous absorption of undiluted and aqueous solutions of 
styrene was studied in 1968-1969 by Dutkiewicz and Tyras [151,152,153], 
With undiluted styrene, either 0.1 ml (88.8 mg) or 0.2 ml (176.8 mg) was 
applied to the forearms of each of seven subjects. A watch glass was
pressed tightly to the skin, and the amount of styrene absorbed was 
calculated from the difference between the amount applied and the amount
recovered after 8-15 minutes. Styrene that was removed from the skin with
gauze and from the gauze and watch glass with glacial acetic acid was
analyzed colorimetrically. On the average, styrene was in contact with 
17.3 sq cm of skin for 11.1 minutes, and 39.4 mg of styrene was absorbed. 
The average calculated rate of absorption in the seven subjects was 11.9 
mg/sq cm/h [151].
In the study of styrene diluted with water, the difference in the
concentration of the solution before and after immersing one hand for an 
hour was directly determined with an ultraviolet spectrophotometer. 
Evaporation of the solution was prevented by enclosing the beaker and hand 
in a polyethylene bag. With styrene concentrations of 67.5-264.0 mg/1 of
water, 14 observations were made on 6 subjects. The rates of styrene
absorption increased linearly with styrene concentration. Rates of 38-184 
pg/sq cm/h were estimated [151].
Dutkiewicz and Tyras [151] also evaluated urinary mandelic acid and 
styrene in exhaled breath in the study of percutaneous absorption of 
styrene. Four subjects each immersed both hands in aqueous styrene 
solutions (215-220 mg styrene/liter of water) for 2 hours. During the 
ensuing 24 hours, mandelic acid was determined polarographically after 
conversion to benzaldehyde. The rate of excretion of mandelic acid in urine 
decreased exponentially from 3-4 mg/h initially to about 0.7 mg/h at 18-24 
hours. On the average, the subjects excreted about 40 mg of mandelic acid 
in 24 hours or only about 13% of the estimated average amount of styrene
absorbed. Traces of styrene were detected in expired air of subjects who 
had absorbed about 200 mg of styrene. The investigators [151] concluded 
that contact of both hands with undiluted styrene for 1.5 minutes or with 
saturated aqueous solutions for 1 hour could result in absorption of styrene 
equivalent to that absorbed by a worker exposed to airborne styrene at 12 
ppm for 8 hours. Whether data from absorption of styrene through the hands 
can be quantitatively applied to other skin areas is not clear, but at least 
the data [151] clearly demonstrate that styrene can penetrate human skin.
In 1978, Riihimaki and Pfaffli [154] described the percutaneous 
absorption of airborne styrene in two male subjects. These subjects were 
exposed to styrene vapor at a concentration of 600 ppm for 3.5 hours. Each 
wore socks, pajamas made of a thin cloth, and, to prevent absorption through 
the lungs, a full-facepiece positive pressure respirator that was monitored 
for proper operation. They exercised at 100 Watts for 10 minutes of each 
hour on a bicycle ergometer, and at all other times remained sedentary; this 
exercise made them perspire for about 15 minutes. Based on amounts of 
urinary metabolites (mandelic, phenylglyoxylic, and methylhippuric acids) 
and styrene in expired air, the amount of styrene absorbed through the skin
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during the exposure averaged 576.1 ymoles for the two subjects. This
amount was estimated to be 19% of the amount that would have been absorbed
through the lungs at the same concentrations, assuming a 60% retention rate
for styrene at 600 ppm. This amount was twice that absorbed by the lungs 
during the exposures of three subjects at 10 ppm (576.1 vs. 288.1 
Vimoles). The small number of subjects and the variability in the data
preclude definite conclusions from this experiment, other than to infer that 
styrene vapor can penetrate intact skin, albeit inefficiently. A question 
should also be raised about the degree of reliance to be placed on 
respirators by those working in high concentrations, such as some work in 
enclosed spaces.
In 1980, Brooks et al. [155] designed a study to determine whether 
styrene absorption through the skin results in measurable changes in 
biological indicators of styrene exposure. Eight female workers engaged in 
hand lay-up operations in fibrous glass boat production during which 
extensive styrene skin contact occurred were studied. Measurements of 
expired breath and blood styrene levels and urinary levels of mandelic and 
phenylglyoxylie acids were made during 4 consecutive days using different 
experimental conditions including either (1) gloves and protective clothing 
alone, (2) respirator alone, (3) gloves, protective clothing, and 
respirator, or (4) no respirator, gloves, or protective clothing. TWA 
airborne styrene levels ranged from 71-91 ppm, as determined with charcoal 
tubes and gas chromatographic analysis. Levels of styrene in venous blood 
and expired breath and excretion of urinary mandelic and phenylglyoxylic 
acids were no different when gloves and protective clothing were used as 
protection compared to when no gloves, protective clothing, or respirators 
were used. Significant reduction in all biological indices studied occurred 
when respiratory protection was used. Brooks et al. [155] concluded that 
percutaneous absorption of styrene was not a significant exposure source and 
did not significantly contribute to the body burden of styrene in the RP/C 
workers studied who were engaged in hand lay-up operations. The lack of
apparent skin absorption was attributed to possible differences in transport 
phenomena attendant to the use of polyester resins in combination with 
styrene, which might have inhibited percutaneous absorption [155]. However, 
Dutkiewicz and Tyras [151] as previously discussed, determined that only 13% 
of the styrene absorbed percutaneously with hands immersed in an aqueous 
solution was eliminated as mandelic acid.
In 1978, Guillemin and Bauer [156] reported a study of the excretion of
urinary mandelic and phenylglyoxylic acids after experimental exposures to
styrene. Nine healthy male volunteers, 21-34 years old, with normal
heights, weights, and vital capacities and with no current styrene exposure 
were used, some several times. The study was conducted in an experimental 
chamber that had been previously described by Guillemin [157], It had an 
internal volume of 10 cu m, and there were provisions for controlling the 
temperature (22°C) and humidity (50%) and for exchanging the air. Styrene 
concentrations inside the chamber were monitored continuously with a total 
hydrocarbon analyzer and periodically by gas chromatography. The 
experimental parameters are shown in Table IV-19.
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TABLE IV-19
STYRENE EXPOSURE SCHEDULE OF HUMAN VOLUNTEERS
Number of Number of Duration of Concentration
Subjects Exposures Exposure (h) (ppm)
5 4 4 99-122
4 1 4 200
4 2 8 42-49
9 3 8 100-112
3 2 3.5 99-101
Taken from Guillemin and Bauer [156]
All urine specimens were collected during exposures and for up to 4 days 
afterwards; urinary mandelic and phenylglyoxylie acids were determined gas 
chromatographica1ly. The urine samples were divided into two portions with
one being analyzed directly for mandelic acid. Phenylglyoxylie acid in the 
second portion was found indirectly after it was converted to the trimethyl 
silyl derivative of mandelic acid as described by Guillemin and Bauer [158] 
and total mandelic acid representing initial mandelic acid and phenylglyoxylie 
acid was determined. Both mandelic and phenylglyoxylie acids were found in 
the urine of subjects within an hour of the beginning of styrene exposure 
[156]. After the 8-hour exposure at 100-112 ppm, the urinary mandelic acid 
concentration decreased from 1,000 mg/g of creatinine at the end of exposure 
to about 10 mg/g of creatinine 56 hours later. Urinary excretion of 
phenylglyoxylie acid decreased exponentially during the 48 hours after 
exposure.
Urinary mandelic and phenylglyoxylie acid excretion data obtained from 
individuals exposed to styrene for 8 hours at 50 ppm were indistinguishable 
from those obtained from individuals exposed for 4 hours at 115 ppm. Thus, 
these investigators [156] showed that urinary mandelic acid concentrations 
reflect exposure dose (as estimated by the product of exposure concentration 
and duration) rather than exposure concentration. Ratios of mandelic acid to 
creatinine calculated for urine samples collected at the end of exposure and 
14 hours later, and total mandelic acid in all urine collected over a 4-day 
period after exposure were correlated to the exposure dose in terms of ppm 
times hours of exposure with coefficients of 0.706, 0.668, and 0.873,
respectively. The data demonstrated that there is no advantage to measuring 
phenylglyoxylie acid or mandelic plus phenylglyoxylie acids over measuring 
mandelic acid only.
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In 1974, Ideda et al. [159] measured urinary metabolites of styrene in 
six workers who were exposed to styrene during the production of electric 
motor parts in a Japanese factory. On the day the workers were studied, 
they were exposed at 50-200 ppm for two 80-minute periods with a 200-minute 
nonexposure interval. One week later, five of these same workers and an 
additional worker were studied. The workers were exposed that day to 
styrene at 4-60 ppm for 120 minutes. Styrene concentrations in the 
workplace were determined by colorimetric detector tubes and by gas-liquid 
chroma tography.
Urinary hippuric acid concentrations following the first exposure 
(50-200 ppm) reached a maximum a few hours after urinary excretion of 
mandelic and phenylglyoxylic acids had returned to normal. At the lower 
level of exposure (i.e., 4-60 ppm) a week later, no increase in hippuric 
acid above control values could be detected. The reason for the delayed 
hippuric acid excretion was considered by Ikeda et al. [159] to be due to a 
slow step in the conversion of mandelic and pheny lglyoxylic acids to 
hippuric acid. The half-lives of mandelic and phenylglyoxylic acids, and 
therefore styrene, were estimated to be about 8 hours [159],
In 1981, Pfaffli et al. [160] verified by gas chromatography/mass 
spectrometry the presence of 4-vinylphenol in the urine of workers in two 
reinforced plastics factories where average airborne styrene concentrations 
were about 130 ppm. The correlation between mandelic acid and 4-vinylphenol 
was good (r=0.93); increasing excretion of mandelic acid was also 
accompanied by increasing amounts of 4-vinylphenol in the urine. The 
presence of 4-vinylphenol was not detected in urine of unexposed 
individuals. The presence of 4-vinylphenol in the urine of styrene workers 
suggested to the investigators [160] that styrene was also metabolized via 
arene oxidation, with styrene-3,4-oxide probably functioning as an 
intermediate. Styrene-3,4-oxide was found in 1982 by Watabe et al. [161] to 
have potent mutagenicity and cytogenicity toward Salmonella typhlmurium 
strain TA 100. However, other pathways to 4-vinylphenol are possibly 
present which do not involve arene oxides. The metabolic pathway via the 
oxidation of the vinyl group is at least quantitatively the more important 
route as compared to arene oxidation, since the amount of 4-vinylphenol was 
only about 0.3% of the amount of mandelic acid.
Analytical methods for determining mandelic acid and relationships 
between urinary mandelic acid concentrations and TWA exposures of workers to 
styrene are discussed further in Chapter V and in Appendix II.
EFFECTS ON ANIMALS
Toxicity
Effects of styrene vapor exposures at 1,300-10,000 ppm on rats, guinea 
pigs, rabbits, and monkeys were reported in 1942 by Spencer et al. [53], 
The styrene contained 0.01% 4-tert-butylcatechol. Rats (405) and guinea
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workplace were determined by colorimetric detector tubes and by gas-liquid 
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acid above control values could be detected. The reason for the delayed 
hippuric acid excretion was considered by Ikeda et al. [159] to be due to a 
slow step in the conversion of mandelic and pheny lglyoxylic acids to 
hippuric acid. The half-lives of mandelic and phenylglyoxylic acids, and 
therefore styrene, were estimated to be about 8 hours [159],
In 1981, Pfaffli et al. [160] verified by gas chromatography/mass 
spectrometry the presence of 4-vinylphenol in the urine of workers in two 
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accompanied by increasing amounts of 4-vinylphenol in the urine. The 
presence of 4-vinylphenol was not detected in urine of unexposed 
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suggested to the investigators [160] that styrene was also metabolized via 
arene oxidation, with styrene-3,4-oxide probably functioning as an 
intermediate. Styrene-3,4-oxide was found in 1982 by Watabe et al. [161] to 
have potent mutagenicity and cytogenicity toward Salmonella typhlmurium 
strain TA 100. However, other pathways to 4-vinylphenol are possibly 
present which do not involve arene oxides. The metabolic pathway via the 
oxidation of the vinyl group is at least quantitatively the more important 
route as compared to arene oxidation, since the amount of 4-vinylphenol was 
only about 0.3% of the amount of mandelic acid.
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The styrene contained 0.01% 4-tert-butylcatechol. Rats (405) and guinea
9 0
pigs (410) were exposed to a series of concentrations during single 
exposures of various lengths of time. After exposure, the animals were 
observed for 2-4 weeks, after which some were sacrificed for microscopic 
study. The responses of animals during exposure to styrene are presented in 
Table IV-20.
TABLE IV-20
EFFECTS ON RATS AND GUINEA PIGS DURING INHALATION OF STYRENE
S tyrene Exposures Observation During Exposure
ppm Hours to 100% Mortality
Rats Guinea
Pigs
1,300 >40 40 Rubbing of eyes and nose, violent scratching 
of face, lacrimation, nasal discharge, 
salivation, general weakness, unsteadiness 
after 12-30 hours
2,000 >30 30 As above, but becoming marked after 24-30 
hours. Some animals lost consciousness
2,500 21 14 Weakness and stupor followed by incoordination, 
loss of equilibrium, tremors, unconsciousness 
after 10-12 hours
5,000 8 8 Weakness, immediate loss of equilibrium, 
tremors, clonic convulsions, 
unconsciousness after <1 hour
10,000 3 3 Same as above, with more rapid onset
Taken from Spencer et al. [53]
Local irritation of the eye, nose, and throat and CNS depression 
manifested by incoordination, loss of equilibrium, tremors, and loss of 
consciousness were observed during exposure [53]. Findings from examination 
of the lungs included congestion, frequent hemorrhage, edema, exudation, and 
varying degrees of leukocytic infiltration. The severity of these effects 
was greater in guinea pigs than in rats and depended on styrene 
concentration and duration of exposure. Mild injury to the liver, 
particularly to the parenchymal cells, and to the kidneys was frequently
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observed in rats. Most deaths that occurred during single exposures were 
attributed to the action of styrene on the central nervous system; delayed 
deaths were attributed to pneumonia secondary to lung irritation.
The authors [53] concluded that because of the irritating properties of 
styrene at 1,300 ppm, it was unlikely that humans would tolerate this 
concentration very long, and that the irritation would serve as an adequate 
warning of hazardous concentrations.
Guinea pigs, rats, rabbits, and monkeys were exposed to styrene for 7-8 
hours a day, 5 days a week for up to 264 exposures by Spencer et al. [53] 
(see Table IV-21).
TABLE IV-21
EFFECTS OF CHRONIC STYRENE INHALATION ON LABORATORY ANIMALS
Animal S tyrene No. of Effects
Species No. (ppm) Exposures
Rat 28 2,000 105 Marked eye and nose irritation, 
listlessness, poor weight gain
Guinea pig 12 2,000 98 Marked eye and nose irritation, 
listlessness, poor weight gain
Rabbit 1 2,000 126 None
Ra t 50 1,300 130-139 Eye and nose irritation, increased 
kidney and liver weight
Guinea pig 94 1,300 130-139 Pronounced lung irritation with 
congestion, hemorrhage, edema, 
exudation, and a general acute 
inflammation; 10% mortality after 
first few exposures; poor weight 
gain in survivors
Rabbit 12 1,300 45-264 None
Monkey 4 1,300 262-264 None
Guinea pig 24 650 23-130 None
Taken from Spencer et a l . [53]
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The authors [53] found no signs of intoxication in rabbits and monkeys 
after repeated inhalation of styrene at 1,300 ppm. Rats exposed at this 
concentration for similar periods of time exhibited eye and nose 
irritation. Guinea pigs exposed at 1,300 ppm exhibited marked lung
irritation but were unaffected at 650 ppm.
In a group of 59 rats, Spencer et al. [53] found that those administered 
styrene orally at 8.0 g/kg all died and those given styrene at 1.6 g/kg all 
survived. The styrene was emulsified in olive oil with gum arable. 
Repeated gastric intubation of styrene at 2.0, 1.0, 0.5, and 0.1 g/kg, given 
5 d/wk for 28 days, was also performed. The number of rats given each dose 
was not given. At 2.0 g/kg, rats died after only a "very few" doses, and 
pronounced stomach and esophageal irritation was found. Similar irritation 
and some deaths resulted at 1.0 g/kg. Slight local irritation of the 
esophagus and stomach and poor weight gains were found in five male rats 
that survived 20 oral doses of 0.5 g styrene/kg. No differences in 
unspecified blood components were found between the rats given 0.5 g/kg and 
the five control rats. Rats that were administered 20 doses of 0.1 g/kg 
survived and were found to be generally in good health.
After one application of undiluted styrene to the ear of a rabbit, 
Spencer et al. [53] found "no appreciable reaction." However, after 20 
applications over a 4-week period, moderate irritation with blistering and 
hair loss was observed. Two applications of styrene to the shaved abdomens 
of rabbits caused marked irritation and some necrosis similar to the effect 
caused by benzene or toluene [53],
In 1956, Wolf et al. [162] applied undiluted styrene 10-20 times to the
ears and shaved abdomens of an unspecified number of rabbits over 2-4 weeks.
Skin effects from styrene were characterized by definite erythema of the 
skin and development of a thin layer of necrotic tissue that resulted in 
exfoliation. Under the conditions of this experiment, there was no
indication that styrene was absorbed through the skin in acutely toxic 
amounts.
Wolf et al. [162] also placed two drops of liquid styrene on the right 
eyes of an unspecified number of rabbits. Visual observations of the degree 
of irritation were made at 3 minutes, 1 hour, 2 days, and 7 days after
administration. External corneal injury was visualized with the aid of 5% 
fluorescein in water. Ocular injury from styrene was manifested by moderate 
conjunctival irritation, inflammation and slight swelling of the eyelids,
and slight transient corneal injury (perceptible superficial necrosis 
involving less than 50% of the cornea).
Wolf et al. [162] also reported a series of studies on alkylated 
benzenes, including styrene. After single-dose intubations of 37 rats with
7 ml or less of styrene (undiluted or emulsified in olive oil or corn oil
with 5-10% gum arabic), data suggesting an approximate LD50 of 5.0 g/kg were 
obtained. Upon necropsy, slight liver changes and occasional kidney 
involvement were observed. Repeated administration of styrene by intubation
9 3
(2-3 ml in olive oil, emulsified with gum arabic) to groups of 10 female 
rats was performed once a day, 5 days per week for 6 months. A group of 20 
rats fed only 2.5 ml of olive oil with gum arabic served as controls. One 
hundred and thirty-two intubations were given at each of the following 
doses: 66.7, 133, 400, and 667 mg/kg/d. Counts of formed elements of the 
blood were performed on selected animals from each group after 20, 40, 80, 
and 130 doses. The examinations included total and differential WBC, total 
RBC, and hemoglobin content. No effect on rats given styrene was found at 
66.7 or 133 mg/kg/d; however, at 400 mg/kg/d, a slight general growth 
depression and slight liver and kidney weight depressions were reported. 
These effects were more pronounced when 667 mg/kg/d was administered [162],
In 1968, Gut [163] reported studies of the behavioral effects of styrene 
on rats. Using spontaneous motor activity as an indicator of behavioral 
effects, the activity of rats after single exposures to styrene for about 8 
hours at 315-1,000 ppm and after repeated exposure concentrations of 228-575 
ppm 8 hours per day, 5 days per week for 4-7 weeks was observed. 
Spontaneous motor activity was measured by the number of movements of the 
rats in a cage with partitions and doors. All testing was done 8 hours 
after styrene exposure.
Spontaneous motor activity decreased after a single exposure at 
325 ppm. Activity initially decreased after repeated styrene exposures at 
345 ppm, but, with further repeated exposures, the effects of styrene 
weakened and the concentration required to decrease activity rose to more 
than 985 ppm. Gut [163] stated that the decreased spontaneous motor 
activity may have been caused by the irritating effects of styrene on the 
rats, because they often spent time rubbing their eyes and nose rather than 
moving about in the cage. In 1968, Gut [164] reported further results from 
this experiment. After 4 weeks, styrene was found to be significantly 
related (p<0.001) to increased relative liver weight in the rats exposed to 
325 ppm. However, after 7 weeks of inhalation exposure, no significant 
change was found in relative liver weight which Gut [164] suggested was due 
to apparent adaptation by the liver parenchyma.
In 1969, Shugaev [165] reported LC50’s of 2,800 ppm for rats exposed to 
styrene for 4 hours and 4,900 ppm for mice exposed for 2 hours. Styrene 
content was measured in the tissues of animals that died during exposure at 
the LC50 to estimate lethal tissue concentrations. Tissue samples (300-500 
mg) were extracted with 10 ml of solvent for analysis of styrene by gas 
chromatography. Concentrations of styrene found in liver, kidney, spleen, 
perirenal fat, and brain, expressed as milligrams percent of tissue extract, 
were about 20, 15, 19, 133, and 25 milligrams percent, respectively. The
concentration of styrene at the LC50 level in the brains of mice that died 
during exposure was 18 mg/100 ml.
In 1977, Szulinska et al. [166] exposed 2 groups of 8 male Wistar rats 
to styrene vapor for 24 hours a day for 172 days. Exposure concentrations 
were 0.02 and 0.16 ppm as measured using a spectrophotome trie method. Blood 
counts, blood cholinesterase activities, and weights of selected organs
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(kidneys, spleen, and liver), expressed as percentages (probably of body 
weights) were studied, and lungs, liver, spleen, heart, and kidneys were 
examined microscopically. The investigators [166] described an increased 
erythrocyte count and a decreased hemoglobin level in the blood (neither 
significant) in both groups of exposed rats. There were also increases in 
liver and spleen weight percentages (not significant) for the rats exposed 
at 0.02 ppm as compared to the controls. The rats exposed at 0.16 ppm had 
an increased spleen weight percentage and a decreased liver weight 
percentage (neither significant) as compared to controls. No pathologic 
changes were found except for an increase in peribronchial tissue in two 
rats exposed at the higher concentration.
In 1979, Quast et al. [167] administered styrene to Beagle hounds by 
stomach tube at 200, 400, or 600 mg/kg/day for up to 561 days. Erythrocyte 
Heinz bodies were found in males dosed with 400 and 600 mg/kg/day, and 
sporadically in females administered 200 mg/kg/day. Other changes found 
occasionally were decreased packed cell volume, erythrocyte counts, 
erythrocyte sedimentation rate, and hemoglobin levels; an increased 
incidence of anisocytosis and hypochromia of erythrocytes, hemosiderin in 
reticuloendothelial cells of the liver; and an increased number of 
hepatocellular intranuclear acidophilic crystalline inclusions. Other blood 
elements examined were not affected by the administration of styrene at 
these doses. The blood changes were readily reversed after the 
administration of styrene was stopped.
Body weight, food consumption, clinical chemistry results, and organ 
weights (brain, heart, liver, kidneys, and testes) were not affected by the 
styrene absorption. There were no significant macroscopic or microscopic 
changes except for the hepatic cells mentioned above, which were attributed 
to the removal of altered red blood cells. Electron microscopy of 
peripheral blood and fixed liver tissue confirmed some of the changes 
detected by light microscopy [167],
In 1978, Seppalainen [168] conducted an experimental study with rats on 
the peripheral nervous system effects of styrene. Twenty young adult rats 
were exposed to 300 ppm of styrene, and 15 littermate control rats were
sham-exposed in a similar chamber with air circulation. The rats were 
exposed for 6 hours a day, 5 days per week for up to 11 weeks. A transient 
increase in the motor conduction velocity of the tail nerve was noted after 
6 weeks, but in the comparison to control rats no significant differences 
were found in measurements taken on rats exposed for 8 and 11 weeks.
In 1979, in another Finnish study, Vainio et al. [169] reported on
styrene inhalation in rats. Forty adult male Wistar rats were 
intermittently exposed for 11 weeks to 300 ppm of styrene 6 hours daily, 5 
days per week in a dynamic exposure chamber of 1 cubic meter. The styrene 
concentration in the chamber air was continuously monitored by infrared
analysis. The exposed animals exhibited microscopic liver alterations after 
2 weeks, consisting of parenchymal hydropic degeneration, intracellular
vacuolization (steatosis), and congestion.
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The Chemical Manufacturers Association sponsored a two-year study [170] 
that was finalized in 1980 on styrene administered in the drinking water of 
albino rats. Styrene was provided continuously in the drinking water at 
intended concentrations of 125 and 250 ppm. The approximate daily styrene 
consumption was estimated to have been, in mg/kg of body weight, 7.7 and 14 
for the low- and high-dose males, respectively, and 12 and 21 for the 
low-and high-dose females, respectively. Initially, there were 50 males and 
70 females in each group receiving styrene and 76 males and 106 females as 
untreated controls. The study [170] concluded that the two-year
administration of styrene in the drinking water of rats at these dosage 
levels resulted in no gross or histological changes. This conclusion was
based on evaluation of data on mortality, body weight gain, food and water
consumption, hemograms, clinical chemistry, urinalysis, clinical signs 
(including ophthalmologic observations), gross necropsy findings (including 
organ weights), and histopathological examination of tissues taken from rats 
at interim and terminal sacrifice, as well as rats that died on study or 
were sacrificed in a moribund condition. All tumors encountered among rats 
dying during the course of the study or at the terminal sacrifice were 
common spontaneously-occurring tumors of Sprague-Dawley rats, or uncommon 
tumors that affected only individual rats without regard to treatment
group. There were no apparent treatment-related increases in tumor 
incidence. Also there were no apparent differences between treated and 
control rats with respect to nontumorous lesions encountered in the study 
[170].
Mutagenicity
Many studies of the potential mutagenicity of styrene have been 
performed. Most of these have been tests with microorganisms or mammalian 
cell cultures ^n vitro, but there have also been some investigations in
mammals ^n vivo. Because of the possibility that styrene oxide was an 
intermediary metabolite of styrene and the likelihood that this epoxide
could be mutagenic or carcinogenic, it was also tested for mutagenicity in 
most of these studies.
In 1976, Vainio et al. [171] studied the mutagenic properties of 
styrene, styrene oxide, and phenylglycol. These substances were dissolved 
in absolute ethanol, mixed with agar, and applied to petri dishes. Liver 
microsomes from rats that had received a polychlorinated biphenyl (PCB) 
mixture 5 days earlier to stimulate microsomal enzyme activity, and
cofactors for generation of reduced nicotinamide adenine dinucleotide 
phosphate (NADPH), were included in the agar mixture added to some petri 
dishes to test for indirect mutagenic activity. Salmonella typhimurium 
strains TA 1535, TA 1537, TA 1538, TA 98, and TA 100 were incubated on the 
petri dishes at 37°C for 2 days, and revertant colonies were counted.
Reversion of S_j_ typhimurium from histidine auxotrophy to prototrophy was 
used to indicate mutagenic activity. Phenylglycol was not found to be 
mutagenic under these conditions. Styrene oxide, however, caused mutations 
in strains TA 1535 and TA 100, the rate of which was not increased by adding
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the microsomal preparation. Therefore, styrene oxide was considered a 
direct mutagen with the effect due to base substitution. The data on 
styrene were difficult to interpret because of styrene's toxicity to the 
organisms, although it seemed to be mutagenic to TA 1535 and TA 100 after
metabolic activation [171],
When diethyl maleate (DEM), which depletes cells of cytoplasmic 
glutathione, or trichloropropane oxide (TCPO), an inhibitor of epoxide 
hydratase activity, were added to the culture media of TA 1535, only a 
slight increase in the rate of mutation with styrene in the presence of the
enzyme preparation was found. If styrene oxide were the first metabolite of
styrene, addition of DEM or TCPO should have resulted in an increase in the 
concentration of styrene oxide and consequently the rate of mutation, 
because glutathione depletion or hydratase inhibition should reduce the rate 
at which the epoxide is inactivated. The authors [171] concluded that a 
more detailed investigation was warranted. (Epoxide hydratase is often 
referred to in various reports as epoxide hydrase; this document will 
uniformly use the former name).
Other investigators [172,173,174,175] have confirmed the mutagenicity of 
styrene oxide, but have found little evidence that styrene is mutagenic. In 
1976, Milvy and Garro [172] tested styrene, styrene oxide, styrene glycol, 
benzyl alcohol, and mandelic, phenylglyoxylic, benzoic, and hippuric acids
by the Ames test using typhimurium TA 1535, TA 1537, TA 1538, TA 98, and 
TA 100. Only styrene oxide was found to be mutagenic under the experimental 
conditions used [172],
In 1977, Stoltz and Withey [173] also investigated the mutagenicity of 
styrene and styrene oxide by the Ames test. Using typhimurium TA 1535, 
TA 1537, TA 1538, TA 98, and TA 100 and a liver microsomal preparation from 
rats or hamsters that had been pretreated with a PCB, styrene was not found 
to be mutagenic, but there was a dose-dependent increase in the rate of 
mutations of both TA 1535 and TA 100 due to styrene oxide. The authors
[173] concluded that styrene and styrene oxide results differed because of a 
slow rate of conversion of styrene to styrene oxide and a very rapid rate of 
removal of styrene oxide due to the action of epoxide hydratase and
glutathione-S-transferase.
In 1977, Greim et al. [174] used a modified Ames test using
S. typhimurium TA 1535 and TA 1538 and E_j_ coli K12, incubated with and
without a liver microsomal preparation that included a NADPH-generating
system, to assay the mutagenicity of styrene and styrene oxide. The
microsomal fraction was prepared from rat livers that had been pretreated 
with phenobarbital for 10 days (0.1% in drinking water) or by a single 
injection (500 mg/kg) of a PCB 4 days before sacrificing. The authors [174] 
concluded that styrene oxide was mutagenic but styrene was not.
In 1976, Loprieno et al. [175] studied the ability of styrene or styrene 
oxide to produce forward mutations at 5 loci in the Schizosaccharomyces
pombe PI strain of yeast and in cultured V79 Chinese hamster cells,
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and to produce gene conversions at 2 loci in Saccharomyces cerevlsiae 
diploid strain D4 yeast. Host-mediated assays were also performed with the 
two yeasts. For the in vitro studies, the yeasts were incubated with a 
purified mouse liver microsome preparation together with NADPH and 
glucose-6-phosphate dehydrogenase. In the host-mediated assay, male Swiss 
albino mice were injected intraperitoneally (ip) with yeast cells, and the 
animals were then treated by gavage with 1 ml of styrene or styrene oxide. 
Styrene was not active in producing forward mutations in S. pombe or in 
Chinese hamster V79 cells or in producing gene conversions in 
S. cerevisiae. In the host-mediated assay, styrene produced gene 
conversions in S^ cerevisiae, but was unable to increase spontaneous forward 
mutation frequency in S. pombe. As the investigators [175] pointed out, 
this ^n vivo mutagenic effect of styrene was produced with a very high dose 
of styrene, i.e., 1 g/kg. Styrene oxide was active, i.e., mutagenic, in all 
systems tested except with S. pombe in the host-mediated assay.
Later in 1978, Loprieno et al. [176] investigated the ability of styrene 
or styrene oxide to induce (1) point mutations in typhlmurlum TA 1535 and 
in Chinese hamster cells with and without metabolic activation, (2) 
unscheduled DNA synthesis in heteroploid human cells, and (3) chromosomal 
changes in mouse bone marrow cells. Styrene was not mutagenic with TA 1535, 
with or without activation with an S9 mix. Styrene oxide, however, was 
mutagenic and after activation it was even more so. Styrene was similarly 
ineffective in the induction of 8-azaguanine resistant mutants in V79 
Chinese hamster cells, whether or not activated by an S10 metabolic 
activation system from mouse liver. Only styrene oxide, and not styrene, 
each activated by an S10 mix, was able to increase incorporation of 
tritiated thymidine above background into the DNA of the heteroploid human 
cells in the presence of an inhibitor of DNA synthesis (hydroxyurea); thus, 
by this test of unscheduled DNA synthesis, styrene oxide but not styrene was 
found to be mutagenic. Styrene or styrene oxide was intubated into male and 
female mice and, after the mice were sacrificed 24 hours later, bone marrow 
cell preparations were made. Styrene oxide but not styrene caused a 
statistically significant increase in chromosomal aberrations. Positive 
controls used in these tests of mutagenicity showed the test systems to be 
effective. Thus, in this investigation of mutagenicity in several test 
systems, styrene oxide was consistently found by Loprieno et al. [176] to be 
mutagenic, while styrene was not.
In 1978, a report by Roberfroid et al. [177] contained data which 
demonstrated that styrene lowered the Michaelis constant of the enzyme aryl 
hydrocarbon hydroxylase in Wistar rats in a manner similar to that of 
benzo(a)pyrene and 3-methylcholanthrene, both of which the investigators 
considered to be mutagenic and carcinogenic. Styrene caused only about 50 
reversions per plate among S^ _ typhimurlum TA 1538, while there were about 20 
spontaneous reversions. In comparison, benzo(a)pyrene caused about 180 
reversions among the same strain, thus suggesting once again that styrene is 
not more than weakly mutagenic [177]. Earlier, investigators from this 
laboratory [178] had found styrene not to be mutagenic to S. typhimurium 
strains TA 98, TA 100, TA 1535, TA 1537, or TA 1538, except that, in the
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presence of S9 mix (microsomal enzymes), a reversion to histidine 
prototrophy was observed with TA 1535 only, suggestive of a 
base-substitution type of mutation. Styrene oxide caused histidine
prototrophy in TA 100 and TA 1535 with or without S9 mix, but did not cause
mutations in TA 98, TA 1537, or TA 1538.
In 1978, Linnainmaa et al. [179] studied the effect of styrene and 
styrene oxide on chromosomes from human lymphocytes. Styrene was incubated 
with a lymphocyte preparation for 72 hours, and styrene oxide for a shorter 
time. A total of 100 metaphases or 100 anaphases were examined at each 
concentration of styrene or styrene oxide for cytogenetic aberrations, and
1,000 interphase nuclei were examined for the presence of micronuclei and 
nuclear bridges.
Styrene mainly caused chromosome breaks (19 breaks/100 metaphases, 
p<0.001); styrene oxide was primarily responsible for the formation of
micronuclei and nuclear bridges (38 micronuclei/1,000 interphase cells,
p<0.001). Linnainmaa et al. [179] suggested that impurities in the styrene 
preparation might have been responsible for the results that differed from 
those of styrene oxide. They reported that the styrene contained 0.60 ppm 
ethylbenzene, 0.75 ppm alpha-methyl styrene, and 0.50 ppm styrene oxide, but 
did not test all of these contaminants for mutagenicity. The investigators 
[179] speculated that the chromosome breaks they observed were due to 
formation of styrene oxide or possibly to the presence of the alleged 
metabolite [160,180] styrene-3,4-oxide.
In a later study by this same group in 1980, Norppa et al. [181] found 
that styrene and styrene oxide showed a clear dose-response relationship in 
the induction of sister chromatid exchanges (SCE) in human whole blood 
lymphocyte cultures. To find out whether the potential of styrene to induce 
SCE was accompanied by metabolic conversion to styrene oxide, gas 
chromatographic analyses were carried out in human lymphocyte cultures after 
0.5, 2, 6, and 24 hours after treatment with styrene and styrene oxide. In 
the styrene-treated cultures, the ratio of styrene oxide to styrene was 
progressively increased with incubation time. In styrene-treated control 
cultures without blood, there was no increase of styrene oxide. In the 
styrene oxide-treated cultures, the amount of styrene oxide gradually 
decreased with incubation time. The investigators [181] concluded that 
styrene oxide could be formed from styrene in human cells but that it was 
not clear which cells in human blood were responsible for the metabolic 
activation of styrene.
In 1978, De Raat [182] tested the ability of styrene and its presumed 
metabolite styrene oxide to induce SCE in Chinese hamster ovarian cells with 
and without metabolic activation. Styrene oxide appeared to be a potent 
inducer of SCE. Styrene in doses up to 1.0 ml/1 did not increase the number 
of SCE per metaphase, even with metabolic activation. Induction of SCE by 
styrene in the presence of metabolic activation only occurred when 
cyclohexene oxide was used as an inhibitor of the enzyme epoxide hydratase. 
De Raat [182] interpreted the lack of induction of SCE by styrene in the
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presence of metabolic activation as being caused by a very rapid 
biotransformation of styrene oxide, clearly a compound that induces SCE, 
rather than styrene not being converted to its oxide.
There is some in vivo experimental evidence in rodents and flies that 
styrene itself can cause mutations. In 1980, Conner et al. [183] exposed
3-4 mice for 6 hours per day to styrene vapor concentrations ranging from 
104-922 ppm for 4 days and at 920 ppm for 1 and 2 days. An increased SCE 
frequency was found in regenerating liver cells, in bone marrow cells, and 
in alveolar macrophages. Some of the mice had two-thirds of their liver 
removed surgically a day prior to the first exposure. On the last day of 
styrene exposure, the mice were injected with 5-bromodeoxyuridine; on the 
following morning, they were injected with colchicine and sacrificed several 
hours later. The SCE frequencies in regenerating liver cells, bone marrow 
cells, and alveolar macrophages of hepatectomized mice exposed to styrene at 
387, 591, and 922 ppm for 4 days and in bone marrow cells and alveolar
macrophages from nonhepatectomized mice exposed to styrene at 591 and 922 
ppm for 4 days were statistically greater (p<0.05) than those in the 
controls. There was also a significant increase (p<0.001) in cell frequency 
in regenerating liver, bone marrow, and alveolar macrophage cells from both 
hepatectomized and nonhepatectomized mice exposed for 2 days at 922 ppm but 
not in those exposed for 1 day at that concentration.
In 1980, Meretoja et al. [184] found clastogenic effects in bone marrow 
cells of rats. Male rats were exposed to styrene vapor at 300 ppm for 6 
hours per day, 5 days per week, for 2-11 weeks. Animals were sacrificed 
weekly, and bone marrow tissue was taken from the femur. A total of 100 
metaphases per animal were examined for aneuploidy and chromosomal 
aberrations. A significant increase in chromosomal aberrations appeared 
after 9 weeks of exposure. Most of the aberrations were chromosomal breaks, 
but there were also a few chromatid breaks. The incidence of aberrant cells
was 8-12% in exposed animals and 1-6% in controls. Polyploid cells were
found in every sample preparation from the rats exposed to styrene for 11 
weeks.
However, in another investigation by these researchers, published in 
1980 by Norppa et al. [185], styrene was not found to cause clastogenic 
effects in bone marrow cells of hamsters. Male Chinese hamsters, 3-4 months 
old, were exposed to styrene vapor at 300 ppm for 6 hours per day. One 
group of 4 hamsters was exposed for 4 days, the other group of 4 was exposed 
5 days per week for 3 weeks. The investigators [185] analyzed 100 bone
marrow metaphases from each animal for chromosome or chromatid aberrations 
and gaps. No significant difference from controls was found in either 
styrene-exposed group. The effect of ethanol, alone and with styrene, was 
also studied. Animals receiving both 300 ppm of styrene and ethanol (15% 
v/v in drinking water, ad libitum) for 4 days had significantly more
chromosomal aberrations, not including gaps, than did controls or hamsters 
administered only styrene, but not more than hamsters given only ethanol. 
The incidence of gaps was not significantly different among the groups. No 
significant differences among the several groups treated for 3 weeks were 
found, either in aberrations or in gaps [185],
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In vivo inhalation exposure of male Chinese hamsters to styrene oxide 
(25, 50, 75, and 100 ppm) was reported in 1979 by these same investigators 
(Norppa et al. [186]) to have no effects on chromosomal aberration rates or 
frequencies of SCE in bone marrow cells. The only positive response in 
chromosome aberration frequency was obtained when styrene was injected ip in 
a lethal concentration (500 mg/kg body weight); 1 of 6 hamsters showed 
slightly elevated values of SCE after this high dose.
In 1979, Donner et al. [187] reported that styrene and styrene oxide 
caused recessive lethal mutations in fruit flies. Drosophila melanogaster 
were exposed to styrene oxide vapor at 200 ppm for 6 hours per day for 4 
days, or to styrene by being fed for 24 hours on tissue paper moistened with 
10 ml of a solution containing styrene at 200 ppm in 1% aqueous sucrose. 
The fruit flies were pretreated either with phénobarbital, to induce 
metabolizing enzymes, or, in the case of flies exposed to styrene oxide, 
with trichloropropane oxide (TCPO), to inhibit epoxide hydratase. Both 
styrene and styrene oxide produced a significant increase in recessive 
lethal mutations. Neither pretreatment showed mutagenic potency, but the 
frequency of recessive lethal mutations from styrene or styrene oxide was 
doubled by phénobarbital pretreatment; also, in fruit flies exposed to 
styrene oxide, pretreatment by an epoxide hydratase inhibitor (TCPO) 
increased the mutation rate about two-fold over that caused by styrene oxide 
alone [187],
Reproductive Effects
There have been a number of experimental animal studies investigating 
possible reproductive effects of exposure to styrene. In 1977, Vainio et 
al. [188] investigated the toxicity of styrene and styrene oxide toward 
chicken embryos from White-Leghorn SK12 chickens. Various amounts of the 
compounds in 50 y 1 of an olive oil-ethanol mixture were injected into the 
air sacs of the eggs. For control purposes, 50 yl of the olive 
oil-ethanol vehicle were injected into other eggs.
After incubation for 14 days at 37°C, 80-90% of the control embryos were 
alive, but no embryos survived that had received 100 ymol of styrene. Of 
those embryos that received 50 ymol of styrene, only 30% survived; with 2 
ymol, 90% survived. Malformations were found in about 15% of the embryos 
that had received styrene and in about 7% of those that had received styrene 
oxide. Vainio et al. [188] determined that the embryos were most 
susceptible to the toxic effects of styrene and styrene oxide on the day of, 
and the day after, the beginning of incubation.
In 1974, Zlobina et al. [189] reported studies of styrene concentrations 
in rat maternal and fetal blood and in amniotic fluid after a 2-hour 
exposure to styrene vapor (3.6 or 10 ppm). Placental styrene concentrations 
were not determined. The results presented in Table Iv-22 demonstrate that 
styrene can cross the placenta.
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TABLE I V - 22
CONCENTRATION OF STYRENE IN MATERNAL BLOOD, FETAL BLOOD, 
AND AMNIOTIC FLUID IN 18- TO 21-DAY RAT FETUSES
S tyrene 
Exposure
Styrene Concentration, Ug/ml
Maternal Blood Fetal Blood Amniotic Fluid
10 ppm 10.95-12.25 8-8.8 2.35-2.8
3.6 ppm 1.07-2.62 0.9-1.65 1.25-1.8
Adapted from Zlobina et al. [189]
In 1974, Ragul'ye [190] reported the effects of maternal styrene
inhalation exposures on the development of the embryo. In one study, 23 
pregnant albino rats were exposed at 1.2 or 12 ppm of styrene for 4 hours 
per day throughout gestation (21 days); there was a control group of 15 
rats. Numbers of live embryos, stillbirths, resorptions, and implantation
sites, together with embryo mortality, pre- and post-implantation deaths, 
and embryo weight and size were studied. In addition, RBC, WBC, hemoglobin, 
oxygen consumption, and respiratory rate of the dams were measured on the 
15th to 17th day of gestation and compared to pre-exposure findings.
Maternal exposure to styrene at 12 ppm significantly increased
pre-implantation loss (20.7 vs. 3.6 in controls) as well as total embryo 
mortality (25.2 vs. 15.5 in controls); no significant changes were found in 
the other indices. No significant changes in any indices studied were found 
in the rats exposed at 1.2 ppm. There was no pathological embryo
development observed in either experimental group. Ragul'ye [190] also 
reported a significant increase in deaths/litter during the first 2 weeks of 
life (1.66 and 0.6 in the rats exposed at 12 and 1.2 ppm, respectively, vs. 
0 in the controls).
Ragul'ye [190] also exposed 10 pregnant rats to styrene at 1.2 ppm and 
10 other pregnant rats at 0.4 ppm for 4 hours per day for 21 days (the 
entire gestation period). At the same concentrations, two other groups of 
10 pregnant rats each were exposed, but only during the first 7 days of 
gestation. Twenty pregnant rats served as controls. All rats were 
sacrificed on the 21st day of gestation.
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In the rats exposed for the entire gestation period, the rate of 
resorptions/dam was 0.2 for those exposed at 0.4 ppm, 1.3 for those exposed 
at 1.2 ppm, and 0 for the control group. There was also a higher rate of 
resorptions/dam (0.66) found in rats exposed at 1.2 ppm for the first 7 days 
of gestation, with none in the control group. Other significant results 
included an increased embryonic mortality in litters of dams exposed at 
1.2 ppm for the entire gestation period (12.8% vs. 2.5%), an increased 
number of pre-implantation deaths at exposures to 1.2 and 0.4 ppm for the 
entire gestation period and during the first 7 days, an increased number of 
post-implantation deaths in both groups exposed for the entire gestation 
period, and a decreased embryo size and weight among rats exposed at 1.2 ppm 
for the entire gestation period [190]. All litters examined appeared to 
have been first litters.
Ragul'ye [190], who did not state the levels of statistical 
significance, gave no data other than means and an undescribed index of 
variation. The description of how pre-implantation and total embryo losses 
were measured was not given; however, observation of corpora lutea, 
resorption sites, and total births seems the obvious method. Had the data or 
a description of methods been given, it would be possible to be more certain 
of the meaning of total embryo mortality; most likely, this term was used to 
mean a total of pre- and post-implantation losses. (The word translated as 
embryo is interpreted to have been applied to all stages of prenatal 
development, from blastocyst through fetus.)
In 1979, Vergiyeva et al. [191] studied embryo toxicity in rats in an 
investigation designed at least in part to check on the results of Ragul'ye
[190]. Three groups of pregnant rats were exposed to styrene vapor 4 hours 
per day, 5 days per week. Groups I and II were exposed at 47 ppm on days 
2-21 of gestation; group III was exposed at 165 ppm on days 2-16 of 
gestation. Progeny from dams of groups I and III were observed for 90 days 
after birth. Dams from group II were sacrificed on the 21st day; maternal 
weights, numbers of corpora lutea, resorptions and autolysis, the number and 
weights of live pups, and structural anomalies were recorded.
There were no changes from controls in the experimental animals as to
the course, duration, and outcome of pregnancies or in indices such as 
implantations, resorptions, and live and still births. Dams and progenies 
kept for 90 days after birth did not differ significantly from controls in 
hemoglobin and RBC, in hexobarbital sleeping time one month after birth, or 
in behavioral tests consisting of an open field test and a measured reaction 
to loud noise. Methods of studying structural anomalies were not described, 
but the investigators [191] stated none were found in either controls or 
Group II progeny.
Vergiyeva et al. [191] gave a few more details of methods and results
than did Ragul'ye [190] and, especially because it described exposures of 
rats at higher concentrations without evidence of embryotoxicity, this study 
is taken as refuting the implications of embryotoxicity found at low
concentrations of styrene in the earlier report [190].
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In 1978, Murray et al. [192] investigated possible styrene 
teratogenicity in rats and rabbits. Groups of 29 or 30 Sprague-Dawley rats 
and 20 New Zealand white rabbits were exposed to styrene vapor for 7 hours 
per day from day 6 of pregnancy through day 15 (rats) or day 18 (rabbits). 
Exposure levels were 0, 300, or 600 ppm styrene. In addition, other rats 
were intubated with styrene in peanut oil at 0, 90, or 150 mg/kg twice daily 
on days 6 through 15 of gestation. There were no significant changes 
(p<0.05) in the exposed animals as compared with controls during gestation 
except for a reduced weight gain on days 6 through 9 of gestation in rats 
(inhalation and gavage treatments) associated with a decreased food 
consumption, and increased water consumption on days 9 through 20 of 
gestation by rats (inhalation treatment). Dams were sacrificed just prior 
to expected delivery, and fetuses were examined. There was a statistically 
significant increase (p<0.05) in fetal crown-rump length in litters from 
rats exposed at 300 ppm but not at 600 ppm. Mean crown-rump length of 
intubated rats was similar to that of controls. External, visceral, and 
skeletal malformations did not significantly differ in incidence from 
matched or historical controls. There were no significant changes (p<0.05) 
seen in rabbits except for the incidence of unossified fifth sternebrae 
among litters from rabbits exposed at 600 ppm; however, this incidence was 
similar to that seen in control groups from other recent studies. Because 
of this and because the change in rat fetal size at 300 ppm was not 
dose-related and the incidence of skeletal changes in rats were not 
different from controls, it seems inappropriate, from the evidence in this 
study, to draw conclusions that styrene is teratogenic or otherwise 
embryotoxic at these levels.
In 1980, Kankaanpaa et al. [193] exposed pregnant BMR/T6T6 mice and 
Chinese hamsters to styrene vapor and examined possible changes in fetal 
development. Pregnant mice were exposed at 250 ppm for 6 hours per day on 
days 6 through 16 of gestation, and were sacrificed for examination of 
fetuses after the day 16 exposure. Chinese hamsters were exposed 6 hours 
per day on days 6 through 18 of gestation, but the exposure concentrations 
were 300, 500, 750, or 1,000 ppm. There were no significant differences in 
ratios of live fetuses to total litter size, in numbers of dead or resorbed 
fetuses, or in numbers of malformed fetuses in either species, except that 
there was a significant excess (p<0.001) of dead or resorbed fetuses from 
hamsters exposed at 1,000 ppm and there was a nonsignificant excess of dead 
or resorbed fetuses from mice. There were also more malformations (rib 
fusion and extra ribs) in exposed mice, but the statistical significance was 
not described. This study [193] suggests ejinbryotoxicity at high exposure 
levels, but is consistent with results of other studies [190,191,192] in 
failing to find a significant excess of terata from styrene exposure.
A report [170] of a three-generation reproductive study on styrene 
administered in the drinking water of rats was finalized in 1980. It was 
part of the study sponsored by the Chemical Manufacturers Association that 
was discussed earlier in the Toxicity Section. At least 10 males and 20 
females (F0 generation) from each group of the chronic study (those dosed at 
125 or 250 ppm, and controls) were mated to produce Fl pups. At breeding
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age, the FI rats were mated within their respective dose groups to produce 
F2 litters, and these rats in turn produced F3 pups. Styrene treatment in 
drinking water was maintained throughout.
The report of the study [170] concluded that styrene administered in the 
drinking water had no deleterious effects on the reproductive capacity of 
rats through three generations. The conclusion was based on evaluation (for 
each generation of each dose group) of fertility indices, mean litter size, 
live-to-total pup ratios, pup survival indices at intervals from birth to
weaning, liver and kidney weights of representative pups necropsied at 
weaning, cytogenetic evaluation of bone marrow samples of other weanlings, 
and gross necropsy of Fl and F2 parents, including organ weights. In 
addition, histopathologic examinations were made of liver and kidneys of
weanlings and of tissues of representative Fl and F2 parents.
In 1981, Sikov et al. [194] assessed the teratogenic effects of styrene 
oxide inhalation on rats and rabbits. Rats were exposed to 100 or 300 ppm 
for 7 hours per day, 5 days per week for 3 weeks before being mated and 
exposed daily through 19 days of gestation. Rabbits were artificially 
inseminated and exposed for 7 hours daily through the 24th day of gestation. 
The rats were sacrificed at the 21st day of gestation and the rabbits at the 
30th day of gestation. Pregnant animals were examined for toxic changes 
including altered tissue weights and histopathological effects. Litters 
were examined for embryotoxicity and live fetuses were examined for 
external, visceral, and skeletal malformations. There was extensive
mortality in rats that received prolonged exposure to 100 ppm styrene oxide, 
and 300 ppm was so rapidly lethal that exposures were terminated. Lower 
concentrations (15 and 50 ppm) were used for exposure of the rabbits; 50 ppm 
styrene oxide produced 79% mortality. Gestational exposure appeared to 
decrease fecundity by increasing loss of embryos before implantation in 
rats, and tended to increase the incidence of resorptions in rabbits. In 
both species, fetal weights and lengths were reduced by gestational 
exposure. The incidence of ossification defects of the sternebrae and
occipital bones was increased by gestational exposure of rats to styrene 
oxide [194].
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C a r c i n o g e n i c i t y
There have a been a number of experimental animal studies investigating 
the long-term effects of styrene. In 1978, Jersey et al. [195] conducted an 
inhalation study of male and female Sprague-Dawley rats exposed at 600 or 
1,200 ppm, the higher concentration being reduced to 1,000 ppm after 2 
months because of excessive toxicity in the male rats. Male rats were 
exposed for more than 18 months and female rats for almost 21 months. 
Exposure periods were 6 hours per day, 5 days per week. All survivors were 
sacrificed for necropsy at 24 months. There were reduced weight gains in all 
exposed groups of rats except in females exposed at 600 ppm. Female rats at 
the higher concentration had increased liver weights and a higher incidence 
of alveolar histiocytosis in their lungs. Male rats in the control group 
and those exposed to styrene at the higher concentration had excessive 
mortality from an Intercurrent disease, chronic murine pneumonia. There was 
no evidence of tumors in the male rats attributable to the exposure 
regimen. The female rats in both exposure groups had an increase (though 
not significant) in the combined frequency rate of tumors in the leukemia 
and lymphosarcoma classifications. The investigators [195] believed that the 
exposure concentrations used overwhelmed the ability of the rats to detoxify 
styrene; because of this, the high incidence of spontaneous disease, and the 
equivocal results, they recommended that a new study be initiated.
In 1978, Ponomarkov and Tomatis [196] investigated the long-term effects 
of styrene in 020 and C57 Bl mice and BD IV rats. Styrene dissolved in 
olive oil was administered by stomach tube; other groups of mice and rats 
were given only olive oil, and others were not treated. All animals were 
fed a commercial food preparation that had been analyzed for aflatoxins, 
which were absent, and nitrosamines, which were present at 0.2-0.6 ppb.
Each of 29 pregnant 020 mice was administered 1,350 mg styrene/kg on the 
17th day of gestation. Nine other pregnant females were given 0.1 ml of 
olive oil only on the same day. After weaning, their progeny received the 
same dose once a week; treatment with styrene was stopped after 16 weeks 
because of the toxicity of styrene. Offspring (54 male and 47 female mice) 
of untreated dams received no treatment [196],
For 020 mice, pre-weaning mortality was significantly greater among the 
styrene-treated animals than among olive oil-treated animals (43% vs. 22%). 
Higher mortality continued even after treatment with styrene had ended. The 
average age of styrene-treated mice at death was 32 weeks for males and 49 
weeks for females, compared with 88 and 85 weeks for olive oil-treated male 
and female mice and 94 and 99 weeks for untreated male and female mice, 
respectively [196],
Multiple centrilobular necrosis of the liver, hypoplasia of the spleen, 
and severe congestion of the lungs were the most frequently observed lesions
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in styrene-treated 020 mice which died within the first 20 weeks [196], 
Extensive inflammation around necrotic foci was often observed in the livers 
of styrene-treated mice that died up to the 45th week of treatment; 
bronchitis and peribronchitis were also frequently observed. Animals that 
died after 45 weeks had what the authors [196] described as multiple 
abscess-like round cavities in the liver that were filled with 
polymorphonuclear leukocytes and were surrounded by connective tissue 
capsules. Calcium deposits were also observed.
The percentage of tumor-bearing, singly-dosed, styrene-treated dams did 
not differ from the group treated only with olive oil. Among their 
offspring, however, 89% of the males and 100% of the females treated with 
styrene had lung tumors compared with 42% of the males and 67% of the 
females of the olive oil-treated controls, both statistically significant 
differences (p<0.01). When styrene-treated 020 mice were compared with 
untreated animals, the incidence of lung tumors was significantly greater 
(p<0.001) only in styrene-treated females.
Average age at death of the lung tumor-bearing 020 mice was 49 weeks for 
male and 58 weeks for female styrene-treated mice, 84 and 85 weeks for olive 
oil-treated males and females, and 87 and 91 weeks for untreated male and 
females, respectively. The lung tumors were histologically identified as 
either adenomas or adenocarcinomas. The incidences of lung tumors in olive 
oil-treated and untreated animals at sites other than the lungs were greater 
than the incidences in styrene-treated mice, perhaps, as the authors [196] 
commented, because of the longer survival of the controls.
Styrene (300 mg/kg in 0.1 ml olive oil) was also given to each of 15 
pregnant C57 Bl mice on the 17th day of gestation; their progeny received 
the same dose after weaning weekly for life, up to 120 weeks. For controls,
0.1 ml olive oil was administered after weaning weekly to the offspring (12 
males and 13 females) of five pregnant mice given 0.1 ml olive oil on the 
17th day of pregnancy; 51 males and 49 females served as untreated controls 
[196].
For C57 Bl mice there was an increase, though not statistically 
significant, in the incidence of tumors, mainly lymphomas, in dams singly 
dosed with styrene. There were three hepatocellular carcinomas in the 
styrene-treated mice and one hepatocellular adenoma each in an olive
oil-treated mouse and in an untreated mouse. Unlike the 020 mice, there
were no significant differences in mortality, life-span, or body weights 
between the C57 Bl mice treated with styrene and those treated with olive 
oil.
On the 17 th day of gestation, each of 21 pregnant BD IV rats were 
administered 1,350 mg styrene/kg in olive oil. Their progeny, 73 males and
71 females, each received 500 mg styrene/kg weekly for 120 weeks after
weaning. Ten pregnant BD IV rats received only olive oil (0.3 ml) and their 
progeny (36 males and 39 females) were given 0.3 ml olive oil weekly after 
weaning. Untreated controls were not used [196].
107
Average litter sizes of the BD IV rats were similar, but offspring of 
styrene-treated dams had a greater pre-weanlng mortality than did the olive 
oil-treated dams (10% vs. 2.5%); the difference was not significant. In 
some styrene-treated animals that died between weeks 50 and 60, the 
investigators [1961 found moderate congestion of the lungs and kidneys and 
small necrotic foci in liver parenchyma. Although liver damage was not 
observed in animals that died between weeks 80 and 90, lesions of the 
forestomach (atrophy or desquamation of epithelium, and necrotic areas with 
inflammation) and of the kidney (hyperplasia of the pelvis epithelium) were 
frequently noted.
The percentage of tumor-bearing BD IV dams given a single dose of 
styrene during pregnancy was greater than that in the olive oil-treated 
group (65% vs. 50%); this difference was not statistically significant. The 
percentage of tumor-bearing, styrene-treated progeny was not significantly 
different from that of the olive oil-treated controls (24% vs. 39%). There 
were, however, a few tumors in styrene-treated rats which were not observed 
in the control animals, namely three neurogenic and three stomach tumors. 
Ponomarkov and Tomatis [196] concluded that their results provided weak 
evidence of the carcinogenicity of styrene in one of the two strains of mice 
tested, when it was given at a high dose level.
In 1979, under the program of the National Cancer Institute (NCI) for
testing possible carcinogenicity, Fischer 344 rats and B6C3F1 mice were 
given styrene in corn oil by stomach tube [197]. The animals were intubated 
5 days a week for up to 103 weeks in the case of rats administered the 
lowest dose and up to 78 weeks in all other groups. Surviving rats were 
sacrificed for necropsy at 104-105 weeks, and mice at 91 weeks. There were 
50 rats of each sex at each of 3 doses (500, 1,000, and 2,000 mg/kg) and 40
of each sex given only the corn oil vehicle. There were 50 mice of each sex
at each of two doses (150 and 300 mg/kg) and 20 of each sex given only the 
corn oil vehicle.
In male mice, there was an excess incidence of lung adenomas and
carcinomas compared with vehicle controls but not compared with historical 
controls at NCI. There was no significant excess of tumors in rats, but so 
few male and female rats survived on the highest dose that there were 
limited numbers of these animals at risk of developing neoplasms. NCI [197] 
concluded that under the conditions of the bioassay the data (i.e., excesses 
of lung adenomas and carcinomas) provided "suggestive" evidence for the 
carcinogenicity of styrene in male B6C3F1 mice, but did not provide 
"convincing" evidence for the carcinogenicity of styrene in Fischer 344 rats 
or B6C3F1 mice of either sex.
In 1979, in a companion experiment by NCI [198], a solution of 
beta-nitrostyrene, consisting of 30% nitrostyrene and 70% styrene, was 
dissolved in corn oil and intubated into Fischer 344 rats and B6C3F1 mice. 
The be ta-nitros tyrene doses were 150 and 300 mg/kg for male rats; 75 and 150 
mg/kg for female rats; and 87.5 and 175 mg/kg for mice of both sexes. Doses 
of styrene, then, in addition, were 350 and 700 mg/kg for the male rats; 175
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and 350 mg/kg for the female rats; and 204 and 408 mg/kg for the mice. The 
doses were administered 3 days a week for 78-79 weeks, after which mice were 
held an additional 14 weeks and the rats an additional 29 weeks before 
survivors were sacrificed for necropsy.
When the incidences of alveolar and bronchiolar adenomas and carcinomas 
were combined, there was a significant excess in low-dose male mice compared 
to the corn oil vehicle controls by the Fisher exact comparison (p=0.016), 
but not by the Cochran-Armitage test. There was no significant excess in 
high-dose male mice found by either test. No other significant excess in 
tumors was found. NCI [198] concluded that under the conditions of the
bioassay, there was no "convincing" evidence for the carcinogenicity of a 
solution of beta-nitrostyrene and styrene in Fischer 344 rats or B6C3F1 mice.
Studies of the potential carcinogenicity of styrene oxide were reported 
by Kotin and Falk [199], Van Duuren et al. [200], Weil et al. [201], and by 
Maltoni et al. [202]. In 1963, Kotin and Falk [199] reported that, 11
months after administering 20 ymoles of styrene oxide by an unspecified 
route to 30 C3H mice, there were 3 malignant lymphomas (16%) among the 19 
survivors. The cause of death in these mice was not stated, nor was the 
time when they died. The use of controls was also not reported.
In 1963, Van Duuren et al. [200] studied possible tumor formation from 
styrene oxide in male Swiss-Millerton mice. Thirty animals were tested with 
10% styrene oxide in benzene that was topically applied. The mice, 8 weeks
old at the onset of the experiment, had their backs painted three times a
week with approximately 100 mg of solution/application. After a median 
survival time of 431 days, three styrene oxide treated mice (10%) were found
to have tumors (type not specified), one of which was considered cancerous.
Control groups were painted with either benzene or acetone. Positive 
controls received 100 mg of benzo(a)pyrene in benzene or acetone; negative
controls received no treatment. Incidence of tumors in the controls was:
(a) benzene group, 11/150 mice (7%), 10 had papillomas, and 1 developed
cancer; (b) acetone group, 7/120 mice (6%) had papillomas; (c) 
benzo(a)pyrene in benzene (positive control), 49/90 mice (54%) developed
tumors, 26 of which were cancerous; and (d) benzo(a)pyrene in acetone 
(positive control), 83/120 mice (69%) developed tumors, 49 of which were 
cancerous. Of the 267 untreated controls, 5% developed tumors, 1 of which 
was a squamous cell cancer, as compared with the long-term incidence of 
tumors in untreated Swiss-Millerton mice in the laboratory of 1.4%, (all 
squamous papillomas). Because the incidence of tumors in mice administered 
styrene oxide in benzene was not significantly greater than the incidence 
due to benzene application alone, this experiment does not give evidence 
that styrene oxide is tumorigenic.
In 1963, Weil et al. [201] studied the possible carcinogenicity of
various epoxides in mice. Styrene oxide dissolved in acetone was applied by 
brush three times a week to the shaved backs of two groups of C3H mice that 
were 90 days old when the experiment began. One group was treated with a 
solution containing 10% styrene oxide and the other with a solution
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containing 5%. The number of mice initially in the group that received 10% 
styrene oxide was not reported, but 18 were in the group at 12 months and 2 
were still alive at 24 months. The maximum number of months the mice in the 
10% group were painted was 18. No tumors were found in the group treated 
with 10% styrene oxide. Forty mice were initially present in the group 
treated with 5% styrene oxide; 35 were alive at 17 months and 17 were still 
alive at 24 months. Administration of styrene oxide continued through this 
period, and no tumors were found [201]. This experiment provides some 
evidence, albeit in small groups of mice, that styrene oxide is not 
tumorigenic by topical application.
In 1979, Maltoni et al. [202] reported that styrene oxide caused stomach 
epithelial tumors in rats. Styrene oxide was administered in olive oil by 
stomach tube at two dose levels, 50 and 250 mg/kg, to Sprague-Dawley rats 
once per day, 4-5 days per week, for 52 weeks, after which the animals were 
allowed to live until their natural deaths. Controls were intubated with 
olive oil alone. Papillomas and carcinomas, both in situ and invasive, were 
observed in the forestomachs of the rats at both dose levels at an incidence 
significantly greater than controls and with an evident dose-response 
relationship. Many of the carcinomas had metastasized to the liver. Rats 
with or without tumors of the forestomach often had precursor lesions. 
Maltoni et al. [202] commented that epithelial tumors of the forestomach 
were rare in this strain of rat, and concluded that styrene oxide was 
carcinogenic, affecting the organ "most directly exposed."
Uptake, Metabolism, and Elimination
In 1954, Danishefsky and Willhite [203] reported a study of the 
metabolism of styrene in Wistar rats. Styrene labeled with carbon-14 at the 
8 position (8-14C styrene) was dissolved in peanut oil to make a 20% 
solution. Each rat was injected subcutaneously with 0.1 ml of the 
radioactive solution. Distribution of the isotope in tissues was determined 
1, 6, and 24 hours after injection. Exhaled carbon dioxide, urine, feces, 
and expired styrene were collected and analyzed for carbon-14. After 1 
hour, the liver, kidneys, blood, and urine had the highest radioactivity. 
Styrene was rapidly metabolized and excreted primarily in the urine. Six 
hours after administration, 37% of the initial radioactivity was found in 
the urine and 6% in expired carbon dioxide. After 24 hours, 71.0% of the 
radioactivity had been excreted in the urine, 11.8% in expired carbon 
dioxide, 2.6% in the feces, and 2.9% as unchanged expired styrene. Although 
the finding of labeled carbon dioxide indicates cleavage of the vinyl moiety 
of styrene, it does not distinguish initial cleavage of the terminal carbon 
from that of the entire vinyl group.
In 1969, Shugaev [165] exposed rats to styrene for 1 hour at 2,800 ppm 
(the LC50 for 4 hours). The animals were sacrificed at various times after 
exposure and brains and livers were removed and extracted for determination 
of styrene levels. Data are presented in Table IV-23.
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TABLE I V - 23
AVERAGE CONCENTRATION OF STYRENE IN THE BRAIN AND LIVER OF RATS 
AFTER EXPOSURE TO STYRENE AT 2,800 PPM FOR ONE HOUR
Time After Removal 
From Exposure (min)
AVERAGE STYRENE 
Brain 
mg/100 ml Extract
CONCENTRATION 
Liver 
mg/100 ml Extract
0.1 21.8 20.2
15 22.2 23.5
30 17.7 19.1
60 8.6 12.8
90 Trace-4.4 6.8
Taken from Shugaev [165]
Shugaev [165] found that styrene was more slowly removed from the organs 
than butadiene or hexene and that the anesthetic effects of styrene lasted 
longer than similar effects from the other compounds. Shugaev [165] also 
found that near-lethal concentrations of styrene were absorbed when tails of 
rats were immersed in liquid styrene for 1 hour (precautions had been taken 
to avoid styrene inhalation). Styrene concentrations of 11.1-17.3 mg/100 ml 
extract in the brain were found in rats sacrificed immediately after the 
exposure ended.
In 1977, Savolainen and Vainio [204] conducted an investigation of 
14C-styrene and tritiated(3H)-styrene oxide injected ip into adult male 
Sprague-Dawley rats. Ten rats each received 460 ymol of styrene oxide and 
15 each received 577 ymol of styrene. Each compound was dissolved in 1 ml 
of olive oil for administration. Three and six hours after injection of 
styrene oxide, 5 rats each were sacrificed. The same procedure was followed 
after injection of styrene, and in addition, five rats were sacrificed 24 
hours after injection. The blood, brain, spinal cord, liver, duodenum, 
lungs, and kidneys were removed for analysis of radioactivity and separation 
into protein, water-soluble, and lipid (brain only) fractions. Radioactivity 
(14C) in blood after styrene injection increased from 3 to 6 hours, but 
remained approximately constant in the liver, lungs, kidneys, duodenum, 
brain, and spinal cord. Radioactivity (3H) from styrene oxide decreased in 
the liver and kidneys from 3 to 6 hours after injection, but remained 
constant in all other organs. After styrene injection, about 91% of the 
radioactivity in the brain was found in the water-soluble and 
chloroform-methanol-soluble fractions. After styrene oxide injection, about
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83% of the radioactivity was found in the water-soluble fraction. The 
investigators [204] did not consider that the observed differences might 
have been due to the different isotopes used. Because tritium readily 
exchanges with hydrogen of other molecules, particularly proteins, nucleic 
acids, and water, it would be necessary to isolate and Identify suspected 
metabolites of styrene and styrene oxide.
In 1978, Plotnick and Weigel [205] studied the tissue distribution and 
excretion of uniformly ring-labeled-14C-styrene in male and female 
Sprague-Dawley rats at various time intervals following a single oral dose 
of 20 mg/kg. Peak tissue levels of radioactivity were achieved at or before 
4 hours after administration. The organ with the highest concentration of 
radioactivity at all time intervals studied (2, 4, 8, 12, and 24 hours), and 
in both sexes, was the kidney, followed in order of decreasing concentration 
by the liver and pancreas. Approximately 90% of the radioactivity 
administered was excreted in the urine within 24 hours of administration.
Less than 2% of the dose was found in the feces. The investigators [205]
speculated that the high levels found in the pancreas might be related to 
increased glucose tolerance, which has been reported in some styrene workers 
[115,116,120].
In 1976, Sauerhoff et al. investigated the metabolism and distribution
of styrene in adult Sprague-Dawley rats after oral administration of a 
single dose of 50 or 500 mg styrene/kg [206] and after exposure to styrene 
vapor at 60 or 600 ppm for 6 hours [207]. For both investigations, 
14C-styrene (uniformly ring-labeled) was used and the animals were
sacrificed 72 hours after exposure. Radioactivity recovered in the urine, 
feces, expired air, and carcass was about 95, 4, 1.5, and 0%, respectively, 
after the oral dose of 50 mg/kg and about 90, 1.5, 9, and 0%, respectively, 
after the 500 mg/kg dose. In both cases, the percentage of radioactivity in 
expired air was lower in female than in male rats (0.9 vs. 1.8% and 5.3 vs. 
12% at 50 and 500 mg/kg, respectively), indicating that female rats retained 
styrene longer than male rats [206],
After a dose of 50 mg/kg, six 14C-labeled metabolites were found in the 
urine. After a dose of 500 mg/kg or exposure at 60 or 600 ppm, seven 
radioactive metabolites were found. After all doses and exposures, four of 
these metabolites were identified as phenylglyoxylic, mandelic, benzoic, and 
hippuric acids. The recovered radioactivity associated with
phenylglyoxylic, mandelic, benzoic, and hippuric acids was about 33, 30,
1.5, and 18%, respectively, in male rats; in females, it was about 25, 41, 
2, and 20%, respectively [206,207].
In 1978, in a later investigation by Ramsey and Young [208] at the same 
laboratory as Sauerhoff et al. [206,207], adult rats were exposed to styrene 
vapor at 80, 200, 600, or 1,200 ppm for up to 24 hours. Styrene
concentrations in the blood of rats were measured during and after a 6-hour 
exposure. The investigators [208] concluded that styrene at exposures up to 
200 ppm did not accumulate in the body. Styrene was highly concentrated in 
fat relative to blood; the ratio of the concentration of styrene in fat to 
that in blood was approximately 40:1 at 80 ppm and 80:1 at 1,200 ppm.
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In 1978, Savolainen and Pfaffli [209] exposed male rats to styrene vapor 
at 300 ppm for 6 hours per day, 5 days per week, for 1-11 weeks. The 
content of styrene In the fat increased linearly during the first 4 weeks 
and decreased in an exponential manner thereafter. Half of the peak styrene 
concentration in fat was detected after 9 weeks of exposure.
In 1958, El Masri et al. [210] investigated the metabolism of styrene in 
rabbits. Hippuric, mandelic, and mercapturic acids, and the glucaronide of 
phenylglycol were isolated from the urine of rabbits that had been 
administered styrene orally. The main metabolite (30-40% of the dose) was 
hippuric acid.
In 1965, Ruvinskaya [211] reported the conversion of styrene to mandelic 
acid in guinea pigs and rabbits. When guinea pigs were given subcutaneous 
Injections of styrene in sunflower oil (1:1) at 50, 100, or 500 mg
styrene/kg, the total mandelic acid found in the urine was 4.0, 7.9, and 36
mg, respectively. At 50 mg styrene/kg, excretion was complete within 1 day; 
2 and 3 days were needed to complete excretion of mandelic acid after 
injection of 100 and 500 mg/kg, respectively. When guinea pigs were exposed 
to styrene at 1,410 ppm for 5 hours, they excreted mandelic acid for 4
days. The total excreted mandelic acid was 121-157 mg, 80% of which was
excreted on the first day.
Ruvinskaya [211] also exposed guinea pigs and rabbits to styrene at 1.2, 
12, 235, 705, or 1,175 ppm for 4 hours daily for 3 days. Urine was
collected from each animal for 20 hours following each exposure. Mean 
levels of mandelic acid excreted daily by rabbits exposed at the four
highest concentrations were 0.9, 11.2, 26.8, and 40.2 mg, respectively, and, 
for guinea pigs, they were 1.0, 12.0, 30.1, and 45.5 mg, respectively. There 
was no elevation of mandelic acid in the urine of rabbits or guinea pigs 
exposed at 1.2 ppm. When rabbits were exposed at 12 ppm for 4 hours daily 
for 30 days, mandelic acid excretion was relatively constant at about 1
mg/d. Having assumed a respiratory volume of 500 ml/min and a retention of 
50%, Ruvinskaya [211] calculated that about 30% of the absorbed styrene was 
excreted in the urine as mandelic acid.
In 1971, Bardodej et al. [212] reported on the excretion of styrene
metabolites by male Wistar rats exposed to styrene at 446, 728, or 1,856 ppm 
of styrene vapor for 2-104 hours. Mandelic and phenylglyoxylic acids in the 
urine were determined by polarography and spectrophotometry. The ratio of 
mandelic acid to phenylglyoxylic acid averaged 0.61 and ranged from 0.47 to 
1.15. There was some indication that the ratios became larger with 
increasing duration of exposure. Only traces of phenylglycol were found by 
paper chromatography.
In 1971, Ohtsuji and Ikeda [213] reported studies on the metabolism of 
styrene (455 mg/kg), styrene oxide (527 mg/kg), phenylglycol (603 mg/kg), 
phenylglyoxylie acid (500 mg/kg), and mandelic acid (500 mg/kg) in female 
Wistar rats. Each compound was dissolved in soybean oil, and 2 ml/kg of the 
mixture was injected ip into rats that weighed about 50 g. Groups of six
113
rats were studied with each chemical administered. Urine collected from 
each rat during consecutive 2-hour periods for 10 hours after injection was 
assayed for glucuronides and hippuric, phenylglyoxylic, and mandelic acids. 
Some rats were pretreated with phenobarbital twice daily for 4 days before 
injection to induce hepatic microsomal enzymes; others were treated with a 
microsomal enzyme inhibitor, 2-diethylaminoethyl-2,2-diphenyl valerate 
hydrochloride (SKF-525A), before administration of styrene [213],
Injection of styrene and phenylglycol into the rats resulted in 
increased urinary excretion of a glucuronide (unidentified, but thought by 
the investigators [213] to be phenylglycol glucuronide) and phenylglyoxylic, 
mandelic, and hippuric acids. Styrene oxide may have increased glucuronide 
excretion in the 2 hours after injection; however, the total glucuronide 
excreted in 10 hours was the same as in controls. Excretion of the acid 
metabolites was increased after administration of styrene oxide. When 
phenylglyoxylic acid was injected, it alone was found in large quantities in 
the urine, indicating that it is an end product of styrene metabolism in the 
rat. When mandelic acid was injected, phenylglyoxylic, hippuric, and 
mandelic acids were excreted. When rats were injected with phenobarbital 
before injection of styrene, the level of styrene metabolites in the urine 
was increased, but this same effect of phenobarbital was not observed after 
injection of styrene oxide, phenylglycol, or phenylglyoxylic and mandelic 
acids [213],
Administration of styrene oxide and phenylglycol resulted in excretion 
of greater amounts of all the styrene metabolites during the first 2 hours 
than was observed when styrene was administered [213]. Inhibition of 
microsomal enzyme activity caused a decrease in the excretion of glucuronide 
from styrene, but did not affect excretion of the other metabolites. 
Administration of the microsomal enzyme inhibitor SKF-525A also resulted in 
a decreased excretion of mandelic acid in the first 2 hours after styrene 
administration, but no difference in mandelic acid excretion was noted after 
10 hours in either the SKF-525A-treated rats or the untreated control rats. 
Mandelic acid was an apparent precursor of both phenylglyoxylic and hippuric 
acids. The data are presented in Table IV-24.
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TABLE I V - 2 4
EXCRETION OF URINARY METABOLITES 2 AND 10 HOURS 
AFTER INJECTION OF STYRENE, STYRENE OXIDE, 
PHENYLGLYCOL, PHENYLGLYOXYLIC ACID (PGA), OR MANDELIC ACID
Subs tance 
Injected
Glucuronides
mg/kg
PGA
mg/kg
Mandelic Acid 
mg/kg
Hippuric Acid 
mg/kg
2 h 10 h 2 h 10 h 2 h 10 h 2 h 10 h
Saline only 9.2 52.1 0.4 1.8 1.4 7.1 3.2 19.4
S tyrene 
S tyrene/PB*
S tyrene/SKF-525A
15.6
48.1
8.6
70.4 
130.0
51.5
9.1
39.3
3.9
70.7 
122.6
54.8
11.0
51.9
5.1
58.8 
131.2
56.9
14.7
75.7 
5.1
78.0 
166.4
47.0
S tyrene oxide 
Styrene oxide/PB
21.8
24.1
53.7
59.5
14.7
18.7
24.1
27.0
27.2
31.7
45.5
47.6
24.9
31.3
43.7
52.4
Phenylglycol 
Phenylglycol/PB
41.1
52.5
77.4
84.5
35.6
41.7
89.0
85.5
45.4
69.6
60.6
85.1
75.0
69.3
110.0
93.4
PGA
PGA/PB
6.7
6.9
16.3
19.7
38.8
47.5
110.4
131.7
1.5
1.6
8.5
9.1
4.0
4.2
18.4
19.9
Mandelic acid 
Mandelic acid/PB
2.8
3.2
16.0
17.6
67.9
64.7
129.8
136.4
110.2
89.3
122.1
99.6
11.9
11.6
35.9
36.9
*PB = Phénobarbital
Use of a slash (/) indicates pretreatment with the substance that follows it. 
Taken from Ohtsuji and Ikeda [213]
In 1974, Ikeda et al. [159] found that the 24-hour urinary excretion of
mandelic and phenylglyoxylic acids of rats exposed to styrene vapor for 8
hours was linear with styrene exposures up to about 100 ppm, whereas 
hippuric acid excretion was linear with respect to styrene exposures up to 
200 ppm.
In 1978» Seutter-Berlage et al. [214] identified, and determined the
molar ratios of, three mercapturic acids that appeared in the urine of adult
female Wistar rats after the ip injection of 250 mg styrene/kg once a day, 5 
days per week, for 3 weeks. Compounds identified as metabolites of styrene 
were: N-acetyl-S-(l-phenyl-2-hydroxyethyl) cysteine, N-acetyl-S-(2-phenyl- 
2-hydroxyethyl) cysteine, and N-acety1-S-(phenacy1) cysteine. These 
metabolites were present in a molar ratio of 65:34:1. In a separate
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experiment, five rats each received a single ip injection of styrene (250 
mg/kg); total mercapturic acids as a percentage of the initial dose were 
determined to be 10.4% on the first day, and 0.26% on the second day. No 
mercapturic acids were found on the third day.
Later, in 1980 these same investigators, Delbressine et al. [215] 
studied whether phenaceturic acid was a urinary metabolite in adult female 
rats after ip injections of styrene (150 mg/kg) or styrene oxide (150 mg/kg)
in sesame oil 5 days per week for 3 weeks. To exclude interference from
naturally occurring phenaceturic acid, the experiments were repeated with 
d8-styrene (styrene with deuterium in the 8 position). After administration 
of styrene to rats, significantly greater amounts (p<0.0025) of phenaceturic 
acid were isolated from urine during the first 24 hours (as compared with 
controls) and identified as its methyl ester by thin layer chromatography 
with the structure confirmed by nuclear magnetic resonance spectroscopy. 
Quantitative results obtained with gas-liquid chromatography showed 1.4% of 
a single administered dose to be phenaceturic acid. Neither a single dose 
nor continuous administration of styrene oxide resulted in any significant 
increase in urinary phenaceturic acid excretion compared to the control 
group; the reason for this finding was not clear to the investigators 
[215], The studies with d8-labeled styrene and styrene oxide confirmed the 
findings with the unlabeled substances.
In 1970, Bakke and Scheline [216] studied the metabolism of styrene to 
phenolic compounds in five male rats. The rats were fed neomycin for 6 days 
before administration of styrene to inhibit formation of natural phenolic 
compounds. Styrene, dissolved in 1 ml of propylene glycol, was administered 
by stomach tube at 100 mg/kg and urine was collected for 48 hours. To 
convert any metabolites from their conjugated form, the urine samples were 
treated with an enzyme preparation that contained beta-glucuronidase and 
sulfatase. During the 48 hours, 0.1% of the initial dose of styrene was 
recovered as 4-vinylphenol. Other alcoholic metabolites identified were
1-phenylethanol and a trace of 2-phenylethanol. Bakke and Scheline [216] 
also looked for, but did not find, phenylglycol. Excretion of p-ethylphenol 
was not greater than control values.
In 1978, Pantarotto et al. [217] administered styrene ip to
Sprague-Dawley rats. In addition to phenylethylene glycol and mandelic, 
benzoic, and hippuric acids, phenolic metabolites, namely, 4-vinylphenol, 
p-hydroxymandelic acid, p-hydroxybenzoic acid, and p-hydroxyhippuric acid 
were identified in the urine of the treated animals. These metabolites were 
characterized by mass spectrometry and by comparative thin layer 
chromatography with standard compounds. The investigators [217] theorized 
that the phenolic metabolites could have been formed as a result of chemical 
rearrangements of unstable arene oxides.
In 1972, Ikeda et al. [218] studied the effects of coadministration of 
toluene or pretreatment with phenobarbital on the metabolism of styrene in 
female Wistar rats. Both styrene (228 mg/kg) and toluene (217 mg/kg) were 
administered ip in soybean oil. Simultaneous administration of toluene
116
suppressed and delayed the excretion of mandelic and phenylglyoxylie acids, 
which suggested a competitive inhibition of styrene metabolism by toluene. 
The observed effect of toluene was attributed to competitive inhibition of 
the oxidative processes involved in the metabolism of styrene, since 
phenobarbital pretreatment counteracted this effect [218]. The suppression 
of oxidation of styrene was a transient effect, since the levels of styrene 
metabolites in the urine returned to control values 6-8 hours after 
injection of toluene.
In 1974, Ikeda et al. [159] further studied the metabolism of styrene in 
rats when styrene was injected ip at doses up to 910 mg/kg into rats and the 
time course of the urinary excretion of mandelic, phenylglyoxylie, and 
hippuric acids was monitored. There was a delay in excretion of mandelic 
and phenylglyoxylie acids; the amounts of these acids excreted were linear 
with respect to dose only up to styrene doses of 200-250 mg/kg. There were 
no significant differences between control and styrene-treated animals with 
respect to urinary hippuric acid excretion at styrene doses below 100 
mg/kg. Excretion of hippuric acid became linear with respect to styrene 
doses above 100 mg/kg [159].
In 1967, James and White [219] studied the formation of mercapturic 
acids in adult female rabbits and rats treated with styrene and styrene 
oxide. In one experiment, rats that had been fed yeast containing 
radioactive sulfur (35S) were given styrene and styrene oxide by stomach 
tube at doses of about 200 or 250 mg/kg, respectively. Urine was collected 
over the next 24 hours and assayed for radioactivity. Administration of 
styrene and styrene oxide resulted in excretion of relatively large amounts 
of radioactively-labeled hydroxyphenylmercapturic acid, indicating that 
hydroxylation of the benzene ring of the parent compound had occurred. 
Traces of labeled phene thylmercapturic acid and an unidentified labeled 
metabolite were also found.
In another experiment by James and White [219], hydroxyphenylmercapturic 
acid but no phene thy lmercapturic acid was found when unlabeled styrene (145 
mg/kg) and styrene oxide (185 mg/kg) were administered by stomach tube to 
rabbits. No mercapturic acids were found when phenylglycol was given to 
either rabbits (185 mg/kg) or rats (170 mg/kg). After administration of 
phenethylmercapturic acid, the rabbits excreted only small amounts of the 
hydroxy derivative, indicating that another source of this compound was 
probable. Administration of 8-14C-labeled styrene oxide to rabbits resulted 
in large amounts of labeled mandelic acid and no naphthoresorcinol-reactive 
substances. In rabbits, 32% of the administered styrene and 30% of the 
styrene oxide were converted to mandelic acid. James and White [219] also 
found that 15-32% of the styrene oxide administered was excreted in rabbits 
as hippuric acid. With phenylglycol, 17-29% was recovered as mandelic acid, 
and 4-13% as hippuric acid [219]. No phenolic compounds other than those 
normally in urine were observed in rabbits given styrene oxide.
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In 1977, Vainio and Makinen [220] found that styrene in olive oil, 
administered ip at 150-1,000 mg/kg, caused a reduction in the hepatic 
nonprotein sulfhydryl content of female mice, male Wistar rats, female 
hamsters, and male guinea pigs in about an hour after the injection. Vainio 
and Makinen [220] suggested that this might reflect the conjugation of 
reactive alkylating metabolites with hepatic glutathione; they pointed out 
that the mouse was the most sensitive to this action of styrene, and the rat 
the least sensitive, possibly because mouse liver has a high epoxide-forming 
capacity and a low epoxide-inactivating capacity as compared to rat liver.
In 1976, Parkki et al. [221] reported that the activity of epoxide 
hydratase in Wistar rats increased with increasing styrene doses. Styrene 
was injected ip in corn oil in daily doses of 100 mg/kg for 3 or 6 days, or 
500 mg/kg for 1, 3, or 6 days, or 2,000 mg/kg in one dose. No increases in 
epoxide hydratase were observed after 3 or 6 doses of 100 mg/kg; 
statistically significant increases occurred after a single dose of
2,000 mg/kg and 3 or 6 doses of 500 mg/kg. No increase in the activity of 
uridine diphosphate-glucuronosyltransferase was observed with styrene at any 
dose, nor was any increase observed in activities of the hydratase or the 
transferase after one or three doses of styrene oxide (375 mg/kg) or 
phenylethylene glycol (750 mg/kg).
In 1976, Delag et al. [222] investigated the effect of styrene on 
carbohydrate metabolism in rats. Glucose, styrene, or glucose and styrene 
together were administered by stomach tube to two groups of Wistar rats that 
were either on standard diet or had been food-deprived for 17 hours. Two 
hours after administration of the compounds, the animals were sacrificed and 
the left caudate lobe of the liver, the left ventricle of the heart, and the 
left thigh muscle were removed, homogenized, and assayed for glycogen using 
anthrone. The results are presented in Table IV-25.
TABLE IV-25
GLUCOSE AND GLYCOGEN IN LIVER AFTER ADMINISTRATION 
OF GLUCOSE, STYRENE, OR GLUCOSE AND STYRENE TO RATS
Glucose Glycogen
Subs tance(s) (mg/g tissue)* (mg/g tissue)*
Administered Fed Fasted Fed Fasted
None (control) 5.0 6.3 49.1 13.4
Glucose** 5.6 5.6 39.3 16.6
Styrene** 4.0 5.9 21.2 10.7
Glucose and styrene** 5.9 6.1 33.0 18.2
*Mean of 7 determinations
**Each administered at 2.5g/kg body weight
Taken from Delag et al. [222]
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Although styrene caused depletion of hepatic glycogen in both fed and 
fasted animals, the data [222] indicate that its effect could be reversed by 
the simultaneous administration of glucose.
In a 1968 abstract, Leibman and Ortiz [223] presented evidence that in 
the conversion of styrene to phenylethylene glycol in mammalian liver 
microsomes requiring NADPH and oxygen, styrene oxide was the primary product 
of the NADPH-dependent oxidation. Mixtures containing styrene, nicotinamide 
adenine dinucleotide phosphate (NADP), glucose-6-phosphate dehydrogenase, 
and 9000 x g supernatant fraction of rabbit liver were incubated in air for 
5 minutes, and extracted. Styrene oxide was identified either by direct gas 
chromatography of the extracts or by thin-layer chromatography of the picric 
derivative. No styrene oxide was found when NADP and glucose-6-phosphate 
dehydrogenase were omitted. When 8-14C styrene was incubated in the above 
system with a pool of unlabeled styrene oxide, about equal radioactivity was 
found in the phenylethylene glycol and in the picric derivative of styrene 
epoxide.
Later, in 1969, Leibman and Ortiz [224] demonstrated the ^n vi tro 
formation of phenylglycol from styrene by hepatic microsomal preparations in 
rats and rabbits pretreated with phénobarbital. Ethyl acetate extracts of a 
reaction mixture that contained 50 pmol of styrene in 0.5 ml of 
dimethylformamide were qualitatively analyzed by gas chromatography. Peaks 
having the same retention times as a reference standard of phenylglycol 
appeared following incubation. In addition, thin layer chromatography of 
the ethyl acetate extracts after both acétylation and trimethylsilylation 
yielded areas having the same reference values in three different solvent 
systems as the acetylated and silylated derivatives of standard phenylglycol 
[224].
In 1970, this work was further extended by Leibman and Ortiz [225] to 
demonstrate that styrene oxide may be an intermediate in the formation of 
phenylglycol. Styrene oxide was identified in ethyl acetate extracts of 
rabbit liver microsomal preparations that had been incubated with unlabeled 
styrene and styrene labeled with carbon-14 at the 8 position. The oxide 
intermediate was demonstrated by three methods: gas-liquid chromatography,
thin layer chromatography, and by accumulation of radioactivity in a pool of 
styrene oxide added to reduce the effect of epoxide hydratase.
In 1976, Salmona et al. [226] studied the enzymatic capacity for 
epoxidation in the liver, lungs, kidneys, heart, spleen, and brain of male 
and female rats. Microsomes from the organs were incubated with styrene or 
styrene oxide, and the activities of monooxygenase and of epoxide hydratase 
were assayed. The investigators [226] found that styrene oxide formation,
i.e., monooxygenase activity, is dependent on the availability of NADPH. 
Inhibitors of cytochrome P-450 (metyrapone and SKF-525A) and inhibitors of 
epoxide hydratase (cyclohexene oxide and epoxytrichloropropene) were studied 
for their effect on enzyme activity of hepatic microsomes. The cytochrome 
P450 inhibitors significantly inhibited (p<0.01) both styrene monooxygenase
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and epoxide hydratase activities. The epoxide hydratase inhibitors markedly 
inhibited epoxide hydratase but not monooxygenase activity.
In 1978, Cantoni et al. [227] studied the activities of styrene 
monooxygenase and epoxide hydratase in rats, mice, guinea pigs, and rabbits 
of each sex and found the highest activity of each enzyme in the liver, with 
the hydratase activity being higher than that of monooxygenase. Each enzyme 
was also found in microsomal fractions from the heart, lungs, spleen, and 
kidneys. Styrene or styrene oxide was the substrate used in incubating the 
microsomal preparations prior to enzyme assay. Because of the high ratio of 
hydratase to oxygenase activity in the rat, Cantoni et al. [227] suggested 
that the rat would be relatively resistant to styrene toxicity, assuming 
that oxygenase caused styrene oxide to form and that hydratase (as well as 
glutathione-S-transferase) inactivated the styrene oxide. Because of the 
low activity of epoxide hydratase in mouse and rabbit lungs in comparison to 
activating capacity, the investigators 1227] speculated that the lungs of 
these two species would be the most sensitive site for styrene toxicity.
Because of the work of Bakke and Scheline [216], who found 4-vinylphenol 
in the urine of rats given large amounts of styrene, Vatabe et al. [180] 
suggested in 1978 that l-vinylbenzene-3,4-oxide (styrene-3,4-oxide) might be 
the precursor of both 4-vinylphenol and 1,2-dihydroxy-l,2-dihydro-4- 
vinylbenzene, and that an oxygenated metabolite of the latter compound is a 
proximate mutagen. In another 1978 investigation, Watabe et al. [228] 
incubated rat liver microsomes with styrene, and identified styrene oxide 
(or at least a chromatographic peak with the same retention time as styrene 
oxide). Maximal amounts of the oxide were found after an incubation period 
of 10 minutes, thereafter decreasing so that at 40 minutes the oxide was not 
detectable. Styrene glycol was formed in increasing amounts until a maximum 
was reached at 60 minutes.
In 1981, Belvedere and Tursi [229] studied the oxidation of styrene to 
styrene oxide in human blood erythrocyte and lymphocyte suspensions. 
Styrene oxide formed enzymatically was quantitatively hydrated by 
acidification to styrene glycol, a compound more suitable for gas 
chromatographic analysis. Styrene oxidation in human erythrocytes was 
inhibited by carbon monoxide, occurred in the absence of NADPH and NADP, and 
was undetectable in the absence of oxygen. The finding that oxygen was 
required to catalyze the formation of styrene glycol is indicative that the 
glycol was in fact formed from styrene oxide and not directly by the 
hydration of styrene. Lymphocytes (with the addition of NADPH and NADP) 
were more active than red blood cells in styrene oxidation.
However, in 1982, Beije and Jenssen [230] conducted a mutagenicity study 
with an isolated perfused rat liver as a metabolizing system and Chinese 
hamster V79 cells as genetic target cells. Styrene oxide was rapidly 
metabolized by the perfused liver, and thus, no mutagenic effect was 
detected. However, when styrene was added to the perfusion system, an 
increase in mutations in the V79 cells were observed regardless of where in
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the circulation perfusion medium the V79 cells were placed. The 
mutagenicity of styrene was five times higher as compared to using an S9 mix 
from the same rat strain as the metabolizing system. The simultaneous 
analysis of styrene oxide in the perfusion medium indicated concentrations 
only 2-4% of the original amount of styrene. Beije and Jenssen [230] 
suggested that their results using the liver perfusion/cell culture system 
mimics the metabolism expected to be found in the intact animal, thus 
indicating that styrene oxide is not the principal mutagenic metabolite of 
styrene in vivo.
In 1977, Ryan and Bend [231] demonstrated that biliary excretion of the 
glutathione conjugate was dose-dependent with respect to styrene oxide in 
perfused rat liver preparations. In 1977, additional work with styrene 
oxide was reported by Bend et al. [232] who perfused rat livers ^n vivo by 
cannulation of the portal vein, the thoracic vena cava, and the bile duct. 
Using styrene oxide at 0-500 ymol per liver, they found labeled 8-14C 
styrene oxide bound to DNA, RNA, and protein, even when the organ was 
challenged with only 1 ymol of styrene oxide. The binding increased with 
increasing styrene oxide concentrations, and at 500 ymol a marked increase 
in its binding to protein was observed simultaneously with microscopic 
changes of the liver and depletion of hepatic glutathione [232].
SUMMARY
A summary of information on possible effects of styrene on health 
follows.
Effects on the Nervous System
Experimental exposures in humans to styrene have demonstrated that 
styrene causes CNS depression [68,69,70,71,72], Within minutes of an 
exposure at 800 ppm, 2 men experienced listlessness, drowsiness, and 
impaired balance [68], During a 1-hour exposure to 376 ppm, decrements in 
balance, coordination, and manual dexterity tests were measured, and 
subjective complaints of headache, nausea, and a feeling of slight 
inebriation were reported [69], A significant difference in reaction time 
was noted in 12 subjects after a 2-hour exposure that included consecutive 
30-minute styrene exposures of 50, 150, 250, and 350 ppm [71]. Slower
reaction times were found in 2 or 3 subjects during 90-minute exposures of 
50, 100, and 200 ppm; loss of balance was found for 3 subjects during the 
90-minute exposure at 200 ppm [72], Subjective complaints reported by 6 
subjects during 90-minute styrene exposures at 50, 100, or 200 ppm included 
headache, fatigue, sleepiness, malaise, difficulty in concentrating, and a 
feeling of intoxication [72], During the course of a study lasting a couple 
of weeks, which included a series of styrene exposures at 20, 100, and 125 
ppm for 7.5 hours, there were some changes in 3 of 6 subjects in both visual
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evoked response and GEG amplitude, which the investigators [70] deemed to be 
consistent with CNS depression.
However, there have also been experimental studies showing styrene to 
have little effect on the central nervous system. After experimental 
styrene exposures of 50 ppm for 1 hour, 99 ppm for 7 hours, 117 ppm for 2 
hours, or 216 ppm for 1 hour, no significant CNS effects (e.g., decrements 
in balance, coordination, and manual dexterity) were noted [69]. No changes 
in manual dexterity or perceptual tests were noted after consecutive 
30-minute exposures to 50, 150, 250, and 350 ppm [71]. Loss of balance was 
not found during 90-minute exposures to 50 or 100 ppm [72], In exposures
for 1, 3, or 7.5 hours to 20, 100, or 125 ppm of styrene, no deleterious 
effects on equilibrium, cognitive testing scores, or EMGs were found [70]. 
No significant optokinetic changes were noted in 5 subjects exposed to 300 
ppm of styrene for 1 hour [73],
Workers exposed to styrene have experienced weakness [105], increased 
reaction times [111,392], abnormal EEGs [63,106,108,118,124,125], and 
headache, fatigue, malaise, tension, or dizziness [59,63,67,82,84,94,101,102, 
105,106,108,109,110,112,113,123,138]. Styrene exposures in many of these 
studies were either not determined [63,67,101,108], or were at times greater 
than 100 ppm for some of the workers [59,102,105,106,111,112,113,123,138]. 
However, at one RP/C facility where the average styrene exposure was 
estimated from urinary mandelic acid measurements to be about 30 ppm, 24% of 
the workers had EEGs judged to be abnormal [124].
There is some evidence of styrene-induced peripheral neuropathy. In an 
investigation of workers at a U.S. styrene and polystyrene production plant 
(with potential exposures to styrene, benzene, ethylbenzene, and toluene), 
radial and peroneal nerve conduction velocities were said to be reduced, but 
comparative data on normal velocities were not given [81]. It was also 
reported in the same study [81] that radial and peroneal nerve conduction 
velocities decreased with increasing duration of exposure, but because 
appropriate corrections for age were not made, it is not evident whether the 
decrement with longer exposure was due to the longer exposure, increasing 
age, or a combination of both. In a Swedish study [123], 10 of 33 workers 
exposed to about 5-125 ppm of styrene had evidence of a mild sensory 
neuropathy with polyphasic sensory responses; these 10 workers were older 
than those not having signs of neuropathy, and they were more heavily 
exposed. The investigators [123] speculated that age alone did not cause 
these effects, but that the effects of age and styrene exposure might have 
been synergistic. It seems evident that more investigation of nervous 
system effects is needed.
Irritant Effects
Irritation of the eyes has occurred in human subjects undergoing single 
exposures [68,69,70,72] and in workers during repeated exposures
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[35,53,58,61,104,110,113,126] to styrene. Styrene has also been reported to 
cause superficial transient burns of the human cornea [55]. Irritation of 
the respiratory tract has occurred in human subjects [68,69,70,72] and in 
workers [35,53,59,56,93,104,113,123,126] exposed to styrene. As would be 
expected since styrene is a defatting agent, styrene is a primary skin
irritant [234], and has caused dermatitis, including a rash and chapped skin
in workers [54,56,61,91,104,113,122,126].
Volunteer subjects exposed to styrene vapor at 800 ppm had immediate 
eye, nose, and throat irritation [68], At 376, 216, and 99 ppm, human
subjects developed eye or respiratory tract irritation within 20 minutes of 
the start of exposure [69], In another experimental study [70], the 
incidence of eye, nose, and throat irritation for male subjects was 13% at 0 
ppm, 17% at 20 ppm, 20% at 100 ppm, 33% during exposures fluctuating between
75 and 125 ppm, and 45% at 125 ppm styrene; the incidence of eye, nose, and
throat irritation for female subjects was 8% at 0 ppm and 32% at 100 ppm. 
Irritation of the eyes was noted by volunteer subjects in another study [72] 
during styrene exposures of 50, 100, 200, and 300 ppm.
Workers exposed to styrene in reinforced plastics applications 
complained of eye and respiratory tract irritation, but were able to
tolerate styrene exposures in excess of 500 ppm for several hours at a time 
[35], Among 35 reinforced plastics workers exposed to styrene at 
44-550 ppm, 34 complained of some sort of eye, nose, or throat irritation; 
and about half of them complained of wheezing, shortness of breath, or chest 
tightness [104]; exposure to an isocyanate (MDI) might have contributed to 
some of these effects. Complaints of wheezing and chest tightness have also 
been noted in workers during an investigation of a styrene and polystyrene 
production plant [82]; however, spirometric studies of airway effects did 
not suggest significant changes, nor was there any radiologic evidence of 
significant lung change observed. In a factory where reinforced plastics 
were made, workers exposed to TWA styrene concentrations of 9-111 ppm
(average 69 ppm) complained of chest tightness (23% of the workers), 
wheezing (18%), and shortness of breath (54%), but ventilatory function was 
significantly changed during the shift only in those workers that smoked 
[113]. Among 21 workers exposed to styrene at about 75 ppm for about 10 
years at another RP/C plant [114], there were four cases of reduced FEV^, 
but whether the cause was age, styrene exposure, or other factors was not 
clear. As compared to controls, a significantly greater number of RP/C
workers in another clinical study had abnormal pulmonary function [91].
Irritation of the eyes and upper respiratory tract has occurred in some 
workers and experimental subjects at styrene concentrations well below 
200 ppm. More research into long-term respiratory effects of styrene is 
needed.
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E f f e c t s  I n v o l v i n g  t h e  L i v e r
Various clinical studies [82,96,103,113,115,116,120] have suggested that 
styrene exposure has affected liver function, based on several tests. Among 
the findings, which may indicate liver function changes, were elevated serum 
enzyme activities [82,96,103], elevated serum uric acid [113], increased 
glucose tolerance [115,116,120], and a low glucose assimilation coefficient 
[116], In one study designed to investigate liver function among 
polystyrene production workers, the authors [96] concluded that styrene 
exposure caused hepatic dysfunction reflecting metabolic disturbances, but 
not of a pathological degree.
A clear-cut trend toward altered liver function has not been 
demonstrated. In addition, the more commonly used tests such as changes in 
serum enzyme levels of hepatic origin were not always used. Animal studies 
[53] have suggested that styrene is hepatotoxic only at concentrations much 
higher than those found in the workplace. Damage to the hepatic parenchyma 
of rats after a single exposure to styrene vapor at 2,500 ppm for up to 21 
hours was reported by one group of investigators [53], who also reported 
increases in the liver weights of rats repeatedly exposed to styrene vapor 
at 1,300 ppm for 130-139 days. However, they found no liver damage in 
guinea pigs exposed at 650 ppm or rabbits and monkeys exposed at 1,300 ppm 
for similar periods. Another group [169] noted parenchymal alterations and 
congestion in the liver of rats intermittently exposed for 2 weeks to 300 
ppm of styrene 6 hours per day, 5 days per week. Research to clarify the 
role of styrene on liver status is needed. Meanwhile, for worker 
protection, liver function should be periodically assessed due to the 
importance of this organ in the biotransformation and detoxification of 
toxic substances.
Mutagenicity
Many in vitro tests of mutagenicity have indicated that styrene has no 
mutagenic activity. This has been found with S^ _ typhimurium strains TA 98, 
TA 100, TA 1535, TA 1537, and TA 1538 [172,173,174,176] as well as with
E. coli K12 [174], the yeasts S. pombe and S. cerevlslae [175], and cultured
Chinese hamster V79 cells [175,176]. However, a few studies [171,177,178] 
have found weak evidence of the mutagenicity of styrene in typhimurium 
strains TA 98 and TA 1538. Styrene oxide has been shown to be mutagenic 
toward S. typhimurium TA 100 and TA 1535 [171,172,173,174,176,178],
E. coli K12 [174], the yeasts S^ _ pombe and cerevlsiae [175], and Chinese
hamster V79 cells [175].
There was increased uptake of tritiated thymidine into the DNA of
heteroploid human cells, reflecting unscheduled DNA synthesis, following 
treatment with styrene oxide but not with styrene [176], Chromosomes from 
human lymphocytes incubated with styrene or styrene oxide had more 
abnormalities than controls, though the abnormalities in chromosomes in 
styrene-treated cells were different from those in the styrene oxide-treated
1 2 4
cells [179], Doubts about the applicability of this in vitro test are 
amplified by the suggestion of the investigators [179] that impurities in 
the styrene preparation might have been responsible for the effects. 
However, a later study by the same group [181] showed a clear dose-response 
relationship in the induction of sister chromatid exchanges (SCE) in human 
whole blood lymphocyte cultures treated with styrene.
In vivo tests have also given conflicting results. In a host-mediated 
assay [175], a high dose of styrene (i.e., 1 g/kg) produced gene conversions 
in the yeast cerevisiae which had been injected ip into mice. Mice 
intubated with styrene oxide, but not those intubated with styrene, had a 
significantly elevated incidence of chromosomal aberrations in bone marrow 
cells removed 24 hours after administration of the dose [176], An increase 
in the frequency of SCE in alveolar macrophages, in bone marrow cells, and 
in regenerating liver cells was observed in mice exposed to styrene at 
565 ppm for 6 hours per day for 4 days [183]. Chromosomal breaks were also 
found in the bone marrow of rats exposed to styrene vapor [184], but not in 
mice [176] or hamsters [185]. Styrene has also caused recessive lethal 
mutations in fruit flies [187],
Chromosomal changes were found to be more frequent in the lymphocytes of 
styrene-exposed workers in several European RP/C factories than among 
controls [76,129,130,131,132]. An increased frequency of SCE in the 
lymphocytes of s tyrene-exposed workers has also been reported [132]. 
However, other studies of workers exposed to styrene have shown no 
significant increases in either chromosomal aberrations [134,136] or SCE 
[136], In a study of unscheduled DNA synthesis in lymphocytes of 
styrene-exposed workers, styrene did not alter the efficiency of DNA repair, 
but rather predisposed the lymphocytes to an increased risk for DNA damage 
from subsequent exposures to genotoxic agents [137].
The reasons for the different results in the many tests of mutagenicity 
of styrene are not known, so a conclusion on whether styrene is a mutagen 
seems premature. It may be that these different results reflect the 
different capabilities or efficiencies of metabolism by the various species 
or mutagen assay systems; for example, if one species hydrates styrene 
epoxide as soon as it is formed, styrene should be less potent, or even 
inactive, as a mutagen than in another species lacking the ability to 
inactivate the epoxide so rapidly. (This argument is based on the 
reasonable although unproved premise that styrene epoxide formation is the 
basis for any mutations.)
Reproductive Effects
Congenital defects in children whose mothers had been occupationally 
exposed to styrene were reported by Holmberg [66]; a more thorough 
investigation is needed to verify the implications of these findings. The 
finding of styrene, at unstated concentrations, in umbilical cord blood [65] 
suggests that styrene can cross the placenta; in these cases, the
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source of the styrene exposure of the mothers was not found. Placental 
transfer of styrene In rats has also been noted [189]. An increased rate of 
spontaneous abortions observed among Finnish styrene workers [139] might be 
compatible with findings of cytogenetic effects or of terata; thus, despite 
lack of confirmation of this study, the finding warrants concern. A later 
study, however, found no difference in the number of spontaneous abortions 
between styrene workers and a group of age- and social class-matched 
controls with no solvent exposures [140],
Ragul'ye [190] found an increased incidence of pre-implantation loss and 
total embryo mortality in female rats that had been exposed to styrene at 12 
ppm for 4 hours per day throughout gestation. The study by Vergiyeva et al.
[191], conducted like that of Ragul'ye [190] but involving a higher styrene 
exposure concentration of 47 ppm, found no significant evidence of 
embryotoxicity, thereby refuting the Ragul'ye study. Murray et al. [192] 
investigated teratogenicity in rats and rabbits exposed to styrene by 
inhalation of vapor or by intubation of liquid and found no significant 
evidence that styrene is teratogenic; however, the dams were not exposed 
during the first or last trimester of gestation. None of these three 
investigations [190,191,192] found evidence of teratogenicity. Similarly, 
Kankaanpaa et al. [193] did not find a significant excess of malformed 
fetuses from mice and hamsters exposed to styrene vapor; however, 
fetotoxicity (an excess of dead or resorbed fetuses) was found from hamsters 
exposed on days 6-18 of pregnancy at 1,000 ppm styrene, but not at lower 
concentrations. Ponomarkov and Tomatis [196] found a significantly greater 
pre-weaning mortality of progeny of female 020 mice administered a single 
1,350 mg styrene/kg dose by stomach tube on day 17 of gestation; significant 
results were not found in similar experiments with C57 Bl mice or BD IV 
rats. A study [170] sponsored by the Chemical Manufacturers Association 
concluded that styrene administered in the drinking water had no deleterious 
effects on the reproductive capacity of rats through three generations.
In summary, styrene does not appear to be teratogenic, embryo toxic, or 
fetotoxic but further investigations of the reproductive outcomes of workers 
exposed to styrene are needed.
Carcinogenicity
The possible carcinogenicity of styrene has been investigated by
long-term administration to rodents [195,196,197,198], One of these 
investigations [195] involved vapor exposure. That study, which used rats, 
resulted in an increase in the combined incidence of leukemia and 
lymphosarcoma in female rats only that was not statistically significant. 
There was a high incidence of intercurrent disease (i.e., chronic murine 
pneumonia) in the male rats such that conclusions from the investigation are 
inappropriate. In another study [196], styrene was administered in olive 
oil by stomach tube to one strain of rats and two strains of mice. There
was a statistically significant increase in lung adenomas and
adenocarcinomas only in female mice of one strain; the authors [196]
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suggested that their data provided weak evidence of the carcinogenicity of 
styrene. An NCI investigation [197] also developed equivocal evidence. 
There was a significant increase in lung adenomas and adenocarcinomas in 
male mice (when compared with matched controls but not when compared with 
historical controls), but not in female mice or rats. NCI [197] concluded 
that the data provided "suggestive" but not "convincing" evidence of the 
carcinogenicity of styrene, and recommended another experiment to help 
resolve the point. A companion experiment [198], involving the 
administration of a mixture of styrene and beta-nitrostyrene, also gave 
equivocal results.
Mortality studies of workers exposed to styrene have not shown an excess 
cancer mortality [31,78,83,84,142]. There have, however, been suggestions
of an excess of leukemia. Nicholson et al. [83] studied the mortality 
experience in one U.S. styrene and polystyrene production plant, and found 
83 total deaths vs. 106 expected among those exposed 5 years or more. There 
was no excess of deaths from cancer or from any of the nonneoplastic
diseases examined such as cardiovascular or respiratory disease. The 
investigators [83] anticipated an excess of leukemia because of previous 
exposure of many of these workers to benzene; they found two cases of 
leukemia and one of lymphoma in the study group. They examined 361 death 
certificates of other workers employed at least 6 months at the plant and 
five additional cases of leukemia and four of lymphoma were found. The
investigators [83] concluded that the information found regarding leukemia 
was not definitive.
In a U.S. styrene production plant, Ott et al. [31] found fewer total
deaths (303 vs. 425) and fewer cancer deaths (58 vs. 76.5) among 2,904
workers at four plants than would be expected from the U.S. white male
population. Most of these workers had been exposed to low levels of styrene 
during their employment (TWA concentrations were 10 ppm or less). The 
mortality data on the styrene workers (i.e., production and non-professional 
research) was also compared with previous mortality experiences from that 
company, and the styrene workers had a lower total mortality and a lower 
cancer mortality. However, there was a significant excess (p<0.05) of 
leukemia deaths compared with other company workers (6 observed vs. 1.6 
expected), although the excess was not significant when compared with the 
U.S. population (6 vs. 2.9). Most of the excess was due to lymphatic 
leukemia. Some workers had been exposed many years earlier to high levels
of benzene, but whether those men with leukemia had been exposed to benzene
was not evident.
No excess of cancer was seen in a German styrene and polystyrene plant
[78], In that study, 74 death certificates were examined, and there were 12 
deaths from cancer, 3 of them from lung cancer, neither significantly 
different from the comparison groups.
In a study of 1,205 reinforced plastics workers in Sweden [142], where 
exposure levels were thought to be 150-300 ppm styrene in recent years and 
higher in the past, a slight but nonsignificant decrement in cancer
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incidence from that expected in the Swedish population was found. The 
latency period was not high for many of the workers, so further foilowup 
might reveal more cases of cancer.
From the experimental animal investigations and from the epidemiological 
studies, there seems little basis to conclude that styrene is carcinogenic. 
If styrene oxide is an intermediate metabolite, covalent binding to nucleic 
acids leading to cancer development might be predicted; however, there is 
little evidence that this epoxide is formed ^n vivo. Nonetheless, the 
enzyme catalyzing the formation of this epoxide from carbon-carbon double 
bonds exists in many tissues, as do the enzymes catalyzing the hydration or 
other inactivation of the epoxide. If these enzymes are in the same cells, 
it may be that the epoxide is formed and then rapidly deactivated; if it 
exists long enough, it might be carcinogenic. This speculation, if valid, 
could suggest that styrene is a weak carcinogen. Examination of the ratios 
of these enzymes in various tissues of several animal species [220,227] 
suggests that the mouse should be one of the more sensitive species. Two 
studies of experimental carcinogenesis [196,197] found positive results only 
in mice, a point compatible with the speculation, even if not proving it. 
Suspicions that the epoxide may be stable long enough to react with other 
molecules before being inactivated are enhanced by evidence [235] that the 
cytochrome P-450 monooxygenase system is not close, in a spatial sense, to 
epoxide hydratase and to transferases in the endoplasmic reticulum.
Thus, while it does not seem appropriate from presently available 
evidence to conclude that styrene can cause cancer among exposed workers, 
there is enough reason to suggest it might be at least a weak carcinogen, 
and priority should be given to further studies of this problem.
While several experimental tests of the carcinogenicity of styrene oxide 
have been inconclusive [199,200,201], an investigation in Italy [202] 
developed persuasive evidence that styrene oxide can cause stomach tumors in 
rats administered the compound by intragastric catheter. It seems reasonable 
to predict that administration of this compound by inhalation could cause 
tumors of the respiratory tract, and that styrene oxide could cause cancer 
in humans.
Uptake, Metabolism, and Elimination
Liquid styrene is readily absorbed through intact skin of man [151] and 
of animals [165]. Moreover, styrene vapor can penetrate the skin of man 
[154], although less efficiently than the liquid. Styrene is also retained 
after inhalation of the vapor, with retention rates reported to vary from 60 
to 75% [69,88,143,146].
Absorbed styrene is eliminated from humans mostly in the urine as 
metabolites, but some excretion of unchanged styrene from the lungs occurs 
[91]. Metabolites reported in human urine include mandelic acid [35,72,88, 
109,125,144,151,159], phenylglyoxylie acid [35,144,159], and, at higher
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doses, hippuric acid [68,159]. These are also the most commonly found 
metabolites in the urine of styrene-treated experimental animals [53,206,207, 
210,211,212,213,217,219], but other metabolites have also been found, 
namely, mercapturic acids [53,210,214,219], benzoic acid [206,207,217], 
4-vinylphenol [216,217], 2-phenylethanol [216], phenaceturic acid [215], and 
phenylglycol [210,212], some of which may be excreted as conjugates of 
glucuronic acid or glutathione [68,203,210,213].
Styrene oxide, also known as styrene epoxide, has been proposed 
[224,225] as an intermediate in the metabolism of styrene, but it has not 
been found ^n vivo. However, phenobarbital-activated rat microsomes 
converted styrene to the epoxide [224] as determined by an indirect method.
An epoxide-forming enzyme (monooxygenase) has been found in a number of 
tissues of mice, rats, guinea pigs, and rabbits [226,227], but an epoxide 
inactivating enzyme (glutathione-S-transferase or epoxide hydratase) was 
also present in these same tissues. Thus, it seems possible that styrene is 
converted to styrene epoxide and is then further converted to such final 
products as mandelic and phenylglyoxylie acids. Whether styrene oxide (if 
formed) is present long enough to bind covalently to genetic material or 
other macro molecules is not known; from indirect evidence, styrene's lack 
of potency in causing mutations or tumors suggests that styrene oxide, if 
formed, is present only briefly.
This ability of epoxides to alkylate or arylate nucleic acid, thereby 
presumably leading to germinal or somatic mutations, is the major concern in 
the question of intermediary metabolism of styrene.
Other Effects
Other effects reported among styrene-exposed persons include gastralgia 
and nausea [72,101,102,104,109,110], nose bleed [93,104,105], blood 
dyscrasias [102], lowered arterial blood pressure [94], elevated blood 
pressure [105], enlarged thyroid [113], retrobulbar neuritis [57], 
thrombosis of the central retinal vein [62], gall bladder inflammation 
[74,105], decreased vision [59], decreased alcohol tolerance [128], abnormal 
thyroid size [113], and psychasthenia [64]. It does not seem appropriate to 
attribute these to styrene absorption (except perhaps for the 
gastrointestinal effects) on the basis of these few, unconfirmed 
observations.
Conclusion
Styrene is readily absorbed by the respiratory and gastrointestinal 
systems, and the skin. Exposures to styrene have caused CNS depression; 
subjective complaints included headache, fatigue, sleepiness, nausea,
malaise, difficulty in concentrating, and a feeling of intoxication.
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Decrements in balance, coordination, and manual dexterity tests have also 
been reported, as have slower reaction times and abnormal EEGs. Styrene 
vapor is also an irritant to the eyes and upper respiratory system, and 
liquid styrene is a skin irritant. Various clinical studies have suggested 
that styrene exposure has affected liver function.
Limited human data suggest that styrene might be teratogenic, but 
several studies with experimental animals indicate that it is not. Most, 
but not all, _in vitro studies suggest that styrene is not mutagenic, but 
some mammalian studies, including observations of several groups of styrene 
workers, suggest cytogenetic changes may result from working with styrene. 
An increased rate of spontaneous abortions was observed in one group of RP/C 
workers, but not in another group. Styrene has been associated with an 
increase in lung tumors (although not consistently among species) in two 
experimental animal studies, while another study showed an elevation, though 
not statistically significant, in the combined incidence of leukemia and 
lymphosarcoma in female rats. Mortality studies of styrene workers have 
shown no excesses in overall cancer incidence. However, excesses of deaths, 
though not statistically significant, have been reported in the specific 
cancer categories "Lymphatic and Hematopoietic, except Leukemia" and 
"Leukemia."
Most of the styrene absorbed by humans is excreted in the urine as 
mandelic and phenylglyoxylic acids, and the urinary concentrations of the 
two or of just mandelic acid reflect amounts of styrene absorbed through the 
respiratory tract and through the skin (as well as through the 
gastrointestinal tract, if poor hygiene and work practices allow ingestion).
1 3 0
V. RECOGNITION OF THE HAZARD 
Environmental Sampling and Analytical Methods
The following discussion about the methods of sampling and analysis of 
styrene briefly describes various methods that have been used or proposed. 
While the recommended methods of sampling and analysis will usually be the 
most useful, local factors, e.g., availability of equipment, knowledge of 
usual concentrations, confounding variables, exposure patterns, etc. may 
make another method desirable.
(a) Sampling Methods
(1) Absorption Methods
Airborne styrene has been absorbed into liquids in glass impingers 
or bubblers. The liquid may be inert to styrene [35,236,237,238,239,
240], may react, or may contain solutes that react with styrene to form 
suitable derivatives [241,242,243,244], Cooling has sometimes been employed 
to minimize evaporation losses and increase trapping efficiency 
[98,107,236,238,242], Liquids that have been used to collect styrene from 
air include ethanol [35,236,237,241,245], isopropanol [107], methanol [98], 
glacial acetic acid [238], isooctane [240], concentrated sulfuric acid 
[246], dilute sulfuric acid [243], cold carbon tetrachloride [98], and 
nitric acid in sulfuric acid [242,244], Some of these liquids are corrosive 
or otherwise toxic, so their use in a manner that might result in contact 
with workers (e.g., from broken impingers) is undesirable. Also, liquid 
impingers should be avoided when possible because they may impose 
restrictions on a worker's activities to avoid spillage.
(2) Adsorption Methods
Styrene has been adsorbed onto the surface of solid sorbents such 
as silica gel [107,238,245,247,248], porous polymers [249,250], and 
activated carbon [249,251,252,253,254,255,256,257],
In 1965, silica gel, as a collection medium for styrene, was 
evaluated by Van Mourik [107] during industrial hygiene surveys. By 
collecting duplicate field samples over a 4-year period at airborne styrene 
concentrations averaging 20 ppm, Van Mourik [107] found that the relative 
standard deviation of duplicate samples was 4.6%. Styrene was desorbed by 
isopropyl alcohol. To investigate the stability of adsorbed styrene, 
duplicate samples were collected in midget impingers containing isopropyl 
alcohol; results with silica gel were always higher. Van Mourik [107] 
concluded that silica gel collected styrene efficiently and that the 
adsorbed styrene was stable. In 1966, Campbell and Ide [245] obtained 
comparable recoveries of styrene from both silica gel and an ethanol bubbler 
over the range of 10-200 ppm.
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Styrene adsorbed on porous polymers or charcoal can be removed by 
heating [249] and can be conveyed directly into a gas chromatograph, thereby 
avoiding dilution of styrene with a solvent. In 1976, Park.es et al. [249] 
found a relative standard deviation of 4.3% from the analysis of samples 
collected from air containing 11.8 ppm of styrene; the total amount of 
styrene collected was 5 yg. By removing styrene from activated charcoal 
with heat, they found a lower detection limit of 0.2 ppb in 10-liter air 
samples. Extrapolating this detection limit to styrene dissolved in 1 ml of 
carbon disulfide, Parkes et al. [249] estimated that the detection limit of 
styrene would be 40 ppb in a 10-liter air sample. This estimate does not 
consider possible problems that may be associated with recovery and solvent 
interference. A disadvantage of using thermal desorption is that the entire 
sample is usually used for a single analysis.
Charcoal as a collection media for styrene has been extensively 
studied [249,251,252,253,254,255,256,257,258,259], In an initial study in 
1966, Fraust and Hermann [251] obtained five replicate samples from air 
containing 100 ppm of styrene by sampling for 10 minutes at 200 ml/min. Each 
sample was analyzed in triplicate and a relative standard deviation of 7% 
was found. The investigators [251] found that when an atmosphere containing 
100 ppm of styrene was sampled at 1 liter/min, the collection efficiency was 
85%, but when the same atmosphere was sampled at 100 ml/min, the collection 
efficiency was only 30%. This rather unexpected variation in sampling 
efficiency with respect to sampling rate has not been confirmed by other 
investigators.
In 1978, using four charcoal tubes in series, each tube containing 
350 mg of charcoal, and by sampling at 200 ml/min, Severs et al. [252] 
recovered 93-100% of styrene under varying relative humidities (23-80%), 
sample volumes (70-95 liters), and styrene concentrations (0.4-14 ppm). The 
smallest quantity of styrene collected during this study [252] was 
equivalent to sampling 10 liters of air at 4 ppm. This study demonstrates 
that styrene can be recovered in high yields from charcoal tubes if 
breakthrough can be avoided, indicating that desorption efficiency is 
adequate.
In 1977, Saalwaechter et al. [258] also studied styrene stability 
on charcoal tubes under varying conditions: temperature (-13 to 48°C),
storage time (1-80 days), and light (19 days of sunlight, light from a sun 
lamp for 24 hours, or no light). The investigators [258] concluded that the 
stability of styrene on charcoal was not affected by temperature, light, or 
storage time. From their studies of the effect of humidity (7-94%) on the 
adsorption of toluene onto charcoal, it was inferred that high humidity may 
also adversely affect the adsorption of styrene onto charcoal. Saalwaechter 
et al. [258] also found that the efficiencies of desorbing styrene from 
charcoal with carbon disulfide were equivalent (85-89%) for charcoal 
obtained from three different manufacturers. Using an air flow of 1 
liter/min, a relative humidity of 7%, and a styrene concentration of about 
150 ppm, 1% breakthrough for the 100 mg front section occurred at 29.1 
liters, at which time the front section of the charcoal tube held 18 mg of 
s tyrene.
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Tubes containing charcoal have been designed for use in industrial 
hygiene surveys and are commercially available [253], Such tubes were 
evaluated in 1976 by Burnett [253] at 50, 100, and 200 ppm of styrene by
sampling these atmospheres at 1 liter/min. The mean percent recovery of 
styrene was 85%. These tubes contained two sections of charcoal; the main 
collecting section had 100 mg, and the reserve (backup) section, 50 mg.
In 1975, using tubes containing 200 mg of charcoal, Kalliokoski and 
Pfaffli [254] found that charcoal could collect 70 mg of styrene by sampling 
at 0.2-0.3 liters/min from a chamber containing 1,120 ppm of styrene. With 
charcoal tubes loaded with up to 66 mg of styrene, about 95% of the styrene 
remained on the charcoal after drawing fresh air through the tubes at this 
flow rate for 3 hours. Styrene was desorbed from the charcoal with dimethyl 
formamide; the desorption efficiency was 72.3%.
In 1972, after sampling air that contained 49, 494, or 987 ppm of
styrene through 200-225 mg of charcoal at 0.2 liters/min for 1 hour, Gotell 
et al. [35] recovered 96%, 90%, and 87% of the styrene, respectively.
Carbon disulfide was used to desorb styrene from the charcoal.
In 1977, NIOSH contractors evaluated data on the collection of 
styrene by charcoal tubes at 100, 200, and 400 ppm by sampling at 0.2
liters/min for 25 minutes [255]. Desorption efficiencies of 87% at 100 ppm, 
88% at 200 ppm, and 93% at 400 ppm were found when carbon disulfide was used
to desorb the styrene. At 400 ppm, sampling continued for 111 minutes
before a significant amount of styrene (5%) passed through the charcoal, 
which then contained 36 mg of styrene.
Although the report by Fraust and Hermann [251] indicated that the 
collection efficiency of charcoal tubes was affected by the sampling rate, 
data from other studies [252,253,254,255,258] indicate satisfactory 
collection of styrene at all sampling rates studied. Passive dosimeters, 
which collect organic vapors through the mechanism of molecular diffusion 
and adsorption onto charcoal can also be used for monitoring styrene 
exposures [257].
(3) Cryogenic Methods
In 1967, Klyuzko and Vovyanko [247] used a liquid oxygen trap for 
sample collection to study styrene and ethylbenzene air pollution caused by 
the polystyrene industry. The frozen compounds were released directly into 
a gas chromatograph by heating the trap. This method, also discussed by 
Parkes et al. [249], did not seem to offer any advantages over other methods 
of collection for industrial hygiene use, but did create a potential hazard 
in the transport and use of liquid oxygen.
(4) Methods of Collecting Total Air Samples
The methods discussed above concentrate and remove styrene from 
air. Total air samples collected in syringes, pipets, bottles, or plastic
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bags for analysis by a variety of methods do not concentrate styrene; these 
methods [69,243,260,261,262] usually sample small volumes of air over short 
periods of time. Because of the small sampling volumes and short sampling 
times, such samples may be better able to reflect periodic fluctuations in 
styrene concentrations than are samples collected by absorption, adsorption, 
or cryogenic methods. This may be desirable if the sampling times are 
carefully chosen [263], Under certain conditions, however, glass surfaces 
may adsorb styrene [264] and some plastic bags are permeable to styrene 
[265]. Thus, care must be taken to ensure that all the styrene has been 
recovered from the collection device. This, however, may not be a problem 
below 100 ppm of styrene. In 1974, De Gesero [32] reported that styrene 
concentrations in air samples collected in plastic bags were stable for 4 
hours. However, in 1978, Severs et al. [252] found that 20% of the sample 
in plastic bags had been lost after the same time period. Various materials 
may be useful as sampling bags, but the user should be aware of possible 
sample loss and evaluate the integrity of the sample in the bags.
(5) Sampling with Analytical Devices
Air samples may be drawn directly into analytical devices such as 
infrared (IR) analyzers, indicator solutions, indicator tubes, and 
combustible gas analyzers. These methods will be discussed in the following 
section and may be useful when immediate results are needed, automatic 
continuous monitoring is desired, or precision and accuracy are not critical.
(b) Analytical Methods
(1) Spectrophotometrie Methods
Measurement of the absorption of light by styrene is the basis of 
spectrophotometrie methods [98,236,237,239]. Spectrophotometrie
determinations are subject to interference from compounds of similar 
structure but can be used when the other components present are known or can 
be shown not to interfere. In cases where other compounds are present, it 
is necessary to determine their interference with the styrene absorption 
spectrum. For example, if styrene were to be analyzed by IR 
spectrophotometry in the presence of butadiene, a wavelength of 11 yim 
would not be appropriate since butadiene also absorbs light at this 
wavelength.
(2) Colorimetric Methods
Although styrene does not absorb visible light, the formation of a 
colored derivative has been used to permit colorimetric analysis 
[98,238,242,243,244,246,248]. The usual requirements of such a method 
(i.e., the color-producing reaction must be quantitative and specific for 
the compound being analyzed, the color must be stable long enough to permit 
measurement of color intensity, and the color intensity must be
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proportional to the concentration of the material being analyzed) have not 
been difficult to meet with styrene except that color stability has often 
been poor, necessitating prompt analysis [242],
(3) Polarographic Methods
Polarography [99] is an electroanalytical method in which the 
analyte undergoes an oxidation or a reduction reaction at an electrode. The 
potential at which the reaction occurs is a function of the structure of the 
analyte and the current produced is generally proportional to its 
concentration. Styrene cannot be determined in aqueous solution by this 
method because water is reduced before styrene. However, a derivative 
formed by the reaction of styrene with nitrous acid has been shown to be
reducible in an aqueous medium [99]. The interferences from other
unsaturated compounds and the completeness of the derivatization have not 
been extensively studied.
(4) Chromatographic Methods
Chromatography [35,241,247,249,250,251,254,255,256,260,266,267], 
including gas, thin layer, and paper methods, can separate a mixture into
its component parts in addition to measuring the amounts of each. Gas
chromatography is the best of these methods because results are easier to 
quantify than with the others. Interferences can usually be circumvented by 
changing the carrier gas flow rate, column temperature, or column packing 
material. Unequivocal identification of each component can be made by a 
combination of gas chromatography and mass spectrometry [250], Portable gas 
chromatographs are available. Detailed analytical methods for styrene have 
been developed [249,254,256,259].
(c) Methods that Combine Sampling and Analysis
Instruments that combine sampling and analysis in one operation include 
combustible gas indicators [35], IR analyzers [69], and direct-reading 
colorimetric devices [35,243,244,261]. An advantage of these methods is 
that concentrations are immediately known. The methods are useful for 
determinations of styrene concentrations before workers enter confined 
spaces, for detection of leaks, etc.
Combustible gas indicators measure total combustible gases in the air, 
and may be used to determine styrene where it is known to be the only or the 
predominant combustible vapor present in the air. IR detectors [69] are 
capable of some selectivity because they can monitor a selected IR 
wavelength to measure concentrations of the desired compound in the presence 
of others that do not absorb in that region. Styrene has its strongest 
absorbance in the region of 10-15 ym, as, for instance, do butadiene, 
acrylonitrile, and methyl methacrylate. An analytical wavelength at which 
interference is minimal must be selected. Direct-reading colorimetric tubes 
[35,121,261] and colorimetric indicator solutions [243,244,261] have also 
been used for styrene determination.
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( d )  R e c o m m e n d a t i o n s
It is recommended that the method developed by NIOSH [259] for styrene 
collection on charcoal with analysis by gas chromatography be used to 
measure worker exposure to styrene. Under certain circumstances, the use of 
other methods such as direct-reading colorimetric devices [35,243,244,261] 
to obtain an indication of styrene concentration before entering a confined 
space may be useful. Similarly, a combustible gas indicator [35] can be 
useful, especially where specificity and accuracy are less important and
where concentrations based on brief sampling are needed (e.g., peak or
ceiling concentrations).
Charcoal is recommended as the adsorbent for collection of styrene 
because it has been tested and found to collect styrene efficiently, because 
tubes containing suitable charcoal are commercially available, and because 
removal of styrene from charcoal can be nearly quantitative. Gas
chromatography is recommended as the analytical method for styrene because 
it is reliable and very sensitive. Although testing has not been extensive 
at low concentrations, the data indicate that the analytical lower limit may 
be less than 100 yg per sample [252,259], This corresponds to 
approximately 2.5 ppm in a 10-liter air sample. If greater sensitivity is 
required, substitution of thermal for liquid desorption could be used 
[249], Field studies with both silica gel [107] and charcoal (FA Madsen, 
written communication, December 1976) and laboratory studies with charcoal
[254,258] indicate that styrene is stable on solid sorbents.
Styrene can be collected efficiently on charcoal at rates of 1 liter/min 
or less. Sampling at 1 liter/min for 15 minutes should provide an adequate 
sample for measuring ceiling concentrations. At a styrene concentration of 
25 ppm, sampling at 1 liter/min for more than 4 hours might result in sample 
loss; sampling at about 250 ml/min is recommended for measuring TWA 
exposures if long sampling times are used. Appendix I gives specific 
directions on the recommended methods of sampling and analysis.
In operations where styrene and peroxides may be mixed, sampling for 
styrene oxide should be conducted as part of a program to investigate the 
possible role of styrene oxide in the production of mutations, terata, 
abortions, and cancer. Styrene oxide can be sampled and analyzed by a 
recently developed NIOSH analytical method [268]; other methods have also 
been used successfully [233,269],
Biological Monitoring of Exposure
There are circumstances where biological evaluation of worker exposure 
to styrene is a desirable adjunct to environmental monitoring. Increased 
styrene absorption may occur with increased respiration [88], An instance 
of possible styrene exposure during its use in a nonoccupational situation 
(i.e., repair work with reinforced plastics at home) has been described in 
the Case Studies and Miscellaneous Reports Section [66], and there is also
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a possibility of ingesting styrene present in foods and beverages because of 
careless work practices. Biological monitoring in conjunction with 
environmental monitoring can aid in identifying and eliminating other such 
sources of styrene absorption. Biological evaluation of exposure may also be 
a valuable. adjunct to environmental monitoring in situations such as RP/C 
processes where skin contact with styrene-containing resins is common and 
inhalation exposures to styrene are especially variable.
Several experimental studies and one occupational study, which have been 
described in Chapter IV, discussed the elimination of styrene in the breath 
of individuals after exposure [35,69,71,72,88,146]. Only 2-3% of the amount 
of styrene absorbed is eliminated in the breath as unchanged styrene during 
several days after removal from exposure. While breath analysis can 
unequivocally establish that exposure to styrene has occurred [69,70], 
concentrations in alveolar air have not been well correlated with arterial 
concentrations. In 1974, Astrand et al. [88] found a poor relationship 
between alveolar and arterial styrene, but because they believed arterial 
and capillary styrene concentrations were in good agreement they recommended 
fingertip blood samples be taken and analyzed for styrene. For biological 
monitoring, Hake et al. [70] preferred analysis of alveolar air for styrene, 
with sampling being performed 15 minutes after exposure and analysis 
performed the same day. Stewart et al. [69] noted a rapid decrease in 
alveolar styrene concentration such that 4 hours after exposure at 117 ppm
only about 0.1 ppm styrene was found in exhaled air. Because of this and
the marked slope of the decay curves [35,69,88], breath analysis does not 
adequately estimate exposures unless conditions, especially time of
sampling, are well controlled.
As described in Chapter IV, urinary mandelic acid has been demonstrated 
to be the major metabolite of styrene in humans [ 1 4 3 , 1 4 4 ] ;  the amount 
excreted in the urine reflects the amount of styrene absorbed from 
respiration [ 8 8 , 1 4 3 , 1 4 4 , 1 5 6 ]  and, to a lesser degree, contact with the skin 
[ 1 5 1 , 1 5 2 , 1 5 3 ] ,  Mandelic acid excretion in the urine has been studied 
extensively in subjects not exposed [ 3 5 , 7 9 , 1 2 1 , 1 5 9 ]  and in workers and
others exposed to styrene [ 3 5 , 7 5 , 7 9 , 9 0 , 9 2 , 1 0 9 , 1 2 1 , 1 2 5 , 1 5 6 , 1 5 9 , 2 7 0 , 2 7 1 , 2 7 2 ,  
2 7 3 ] ,  Phenylglyoxylie acid, which is a metabolite of mandelic acid, has 
also been found in the urine of workers and experimental subjects exposed to 
styrene [3 5 , 8 3 , 9 0 , 1 2 1 , 1 4 4 , 1 5 6 , 1 5 9 , 2 7 0 , 2 7 1 ] .
Other investigators [68,121,159] have evaluated urinary hippuric acid 
concentrations after styrene exposure. However, in one study [159] hippuric 
acid was found to be a poor indicator of styrene exposure unless the styrene 
concentration was greater than 100 ppm, and, in another study [121], no 
increase in hippuric acid concentration was found after exposure to styrene 
at 30 ppm.
Methods that have been developed to measure urinary mandelic and 
phenylglyoxylic acids include polarography [144], colorimetry [121,270], 
paper chromatography [122,144], gas chromatography [79,89,122,158,274,275, 
276,277], fluorometry [278] and isotachophoresis [279].
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In a method described in 1964 by Bardodej [144], mandelic acid was 
converted to benzaldehyde, which was steam-distilled and analyzed by 
polarography. Other substances that can be converted to benzaldehyde and 
thus interfere with this analysis method include phenylglycol and its 
glucuronide, styrene oxide, aminophenyl acetic acid, phenylalanine, and 
phenylpyrotartaric acid. In urine samples from unexposed subjects, 
measurements equivalent to 20 mg mandelic acid/liter were found by Bardodej 
[144]. In 1967, Huzl et al. [109] used the method of Bardodej [144] and 
found a relationship between mandelic acid in urine collected during the 
second half of the workshift and concentrations of styrene measured on 
single occasions in various workplaces. In 1974, Burkiewicz et al. [272] 
studied mandelic acid excretion and styrene exposures in workers for 1 week 
also using the method of Bardodej [144]; no mandelic acid was found in urine 
samples from 30 unexposed workers. About 436-1,630 mg mandelic acid/liter 
of urine was found in samples collected during the last 3 hours of work from 
workers with average styrene exposures of 28-110 ppm. In 1970, Sedivec and 
Flek [274] used the method of Bardodej [144] to convert mandelic acid to 
benzaldehyde, but assayed benzaldehyde by gas chromatography rather than by 
polarography.
Bardodej [144] also described a colorimetric method for analysis of 
mandelic acid that was based on the reaction of mandelic acid with ferric 
chloride. Endogenous substances that may interfere with this analysis 
method are lactic acid, pyrotartaric acid, acetoacetic acid, 
beta-hydroxybutyric acid, atrolactic acid, and phenylpyrotartaric acid. 
Thiocyanates, some indole derivatives, and salicylic acid may also 
interfere. Using the colorimetric method, there were only trace amounts of 
mandelic acid in urine from healthy unexposed people. This method [144] was 
studied using workers from various industries who were exposed to styrene at 
average concentrations of about 20-80 ppm. At the lowest exposure, urinary 
mandelic acid concentrations were about 200 mg/1 and, at the highest 
exposure concentrations, about 1,600 mg/1.
In 1970, Ohtsuji and Ikeda [121] reported the quantitative reaction of 
mandelic and phenylglyoxylie acids with a sulfuric acid-formalin reagent.
Mandelic acid was measured colorimetrically at 450 nm and phenylglyoxylie
acid at 350 nm. When Horiguchi and Teramoto [271] studied this method in 
1972, they found that normally occurring substances in urine such as 
cholesterol, and hydroxyphenylace tic, phenylace tic, vanillic, and ferulic 
acids would also react with the sulfuric acid-formalin reagent. Because of 
such interferences, urine samples from unexposed people have indicated 
concentrations of mandelic acid of 22-698 mg/1 [35,79,88,121,159,270,271]. 
In 1972, the method of Ohtsuji and Ikeda [121] was also used to evaluate
industrial exposures by Gotell et al. [35], who found better correlation 
between 8-hour TWA exposures and urinary mandelic acid concentrations than 
between the TWA exposures and urinary phenylglyoxylie acid concentrations. 
However, the data were not linear over the range of the TWA exposure
concentrations (17-292 ppm). In 1974, Harkonen et al. [270] also found that 
urinary mandelic acid concentrations correlated better than phenylglyoxylic 
acid with TWA exposures to styrene at concentration up to 150 ppm; the data
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were also not linear over the range of TWA exposures. Harkonen et al. [270]
concluded that because of the variation in the results, the probability of a
worker being exposed at less than 50 ppm could not be calculated with 
precision when using this colorimetric method.
In 1973, Slob [280] used paper chromatography to separate mandelic acid 
and used gas chromatography of the silyl derivative to measure it. With
these techniques, 0.5-10 mg of mandelic acid were found to have been 
excreted in urine during 8 hours by workers exposed to styrene at about 1 
ppm.
In 1974, Buchet et al. [89] and Vivoli and Vecchi [275] described gas 
chromatographic methods that involved methylation of mandelic and 
phenylglyoxylie acids. With these methods neither mandelic acid nor 
phenylglyoxylie acid were found in the urine of unexposed subjects. In 
styrene-exposed workers the concentrations of both acids using these methods 
were related to exposure [90,275].
In 1976, Bauer and Guillemin [277] used gas chromatography after
methylation of the acids with diazomethane as described by Buchet et al. 
[89]. They discovered, however, that unless the conditions for methylation 
were precisely controlled, conversion of phenylglyoxylie acid to its methyl 
ester was not quantitative (a possible explanation for the relatively poor 
recoveries of phenylglyoxylie acid found by Saeki [276] in another study).
In 1980, Flek and Sedivec [281] described a method for the simultaneous 
determination of mandelic and phenylglyoxylie acids in urine. Urine was 
saturated with ammonium sulfate and acidified, and the two acids were then 
extracted with ethyl acetate. The mandelic and phenylglyoxylie acids were
converted into methyl esters with diazomethane, and then analyzed by gas
chromatography. The investigators [281] found no interferences from other 
urine components. The methyl ester of hippuric acid was found to have a
much longer retention time under the specified chromatographic conditions, 
and thus did not interfere. The lower limits of detection of the two acids 
were about 10 yg/ml. Flek and Sedivec [281] believed the use of an iodine 
indicator to show completion of esterification, with the supply of
diazomethane then being shut off, corrected the potential of methylation 
problem described earlier by Bauer and Guillemin [277].
In 1974, a procedure for analysis of the silyl derivative of mandelic 
acid by gas chromatography was described by Engstrom and Rantanen [79], 
They found 94% recovery of mandelic acid that had been added to urine; the 
coefficient of variation of 10 replicate analyses of the urine of a worker 
who made plastics was 2%, and the lower limit of detection was 1 mg/1.
However, mandelic acid was found in the urine of 10 people who had no
history of styrene exposure. The method of Engstrom and Rantanen [79] has 
been studied extensively in styrene-exposed workers [75,79,92,125], and in 
control subjects [79,92], The sensitivity of the method is less than that
of the method of Slob [280], but there is a good relationship between
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average TWA styrene exposures and urinary mandelic acid concentrations in 
workers exposed to styrene in the range of about 5-300 ppm [79,92,125], as 
shown in Figure V-l on p. 141. The lower figure, representing the 
regression of mandelic acid with styrene at a urine specific gravity of 
1.018, has been copied with permission from the report of Harkonen et al. 
[125]; the upper figure represents the same regression at a urine specific 
gravity of 1.024.
In 1976, Saeki [276] also described a method for analyzing the silylated 
derivatives of mandelic and phenylglyoxylie acids by gas chromatography. By 
this method, recoveries were 95-100% for mandelic acid and 73-91% for 
phenylglyoxylie acid. Apparently the method was not used to evaluate 
exposures of workers.
In 1979, Chakrabarti [278] described a method of analysis of mandelic 
and phenylglyoxylic acids in urine by fluorometry, after extraction into 
ether and separation of the acids by thin-layer chromatography. The 
fluorescent derivatives formed by treatment with concentrated sulfuric acid 
were described as highly stable. The limits of detection of both acids were 
2 ug/ml of urine, with coefficients of variation being less than 15%.
1 4 0
Figure 31-1 TWA STYRENE CONCENTRATION VERSUS URINARY 
MANDELIC ACID CONCENTRATION
(Taken from Harkonen et al [125])
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An isotachophoretic method for analysis of urine samples for mandelic, 
phenylglyoxylic, hippuric, and methylhippuric acids was described in 1977 by 
Sollenberg and Baldesten [279]. The analytical range was 0.5-35 nmol/0.5 ml 
sample for each acid. With this method, mandelic acid was not found in the 
urine of 14 control subjects, but phenylglyoxylic acid at concentrations of
144 and 196 nmol/ml was found in the urine of two subjects. Good agreement
was found when some samples were also analyzed by gas chromatography [279],
In a 1979 study of biological monitoring, Fields and Horstman [282] 
evaluated the styrene exposures of two groups of workers by (1) the sampling 
and analysis of workers' breathing zones, (2) the sampling and analysis of 
expired breath at the end of the workshift, and (3) the analysis of urine
samples collected just before and just after the workshift, as well as at
various times after the shift was over. Both study groups made fibrous 
glass reinforced boats. The first group consisted of five healthy males, 
19-23 years of age, who had been employed making reinforced plastic boats 
for 2 weeks to 18 months. The second group consisted of 18 healthy males, 
aged 19-48 years; the authors did not state how long this group had worked. 
These men in the second group occasionally wore double cartridge organic 
vapor respirators during some phases of their work.
The investigators [282] found a poor correlation (r=0.234) between
airborne styrene concentrations and alveolar air concentrations. Urinary 
mandelic acid was analyzed by the gas chromatographic method of Engstrom and 
Rantanen [79]; data were categorized by whether or not respirators were 
worn, and were calculated in terms of three specific gravities, i.e., the
two most commonly used literature values of 1.024 and 1.018, and the mean 
specific gravity of the 62 postshift urine samples, 1.033. For the group 
not wearing respirators, a correlation coefficient of 0.85 between urinary 
mandelic acid and airborne styrene exposure was found. With those wearing 
respirators, there was a poorer correlation (r=0.57). These coefficients
were the same regardless of which specific gravity adjustment was used. For 
the group not wearing respirators, a urinary mandelic acid concentration of 
1,655 mg/1 (adjusted to a specific gravity of 1.024) was equivalent to a
styrene exposure of 100 ppm, with 95% confidence limits of 83-117 ppm 
styrene. Stated another way, an 8-hour TWA exposure of 100 ppm was 
equivalent to a urine mandelic acid concentration of 1,275-2,063 mg/1.
Fields and Horstman [282] also estimated from daily urinary excretion data 
that mandelic acid concentrations increased slightly through the week, 
indicating that the amount of mandelic acid excreted in urine sampled at the 
end of the shift depends largely on that day's absorption and partly on 
absorption on previous days. In this study [282], there was a markedly 
better correlation between urinary mandelic acid excretion and styrene 
exposure than between expired styrene and styrene exposure; thus, mandelic 
acid excretion would be expected to be a superior method of biological 
monitoring.
The study of Hake et al. [70] on biological monitoring was reviewed in 
Chapter IV. These investigators [70] concluded that blood analysis for
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styrene, analysis of urinary metabolites, and alveolar breath analysis for
styrene were all useful indices of exposure to styrene, though the
investigators preferred analysis of alveolar air samples taken 15 minutes 
after exposure. Hake et al. [70] exposed volunteers at known and, except 
for one experiment, relatively constant concentrations, whereas the workers
studied by Fields and Horstman [282] were performing regular work and
exposed at variable concentrations.
As part of the investigation of the workers in a reinforced plastics 
workshop, Brooks et al. [91] in 1979 and Elia et al. [283] in 1980 described 
biological monitoring. Post-shift urine samples were collected within 30 
minutes of the end of the shift, and analyzed for mandelic acid by the gas 
chromatographic method of Guillemin and Bauer [158]. Phenylglyoxylic acid 
was analyzed by reduction with zinc followed by measurement as mandelic 
acid. Both groups of investigators [91,283] studied correlations of urinary 
metabolites with airborne styrene in terms of types of coordinates (log-log 
or linear plots), in terms of mandelic acid alone or the sum of the
concentrations of mandelic and phenylglyoxylic acids, and in terms of 
adjustment for urine dilution either by adjusting for urine specific gravity 
or by analyzing urine creatinine and expressing results as mass of 
metabolites per gram of creatinine.
A linear plot of the sum of urinary mandelic and phenylglyoxylic acids 
vs. airborne styrene concentrations gave a correlation coefficient of only 
0.74. All other comparisons gave higher correlation coefficients and 
involved log-log plots. Log of the sum of the two acids vs. log of the 
airborne styrene gave r=0.96 when urine dilution was corrected for 
creatinine, 0.95 when urine dilution was corrected by adjusting urine
specific gravity to 1.024, and 0.93 when urine dilution was not corrected. 
Log of the concentration of mandelic acid only vs. log of the airborne
styrene gave r=0.96 when urine dilution was corrected for creatinine, r=0.95 
when urine was adjusted to a specific gravity of 1.024, and r=0.94 when
urine dilution was not corrected.
These investigators [91,283] concluded that the most effective
monitoring of workers exposed to styrene included both biological monitoring 
and monitoring of airborne exposures; they believed monitoring of post-shift 
urine samples for metabolites should involve analysis for both acids and 
that adjustments for urine dilution by correction for either creatinine 
content or specific gravity should be made.
In 1974, Engstrom and Rantanen [79] compared the results of their gas 
chromatographic method with the results of the colorimetric method of
Ohtsuji and Ikeda [121]. With parallel analyses of urine samples from 10
subjects not exposed to styrene, no mandelic acid was found by gas
chromatography whereas 46-698 mg/1 were found by the colorimetric method.
With parallel analyses of urine samples from 35 plastics workers, the 
results from the two methods had a correlation coefficient of 0.98 and an 
average difference of 254 mg/1. It appears that despite the lack of
specificity offered by colorimetric methods [121,144], they may be
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useful. Application of a colorimetric method may be of particular 
importance in those situations where appreciable skin contact is possible 
and where other equipment such as a gas chromatograph is not readily 
available. With the method of Ohtsuji and Ikeda [121], Harkonen et al. 
[270] found that the average urinary mandelic acid concentration at a 
specific gravity of 1.018 associated with an 8-hour TWA exposure of 50 ppm 
was about 1,660 mg/1. However, the lower 97.5% confidence limit of the 
mandelic acid concentration for an individual exposed at 50 ppm was below 
the background of the method, so that the probability of an individual being 
exposed at less than 50 ppm cannot be calculated with precision from 
colorimetrically determined mandelic acid concentrations. It is possible 
that the colorimetric method of Bardodej [144] is at least as accurate and 
precise as the method of Ohtsuji and Ikeda [121]; however, it has not been 
as thoroughly evaluated.
When a gas chromatographic method such as that of Engstrom and Rantanen
[79] is used to determine mandelic acid concentrations, 500 mg of mandelic 
acid/liter of urine (corrected to a specific gravity of 1.018) may indicate 
a recent exposure to at least 10 ppm styrene. From Figure V-l (see p. 141) 
a concentration of 1,200 mg mandelic acid/liter of urine (adjusted to a 
specific gravity of 1.018) corresponds to an average 8-hour TWA styrene 
exposure estimate of 55 ppm, with 95% confidence limits of about 25-120 
ppm. Thus, mandelic acid concentrations in excess of 1,200 mg/1, as
determined by the method on Engstrom and Rantanen [79], indicate with 97.5% 
statistical confidence that styrene absorption was in excess of that from an 
8-hour TWA exposure to styrene at 25 ppm. The average mandelic acid
concentration (i.e., the point estimate) corresponding to an 8-hour TWA 
concentration of 50 ppm is about 1,100 mg/1.
Of the various urinary excretion products of styrene, mandelic acid and 
phenylglyoxylie acid are the most useful for biological monitoring. Although 
both acids can be analyzed, analysis of just mandelic acid can give useful 
results [156]. Because the decay curves of urinary metabolites are not as 
steep as the decay curves of styrene elimination in exhaled air, the time of 
sampling is less critical. Furthermore, variations in exposure 
concentrations during the workday should cause fewer variations in urine 
metabolite elimination than in styrene excretion in exhaled air. The
urinary metabolite concentration is more likely to reflect total absorbed
dose than is alveolar styrene when workday exposure concentrations have 
fluctuated.
When evaluating styrene exposure from mandelic acid data, consideration 
should also be given to pulmonary ventilation, other sources of mandelic 
acid such as environmental exposure to ethylbenzene [216] or phenylethanol 
[156], and the metabolism of alpha-hydroxybenzylpenicillin [284]. The 
suggested analytical method for mandelic acid in urine is described in
Appendix II.
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M e d i c a l  S u r v e i l l a n c e
Styrene has been shown to have effects on the central nervous system 
(CNS) and on the skin, eyes, and upper respiratory tract; furthermore, 
although the evidence is not strong styrene exposure may affect liver 
function. Thus, preplacement and periodic medical surveillance should 
include physical examinations and medical and work histories directed to 
ascertaining the status of the CNS, skin, upper respiratory tract, and the 
liver. Specific tests, except for serum enzyme assays for assessment of 
liver status, are not proposed, because other tests are not sufficiently 
specific or available.
Although the data on teratogenicity and on spontaneous abortions, 
discussed in Chapter IV, have not been confirmed, they are sufficiently 
suggestive to warrant, as a prudent preventive measure, advising workers of 
this information and on the possible risks that could be associated with 
exposure to styrene during pregnancy.
Biological monitoring of styrene exposure by the analysis of urine for 
mandelic acid may be a useful adjunct to the environmental monitoring of 
exposures, especially where breathing zone monitoring does not adequately 
represent a worker's exposure, for example, where great excursions in 
airborne concentrations are not detected or where significant percutaneous 
absorption may occur. Because of the likelihood of both of these occurring 
in reinforced plastics fabrication (RP/C) operations, biological monitoring 
may be especially useful there. It may be best to establish the acceptable 
limit of mandelic acid excretion, in relation to the permissible exposure 
limit, in each plant, with consideration to the analytical method and, 
perhaps, sampling circumstances. Pending such a determination, Figure V-l 
(see p. 141) can be used for guidance in setting limits of acceptable 
mandelic acid excretion. Where this biological monitoring indicates 
excessive styrene absorption, an investigation of the source of the 
excessive exposure should be initiated. If the cause resulted from failures 
of engineering controls (leading to excessive exposures) or work practices 
(leading to ingestion or skin exposure), appropriate corrective action 
should be taken. If personal habits are the cause (for example, from home 
activities such as hobbies that lead to additional exposure), the worker 
should be counseled.
Styrene Oxide in Some Styrene Operations
Two 1979 reports [233,269] described finding styrene oxide at low 
concentrations in the workroom air in factories making reinforced plastic 
objects. In the study in Finland by Pfaffli et al. [269], air samples were 
collected on charcoal, desorbed with dichloromethane, and assayed by 
capillary gas chromatography with a flame ionization detector. Styrene 
oxide concentrations were about the same in both personal and general air 
samples; concentrations were 0.04 ppm in hand lay-up and 0.12-0.17 ppm in 
spray operations, when styrene concentrations were 59-133 ppm. In the study
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in Norway by Fjeldstad et al. [233], personal samples were collected on 
charcoal, desorbed with carbon disulfide, and analyzed by gas chromatography 
with a flame ionization detector; confirming analyses were made by high 
performance liquid chromatography. Styrene oxide concentrations ranged from 
less than 0.003 ppm to 0.086 ppm; styrene concentrations were 17-289 ppm.
The investigators [233,269] believed that the styrene oxide was formed 
by the mixing of styrene with peroxides added as curing agents. This seems 
reasonable, inasmuch as one method of synthesis of epoxides is to react 
olefins with peroxides.
Thus, it is important to evaluate styrene oxide exposures in work areas 
where peroxides and styrene are mixed, in view of the toxic problems (i.e., 
mutagenicity and carcinogenicity) posed by styrene oxide.
In addition to the methods of sampling and analysis for styrene oxide 
described in the two Scandinavian reports [233,269], a method was developed 
in 1979 by the Los Alamos Scientific Laboratory under NIOSH sponsorship 
[285]. Samples were collected in a tube holding a glass fiber filter 
followed by a sorbent, Tenax-GC. The styrene oxide was desorbed with ethyl 
acetate and analyzed by gas chromatography with a flame ionization 
detector. Recoveries of greater than 95% were reported at a relative 
humidity of 80% with samples of 0.5-44 yg. The limit of detection of the 
analytical method was 0.1 yg/sample.
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V I .  DEVELOPMENT OF OTHER OCCUPATIONAL HEALTH STANDARDS
The first recommendation for a worker exposure limit for styrene was by 
Spencer et al. [53] in 1942. Although they wrote that repeated exposures to 
styrene at 650 ppm would "probably produce no serious disturbances in man," 
they recommended 400 ppm as a permissible limit, which Spencer et al. [53] 
reported had a disagreeable odor but would not cause appreciable eye or nose 
irritation. In 1943, Mallette [54], in discussing industrial hygiene in 
synthetic riibber manufacture, pointed out that 200 ppm was a preferable 
upper limit of styrene exposure because of the eye and nose irritation 
experienced by workers at 400 ppm.
In 1944, the American Standards Association (ASA) published its American 
War Standard Allowable Concentration of Styrene Monomer [ 2 8 6 ] . The
recommended maximum allowable limit was 400 ppm for exposures not exceeding 
a total of 8 hours daily. The report by Spencer et al. [53] was cited, but 
it was noted that the limit was based on animal experiments and that there 
had not been sufficient experience with humans to evaluate the response of 
man.
In 1945, Cook [287] compiled a list of maximum allowable concentrations 
(MACs) of atmospheric contaminants of several American governmental
agencies. Five of the State agencies recommended a MAC of 400 ppm of 
styrene, but Cook [287] recommended that the value be lowered to 200 ppm 
because workers had experienced irritation at 400 ppm.
In 1946, the American Conference of Governmental Industrial Hygienists 
(ACGIH) endorsed the ASA styrene standard of 400 ppm, along with 15 other 
ASA standards, because they considered that that values had been established 
and substantiated by the necessary scientific research [288]. In 1947, the 
ACGIH proposed lowering the MAC to 200 ppm [289]; reasons for the 
recommendation were not given. In 1956, the ACGIH reported that 
recommendations for changes in the values of a number of substances had been 
made [290], among them a change in the value for styrene from 200 to 100 
ppm. Subsequent to the 1947 recommendation [289], the terminology for an
environmental limit had changed from MAC to Threshold Limit Value (TLV)
defined as "the maximum average atmospheric concentration to which workers 
may be exposed for an eight-hour working day without injury to health" [290].
In 1957, the ACGIH adopted a TLV of 100 ppm [291]. The notation "skin"
was added in 1961 by the ACGIH to the TLV of those substances which in
liquid form could penetrate the skin and cause systemic effects; styrene 
was not so noted [292], In 1962, reports by Spencer et al. [53], Carpenter 
et al. [68], and an industry bulletin were cited by the ACGIH in support of 
the styrene TLV of 100 ppm. In 1964, the ACGIH changed the TLV of 100 ppm
for styrene from a TWA value to a ceiling value that should not be exceeded
[293]; the basis for the change was not given.
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In 1967, the ACGIH proposed lowering the TLV for styrene to 50 ppm
[294], and it was so listed under "Notice of Intended Changes" in the 1967 
and 1968 TLV lists [295,296]. However, the ACGIH decided in 1969 that the 
TLV for styrene should remain at 100 ppm but as a TWA, i.e., with the 
removal of the ceiling notation [297]. According to the 1969 ACGIH 
transactions [298], the recommendation of 100 ppm was based on the 
experimental human exposure studies of Stewart et al. [69]. The ACGIH [298] 
stated that, in the study cited [69], none of the subjects exposed at 50 ppm 
for 1 hour had experienced any symptoms or had abnormal clinical findings; 
however, exposure at 100 ppm produced mild untoward, but transient, 
subjective responses in half the subjects exposed. In 1981, the ACGIH [299] 
decided to change the styrene TLV to 50 ppm with a short-term exposure limit 
(STEL) of 100 ppm. A TLV of 50 ppm, noted by the ACGIH in their 1980 
Documentation of the TLVs [300] as being one-tenth the lowest concentration 
possibly causing lymphoid or hematopoietic tumors in female rats studied by 
Jersey et al. [195], and a STEL of 100 ppm were suggested as being 
reasonable.
^ Documentation of MAC in Czechoslovakia [301] was published in 1969. The
suggested styrene limit was 47 ppm for an average exposure, which was 
considered to be adequate to prevent chronic poisoning, and 235 ppm for a 
peak exposure, which was considered adequate to prevent narcotic symptoms. 
In support of the recommendations, 12 references were cited, including those 
by Bardodej et al. [97,143], Carpenter et al. [68], and Spencer et al. [53].
In 1970, the American National Standards Institute, Inc., (ANSI) 
published a standard, Z37.15-1969, for acceptable concentrations of styrene 
[302]. There were three components, all assuming an 8-hour workday: (1) an
acceptable TWA for protection of health; (2) an acceptable ceiling 
concentration for protection of health; and (3) acceptable maximum peaks 
above the acceptable ceiling. The ANSI values were a TWA concentration of 
100 ppm, a ceiling of 200 ppm (provided the TWA was not exceeded), and 
maximum peaks of 600 ppm for a duration of not more than 5 minutes once
every 3 hours. These recommendations were based on the reports of Spencer
et al. [53], Carpenter et al. [68], Wolf et al. [162], and Stewart et al. 
[69].
The 1969 ANSI Z-37 limit [302] was adopted in 1971 as the Federal OSHA 
standard (29 CFR 1910.1000, Table Z-2). It consists of a TWA concentration 
of 100 ppm for an 8-hour day, a ceiling concentration of 200 ppm, and a
maximum peak of 600 ppm for no more than 5 minutes in any 3 hours.
A Scandinavian expert group consisting of representatives from Denmark, 
Finland, Norway, and Sweden, published a review [303] of much of the 
scientific and technical literature on styrene which included the hygienic 
limit values in force in various countries. According to their tabulation, 
100 ppm was the limit in Australia, Belgium, Finland, Yugoslavia, the 
Netherlands, Switzerland, Great Britain, and the United States (OSHA); 72 
ppm in Italy; 50 ppm in Denmark, Norway, and Japan; 47 ppm in Romania,
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Czechoslovakia, and the German Democratic Republic; 24 ppm in Poland; 12 ppm 
in Hungary; and 1 ppm in Bulgaria and Russia [303]. The MAK value (maximum 
concentration value in the workplace) for styrene in the Federal Republic of 
Germany is 100 ppm [304], In 1981, Sweden [305] adopted a TWA styrene 
standard of 25 ppm with a 15-minute short-term value of 75 ppm; styrene was 
designated as being easily absorbed into the body.
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V I I .  ASSESSMENT OF EFFECTS
The principal health effects due to styrene exposure involve the central 
nervous system. These effects include subjective complaints of headache, 
fatigue, dizziness, confusion, drowsiness, malaise, difficulty in 
concentrating, and a feeling of intoxication. Objective signs of these 
effects are altered equilibrium, delayed reaction times, and abnormal EEGs. 
Local irritation of the eyes, nose, and respiratory tract and skin 
irritation are also widely acknowledged as effects of styrene exposure. 
There have also been reports of liver injury, peripheral nervous system 
dysfunction, abnormal pulmonary function, chromosomal changes, reproductive 
effects, and carcinogenicity related to styrene exposures. Although data 
concerning these latter adverse effects are not well defined at this time, 
they do provide cause for concern.
Experimental studies have provided some of the evidence of adverse 
health effects related to styrene. Two human subjects experimentally 
exposed to styrene at 800 ppm for 4 hours experienced eye and throat 
irritation immediately [68]. Listlessness, drowsiness, and impaired balance 
occurred during exposure, and subjects were weak, unsteady, and responded 
poorly after the exposure [68], During a one-hour exposure at 376 ppm, five 
human subjects experienced eye or respiratory tract irritation within 20 
minutes, and decrements in tests of balance, coordination, and manual 
dexterity were measured [69]. Subjective complaints of headache, nausea, 
and a feeling of slight inebriation were also reported during the same study 
[69]. At 216 ppm, one of three subjects noted nasal irritation after 20 
minutes of exposure [69]. In another experiment [71], simple psychomotor
reaction times increased for the twelve subjects, but only after consecutive 
30-minute exposures at 50, 150, 250, and 350 ppm styrene (i.e., an average 
of 200 ppm during the two-hour testing period). Eye irritation, slower
reaction times, and loss of balance were found in subjects during a 
90-minute exposure at 200 ppm [72],
Some of these experimental studies of human subjects have also 
demonstrated adverse effects of styrene exposure at concentrations as low as 
100 ppm. Slower reaction times (26-28%) were found in three subjects during 
a 90-minute exposure at 100 ppm [72]. In the same study [72], six subjects 
who received a total of 13 exposures of 90-minute duration at 100 ppm 
styrene noted sleepiness (92% of the exposures), fatigue (77%), headache
(77%), difficulty concentrating (69%), malaise (54%), nasal irritation
(54%), and nausea (38%). In an experimental study that lasted 6 weeks, the 
investigators [70] stated that there were changes consistent with CNS 
depression; three of the six subjects had both visual evoked response and 
EEG amplitude changes after exposures at 20, 100, and 125 ppm styrene. In
the same study [70], the incidence of eye, nose, and throat irritation for 
the ten male subjects was 13% at 0 ppm, 17% at 20 ppm, 20% at 100 ppm, 33% 
during exposures fluctuating between 75 and 125 ppm, and 45% at 125 ppm 
styrene. The incidence of eye, nose, and throat irritation for the two 
female subjects was 8% at 0 ppm and 32% at 100 ppm [70]. In another study 
[69], three of six subjects noted mild eye or throat irritation during the
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first 20 minutes of a 7-hour exposure to 99 ppm styrene; the irritation
subsided after an additional 30 minutes. In addition, both simple visual 
and audiovisual choice reaction times in tests of two subjects were 22-25% 
slower during a 90-minute exposure at 50 ppm styrene [72], During a total of
6 exposures each of 90-minute duration at 50 ppm in the same study, the
subjects noted eye irritation, fatigue, and difficulty concentrating during
67% of the exposures, and headache during 50% of the exposures; the
incidence of these complaints during exposures at 0 ppm was 10-20%.
The experimental study by Oltramare et al. [72] provides some evidence 
•of CNS depression, manifested by subjective complaints and delayed reaction 
ability in human subjects exposed to styrene at 50 ppm and 100 ppm. The 
experimental studies by Oltramare et al. [72], Hake et al. [70], and Stewart 
et al. [69] indicate that styrene irritates the eyes, nose, and throat of 
some subjects at 100 ppm and a few subjects at concentrations as low as 50 
ppm.
There are many clinical studies demonstrating these same CNS and
irritation effects, as well as other health effects, among styrene-exposed 
workers. Subjective complaints indicative of CNS depression have been noted 
in numerous studies [94,101,105,106,109,110,112,113,123,138]. Although no 
exposure data were given, 68 of 70 workers in a Russian RP/C plant [101] 
complained of constant headache increasing throughout the day with fatigue 
and sleepiness increasing after the workshift, while 46 of the 70 workers 
complained of nausea, dizziness, and heart pain. In a study of 128
Czechoslovakian RP/C workers exposed to styrene at TWA concentrations of
4-195 ppm [105], 20% reported headache, 15% reported tiredness, and 13%
reported symptoms of drowsiness. Similarly, higher incidences of unusual 
tiredness, reduced short-term memory, giddiness, and headache were reported 
among 33 workers from three Swedish RP/C factories with TWA styrene 
exposures of 5-174 ppm, than among controls with no solvent exposures 
[123], Subjective complaints were also noted among 35 Czechoslovakian RP/C 
workers exposed at 19-130 ppm styrene [106]; these complaints included 
headache (51% of the workers), fatigue (41%), and drowsiness (34%). In a 
U.S. RP/C factory with TWA styrene exposures of 9-111 ppm, 50% of the 22 
workers complained of headache and 36% of fatigue [113], Among 22 workers 
in two RP/C factories in the Netherlands who were exposed at about 24-94 ppm 
styrene [110], 50-90% complained of drowsiness, and 30-70% noted headache
and dizziness. Headache was reported by 36% and drowsiness by 24% of 55 
Czechoslovakian RP/C workers exposed at 6-94 ppm styrene [109],
Among 81 Swedish RP/C workers with TWA styrene exposures of 3-312 ppm, 
but with 74% less than 100 ppm [112], the following subjective complaints 
were reported: fatigue (60% of the workers), dizziness (38%), headache
(25%), poor memory (21%), and nausea (14%). Among 27 English RP/C workers 
exposed to styrene at about 92 ppm, 52% felt unduly tired compared to 19% of 
a control group comprised of workers in the same factory, but without
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exposure to styrene [138]. Complaints of frequent headaches were reported 
by 38% of the 40 workers in a Russian polystyrene production facility where 
styrene exposures sometimes exceeded 12 ppm [94].
Slower reaction times [111,392] and abnormal EEGs [118,124,125] have 
also been reported in clinical studies. The reaction times of seven Swedish 
RP/C workers with TWA exposures of 3-14 ppm styrene [392] were significantly 
slower (p<0.05) than the comparison group; however, the investigators were 
unable to determine whether styrene was responsible. Significantly longer 
reaction times as compared to age-matched controls were also found in 106 
workers from four Swedish RP/C plants where TWA styrene exposures were 
10-120 ppm [111].
At a Finnish RP/C facility where the average styrene exposure was 
estimated from urinary mandelic acid measurements to be about 30 ppm, 23 of 
96 workers (24%) had EEGs judged to be abnormal [124,125], Among 35
Czechoslovakian RP/C workers with TWA styrene exposures of 19-130 ppm, only 
five of eighteen EEGs given were judged to be normal [106], In a subsequent 
Czechoslovakian clinical study of 21 RP/C workers [108], some had abnormal 
EEGs after three years of styrene exposure (concentration was not
specified), whereas no abnormal EEGs were found during a pre-exposure 
examination. In a study of Polish RP/C workers [118], abnormal EEGs were 
found in 31 of 43 workers (72%) with about one year of styrene exposure at 
25-75 ppm, and in four of twenty-one workers (19%) with ten years of
exposure at about 75 ppm.
Styrene has also been shown to cause irritation of the eyes
[35,53,58,61,104,110,113,126] and respiratory tract [35,53,56,59,93,104,113,
114,115,123,126] of exposed workers. Complaints of irritation of the eyes 
and nasopharynx were common in a study of 17 Swedish RP/C workers whose TWA 
styrene exposures were 17-292 ppm [35], In a U.S. RP/C facility where 
styrene exposures were 45-550 ppm [104], complaints of eye, nose, or throat 
irritation were made by 34 of the 35 workers (97%) examined. Among 22
workers in two RP/C facilities in the Netherlands who were exposed at 24-94 
ppm styrene, 90% complained of eye irritation [110]. Complaints of
irritation of the mucous membranes of the respiratory tract were reported by 
44% of the workers in a Russian polystyrene production facility where
styrene exposures were characterized as sometimes exceeding 12 ppm [94], In 
a U.S. RP/C facility with TWA styrene exposures of 9-111 ppm, 93% of the 14 
workers interviewed complained of eye irritation, 50% of nose irritation, 
and 29% of throat irritation [113]. The reported incidence of throat
irritation was higher in 33 workers from three Swedish RP/C factories (where 
TWA styrene exposures ranged from 5-175 ppm) than in controls with no
solvent exposures [123]. A group of 96 Finnish RP/C workers whose average 
styrene exposure was estimated from urinary mandelic acid measurements to be 
about 30 ppm, frequently experienced irritation of the eyes and nose [126],
There is some evidence of styrene-induced peripheral neuropathy. The 
frequencies of distal hypoesthesia of the lower extremities and hypoactive
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deep tendon reflexes increased with duration of exposure in styrene and 
polystyrene production workers [81], The data presented did not clarify, 
however, whether the changes were due to age or to styrene exposures which, 
at the time of the study, were usually less than 20 ppm [81]. The findings 
of impaired radial nerve conduction in 15 of 80 workers and impaired 
peroneal nerve conduction in 12 of 73 workers was also reported [81].
Although the effects on the radial or peroneal nerve were not related to the 
magnitude of exposure, those effects on the peroneal nerve were related to 
the duration of exposure to styrene. However, these effects also could have 
been related to age; moreover, the changes were not statistically
significant. In a Swedish study [123], 10 of 33 workers with TWA exposures 
of about 5-125 ppm had evidence of a mild sensory neuropathy with polyphasic 
response. Although the 10 affected RP/C workers were older, the
investigators [123] concluded that age alone was not the cause. In a
Finnish study [124], slightly abnormal nerve conduction velocities were 
found in 9 of 40 workers in a facility where the average styrene exposure 
was estimated from urinary mandelic acid to be about 31 ppm. In 4 of the 9 
affected workers (1 with mononeuropathy, 3 with polyneuropathy) no cause 
other than styrene exposure could be found; however, there was no 
association between urinary mandelic acid concentration and nerve conduction 
velocity in the four workers with unexplained abnormalities. Neurological 
effects reported in a Czechoslovakian RP/C plant [106] included cranial 
nerve disturbances (in 91% of the workers), diminished reflexes (86%), and 
impaired balance (83%). Among 101 Polish RP/C workers with one year of 
exposure to 25-75 ppm of styrene, 26 had signs that the investigators [115] 
classified as autonomic nervous system disturbances; hypoesthesia, whitening 
of the fingers, trembling of the hands, weakened reactions, cat's eye 
pupils, excitability, and nystagmus were noted among the 26 workers. While 
the evidence for chronic nervous system damage (peripheral neuropathy or CNS 
changes) from styrene exposure is not strong, further study is warranted due 
to the importance of these effects.
The data on possible long-term respiratory effects of styrene is also 
limited. Among 35 U.S. RP/C workers exposed to styrene at 44-550 ppm, about 
half complained of wheezing, shortness of breath, or chest tightness [104]; 
exposure to an isocyanate (MDl), another respiratory system irritant, at 
0.01-0.27 mg/cu m (the OSHA standard is a ceiling value of 0.2 mg/cu m) 
might have contributed to these effects. A possible relationship between 
styrene exposure and a history of wheezing or chest tightness was suggested 
in a study of workers making styrene and polystyrene [82]; there appeared to 
be some spirometric evidence of airway obstruction, but not significantly 
related to exposure. Conjunctival irritation related to styrene exposure 
was a complaint in 22% of these workers [82]. In a U.S. RP/C factory with 
TWA styrene exposures of 9-111 ppm [113], 54% of the workers complained of 
shortness of breath, 23% of chest tightness, and 18% of wheezing; however, 
ventilatory function was significantly changed during the shift only in 
those workers that smoked. Four cases of reduced FEV]^  were found among 21 
RP/C workers exposed to styrene at approximately 75 ppm for about 10 years, 
but whether the cause was age, styrene exposure, or other factors was not 
clear [114]. In another clinical study [91], a significantly greater
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number of RP/C workers had abnormal pulmonary function (i.e., FVC less than 
80% of predicted values, FEV^/FVC X 100 below 70, FEV]^  less than 80% of 
predicted values, and FEF(25-75) less than 70% of predicted values), when 
compared to unexposed workers from an electronic products plant.
Although various clinical studies [82,96,103,113,115,116,120] have 
suggested that styrene exposure has affected liver function, a clear 
relationship has not been demonstrated; clarifying research is needed. In 
any case, periodic screening of the liver function of styrene workers should 
be conducted due to the importance of this organ in the biotransformation 
and detoxification of toxic substances.
There is suggestive but conflicting evidence of mutagenicity by 
styrene. Workers exposed to styrene in reinforced plastics applications 
[76,129,130,131,132] had an increased incidence of chromosomal aberrations. 
There were more chromosomal aberrations (16.7 vs. 1.8/100 cells in controls, 
p<0.001) among 10 Finnish RP/C workers whose average styrene exposure was 
estimated from urinary mandelic acid measurements to be about 30 ppm [129], 
In a related study of 16 RP/C workers [130], which included 8 workers from 
the previous study [129], a statistically significant increase in the 
incidence of chromosomal aberrations was found (15.1 vs. 2.0/100 cells in 
the controls, p<0.001); this was confirmed when 10 of the 16 workers were
reexamined a year later and the incidence was 16.2%. In a Swedish RP/C
factory with styrene exposures of 14-73 ppm [131], an increased frequency of 
chromosomal aberrations was also found (10.8 vs. 5.2/100 cells, p<0.001). 
In a study of an RP/C factory where styrene exposures were 8-158 ppm [132], 
the 39 styrene-exposed workers studied had a significantly higher incidence 
of chromosomal aberrations as compared with controls (7.9 vs. 3.9/100 cells, 
p<0.001). There was also a significant increase in the average frequency of
sister chromatid exchanges (8.4 vs. 7.5 SCE/cell) in 20 of the same RP/C
workers [132]. In another study [76], a significant excess of chromosomal 
aberrations in 14 RP/C workers as compared to 20 controls was also found
(9.2 vs. 5.5%); styrene concentrations ranged from 50 to 300 ppm, but
urinary mandelic acid concentrations for the RP/C workers were less than
1,500 mg/1 (equivalent to an 8-hour TWA styrene exposure of about 80 ppm).
Conversely, mutagenic activity has not been found in most in vitro tests 
of styrene. This has been the case with typhimurium [ 172, 173,174,176], 
E. coli [174], the yeasts S^ _ pombe and Sj^  cerevisiae [175], and cultured
Chinese hamster cells [175,176]. However, a few studies [171,177,178] have 
found weak evidence of the mutagenicity of styrene in S. typhimurium.
A dose-response relationship has been shown in the induction of sister 
chromatid exchanges in human whole blood lymphocyte cultures treated with 
styrene [181], In a study of unscheduled DNA synthesis in lymphocytes of 
styrene-exposed workers, styrene did not alter the efficiency of DNA repair 
but rather predisposed the lymphocytes to an increased risk for DNA damage 
from subsequent exposures to genotoxic agents [137]. Some studies in lower
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mammals suggest mutagenicity by styrene while others suggest otherwise. 
In vitro studies, such as the Ames tests, tentatively suggest that styrene 
is not mutagenic. Clearly, these conflicts in the data on the mutagenicity 
of styrene need to be resolved. These same tests, on the other hand, 
uniformly show styrene oxide to be mutagenic. Styrene oxide, also known as 
styrene epoxide, has been proposed [224,225] as an intermediate in the 
metabolism of styrene, but it has not been found in vivo. The ability of 
epoxides to react with nucleic acids, and possibly lead to germinal or
somatic mutations, is a major concern in the question of intermediary 
metabolism of styrene. Whether styrene oxide (if formed) is present long
enough to bind covalently to genetic material or other macro molecules is 
not known. Airborne styrene oxide is present in some workplaces, apparently 
those in which peroxides and styrene are mixed [233,269]. While the 
toxicity of styrene oxide has not been adequately studied, it is mutagenic 
and carcinogenic. Its health significance in these workplaces needs 
evaluation both in terms of its own toxicity and possible toxic interactions 
with styrene and other chemical substances.
There have been a few reports of defects in children born to women 
exposed to styrene [66], but this implication of teratogenesis has not been 
confirmed by experimental animal studies [190,191,192,193]. It has been 
demonstrated, however, that styrene can cross the rat placenta and that 
styrene concentrations in fetal blood are almost as high as in maternal 
blood [189], Styrene can also cross the human placenta, as demonstrated by
the fact that styrene was found in umbilical cords [65].
An increased incidence of spontaneous abortions among Finnish styrene 
workers has been reported [139], However, the study involved only six 
cases, and the investigators [139] were not able to control for smoking or 
economic status (two variables that are risk factors in spontaneous 
abortions). In 1982, the same Finnish investigators [140] reported that 67 
female RP/C workers, prior to the period of exposure, had no significant 
differences in their reproductive outcomes as compared to controls, matched 
for age and social class, with no solvent exposures. During styrene 
exposure the numbers of pregnancies were not significantly different, but 
there were significantly fewer births among the RP/C workers (4 vs. 14); one 
cause was an increased (although not significantly) number of induced 
abortions (8 vs. 4). The number of spontaneous abortions was identical with 
four in the exposed group and four in the control group. Suggestions that 
styrene is teratogenic and abortifacient need to be pursued, but resolution 
will be difficult because of the problems typically associated with attempts 
to relate human defects to causal factors. However, the findings presented 
above provide strong rationale for an investigative program, including 
appropriate recordkeeping and registries, to develop etiological information 
on birth defects and abortions associated with occupational exposures.
There seems to be little basis from experimental animal investigations 
or epidemiological studies to conclude at this time that styrene is 
carcinogenic. Two animal studies [196,197] reported an increased incidence 
of lung tumors, but not consistently either in one sex or in one
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species. Another animal study [195] reported an elevation (not 
statistically significant) in the combined incidence of leukemia and 
lymphoma. Existing mortality studies [31,78,83,84,142] have shown no 
relationship between styrene exposure and an excess in the incidence of 
deaths in the overall category, "All Malignant Neoplasms." However, excesses 
of deaths were reported in the specific cancer categories "Lymphatic and 
Hematopoietic, except Leukemia" (7 observed vs. 5.3 expected, not 
significantly different) and "Leukemia" (6 observed vs. 3.4 expected, not 
significantly different) in the study by Ott et al. [31]. While the evidence 
developed so far concerning the carcinogenicity of styrene is not 
conclusive, it does provide sufficient bases for carefully considering to 
what extent workers are exposed to styrene and for instituting controls to 
reduce those exposures. The recommendation of NCI [197] for additional 
animal experimentation to add more evidence because of deficiencies in
present data seems the most appropriate recommendation that can be made 
now. Two factors warrant a high priority for investigations to help resolve 
this important issue: the commercial importance of styrene and the large
population that is exposed to the compound.
The experimental evidence [69,70,72] for styrene-induced health effects 
at a concentration of 100 ppm is not strong; however, there are many
clinical studies showing similar, as well as other, adverse health effects 
in occupational settings. Although these workers also had potential 
exposures to other substances, their major exposure was to styrene. 
Additionally, in some of the studies, peak and TWA styrene exposures may 
sometimes have exceeded 100 ppm, but exposures for most workers were judged 
to be at TWA styrene concentrations at about 100 ppm [76,81,82,84,91,94,106, 
109,110,111,112,113,115,118,120,124,129,130,131,132,138,392]. CNS effects 
noted in those workers exposed to styrene at or below 100 ppm included 
subjective complaints such as fatigue, dizziness, headache, nausea, poor 
memory, and drowsiness [106,109,110,112,113,138]; increased reaction times 
[111,392]; abnormal EEGs [106,118,124]; and impaired balance [106].
Chromosomal changes were also more frequent in the lymphocytes of
styrene-exposed workers in several RP/C factories with TWA exposures of 
about 100 ppm than among controls [76,129,130,131,132].
Based on the adverse health effects demonstrated in experimental 
subjects and workers exposed to styrene concentrations at and below 100 ppm, 
a TWA exposure limit of 50 ppm is proposed over the workshift for up to a 
10-hour workday and a 40-hour workweek. This recommendation is further 
supported by studies showing effects such as slower reactions [72], 
subjective complaints related to CNS depression [72], and abnormal EEGs 
[124] at styrene concentrations around 50 ppm.
A ceiling limit of 100 ppm based on a 15-minute sampling period is 
recommended to prevent acute irritation effects on the eyes and upper 
respiratory system. Since styrene is a defatting agent and can cause 
primary skin irritation [234] and dermatitis [54,56,61,91,104,113,
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122,126] in workers, as well as be absorbed percutaneously [86,151,152], 
skin contact with styrene should be avoided through the use of good work 
practices and personal protective clothing.
Other toxic effects such as peripheral neuropathy, abnormal pulmonary 
function, liver toxicity, mutagenicity, teratogenicity, and carcinogenicity 
would be relevant to an occupational exposure limit if the available 
information established them as effects of styrene exposure or gave 
information on exposure-response relationships. These health effects need 
further investigation and would provide additional evidence for a reduction 
in the current occupational exposure standard if they were found to be 
styrene-related.
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VIII. METHODS OF WORKER PROTECTION
Informing Workers of the Hazards of Styrene
Each worker with potential exposure to styrene should be informed of (1) 
relevant prenarcotic symptoms, (2) effects of overexposure, including 
suspected but as yet unproven effects, (3) proper use and handling of 
styrene, (4) methods that minimize exposure, (5) proper maintenance 
procedures and cleanup methods, (6) correct use of protective clothing and 
equipment, including respiratory devices, (7) engineering controls in use or 
being planned to limit exposures, and (8) medical and environmental 
monitoring procedures in use. The advantages to the worker of participating 
in the monitoring procedures should be stressed. Oral as well as written 
instructions informing workers of proper handling methods, cleanup and 
emergency procedures, use of personal protective equipment, etc. should be 
presented by persons qualified by experience or training in occupational 
safety and health as part of a continuing education program. The NIOSH 
publication A Recommended Standard--An Identification System for
Occupationally Hazardous Materials[306]shouldbe used as aguide when 
preparing written material for readily available reference on the relevant 
physical, chemical, and toxicological properties of styrene or of mixtures 
or formulations containing the compound. Required information shall be 
recorded on the "Material Safety Data Sheet" shown in Appendix III, or on a 
similar form approved by OSHA, U.S. Department of Labor. Pertinent 
information on over 1,300 substances may be found in the Hazardous Chemicals 
Data Book [307] or other similar references.
Workers should also be instructed on their responsibilities for proper 
work practices and sanitation procedures to help protect the health and
safety of themselves and their fellow workers.
Work Practices
(a) Storage, Handling, and Transportation
Because of the volatile and flammable nature of styrene (see 
Table III-l, p. 17), proper handling and storage should be given special 
attention. Good ventilation systems with explosion-proof motors are
necessary in areas where styrene is handled and stored. Grounding of all 
equipment, tank cars and trucks, and hose connections will discharge static 
electricity. An inlet line that discharges at or near the bottom of the 
tank and makes electrical contact with the tank will eliminate uncontrolled 
electrical discharges [308]. If the inlet line cannot reach the tank
bottom, a chain should be attached that does reach [309],
Precautions to ensure that styrene vapor does not ignite are mandatory 
for safe conditions, especially at elevated temperatures. Recommendations
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include: (1) regular inspection of equipment and storage tanks, (2)
immediate repair of leaks, pumps, and lines, (3) ventilation to reduce vapor
concentrations, (4) use of special nonsparking alloy tools, (5) periodic
tests of pressure equipment, (6) rapid removal of spills, and (7)
elimination of ignition sources [309]. Portable electric lights and power 
tools must conform with the National Electrical Code, Article 500 [310]. 
Receptacles that contain styrene monomer or hot styrene-containing resins 
must be tightly covered at all times except when material is removed. Safety 
cans can be used to hold working amounts of liquid styrene.
Styrene may polymerize if it comes in contact with oxidizing agents and 
catalysts such as peroxides, strong acids (e.g., sulfuric or hydrochloric), 
aluminum trichloride, phosphoric anhydride, and iron chloride. Storage of
styrene away from oxidizing agents, catalysts, and strong acids will also 
help prevent explosions or fires. Centrifugal pumps will cause 
polymerization if allowed to run with a closed discharge line. Storage of 
styrene outdoors or in detached areas can be advantageous [311].
If styrene is stored more than 30 days at 90°F (about 32°C) or above, 
the inhibitor concentration must be checked at least bi-weekly [312]. 
Styrene storage containers can be installed with a temperature alarm system 
to signal interior temperature increases that may result in runaway 
polymerization, a special concern in hot climates [309,313], The rate of 
polymer formation in storage tanks can be reduced by cooling the tank by 
means of a water spray, refrigeration, insulation, or reflective painting 
[313],
Catalysts, promoters, and accelerators should be stored in cool, dry, 
dark areas away from reducing agents, and in their original shipping 
containers [314], Fuller and Jensen [314] also suggested that only a 1-day 
supply of peroxides be kept in laminating areas. (As was discussed in 
Chapter V, styrene and peroxides can possibly react to form another toxic 
compound, styrene oxide.)
(1) Drums
Unless drums are unloaded carefully, they may be damaged; dropping 
or bumping drums can lead to leaks or ruptures. Examination of each shipment 
for leaks can identify those drums that need special handling. If any are 
found, spillage can be minimized by turning the leaking part up while they 
are being moved to a safe place to stop the leak or by transferring the 
contents.
Containers that have held styrene monomer must be thoroughly 
cleaned with steam and then drained and dried before reuse, because small 
amounts of the monomer may remain and present a fire hazard. Explosions can 
occur if drums are not filled and emptied carefully as demonstrated in a 
report by the Manufacturing Chemists Association [315]. A supposedly empty 
drum was placed over a steam line so that the drum could be cleaned. The 
residual styrene ignited (probably due to a discharge of static electricity
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between the nozzle of the steam line and the drum) and then exploded. Drums 
cleaned by steam should be electrically bonded to the steam lines and the 
entire assembly grounded.
A similar accident occurred [316] when a worker who was filling 
drums with styrene failed to ensure that the drums were properly grounded. 
While the last drum was being filled, the worker moved it; a spark 
discharged between the filling line and the drum, causing an explosion.
Before drums are emptied they should be supported and blocked to 
prevent movement. When filling open containers from a drum, electrical 
bonding must be provided to prevent static sparks. Styrene workers should 
avoid striking fittings with tools or other hard objects that may cause 
sparks. The National Fire Protection Association (NFPA) Standard No. 77, 
"Static Electricity" [317], contains detailed information on the subject.
During lay-up operations in the reinforced plastics industry, it is 
recommended that all styrene monomer be kept in safety cans, rather than in 
large open containers, to prevent high local styrene concentrations.
(2) Tank Trucks and Cars
Fire hazards around tank trucks and cars can be reduced by turning 
off truck motors and not starting them while tank trucks are being loaded or 
unloaded. If tank trucks and cars are unloaded through an open dome, the 
unloading equipment must be electrically bonded and grounded before 
operations are started. Use of a rubber-type flexible hose to unload
styrene is not recommended because it may not be resistant to styrene. 
Fluoroelastomer hoses, however, are satisfactory because they are more 
resistant to styrene penetration [308].
There are other hazards involved in transferring styrene from or to 
tanks that should be identified, so that workers can be instructed on 
appropriate precautions. This is exemplified in the case of one worker who, 
after unloading styrene from a tank car [315], disconnected a supposedly
empty line that was, in fact, filled with styrene. The styrene spilled on
his face and shoulders; although he was wearing safety glasses and a hard 
hat, the styrene ran down his forehead and into his eyes. Details regarding 
the extent of his injuries were not provided. After this accident, rubber 
gloves and goggles were worn by personnel who unloaded tank cars, and
written guidelines were provided that detailed safe procedures for unloading 
tank cars [315].
Department of Transportation (DOT) regulations that apply to the 
handling, unloading, and transportation of hazardous substances are set 
forth in 49 CFR 100-199.
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Extra care in completely draining the contents and properly closing
all openings before shipping containers are returned to suppliers will help
prevent explosion and fire. As soon as a tank car or truck is completely
unloaded, all valves must be closed tightly, the unloading connection 
removed, and all other closures made tight, except the heater coil inlet and 
outlet pipes (if any), which must be left open for drainage.
(b) Sanitation and Hygiene
In the interest of good hygiene and to prevent accidental ingestion of 
styrene, it is important that storing, handling, dispensing, and eating of 
food be prohibited in all areas where styrene is kept or used. It is also 
important that workers who handle styrene wash their hands thoroughly before 
eating, smoking, or using toilet facilities. Workers should also be
provided with facilities so they can shower with soap and water at the end 
of each workshift, or as soon thereafter as practicable before leaving 
work. Facilities such as double lockers should be provided for workers so 
soiled clothing can be stored separately from clean clothing.
Clothing that has become saturated with styrene must be removed
immediately because styrene is absorbed through the skin [151,152,153], 
Because skin absorption can occur, contaminated skin must be promptly washed 
with soap and water. Use of acetone or other organic solvents to clean
styrene from the skin can be harmful since they may be toxic themselves and 
contribute to the effects of styrene. In case of eye contact, flush the 
eyes immediately with a copious flow of water for 15 minutes to prevent 
corneal injury. If irritation persists, get medical attention. Eye contact 
can be prevented if workers wear splash-proof safety goggles or face shields 
that comply with 29 CFR 1910.133(a).
(c) Housekeeping
Good industrial housekeeping is imperative to prevent fires or 
accidental ingestion where styrene is used. Vacuuming of work areas at the 
end of each shift to remove particulate matter such as polymer dust, fibrous 
glass, and fibrous glass-reinforced plastic dust is a simple and effective 
measure.
Styrene spills should be cleaned up immediately after eliminating
potential sources of ignition and using available ventilation. Stopping
leaks and spills will also eliminate fire hazards and help conserve raw 
materials, keep chemicals out of the effluent system, and reduce worker
exposure [32], Vermiculite, dry sand, earth, or similar nonreactive
material can be used to absorb styrene but, for best results, pretest 
absorbing agents for their effect on polymerization of styrene. For spills 
on hard surfaces, scrubbing the area with soap and water after most of the 
styrene has been removed is recommended. If spills occur in a confined
space, pumping water into the area will prevent the ground from absorbing
(3) Return and Disposal Precautions for Styrene Containers
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the styrene and may allow styrene to be recovered later [318], Small spills 
can be absorbed by paper, which can be burned after evaporation in a hood or 
in another safe place. Only properly protected personnel should perform 
these procedures. Wiping rags or cloths should be placed in fireproof 
receptacles equipped with tight-fitting lids.
(d) Waste Disposal
Because of the exothermic nature of styrene polymerization, it is 
recommended that waste catalyst be disposed of separately from waste 
monomer. If this is not possible, the waste receptacle should be located 
away from any sources of heat, flame, or electrical discharge, or from any 
combustible material. Besides cleaning work areas at the end of each 
workshift, it is a good practice to determine if all wiping cloth 
containers, excess plastic, plastic constituents, and other refuse are 
removed from the building and disposed of properly. Workers should be 
informed of proper storage and disposal procedures and be adequately 
supervised in handling waste receptacles.
All waste styrene and styrene-contaminated material should be removed to 
a disposal area and safely burned by introducing it as a spray or mist into 
a suitable combustion chamber; incineration will be more complete if styrene 
is mixed with a more flammable solvent [314]. Water contaminated by styrene 
can be safely treated by removing the mixture to a safe location and blowing 
it with air. The outlet air stream can then be burned to remove the styrene 
[308], Waste effluent gases can also be burned to remove styrene [319], 
Liquid styrene should not be allowed to enter a confined space, such as a 
sewer, because of the possibility of an explosion, at least in warm or hot 
areas.
(e) Fire Control
Styrene poses a significant fire hazard. As shown in Table III-l (see 
p. 17), styrene has a boiling point of 145.2°C (293.4°F), a flashpoint of 
34° to 37°C (94° to 98°F), and flammable (explosive) limits of 1.1-6.1% by 
volume in air. Thus, according to the criteria of OSHA, styrene would be 
classified as a Class 1C flammable liquid (29 CFR 1910.106) and a Class B 
fire hazard (29 CFR 1910.156).
If ventilation is adequate to maintain the concentration of styrene at 
recommended levels, the potential for fire and explosion will be greatly 
reduced. However, elevated styrene concentrations may occur if the vapor 
accumulates, for example, above the liquid surface, in depressions, at 
container openings, at vent openings, or in areas having poor ventilation. 
Thus, all ignition sources, such as fire, sparks, and smoking materials, 
must be prohibited in those areas where styrene is made, used, or stored. 
NFPA Standard No. 77, "Static Electricity" [317], lists precautions designed 
to prevent the accumulation of static electricity, a potential ignition 
source. Fifty feet from open flames or other possible ignition sources, 
such as sparks, hot surfaces, or arcs, has been suggested as the
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minimum safe distance for location of processes that involve styrene [314], 
Fire hazards can also be reduced by isolating mixing and formulating 
operations from other operations (particularly laminating areas) in a 
well-ventilated area equipped with an automatic sprinkler system; mixing, 
formulating and laminating operations should also be separated from 
finishing areas by at least 2-hour fire partitions to slow the spread of a 
fire [314].
Some processes do not lend themselves to control by physical 
separation. This is especially true when the contaminant permeates an 
entire work area. In those cases, either isolation or enclosure of the 
operation will limit the amount of contaminant dispersed in the workplace 
[90].
Fires involving styrene can be safely extinguished with the proper use 
of foam, dry powder, or carbon dioxide. Water is not an effective 
extinguishing agent but can be used to keep fire-exposed containers cool. 
Regulations governing the use of electrical equipment where styrene is 
present can be found in the National Electrical Code NFPA 70-1971, ANSI 
CI-1971 (Rev. of Cl-1968) which was adopted as a national concensus standard 
by OSHA in 29 CFR 1910.308.
Incomplete combustion of styrene-containing materials may result in the 
formation of a toxic gas such as carbon monoxide; the breathing of fumes, 
smoke, and gas liberated by styrene, polystyrene, or other 
styrene-containing materials [309,318] can be avoided by using the 
appropriate respiratory protection.
Fuller and Jensen [314] suggested that sprinkler systems be installed in 
new factories where reinforced plastics are laminated. They recommended 
that these systems deliver a minimum of 0.3 gallons of water/min/sq ft (3.7 
liters/min/sq m) applied over an area of 5,000 sq ft (464 sq m), that the 
sprinkler system be provided with hand hose connections, and that portable 
Class B fire extinguishers also be available [314].
To help control potential fires, Fuller and Jensen [314] suggested that 
smoke and heat vents be installed with about 100 feet (30.5 m) between their 
centers. They also suggested that curtain boards be installed at 100-foot 
intervals so that curtained areas are no greater than 10,000 square feet 
(929 sq m).
(f) Entry into Confined Spaces
Entry into confined spaces (tanks, pits, tank cars, barges, process 
vessels, and tunnels) should be controlled by a permit system or other 
program offering equal protection. These spaces need to be tested for
oxygen deficiency, styrene concentration, and the presence of any other 
harmful gas or vapor. Only supplied-air hoods or suits impervious to
styrene are recommended for entering a confined space unless sampling data
indicate that the area is safe for entry with other equipment. Air- or
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oxygen-supplied masks equipped with full facepieces are recommended to be 
worn when the oxygen content of the air is less than 16% or when the styrene 
vapor concentration is over 5,000 ppm.
It is imperative that confined spaces be thoroughly ventilated and 
cleaned before workers enter without respiratory protection. It is a good 
practice to flush the confined space with steam or water to remove styrene 
vapor. When a worker enters a confined space, use of a safety line is 
recommended with another properly protected worker on standby outside to 
maintain communication by voice and sight with the worker inside. The 
safety line must never be abandoned while the worker is in a confined 
space. An additional safety measure is to have the workers in or near to 
the confined space close to others who can be quickly contacted in an 
emergency [308]. The NIOSH document Working in Confined Spaces [320] 
contains a more thorough discussion on the subject of confined spaces.
A number of effective work procedures and housekeeping practices in the 
RP/C industry were noted during a 1981 NIOSH-sponsored study on worker 
education, training, and motivation [321].
Engineering Controls
Engineering controls for production and use of styrene are designed in 
consideration of its volatility, flammability, and toxicity. Styrene 
undergoes rapid, exothermic polymerization. If unchecked, this reaction can 
become violent and ignite or explode [322]. Fuller and Jensen [314] reported 
that one such incident occurred in 1971 in a plastics manufacturing plant in 
Ohio. To avoid this problem, continuous monitoring of the temperature and 
pressure of liquid styrene storage tanks can be used to alert workers of any 
temperature or pressure increase that would indicate polymerization.
The following control principles and methods are pertinent to all 
processes used for the production of styrene, polystyrene, reinforced 
plastics, synthetic rubber, and other styrene-based plastics. The methods 
of control include process isolation, process containment, and ventilation.
(a) Isolation of Incompatible Processes
The physical isolation of incompatible processes is sometimes required 
to achieve a safe work environment. For example, styrene readily reacts 
with low concentrations of halogens in the presence of ultraviolet light to 
form a potent lacrimator [323], a problem that can be prevented by isolating 
processes that generate halogens from processes that use or make styrene. 
In the reinforced plastics industry, the separation of grinding and sanding 
operations and fibrous glass cloth cutting areas from areas where styrene is 
being used has been recommended to reduce dermatitis [324],
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(b) Containment
Closed process systems are the best way of preventing worker exposure to 
styrene; where practical, closed systems with negative pressure inside are 
preferred. Even with the use of closed systems, contact with styrene may 
still occur at pump seals and sampling ports, during draining, filling, and 
cleaning processes, and at spills. Unreacted styrene may be recycled to 
separate it from the polymerized product by vacuum devices. Closed loop 
sampling devices help minimize worker exposure [32]. For these systems to 
be effective, proper operation, maintenance, and frequent testing for leaks 
or other malfunctions are necessary. Use of remote control and automated 
processes can also reduce exposure to styrene.
(c) Ventilation
When closed process systems are not possible, exhaust ventilation, 
preferably local exhaust ventilation, may be needed to limit exposures to 
styrene. Because of fire hazards, ventilation systems need nonsparking fans 
and ducts. In addition, ventilation systems should prevent the 
recirculation of contaminated air. The ease of periodic inspection and 
cleaning are necessary considerations in proper design and location of 
valves, vents, gauges, pressure-relief devices, and other engineering 
controls. This is very important because styrene can easily polymerize and 
block vents or prevent valves, gauges, and pressure-relief devices from 
functioning properly [308],
(1) Local Exhaust Ventilation
Well-designed local exhaust systems can be used to effectively 
control styrene vapor, particularly during such work as spray-up, lay-up, 
and open molding operations where high concentrations of styrene are often 
encountered. Intensive local ventilation has been recommended as the only 
practical method of reducing styrene vapor concentrations during the 
construction of large reinforced plastic objects [324].
During the production of synthetic rubber, a large amount of 
styrene may be vaporized and released during drying operations, which are 
usually performed at elevated temperatures and are open to the atmosphere. 
Mallette [54] recommended that dryers be operated with a slight negative 
pressure or, if this was not feasible, that exhaust hoods be installed at 
the dryer outlets to regulate the escape of styrene vapor. When local 
exhaust systems are not feasible, area fans may have to be used to direct 
vapors away from the workers.
(2) Dilution Ventilation
When the concentration of the contaminant cannot be reduced at its 
source, other methods are necessary. One method controls the concentration 
in the general work environment by using general dilution ventilation, a 
method which is not usually as satisfactory as local exhaust ventilation.
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Data such as the evaporation rate, temperature, and the surface area of the 
source of the contaminant, together with information on the toxicity of the 
contaminant, are needed to design an efficient dilution ventilation system 
[325], To help reduce the risk of fires in the reinforced plastics 
industry, Fuller and Jensen [314] recommended use of a general ventilation 
system with an air flow of 1 cu ft/min/sq ft of floor space.
When ventilation is used to control exposure, it is desirable to 
have trained personnel make measurements that demonstrate system efficiency 
(i.e., velocity pressure, static pressure, or total pressure) on a periodic 
schedule as determined by a qualified industrial hygienist. It is also a 
good practice to measure system efficiency when there is any change in 
production, process, or control method. This necessitates maintenance of 
records that demonstrate the effectiveness of such changes; information 
needed includes date, type, and location of test, and results of the 
measurements taken.
(d) Other Control Methods
The difficulties in limiting exposures of workers to styrene and other 
materials in RP/C operations by conventional methods such as local exhaust 
ventilation or closed processes have motivated development of other 
approaches. Several of those attempts are described below.
In 1971, Maisonneuve and Lardeux [326] described a ventilation scheme 
that could be used in the construction of reinforced plastic boats. They 
suggested that the boat form should be mounted on wheels and be made so that 
it could rotate on its axis to facilitate work on both sides from one 
position. They also suggested that the boats (6.5 m long in this case) be 
constructed in a room that was 8 m long and had a fresh air stream with a 
flow of 0.5 m/s (about 100 ft/min). This air stream should be supplied 
across the entire length of the room, particularly at worker breathing 
zones. The investigators [326] also described various ventilation systems 
designed to reduce a worker's exposure to styrene during production of boats 
made from reinforced plastics.
In 1980, Willis [327] described some of the problems in trying to reduce 
styrene emissions during the curing process in boat building. An attempt to 
reduce styrene emissions by decreasing gel time was unsuccessful because the 
method used to decrease gel time involved increasing the workshop 
temperature to a high level. This halved the cure time but increased the 
amount of styrene evaporated to three times normal. Low-styrene emission 
(LSE) resins (also known as environmental resins) were tried several years 
ago, but there were disadvantages with the first resins tried. At first, 
addition of paraffin wax to the resin was thought likely to produce a screen 
between the resin and the air; however, the wax did not rise to the surface 
soon enough, and the wax impaired interlaminar adhesion. Other resins have 
subsequently been developed, but their nature, other than that some act to 
increase surface tension, was not described; apparently, their formulation 
or exact nature is proprietary.
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LSG resins are now available, according to undocumented statements by
Willis [327], that do not inhibit interlaminar adhesion, and claims for
reduction of emissions of as much as 95% have been made. It was emphasized 
that use of these resins did not preclude the necessity for proper
ventilation, but it was said that their use reduced the amount of
ventilation needed, and assisted in reducing airborne concentrations of
s tyrene.
In 1980, a group of representatives from the RP/C industry in the U.S. 
visited Sweden to assess Swedish technology in reducing styrene emissions
and its applicability to U.S. operations. Their unpublished report [328] 
was furnished to NIOSH by The Society of the Plastics Industry, Inc. Only 
plants manufacturing small boats (up to 30 feet in length) were visited; 
these shops utilized hand lay-up/spray-up operations. The visiting group 
concluded that, in these small boat plants, engineering controls alone were 
not sufficient to achieve the occupational environmental limit in force at 
the time (i.e., 40 ppm), but that compliance could be achieved through a 
combination of high volume, low velocity air movement, use of personal
protective equipment, different plant layouts, proper work practices, and 
environmental resins. Moreover, plant layouts needed to help achieve these 
reduced emissions were judged to result in productivity lower than that 
found in U.S. plants. It seemed doubtful to the study team that the 60 ppm 
ceiling limit was being met. (Verification of such a ceiling limit has not 
been found in other sources, including an official Swedish listing [329].) 
It was noted that there were no styrene emission standards in Sweden, so
styrene could be exhausted directly outside the plant.
Other Swedish control systems found useful, in addition to ventilation, 
were the use of airless spray guns, and the bulk storage of resins 
underground which were piped directly to the spray guns. Specially designed 
cutting and grinding tools reduced dust exposure. In one boat plant, the 
spray booths had movable curtain walls that could completely surround the 
object being fabricated. In all cases, the inlet to the booths was
constricted in some manner. Swedish experiments had indicated that an air
velocity of 0.5 m/s was necessary to achieve 40 ppm, and 0.8 m/s to achieve 
25 ppm. This air was introduced through diffusion filters. Elephant trunk 
hoses were placed at strategic locations around styrene sources for the 
purpose of exhausting the air. Dust emissions were exhausted through 
tool-mounted vacuum systems [328].
The Swedish workers were well trained, and followed proper practices 
well; work practices were reinforced by management attitudes. Workers were 
rotated so that only about half of their time was spent on spraying or
rolling. During spraying, workers wore full head coverings, charcoal
respirators, ear protection, and full-face plastic shields. Management of 
the Swedish boat plants felt that these protective items were not needed 
[328].
Initial LSE (environmental) resins, put into use in Sweden in early 
1977, posed delamination problems, but these were eliminated in the second
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generation resins introduced about a year later. In addition to resulting 
in reduced styrene emissions, these resins result in a surface that is less 
tacky, thereby reducing the potential for dust accumulation with consequent 
lamination problems [328]. One Swedish firm installed strips of fibrous 
glass screen in areas where further lamination to stringers or bulkheads was 
expected. It was installed in the final application of wet resin, then 
peeled off just before the stringer or bulkhead was installed, revealing a 
clean surface for lamination.
The nature of the environmental resins was not described in the Swedish 
report [328], although several European purchase sources were listed; this 
reinforces the inference made earlier that these resins are proprietary in 
nature.
A 1980 report [330] gave drawings and some specifications for a number 
of types of hoods, canopies, and ducts, with exhaust air quantities and
velocities and other general information, recommended for use in various 
RP/C operations. These were described as hardware either currently in use or 
available for use to control styrene emissions in RP/C operations. Efficacy 
data, for example, data regarding what the airborne emissions were, or how 
much of a reduction in air emissions could be or was achieved, were not 
reported.
As was indicated in Chapter V, airborne styrene oxide may be found in 
reinforced plastics operations. While the concentrations reported in
limited studies [233,269] have been low, they may nevertheless be
toxicologically significant.
When worker exposure cannot be adequately controlled by engineering 
controls, protective clothing and equipment, including respirators, may be 
needed. These are controls of last choice because of the difficulty of 
program management, which includes selecting and maintaining equipment and 
instructing workers on proper use and fitting, and worker acceptance and
efficiency. Thus, neither respiratory protective equipment nor personal 
protective clothing is an acceptable substitute for proper engineering 
controls.
More detailed information on industrial ventilation can be found in 
publications of the American National Standards Institute (ANSI) [331], the 
American Conference of Governmental Industrial Hygienists (ACGIH) [325], and 
NIOSH [332]. Other NIOSH publications [333,334] give details of engineering 
control technology in use in the plastics and resins industry.
Personal Protective Clothing and Equipment
There have been several reports of skin irritation caused by styrene
[2,54,56,61,91,104,113,122,126]. Blistering of the skin with loss of hair 
occurred when liquid styrene was applied repeatedly to the ear of a rabbit, 
and marked irritation with necrosis was found with two applications
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of liquid styrene to the shaved abdomens of rabbits [53,162], Liquid
styrene has been shown to be absorbed through the skin of both humans [151] 
and animals [165], It was estimated that exposure of the palms of both
hands to liquid styrene for 90 seconds would result in an absorption of 
styrene equivalent to the inhalation dose during a day of work at about 12 
ppm [151],
Where workers may come in contact with liquid styrene, the use of
appropriate equipment such as impervious gloves, boots, overshoes, bib-type 
aprons (at least knee length), face shields with goggles, and appropriate 
protective clothing is recommended. Proper selection of protective 
equipment is also necessary. For example, neoprene gloves and boots
deteriorate rapidly and give protection for only a short time [32]. Leather
shoes also do not provide adequate protection against liquid styrene 
[308,318]. Polyvinyl alcohol and polyethylene are reported to provide good 
protection against styrene [335].
Dermal contact may be a particular problem in those shops where styrene
is poured, spread by hand, and sprayed. It is during the use of these
techniques that the greatest airborne concentrations of styrene should also 
be expected. Thus, any worker who performs these operations or is near them 
while they are being performed should be provided with protective clothing 
and eye protection that will prevent skin and eye contact with styrene. 
These precautions should also be taken when workers enter an area where a 
leak or spill has occurred. Suitable pre-tested respiratory protective 
devices should also be made available to the worker.
Although barrier creams have been suggested as a beneficial method of 
preventing skin irritation [102], it has not been demonstrated that barrier 
creams are sufficiently impermeable to prevent absorption of styrene and 
dermal irritation. It is also possible that barrier creams may hold styrene 
in contact with skin and thereby increase irritation and penetration.
Styrene vapor can also penetrate the skin [154], Thus, when work is 
being performed in areas where there are high concentrations of styrene, 
such as some confined space work, protective clothing as well as respiratory 
protection may be needed to prevent undue absorption.
In 1971, Bagdinov [336] reported that styrene vapor does not diffuse 
through certain protective textiles until the vapor concentration is greater 
than 5 ppm. In a comparison of the protective properties of various 
textiles, the least diffusion was through a mixture of wool and 
polyacrylonitrile . The effects of body movements that might force air 
through the fabric faster than it could diffuse were not considered.
While inside protective gloves, the hands may perspire. This problem 
can be minimized by wearing white cotton inner liners and making replacement 
liners available [337].
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Workers exposed to styrene have experienced eye or nasal irritation or, 
usually, both [35,53,56,58,59,61,93,104,110,113,114,115,126], To prevent 
eye irritation at moderately low concentrations, full-facepiece rather than 
half-facepiece respirators are recommended whenever work must proceed in 
areas where styrene concentrations are excessive.
If a worker complains of eye irritation from styrene while wearing an 
approved full-facepiece respirator, poor fit or sorbent exhaustion may be 
the cause [338], Chemical cartridge respirators provide respiratory 
protection for relatively short periods. Respirators currently available do 
not contain an end-of-service-life indicator for styrene; therefore, the 
user must follow the manufacturer's recommendations for changing canisters 
or cartridges.
Although many workers may become accustomed to the irritancy of styrene 
vapor, systemic effects may still occur. Therefore, it is important that
the employer follow the manufacturer's directions for changing canisters or 
cartridges on a regular schedule and not rely on worker complaints of
irritation as an end-of-service-life indicator for respirators.
The type and class of respiratory device to use (see Table 1-1, p. 8) is
determined by taking atmospheric samples in the work areas and then
selecting the appropriate device according to guidance on respirator
selection. Routine sampling, as well as sampling after control, process, or 
climatic changes is recommended. Approved full-facepiece respiratory 
protection is desirable if the worker is exposed concurrently to styrene and 
benzene, toluene, or ethylbenzene, because simultaneous exposures to styrene 
and one or more of these other solvents may cause a decrease in the rate of 
metabolism of styrene, according to an experimental study [218]. Such 
exposure should be avoided whenever possible.
Regulations concerning personal protective equipment and respiratory 
protection can be found in 29 CFR 1910.133, 29 CFR 1910.134, and 30 CFR 11. 
NIOSH test data and recommendations for eye protection, which comply with 
ANSI Z87.1, can be found in two NIOSH publications [339,340],
Exposure Monitoring and Recordkeeping
To characterize worker exposures, the employer should conduct personal 
sampling and analysis for styrene. Estimates of the exposure of each worker 
should be made, whether or not each worker's exposure is measured by a
personal sampler. Thus, a sampling strategy that allows reasonable 
estimates of each worker's exposure should be used. Records of such
monitoring should include sampling and analytical methods, times and 
locations of samples, whether protective devices (especially respiratory 
protective devices) were in use, and the concentrations found or estimated. 
It is important, in the case of estimated concentrations, that information 
on which the estimates were based be included.
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It is also important that pertinent medical records (i.e., results of 
medical examinations, the physician's written opinion, medical complaints, 
medical and work histories, etc.) be established and maintained for all 
workers, and that copies of any environmental monitoring data applicable to 
the worker be included in these records. To ensure that they will be 
available for future reference and correlation, they should be maintained 
for the duration of employment plus a period of 30 years. Copies of these 
medical and environmental records should be made available to the worker, 
former worker, or to his or her designated representative following specific 
written consent of the worker. In addition, the designated representatives 
of the Secretary of Health and Human Services and the Secretary of Labor 
should have access to the records or to copies of them.
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X. APPENDIX I 
METHOD FOR SAMPLING AND ANALYSIS OF STYRENE IN AIR
General Requirements for Styrene Air Sampling
Air samples are collected that represent the air a worker breathes while 
performing each job or specific operation. It is advisable to maintain
records of the date, time, rate, duration, volume, and location of 
sampling. It is also advisable to record the temperature, pressure, and 
relative humidity at the time the sample was taken, as well as other
pertinent information.
Sampling
(a) Sampling Strategy and Apparatus
Air samples are collected as near to the worker's breathing zone as
practicable, but without interfering with the worker's freedom of movement. 
These air samples are collected in a manner that will allow the 
determination of the worker's exposure for every job he or she performs 
where styrene is used. It is recommended that a number of air samples be 
collected so that the variability of exposures throughout the work area can 
be determined. Statistical sampling strategies are given in the NIOSH 
publication Occupational Exposure Sampling Strategy Manual [341].
To collect these air samples on charcoal tubes, battery-operated pumps
are needed that have clips for attachment to the worker’s clothes. It is
necessary that these pumps be capable of calibration within 5% at
operational flow-rates.
The analytical method as described later in this appendix is for samples 
collected by use of glass tubes, 7 cm long, with an outside diameter of 6 mm 
and an inside diameter of 4 mm. These tubes contain two sections of 20/40 
mesh activated coconut-shell charcoal that was fired at 600°C. The first 
section is the adsorbing section and contains 100 mg of charcoal. The
second, or reserve (backup) section, contains 50 mg of charcoal. The
sections are separated by 2 mm of urethane foam, with 3 mm of urethane foam 
placed between the reserve section and the end of the tube; a plug of 
silylated glass wool is placed between the other end of the tube and the 
adsorbing section. Tubes that contain larger amounts of charcoal are also 
available. Such tubes may be used if results obtained using the standard
size tubes indicate that breakthrough has occurred or if substantial amounts
of organic compounds that may interfere with styrene collection are also 
known to be present. The pressure drop across the tube must be less than 1
inch of mercury at a flow-rate of 1 liter/min. Tubes that meet the
specifications described above are commercially available.
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(b) Calibration of Sampling Instruments
Air sampling instruments should be calibrated at operational flow-rates 
with a representative charcoal tube in line. Positive-displacement diaphragm 
pumps require accurate determination of the stroke factor. In addition, 
pumps must be recalibrated after any repair to, or modification of, the 
sampling system is made. It is also necessary to spot check the volumetric 
flow-rate through the sampling system and to make adjustments before and
during each study to ensure accurate airflow data.
(c) Collection and Handling of Samples
The following steps are recommended for the proper collection and
handling of air samples:
(1) Immediately before sampling the air, both ends of the charcoal 
tube are scored and broken so that openings of at least one-haIf the 4-mm 
internal diameter of the tube are made.
(2) The smaller, or reserve, section of charcoal is positioned
toward the sampling pump.
(3) The charcoal tube is placed in a vertical position during
sampling to prevent channeling and consequent sample loss.
(4) The air sample is drawn directly through the adsorbing section 
of charcoal without first passing it through any tubing; tubing may be used 
to connect the back of the tube to the pump.
5) Sampling at 1 liter/min for 15 minutes should provide an 
adequate sample for measuring ceiling concentrations. A sampling rate of 
250 ml/min is recommended for measuring TWA exposures over an entire shift.
(6) Immediately after sampling, the charcoal tubes are sealed with 
plastic caps that are inert to, and contain no styrene. Under no 
circumstances should rubber caps be used.
(7) Prepare a charcoal tube to serve as an analytical blank. No
air is drawn through this tube, but it is broken, sealed, and, if 
appropriate, transported in the same way as the charcoal tubes that were 
used to collect the sample.
(8) If tubes are to be shipped it is necessary to ensure that they
are packed tightly and well padded to prevent breakage.
(9) A sample of the bulk styrene used in the facility where the 
air has been sampled should be submitted to the laboratory in a glass 
container sealed with a Teflon-lined cap. This sample should not be 
transported in the same container as the charcoal tubes.
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Principle of the Method of Styrene Analysis
A measured volume of air is drawn through a charcoal tube to adsorb 
airborne styrene onto the charcoal. The adsorbed styrene is subsequently 
desorbed from the charcoal with carbon disulfide. A suitable portion of the 
desorbed sample is subjected to gas chromatography, and the amount of 
styrene is determined by comparing the area under the styrene peak with a 
standard curve that relates peak areas to the concentration of a known 
s tandard.
Range, Sensitivity, Precision, and Accuracy
(a) Although the lower detection limit of the method [259] has not been 
determined for styrene, a sample volume of 10 liters is considered adequate 
for measuring styrene at 10 ppm. Desorption efficiency studies [255] were 
conducted with amounts of styrene that would be collected from 10-liter air 
samples containing styrene at 50, 100, and 200 ppm. The desorption 
efficiencies were 0.87, 0.88, and 0.93, respectively. This method [259] is 
capable of measuring amounts of styrene smaller than the amounts used to 
evaluate it, if the desorption efficiency is determined to be adequate. The 
desorption efficiency must be determined over the range of concentrations to 
be sampled.
The method has been evaluated for precision and accuracy with styrene 
over the range of 100-400 ppm at 0% relative humidity and at an atmospheric
temperature of 23°C and a pressure of 754 mm Hg [255]. This evaluation was
performed using 5-liter air samples collected at 200 ml/min. The 
coefficient of variation for the total analytical and sampling method was 
0.057. On the average the combined sampling and analytical method 
underestimated the nominal concentrations by about 8%. The method has not 
been tested with styrene for precision and accuracy by NIOSH below 100 ppm. 
However, field data from NIOSH indicates that the method has acceptable 
precision below 5 ppm [342].
(b) The upper limit of the range of the method is dependent on the 
adsorptive capacity of the charcoal tube. This capacity varies with the 
concentrations of styrene and other substances in the air. It was estimated 
that 36 mg of styrene was the maximum amount that could be collected on 100 
mg of charcoal in the front (adsorbing) section before the styrene 
penetrated in significant amounts (i.e., 5%) to the reserve section [255],
This estimate was based on a sampling rate of 0.19 liters/min for 111
minutes in a test atmosphere that contained 400 ppm of styrene.
Interferences
(a) The volume at which breakthrough occurs in a charcoal tube is 
severely reduced when the humidity is high, at which time a smaller air 
sample should be taken or a larger charcoal tube should be used.
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(b) When other compounds are known or suspected to be present in the 
air, the suspected identities of those compounds should be recorded.
(c) Any compound that has the same retention time as styrene using the 
chromatographic conditions described in this method will interfere with 
analysis. Such interferences may be eliminated by altering the operating 
conditions of the gas chromatograph or by changing the column liquid phase.
(d) Retention time data obtained by gas chromatography on a single
column cannot be considered proof of chemical identity.
Apparatus
(a) Gas chromatograph (GC) equipped with a flame ionization detector.
(b) Stainless steel column (10 feet long x 1/8 inch outer diameter)
with 10% free fatty acid polymer (FFAP) stationary phase on 80/100 mesh
Chromosorb W HP (or equivalent), acid washed and treated with 
dimethyldichlorosilane (DMCS).
(c) Recorder and some method for determining peak area.
(d) Glass stoppered microtubes or vials, which can be sealed with 
Teflon-lined caps, that have a capacity twice the volume of carbon disulfide 
used for desorption (1 ml for standard size tubes).
(e) Microsyringes of appropriate size for preparing standards.
(f) Pipets that can accurately deliver the volume of carbon disulfide 
needed for the charcoal tubes used, such as 1.0 ml graduated in 0.1 ml 
increments.
(g) Volumetric flasks of appropriate sizes for preparing standard
solutions.
Reagents
(a) Carbon disulfide, chromatographic quality.
(b) Styrene, reagent grade.
(c) Nitrogen, purified.
(d) Hydrogen, prepurified.
(e) Air, filtered, compressed.
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Analysis of Samples
(a) Sample Preparation
Wash the equipment used for analysis in detergent followed by a tap 
water rinse and finally a distilled (not deionized) water rinse.
Score the charcoal tube with a file in front of the first (adsorbing)
section of charcoal and break it open. Remove the glass wool and discard
it. Transfer the charcoal from the first section to a 2-ml stoppered test 
tube or container. Remove and discard the separating foam and transfer the 
charcoal from the second (backup) section to another, similar, test tube or 
container. The two sections of charcoal are analyzed separately. Prior to 
analysis, when charcoal tubes containing 100 mg of charcoal in the adsorbing 
section are used, pipet (not by mouth) 1.0 ml of carbon disulfide into each 
sample container to desorb styrene from the charcoal. Use this same ratio 
of carbon disulfide to charcoal if larger charcoal tubes are used. A
desorption time of at least 30 minutes, with occasional agitation, is
recommended. It is further recommended that samples be analyzed as soon as 
possible after desorption; this will help prevent losses due to sample 
decomposition.
EXTREME CAUTION MUST BE EXERCISED AT ALL TIMES 
WHEN USING CARBON DISULFIDE BECAUSE OF ITS HIGH TOXICITY 
AND FIRE AND EXPLOSION HAZARDS. IT CAN BE IGNITED BY 
HOT STEAM PIPES. ALL WORK WITH CARBON DISULFIDE SHOULD BE 
PERFORMED UNDER AN EXHAUST HOOD.
(b) GC conditions (should be optimized according to the manufacturer's 
specifications). Typical operating conditions for the gas chromatograph are:
(1) 50 ml/min (60 psig) nitrogen carrier gas flow.
(2) 65 ml/min (24 psig) hydrogen gas flow to detector.
(3) 500 ml/min (50 psig) air flow to detector.
(4) 195°C injector temperature.
(5) 255°C manifold temperature (detector).
(6) 109°C column temperature.
(c) Injection of sample
To eliminate difficulties that may arise from blowback or distillation 
within the syringe needle, the solvent flush injection technique should be 
used for injection of the sample into the gas chromatograph. With this 
technique, the syringe is first flushed with carbon disulfide several times 
to wet the barrel and plunger and then 3 yl of carbon disulfide is drawn
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into the syringe to increase the accuracy and reproducibility of the
injected sample volume. The syringe needle is removed from the carbon 
disulfide and the plunger is pulled back about 0.2 pi so that the solvent
flush is separated from the sample with a pocket of air, which may be used
as a marker. The needle is then immersed in the sample, and a 5-yl
portion is withdrawn. The volume of the needle is taken into consideration 
since the sample in the needle will be completely injected. After the 
needle is removed from the sample, and prior to injection, the plunger is 
pulled back a short distance to minimize evaporation of the sample from the 
tip of the needle. It is recommended that duplicate injections of each 
sample and standard be made. Using this technique, the maximum difference 
expected between results of duplicate injections is 3%.
Other injection techniques, such as use of automatic sample injectors, 
are acceptable if their reproducibility is at least as good as the solvent 
flush injection technique.
(d) Measurement of area
Measure the area of the sample peak by an electronic integrator or some
other suitable form of area measurement, and read the preliminary results
from a standard curve prepared as discussed below.
Determination of Desorption Efficiency
It is necessary to determine the percentage of styrene on the charcoal 
that is removed by the desorption process. This desorption efficiency may 
vary with the amount of styrene adsorbed onto the charcoal and the
adsorption characteristics of the batch of charcoal being used. These
variables necessitate determination of a desorption efficiency curve for 
each batch of charcoal as described below for 100-mg quantities of 
charcoal. Charcoal from the batch used in preparing the sample tubes can be 
obtained from unused tubes of the same batch.
Measure 100-mg quantities of charcoal into glass tubes that are 5 cm 
long, 4 mm inside diameter, and flame-sealed at one end. Inject known 
amounts of styrene directly into the charcoal with a microliter syringe, and 
cap the tubes with an inert plastic (e.g., Parafilm).
At least five tubes that contain different amounts of styrene are 
prepared in this manner and allowed to stand at least overnight to ensure 
complete adsorption of styrene onto the charcoal. Preparation of replicate 
tubes with each amount of added styrene is recommended. These tubes will be 
referred to as the desorption samples. Prepare a parallel blank tube in the 
same manner, except for addition of styrene. Desorb and analyze the 
desorption samples and blanks in exactly the same manner as previously 
described.
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Prepare desorption standards by injecting the same volumes of styrene
into 1.0 ml of carbon disulfide with the same syringe used in the
preparation of the desorption samples. Replicate standards are recommended 
with each amount of added styrene. These are analyzed with the desorption 
samples.
The desorption efficiency equals the difference between the average GC 
peak area due to styrene recovered from the charcoal and the corresponding
peak area due to the charcoal blank divided by the average peak area due to
styrene added directly to the carbon disulfide or,
desorption efficiency = area of desorption sample - area of blank
area of standard
The desorption efficiency is plotted vs. weight of styrene found, and 
the curve is used for correction for incomplete desorption.
Calibration and Standards
It is convenient to prepare standards in terms of milligrams of 
styrene/1.0 ml of carbon disulfide if samples are desorbed in this amount of 
carbon disulfide. To minimize error due to variability of carbon disulfide, 
10 times the weight of styrene can be injected into 10 ml of carbon 
disulfide. For example, to prepare 0.2 mg/1.0 ml of standard, inject 2.0 mg 
of styrene into exactly 10 ml of carbon disulfide in a glass-stoppered 
flask. Use the density of styrene (0.9018 g/cu cm at 25°C) to convert mg 
into yl for easy measurement with a microliter syringe.
Prepare a series of standards, varying the amount of added styrene over 
the range of interest, and analyze them under the same GC conditions and 
during the same time period as the unknown samples. Establish curves by 
plotting average peak area vs. milligrams of styrene/volume of carbon 
disulfide used for desorption.
Alternatively, carbon disulfide containing a predetermined amount of an 
internal standard can be used, and the styrene concentration in mg/ml can be 
plotted against the ratio of the area of styrene to the area of the internal 
standard. However, it needs to be established whether the concentration of 
the internal standard in solution is changed by adsorption on the charcoal.
Calculations
(a) From the standard curve, read the weight in milligrams that 
corresponds to the peak area. No volume corrections are needed since the 
standard curve is based on mg styrene/volume of carbon disulfide used for 
desorption, and the volume of sample injected is identical to the volume of 
the standards injected.
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(b) The weights of styrene on the front and reserve sec tion s  of the 
charcoal tube must be determined separately .
(c )  Corrections to the styrene weights, determined on both the front  
and reserve sec t io n s ,  for the weights of the respective  sec tion s  of the 
blank charcoal tube are made in the following manner:
(1) Subtract the weight of styrene found on the fron t (adsorbing) 
sec t ion  of the blank charcoal tube from the weight of styrene found on the 
front sec t ion  of the sample charcoal tube to determine the corrected front  
sec tion  weight.
(2) Subtract the weight of styrene found on the reserve (backup) 
sec tion  of the blank charcoal tube from the weight of styrene found on the 
reserve sec t ion  of the sample charcoal tube to determine the corrected  
reserve sec tion  weight.
(3) Add the corrected amounts of styrene present on the front and 
backup sec t ion s  of the sample tube to determine the to ta l  amount of styrene  
in the sample, and divide th is  to ta l  weight by the appropriate desorption  
e f f ic ie n c y  to obtain M, the to ta l  (corrected) milligrams per sample. The 
sample should be considered inva lid  i f  the backup sec tion  contains more than 
20% of the amount of styrene on the front section .
(d) Convert the l i t e r s  of a ir  sampled (V) to the volume (V') a t  
standard conditions of 25°C and 760 mm Hg, as follows:
V' = 298VP = 0.392VP
760(T+273) (T+273)
Where:
V' = volume of sampled a ir  in l i t e r s  a t  25°C and 760 mm Hg
V = measured volume of sampled a ir  in l i t e r s
P = barometric pressure in mm Hg, measured a t  time of 
sampling
T -  temperature of a ir  in degrees C els iu s , measured a t  time of 
sampling
(e) The concentration of styrene in the sampled a ir  a t  the standard 
conditions (25°C, 760 mm Hg) can be expressed in various ways using M, the 
weight of styrene obtained in ( c ) ( 3 ) ,  and V', the standardized sample 
volume, obtained in (d ),  as fo llows:
(1) mg/1 = M/V'
(2) mg/cu m = y g / l i t e r  = 1,000 M/V'
(3) ppm = 235 M/V'
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X I . APPENDIX I I
DETERMINATION OF MANDELIC ACID IN  URINE
General Considerations
About 50-85% of absorbed styrene i s  eliminated as urinary mandelic acid
in humans [88 ,144,148], Urinary mandelic acid has been demonstrated to
corre la te  with time-weighted average (TWA) styrene exposures [79 ,91 ,92 ,125,  
282], Another major styrene m etabolite , urinary phenylglyoxylie  a c id , can 
a lso  be e f f e c t iv e ly  determined, but th is  information adds l i t t l e  information
to that gained from the determination of mandelic acid [156],
Urine contains many substances that may react with the reagents used to 
determine mandelic acid by colorim etric  and polarographic methods. In 
colorim etric  methods, phenols react with su lfu r ic  acid-form alin [121], and 
la c t ic  acid reacts with fe r r ic  chloride [144]; in polarographic a n a ly s is ,  
phenylalanine, as w ell as mandelic acid , w i l l  be converted to benzaldehyde 
[144], the material that i s  analyzed. Because of varying in terferences  from 
such substances, these co lorim etric  and polarographic methods are not 
s p e c if ic  and cannot be re l ied  upon to give accurate r e s u lt s  a t  low urinary 
concentrations of mandelic acid . However, because of th e ir  s im p lic ity ,  
colorim etric  and polarographic methods may be use fu l for spot checks when 
other a n a ly t ica l  methods are not read ily  a v a ila b le .
Gas chromatography can be s p e c i f ic  for mandelic acid in urine; methods 
have been w e ll  developed, in ter feren ces  are minimal, and s e n s i t iv i t y  is  
s u f f i c i e n t  to evaluate occupational exposures to styrene. The method of 
Engstrom and Rantanen [79], as modified by Riihimaki and P f a f f l i  [154], has 
been su ccessfu lly  used to re la te  urinary concentrations of mandelic acid to 
the 8-hour TWA styrene exposures of workers and i s  presented a t  the end of 
th is  appendix; mandelic acid i s  analyzed by gas chromatography as i t s  
tr im e th y ls i ly 1 d er ivative . In 1979, Wilson e t  a l .  [343] used a s im ilar  
method that included the use of p h en y llac tic  acid as an in tern a l standard.
B io lo g ica l  monitoring should c o n s is t  of the c o l le c t io n  and an a lys is  of 
each worker's urine for mandelic acid a t  the time of personal in d u str ia l  
hygiene monitoring of airborne styrene. Mandelic acid concentrations in 
urine samples co llec ted  a t  the end of a workshift have been found to be 
roughly proportional to TWA styrene exposures. Because a substantia l  
portion of styrene absorbed during a workshift i s  s t i l l  present the next day 
[92 ,159 ,282] , the measured value of urinary mandelic acid may r e f l e c t  
styrene exposure w ithin the preceding 24 hours.
Based on the gas chromatographic method described below, on the average, 
a urinary mandelic acid concentration of 1,200 mg/1 (adjusted to a s p e c i f ic  
gravity  of 1.018) corresponds to an average 8-hour TWA styrene exposure 
estimate of 55 ppm, with 95% confidence l im its  of about 25-120 ppm (see
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Figure V -l ,  p. 141). I f  the urine samples have a low s p e c i f ic  gravity  
( i . e . ,  below 1 .010), add itional samples should be c o l le c te d .  Correction may 
a lso  be made by div id ing the amount of mandelic acid by the amount of 
creatin ine  in the sample [92].
Because of the individual v a r ia b i l i t y  of urinary mandelic acid values  
re la t iv e  to airborne styrene concentrations, urinary mandelic acid  
measurements serve only as a guide to estimate the overa ll  worker exposure 
to styrene. However, i f  urinary mandelic acid concentrations tend to exceed 
1,200 mg/1 (adjusted to a s p e c i f ic  gravity  of 1 .018), the work se t t in g  
should be evaluated to id en t ify  the source of exposure. Among the p oss ib le  
sources that may need to be reevaluated are TWA exposure concentrations, 
exposure to some other substances such as ethylbenzene, improper work 
p ractices  resu lt in g  in s ig n i f ic a n t  percutaneous styrene absorption or, 
conceivably, styrene ingestion  or nonoccupational exposure. Among 
nonoccupational sources that r e s u lt  in urinary mandelic acid elim ination  are 
hobbies that r e s u l t  in styrene exposures and the use of medications that may 
be sources of mandelic acid .
I f  immediate processing of c o l le c te d  urine samples i s  not p o ss ib le ,  the 
samples should be kept in a refr ig era to r  a t  4°C; Flek and Sedivec [281] 
found that urine samples remained unchanged for a t  l e a s t  14 days under those 
conditions.
Recommended A nalytica l Method [79,154]
(a) P r in cip le  of the Method
(1) Urine i s  c o l le c te d  from workers a t  or near the end of a 
workshift; s p e c i f ic  gravity  i s  measured.
(2) The urine i s  a c id i f ie d  with HC1, saturated with sodium
chlor ide , and extracted with d ie th y l  ether.
(3) An appropriate volume of the ex tract  i s  removed and evaporated
to dryness.
(4) A p y r id in e -N ,0 -b is -( tr im eth y ls i ly l) - tr if lu o ro a ce ta m id e  (BSTFA) 
so lu tion  i s  added (to  s i l y l a t e  the mandelic acid) and the mixture i s  allowed 
to react a t  room temperature for a few minutes.
(5) A portion of the reacted material i s  in jected  d ir e c t ly  into  a 
gas chromatograph.
(6) The amount of mandelic acid in the urine i s  proportional to
the height of the s i ly la te d  mandelic acid GC peak; peak id e n t i f ic a t io n  i s
made by comparing retention  time with that of authentic  s i ly la t e d  mandelic 
acid .
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(b) E ff ic ien cy , R eproducib ility , and Range of the Method
The mean concentration found in 10 r ep lica te  samples of urine containing
1.6 mg mandelic acid (equivalent to a concentration of 800 mg/1 of urine) 
was 750 mg/1, an average recovery of 94% [79], The c o e f f i c i e n t  of var iation  
determined from rep lica te  analyses was about 2%. The peak heights of the 
p lo t  from the gas chromatograph were proportional to the concentration of 
mandelic acid added to normal urine over the range of 0-800 mg/1.
(c) Advantages of the Method
The c o l le c t io n  of samples and their  subsequent a n a lys is  i s  simple and
rapid. The method can detec t low concentrations and small changes in the
excretion  of mandelic acid; blank samples ind icate  l i t t l e  or no interference  
from the reagents or other substances present in the sample.
(d) Apparatus
(1) Gas chromatograph (GC) equipped with a flame ion iza tion
detector.
(2) S ta in le ss  s t e e l  column (4 .6  f e e t  long x 1/8-inch outer 
diameter) with 10% OV-17 stationary phase on 80/100 mesh Chromosorb W HP (or  
eq u iv a len t) .
(3) Recorder.
(4) Microsyringes and p ipets  of appropriate s iz e s  for preparing 
standards.
(e )  Reagents
(1) D iethyl ether.
(2) Hydrochloric ac id , 6N
(3) Sodium chloride .
(4) Pyridine.
(5) N ,0 -b is - ( tr im e th y ls i ly 1 ) - trifluoroacetam ide (BSTFA).
( f )  Analysis of Samples
(1) Sample Preparation
A ll glassware i s  thoroughly cleaned and rinsed. A 2-ml portion of 
urine i s  p ipetted into a t e s t  tube or other convenient container and i s
2 1 6
a c id if ie d  with 40 y l  of 6N HC1 and saturated with NaCl. The mixture i s  
diluted  to 10 ml with d ieth y l ether and i s  shaken for 10 minutes.
A 0 .5 -  to 5.0-ml portion of the ether ex tra ct  i s  evaporated to
dryness, and a pyridine-BSTFA ( 1 : 1 ,v /v ) mixture i s  added to the residue to 
obtain a volume of 100 y l .  After a few minutes a t  room temperature, a
portion (1-2 y l )  of the reaction  mixture i s  in jected  into  a gas
chroma to grap h.
(2) GC Conditions (should be optimized according to the 
manufacturer's s p e c i f ic a t io n s ) .  Typical operating conditions for the gas 
chromatograph are as follows:
(A) 15 ml/min nitrogen carr ier  gas flow.
(B) 60 ml/min hydrogen gas flow to detector.
(C) 300 ml/min a ir  flow to detector.
(D) 200°C in jec to r  temperature.
(E) 320°C manifold temperature (d e tec to r ) .
(F) 155°C oven temperature.
(g) Calibration and Standards
I t  i s  convenient to prepare standards in terms of mg of mandelic
a c i d / l i t e r  of urine (1 mg mandelic acid/ml of urine i s  equivalent to 1,000
mg/1). To minimize errors in weighing and measuring, a concentrated
so lu tion  can be prepared, and a s e r ie s  of standards can be made by p ip ett in g  
varying volumes from the concentrated so lu tion  into  a ser ie s  of volumetric 
f la sk s .  The standards are treated the same as the urine samples. Measured 
volumes (1-2 y l )  of the standards are injected  into a gas chromatograph 
using the same solvent f lu sh  technique recommended for styrene analysis
which was discussed in Appendix I; a standard curve i s  prepared by p lo t t in g
peak heights vs . the amounts of mandelic acid in jected .
Each time the an a lys is  i s  performed a blank tube and a t  l e a s t  one 
standard tube ( in  the midrange of the a n a ly s is )  should a lso  be analyzed so 
that corrections for day-to-day var ia tion  in technique or reagents can be
made.
(h) Calculations
(1) The weight of mandelic acid in the sample is  determined by 
comparing the peak height of the sample with the standard curve.
(2) The volume (V) of urine represented by the sample that was 
injected  into  the gas chromatograph i s  determined as follows:
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V ■ a  x  b  x  c
Where:
a = volume of urine treated for analysis  
b = fraction  of the ether ex tract evaporated to dryness 
c = fra c tio n  of s i ly la t e d  mixture in jected  into  GC
For example, i f  2 ml of urine was treated for a n a ly s is  (a=2), and i f  a 
5-ml portion of the ether ex tract  was evaporated (b=5/10), and i f  1.5 y l
of the reaction  mixture was in jected  (C = l.5 /100), then the volume (V) of
urine in jected  would be 0.015 ml.
(3) The concentration (C=yg/ml=mg/l) of mandelic acid in the
urine sample is  determined by dividing the weight of mandelic acid in yg
found in (1) by the urine volume V
(A) The concentration of mandelic acid obtained in (3) i s
converted to the concentration in urine a t  s p e c i f ic  gravity  of 1.018 as
follows:
C’ = 18C
(SG-1.000) 1,000
Where:
C' “ corrected concentration (mg/l)
C = measured concentration (mg/l)
SG = measured s p e c i f ic  gravity of the urine sample
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X I I .  APPENDIX I I I
MATERIAL SAFETY DATA SHEET
The following items of information which are applicable  to a sp e c if ic  
product or material sh a l l  be provided in the appropriate block of the 
Material Safety Data Sheet (MSDS).
The product designation i s  inserted in the block in the upper l e f t  
corner of the f i r s t  page to f a c i l i t a t e  f i l i n g  and r e tr ie v a l .  Prin t in upper 
case l e t t e r s  as large as p o ss ib le .  I t  should be printed to read upright 
with the sheet turned sideways. The product designation is  that name or 
code designation which appears on the la b e l ,  or by which the product is  sold  
or known by workers. The r e la t iv e  numerical hazard ratings and key 
statements are those determined by the rules in Chapter V, Part B, of the 
NIOSH pu blication , A Recommended Standard.. . .An Id e n t i f ic a t io n  System for  
Occupationally Hazardous M aterials [306], The company id e n t i f ic a t io n  may be 
printed in .the upper r ig h t corner i f  desired.
(a) Section I .  Production Id e n t if ic a t io n
The manufacturer's name, address, and regular and emergency telephone 
numbers (including area code) are inserted in the appropriate blocks of 
Section I .  The company l i s t e d  should be a source of d eta iled  backup 
information on the hazards of the m ater ia l(s )  covered by the MSDS. The 
l i s t i n g  of suppliers or wholesale d is tr ib u tors  i s  discouraged. The trade 
name should be the product designation or common name associated  with the 
m aterial. The synonyms are those commonly used for the product, e sp ec ia l ly  
formal chemical nomenclature. Every known chemical designation or 
com petitor's trade name need not be l i s t e d .
(b) Section I I .  Hazardous Ingredients
The "materials" l i s t e d  in Section II  sh a l l  be those substances which are 
part of the hazardous product covered by the MSDS and in d iv id u a lly  meet any 
of the c r i t e r ia  defining a hazardous m aterial. Thus, one component of a 
multicomponent product might be l i s t e d  because of i t s  t o x ic i ty ,  another 
component because of i t s  flammabi1i t y , while a third component could be 
included both for i t s  to x ic ity  and i t s  r e a c t iv i ty .  Note that a MSDS for a 
s in g le  component product must have the name of the m aterial repeated in th is  
sec tion  to avoid giving the impression that there are no hazardous 
in gred ien ts .
Chemical substances should be l i s t e d  according to th eir  complete name 
derived from a recognized system of nomenclature. Where p o ss ib le ,  avoid 
using common names and general c la s s  names such as "aromatic amine," "safety  
so lvent,"  or "aliphatic  hydrocarbon" when the s p e c i f ic  name i s  known.
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The "%" may be the approximate percentage by weight or volume (in d icate  
b asis)  which each hazardous ingredient of the mixture bears to the whole 
mixture. This may be indicated as a range or maximum amount, i . e . ,  "10-40% 
v o l."  or "10% max. wt." to avoid d isc losu re  of trade s ec r e ts .
Toxic hazard data sh a l l  be stated  in terms of concentration, mode of 
exposure or t e s t ,  and animal used, e . g . ,  "100 ppm LC50-rat," "25 mg/kg
LD50-skin-rabbit," "75 ppm LC man," "permissible exposure from 29 CFR
1910.1000," or, i f  not a v a ila b le ,  from other sources such as publications of 
the American Conference of Governmental Indu str ia l H ygienists (ACGIH) or the 
American National Standards I n s t i t u t e ,  Inc (ANSI). Flashpoint, shock 
s e n s i t iv i t y ,  or s im ilar d escr ip t ive  data may be used to indicate  
flam m ability, r e a c t iv i t y ,  or s im ilar  hazardous properties of the m aterial.
(c) Section I I I .  Physical Data
The data in Section I II  should be for the to ta l  mixture and should 
include the b o il in g  point and melting point in degrees Fahrenheit (Celsius  
in parentheses); vapor pressure, in conventional m illim eters of mercury 
(mm Hg); vapor density of gas or vapor (a ir  = 1); s o lu b i l i t y  in water, in 
parts/hundred parts of water by weight; s p e c if ic  gravity  (water = 1);
percent v o la t i l e s  (indicated  i f  by weight or volume) a t  70°F (21.1°C);
evaporation rate for liq u id s  or sublimable s o l id s ,  r e la t iv e  to butyl 
aceta te;  and appearance and odor. These data are u se fu l for the control of 
toxic substances. B oiling  p oin t, vapor density , percent v o l a t i l e s ,  vapor 
pressure, and evaporation are u sefu l for designing proper v e n t i la t io n  
equipment. This information i s  a lso  usefu l for design and deployment of 
adequate f i r e  and s p i l l  containment equipment. The appearance and odor may 
f a c i l i t a t e  id e n t i f ic a t io n  of substances stored in improperly marked 
containers, or when s p i l le d .
(d) Section IV. Fire and Explosion Data
Section  IV should contain complete f i r e  and explosion  data for the
product, including f la sh p o in t  and au to ign ition  temperature in degrees
Fahrenheit (C elsius in parentheses); flammable l im it s ,  in percent by volume 
in a ir ;  su itab le  extinguish ing media or m aterials; sp ec ia l  f ir e f ig h t in g  
procedures; and unusual f i r e  and explosion hazard information. I f  the 
product presents no f i r e  hazard, in se r t  "NO FIRE HAZARD" on the l in e  labeled  
"Extinguishing Media."
(e )  Section V. Health Hazard Information
The "Health Hazard Data" should be a combined estimate of the 
hazard of the to ta l  product. This can be expressed as a TWA concentration, 
as a perm issible exposure, or by some other ind ication  of an acceptable
standard. Other data are acceptable , such as lowest LD50 i f  multiple
components are involved.
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Under "Routes of Exposure," comments in each category should r e f l e c t  the 
p o ten tia l  hazard from absorption by the route in question . Comments should 
ind icate  the sever ity  of the e f f e c t  and the b asis  for  the statement i f  
p o ss ib le .  The b asis  might be animal s tu d ies ,  analogy with s im ilar  products, 
or human experiences. Comments such as "yes" or "possible" are not he lp fu l.  
Typical comments might be:
Skin C ontact--s ing le  short contact, no adverse e f f e c t s  l ik e ly ;  prolonged
or repeated contact, possib ly  mild ir r i t a t io n .
Eye Contact--some pain and mild transient ir r i ta t io n ;  no corneal
scarring.
"Emergency and F ir s t  Aid Procedures" should be w ritten  in lay language 
and should primarily represent f i r s t - a i d  treatment that could be provided by 
paramedical personnel or ind iv iduals  trained in f i r s t  a id .
Information in the "Notes to Physician" sec t io n  should include any 
sp ec ia l  medical information which would be of a ss is ta n ce  to an attending  
physician including required or recommended preplacement and periodic  
medical examinations, d iagnostic  procedures, and medical management of 
overexposed workers.
( f )  Section VI. R eactiv ity  Data
The comments in Section VI re la te  to safe  storage and handling of 
hazardous, unstable substances. I t  i s  particu lar ly  important to h igh ligh t  
in s t a b i l i t y  or incom patib ility  to common substances or circumstances, such 
as water, d ir e c t  su n ligh t, s t e e l  or copper p ip ing, a c id s ,  a lk a l ie s ,  e tc .  
"Hazardous Decomposition Products" s h a ll  include those products released  
under f i r e  conditions. I t  must a lso  include dangerous products produced by 
aging, such as peroxides in the case of some e th ers . Vhere app licable ,  
sh e lf  l i f e  should a lso  be indicated.
(g) Section VII. S p i l l  or Leak Procedures
D etailed  procedures for cleanup and d isposal should be l i s t e d  with  
emphasis on precautions to be taken to p rotect workers assigned to cleanup 
d e t a i l .  S p ec if ic  neu tra liz in g  chemicals or procedures should be described in 
d e ta i l .  D isposal methods should be e x p l i c i t  including proper labeling of 
containers holding residues and ultim ate disposal methods such as "sanitary  
la n d f i l l"  or inc in eration ."  Warnings such as "comply with lo c a l ,  s ta te ,  and 
Federal a n t ip o llu t io n  ordinances" are proper but not s u f f i c i e n t .  S p ec if ic  
procedures s h a l l  be id e n t if ie d .
(h) Section VIII. Special Protection  Information
Section  VIII requires s p e c i f ic  information. Statements such as "Yes," 
"No," or "If necessary" are not informative. V en tila t ion  requirements 
should be sp e c i f ic  as to type and preferred methods. Respirators sh a ll  be
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sp ec if ied  as to type and NIOSH or Mine Safety and Health Administration  
approval c la s s ,  i . e . ,  "Supplied a ir ,"  "Organic vapor can is ter ,"  e tc .  
Protective  equipment must be sp e c if ied  as to type and m aterials of 
construction.
( i )  Section IX. Special Precautions
"Precautionary Statements" sh a ll  c o n s is t  of the lab e l statements  
se lec ted  for use on the container or placard. Additional information on any 
aspect of sa fe ty  or health not covered in other sec t ion s  should be inserted  
in Section IX. The lower block can contain references to published guides 
or in-house procedures for handling and storage. Department of 
Transportation markings and c la s s i f i c a t i o n s  and other fr e ig h t ,  handling, or 
storage requirements and environmental controls  can be noted.
( j )  Signature and F il in g
F in a l ly ,  the name and address of the responsible person who completed 
the MSDS and the date of completion are entered. This w i l l  f a c i l i t a t e  
correction  of errors and id en t ify  a source of add itional information.
The MSDS sh a ll  be f i l e d  in a location  read ily  a c ce ss ib le  to workers 
exposed to the hazardous substance. The MSDS can be used as a training aid  
and basis  for d iscussion  during sa fe ty  meetings and training of new 
workers. I t  should a s s i s t  management by d irect in g  a tten t io n  to the need for  
s p e c if ic  control engineering, work p ra c t ic es ,  and p ro tec tiv e  measures to 
ensure safe  handling and use of the m aterial. I t  w i l l  aid the safety  and 
health s t a f f  in planning a safe and h ea lth fu l work environment and in  
suggesting appropriate emergency procedures and sources of help in the event 
of harmful exposure of workers.
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M ATERIAL SAFETY DATA SHEET
1 PRODUCT IDENTIFICATION
M AN U FA CTU RER'S NAME REGULAR TELEPHONE NO EMERGENCY TELEPHONE NO
ADDRESS
TRADE NAME
SYNONYMS
II HAZARDOUS INGREDIENTS
M ATERIAL OR COMPONENT % HAZARD DATA
III PHYSICAL DATA
BOILING POINT, 760 MM HG MELTING POINT
SPECIFIC GRAVITY (H20  = 1) VAPOR PRESSURE
VAPOR DENSITY (AIR = 11 SOLUBILITY IN H20  % BY WT
% VOLATILES BY VOL EVAPORATION RATE (BUTYl. A C ETA TE O )
APPEARANCE AND ODOR
2 2 3
IV FIRE AND EXPLOSION DATA
FLASH POINT 
(TEST METHOO)
AUTOIGNITION
TEM PERATURE
FLAMMABLE LIMITS IN A IR . % BY VOL. LOWER UPPER
EXTINGUISHING
MEDIA
SPECIAL FIRE
FIGHTING
PROCEDURES
UNUSUAL FIRE 
AND EXPLOSION 
HAZARD
V HEALTH HAZARD INFORMATION
HEALTH HAZARD DATA
ROUTES OF EXPOSURE 
INHALATION
SKIN CONTACT
SKIN ABSORPTION
EYE CONTACT
INGESTION
EFFECTS OF OVEREXPOSURE 
ACUTE OVEREXPOSURE
CHRONIC OVEREXPOSURE
EMERGENCY1 AND FIRST AID PROCEDURES 
EVES
SKIN:
INHALATION:
INGESTION:
NOTES TO PHYSICIAN
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VI REACTIVITY DATA
CONDITIONS CONTRIBUTING TO INSTABILITY
INCOMPA1 iBILITY
HAZARDOUS DECOMPOSITION PRODUCTS
CONDITIONS CONTRIBUTING TO  HAZARDOUS POLYM ERIZATION
VII SPILL OR LEAK PROCEDURES
STEPS TO BE TAKEN IF M ATERIAL IS RELEASED OR SPILLED 
NEUTRALIZING CHEMICALS
WASTE DISPOSAL METHOD
VIII SPECIAL PROTECTION INFORMATION
VENTILATION REQUIREM ENTS
SPECIFIC PERSONAL PROTECTIVE EQUIPMENT 
RESPIRATORY (SPECIFY IN DETAIL!
EYE
GLOVES
OTHER CLOTHING ANO EQUIPMENT
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IX SPECIAL PRECAUTIONS
PRECAUTIONARY
STATEMENTS
OTHER HANOLING AND 
STORAGE REQUIREMENTS
PREPARED BY
ADDRESS
OATE
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X I I I .  TABLES
Polystyrene
A crylon itr ile -B utad iene-  
Styrene (ABS)
S tyrene-A crylonitrile  
(SAN)
S tyrene-Bu tadiene  
Latexes
Other Copolymers
S tyrene-Butadiene 
Rubber (SBR)
Unsaturated Polyester  
Resins (Reinforced  
p la st ic s /co m p o site s)
TABLE X I I I - 1
E ND-USES OF STYRENE
Insu la tion  board, l o o s e - f i l l  packaging, 
disposable dinnerware, food containers, toys, 
games, hobby k i t s ,  housings for room a ir
conditioners and small handheld appliances, 
t e le v is io n  cab inets , shower doors, drain pipes, 
tubing, l ig h t  d i f fu s e r s ,  audio and video tape
c a s s e t t e s ,  combs, brushes, ey eg la sses ,  p icnic  
co o lers ,  molded sh u tters , furniture parts ,  
watering cans, soap d ish es , room dividers
Piping (drain , waste, and v e n t ) ,  conduit,
p ip e f i t t in g s ,  automotive components (instrument 
panels, conso les , front radiator g r i l l e s ,  
headlight housings, e t c . ) ,  refr igerator  
doorliners and food compartments, telephones, 
luggage and cases , toys , hobby k i t s ,  shower 
s t a l l s  and bathroom f ix tu r es  for mobile homes, 
margarine tubs, radio ch assis
Drinking tumblers, blender jars and covers, 
dishes , instrument panel le n se s ,  battery cases
Tufted carpet and upholstery backcoatings, 
binder for paper coatings, binder for f e l t  base 
of v in y l  f lo o r  t i l e ,  cement a d d it iv e ,  component 
of la tex  paints
Ion-exchange res in s  (divinylbenzene-modified  
p olystyren e),  p a in ts , paper coa tin gs , and f lo o r  
p o lish es  (s ty ren e-a cry lic  copolymer emulsions), 
footwear and adhesives (styrene block copolymers)
Passenger car t i r e s ,  in d u str ia l  hoses, conveyer 
b e l t s ,  appliance p arts , wire and cable 
in su la t io n ,  footwear, coated fa b r ic s ,  car 
bumpers and w eatherstr ips, add itive  in cements 
and adhesives
Boats, open storage tanks, tub and shower units  
truck camper tops, recreational v e h ic le s ,  w all  
panels
Adapted from r e f e r e n c e s [23 ,25 ,344 ,345].
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TABLE X III-2
Occupational Styrene Exposures by Worksite or Process
(Excluding the Reinforced P la s t lc s /C o n p o s l t e s  Industry)
Worksite or Process Reference Year Sanples
S tyrene 
Range i EE", Average Connents
Styrene Mononer Production 156] '52 6 ND * NAH
184] •74 29 0.8-7.8 2.5
(75] '78 60 ND-6.8 0.5 LDLsl ppb
131] *80 * <10 * NAH
SAN Copolyner Production 193] •71 * < 1.2 <1.2 NAH
ABS-SAN Resin Production 1333] '77 11 ND-3.1 0.7 LDL:10 ppb
Copolymer Production
(maleic anhydride) 184] •74 6 0.9-2.1 1.5
S tyrene-Butadiene
Latex Production 184] '74 11 1.0-3.9 2.5
131] *80 • 4-22 * NAH
Acrylic Ester-S tyrene
Copolyner Production [346] ’82 50 ND-20 0.6 LDL:10 ppb
alpha-Hethyl Styrene Production 1347] '80 14 ND-0.1 0.03 LDL: 2 ppb
Polystyrene Production 156] *52 2 ND-188* NAH
194] *63 * 0.05-2.2 <2.2 NAH
1931 ‘71 * < 5 <5 NAH
[84] •74 13 1.2-18 7.2
[32] •74 * < 5 <5
[333] '77 11 ND-1.7 0.2 LDL:100 ppb
[75,77] •78 70 0.1-47 1.8
[31] *80 * <10 • NAH
SBR Production 1348] *44 * < 500* NAH
[349] *68 * 14-31* NAH
[350] •77 50 0.05-10 0.07
[333] •77 119 ND-3.8 1.3 LDL:20 ppb
[351] •78 21 ND-2.3 0.4 LDL:20 ppb
[352,353] *81 57 ND-4.4 0.9 LDL:50 ppb
[352,353] •81 35 0.04-12 2.0
[354] •82 159 0-65 1.7 CT & PDD
SBR Vulcanlzation/Curlng [3551 *69 * 0.5-9.4* NAH
[356] •77 18 0.06-0.18 0 .10
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TABLE X I I I -2 (CONTINUED)
Occupational Styrene Exposures by Worksite or Process
(Excluding the Reinforced P la st lc s /C o m p o s ltea  Industry)
Styrene, ppm
Worksite or'Process Reference Year Samples Range Average Consents
MISC. APPLICATIONS/USES 
Styrene-Polyester Resins 
Surface coatings 
Filter parts (molding) 
Furniture parts (molding) 
Electrical parts (molding) 
Putty (splicing)
Imitation Ice cubes (molding) 
Marble bath tubs & vanity tops
S tyrene-Acryllc Pump Parts
Plastic Concrete Pouring 
(confined space)
ABS Fabrication
Injection Molding (dashboards) 
Extrusion and Injection Molding 
Injection Molding (visors)
Paper Coating
Glues and Fillers 
SBR Extrusion (hose)
Recording Tape
Polystyrene Injection Molding
[357) ’60 *
[ 1 0 2 1  ’6 6  *
[3581 *74 5
[1591 * 74 2
|359l *76 5
1360) *79 5
[361j ’81 2
l36lj *81 9
[3611 ’81 1
[3621 ’80 32
[3631 ‘67 *
[3641 *76 7
(3651 '78 4
[3661 *80 10
[3671 '75 9
[3681 *80 2
[3691 ’77 5
[3701 '73 24
[3711 '81 13
[3721 '81 19
200-700 * NAM
40-100 * NAM
2-13 8
50-200 125
2-16 7 15-min. Peaks
0.5-3.1 1.1
15-19 17
1.6-60 23 15-min. Peaks
82 82 5-mln. Peaks
4-220 40
25-1000 * DT & CGM
ND
ND
0.3-0.9
<LD
<LD
0.5
LDL:20 ppb 
LDL:4 ppb
1
0.7-3.1 
ND
1.6
<LD LDL:1 ppm
ND-38 11 LDL:10 ppb
ND <LD LDL:5 ppb
<1 <1
ND <LD LDL:2 ppb
Note: Unless specified as 'Peaks, exposure levels are time-weighted averages
ND - non? detected
* - not given
NAM - no analysis method given
LDL - lower detection limit in parts per billion (ppb) of styrene
DT & Cfirt - peak samples measured with detector tubes and a combustible gas meter
CT & PDD - charcoal tubes and passive diffusion dosimeters
Gas chromatography analysis techniques were used unless noted by NAM or DT-CGM.
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TABLE X I l l - 3
Occupational Styrene Exposures In the
R einforced P las  t lc a /C o ap os l  t e s  Industry
Iteaa Fabricated Reference Year Samplea
Styrene
Range
. PP" 
Average Coaacnt*
Boats (373) '55 * 200-700 * NAN
(HO) *63 * 11-736 <209 HAH
(35) *72 IS 17-292 *
• 1500 * 5-10 aln. Peak
(113) •77 25 1-144 49
2 87-102 95
41 ND-111 44 LDLtO.l ppi
1112) •77 • < 1-217 3-44 1 hr.* < 1-402 5-312 1 hr.* < 1-324 3-171 1 hr.* 2-384 20-144 1 hr.
(751 *78 11 50-300 148 DT
(374) •81 23 6-90 39
21 4-179 52
57 1-399 142
19 13-382 71
100 2-509 143
94 26-745 203
19 11-371 133
37 10-161 86
77 30-466 179
70 43-214 86
18 64-187 126
97 1-226 63
(343) •82 53 7-85 37 CM
67 10-183 60 CH
38 18-179 70 GH
69 30-158 86 GH
62 17-154 58 GH
116 2-121 28 CH
59 15-160 74 GH
Saall parta (110) •63 * 3-75 <44 NAM
Big parts * 4-329 <106 NAH
Occupational Styrent Exposures In the 
Reinforced Plastlcs/Coaposites Industry
TABLE X1II-3 (CONTINUED)
Items Fabricated Reference Year Samples
Styrene
Range » EE" .. Average Comaen ts
Large parts 11091 ’67 10 6-94 * POL
Truck parts [ 375) *72 60 0.2-70 9
Storage Tanka 1376) •73 71 10-210 •
Bathroom fixtures 1377) *73 18 7-188 49
Tubs and Showers |104) *74 32 45-550 183
Large Containers [378) •75 21 7-162 63
Pipe connectors 1379) *76 23 2-54 13
13801 *76 24 ND-34 8 LDL:0.2 ppm
[381] •76 20 0.2-136 27
Various items [382) ’78 * 4-291 56 HED
Holdings, sheets 175) *78 9 50-70 * Peaks, DT
Holdings, mats ’78 9 50-300 129 Peaks, DT
Holds 1383) •78 1 12 12
Aircraft parts [36] •79 43 6-293 36
18 39-1080 368 15-min. Peaks
Instrument cases [384] '79 12 9-48 22
20 4-200 44
9 10-700 * Peaks, PI
Scrubber component [385) '79 24 ND <LDL LDL:0.2 ppm
Pump parts 1362) *80 32 4-200 40
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TABLE X III-3  (CONTINUED)
Occupational Styrene Exposures In the 
Reinforced Plastics/Composites Industry
Items Fabricated Reference Year Samples
Styrene
Range L PE" Average Comments
Storage tanks, pumps 13861 o«0 9 15-47 30
Large pipes [387) *81 38 1-29 8
Storage tanks, hoods, ducts [3881 •81 12 4-35 13
Nodel trucks [389) •81 3 ND-3 2 LDL:0.2 ppm
* - not given 
ND - none detected
NAN - analytical Method not given, otherwise gas chromatographic methods were used
LDL - lower detection limit
DT - detector tubes
POL - polarography used
PI - photoioniser used
CM - geometric mean Instead of average
NED - median value Instead of average
TABLE X I I I - 4
O t h e r  S u b s t a n c e s  F o u n d  a t  W o r k s i t e s  P r o c e s s i n g ,  H a n d l i n g ,  o r  U s i n g
S t y r e n e  o r  S t y r e n e - C o n t a i n i n g  M a t e r i a l s
Worksite or Process Substances Found in Measurable 
Q uantitites  in Air Samples
Styrene Monomer Production Benzene, ethylbenzene [3 1 ,33 ,56 ,84 ];  
toluene [33 ,84]; ethane, e th y len e[33]
Polystyrene Production Ethylbenzene [32]; benzene, toluene, 
tricalcium  phosphate dust, cadmium 
su lf id e  dust, pentane [84];  
phenylether, diphenylether [32]
SBR Production Butadiene [333,349,350,351,353,354];  
toluene [350,353,354];
4-viny1-1-cyclohexene [350,353];  
benzene [350,354]; cyclooctadiene  
[350]; benzene [333];
4-isopropy1-1-methy1-cyclohexane, 
methanes, ethylbenzene, dust [353]
SBR Vulcanization/Curing Toluene, 4 -v in y l- l-cy c lo h ex en e ,  
ethylbenzene,
1 ,5 -cy c lo o c ta d ien e ,1 ,5 ,9 -c y c lo -  
dodecatrienes [356]; butadiene, o i l  
a ero so ls ,  formaldehyde, methanol, 
sulfur  d ioxide, a cro le in ,  aromatic 
amines, a c r y lo n i t r i l e ,  carbon monoxide 
[355]
Styrene-maleic Anhydride Resin
Production Toluene [84]
S tyrene-butadiene Latex Production Toluene, benzene [84]; ammonia, 
formaldehyde [31 ,84];  butadiene, 
a c ry l ic  ac id , hydroxyethyl acry la te ,  
sodium pentachlorophenate, s i l i c a  [31]
SAN Production A c ry lo n itr i le  [93]
ABS Production A cry lo n itr i le  [333]
Acrylic  Ester-Styrene Alpha-methyl styrene, methyl
Copolymer Production methacrylate, e thy l a cry la te ,  n-butyl 
a c ry la te ,  2-ethylhexyl acry la te  [346]
2 3 3
TABLE X I I I - 4  (CONTINUED)
O t h e r  S u b s t a n c e s  F o u n d  a t  W o r k s i t e s  P r o c e s s i n g ,  H a n d l i n g ,  o r  U s i n g
S t y r e n e  o r  S t y r e n e - C o n t a i n i n g  M a t e r i a l s
W o r k s i t e  o r  P r o c e s s Substances Found in Measurable 
Q uantitites  in Air Samples
Miscellaneous P la s t i c  Operafcions/Uses 
SBR extrusion (weatherstrips) N-butyl a ce ta te ,  a sb estos , acetone, 
isopropyl a c e ta te ,  petroleum naphtha, 
methyl ethyl ketone, carbon monoxide
[390]
Styrene-polyes ter Usage
molding (furniture  parts)
molding(ice cubes) 
molding (marble bath tubs)
coating (paper)
Styren e-acry lies  Molding
ABS Usage
in jec t io n  molding (v iso r s )  
extrusion & in jec t io n  molding
molding (a ir c r a f t  parts)  
in jec t io n  molding
Paper Coating 
Recording Tape
Combustion Products of Polystyrene  
(experiment)
Methylene ch lor ide , petroleum naphtha 
[358]
Methyl ethyl ketone peroxide [360] 
Acetone, toluene, methyl e thy l ketone, 
dust [361]
Petroleum naphtha, toluene, xylene  
[367]
Xylene, 1 , 1 , 1-trichloroethane [362]
Butadiene, methyl e thy l ketone [366] 
Carbon monoxide, hydrogen cyanide, 
butadiene, benzene, a cro le in ,  dust, 
acetaldehyde, formaldehyde, a l ip h a t ic  
amines [365]
Methylene ch lor ide , methyl e thy l  
ketone, methanol, dust [36] 
B u ty l-p -creso l,  dust, carbon monoxide, 
formaldehyde [364]
Formaldehyde [368]
M ethyl-iso-butyl ketone, toluene,
1 ,1 ,1 - trichloroethane [371]
Benzaldehyde, styrene oxide,  
acetophenone, 1-phenylethanol, phenol, 
formaldehyde, carbon monoxide, 
a lly lb en zen e , benzene, toluene, 
ethylbenzene, isopropylbenzene, 
alpha-methyl styrene, aerylaldehyde
[391]
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TABLE X I I I - 4  (CONTINUED)
O t h e r  S u b s t a n c e s  F o u n d  a t  W o r k s i t e s  P r o c e s s i n g ,  H a n d l i n g ,  o r  U s i n g
S t y r e n e  o r  S t y r e n e - C o n t a i n i n g  M a t e r i a l s
Worksite or Process Substances Found in Measurable
Q uantitites  in Air Samples
Reinforced Plastics/C om posites Acetone [36 ,113,375,376,377,378,383,
384,388]; methylene chloride
[113.375.376.383.386.388]; dust 
[361,375,383,386,387]; fibrous g lass
[377.378.386.388]; toluene
[113.375.376.389]; methyl e thy l ketone 
[113 ,375,383,386]; m ethyl-iso-buty l  
ketone [375,389]; s i l i c a  [379,380];
MDI [104,376]; xylene [113,375];  
amines [104]; naphtha, mold re lease  
agents [113];methyl aceta te  [113]; 
isopropyl a lcoh o l,  n-butyl a c e ta te ,  
c e l lo s o lv e  aceta te  [375]; TDI [377];  
benzene, ethylbenzene [380]; benzoyl 
peroxide [387]; bisphenol A, 
d ig ly c id y l  ether of bisphenol A [389];  
a lip h a t ic  hydrocarbons, 
perchloroethylene [383];  
tr ich loroethylene [36]; methyl e thy l  
ketone peroxide [384]; styrene oxide 
[233,269].
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TABLE X I I I - 5
I d e n t i f ic a t io n  of Major Industries  Producing, Using, 
or Handling Styrene
Industry (Use or P r o d u c t ) S I C  Major Group Code*
Construction (painting, concrete f in ish in g )  15,16,17
T ex t i le s  (coated fab rics )  22
Wood Products and Furniture (RP/C - mobile home 24,25
components)
Paper Products (paper coatings) 26
Chemicals and A ll ied  Products (monomer, r e s in s ,  28
pa in ts ,  adhesives, e t c . )
Rubber and P la s t i c  Products ( t i r e s ,  molded and extruded 30
items, RP/C - tanks, bathtubs, shower s t a l l s ,  e t c . )
Stone, Clay, Glass, and Concrete Products (pressed g la s s ,  32
pipe connectors, marble items)
Fabricated Metal Parts (painting) 34
Machinery(painting, molded parts , RP/C - TV cab in ets ,  35,36
farm equipment, v e n t i la t io n  ducts, e t c . )
Transportation Equipment (RP/C - boats , sh ip s , parts) 37
Measuring Instruments; Medical Goods (su rg ica l  38
instruments, RP/C - instrument cases)
Miscellaneous Manufacturing (sporting  goods, costume 39
jewelry, buttons, s ig n s ,  RP/C - swimming pools)
Automotive Repair Shops (RP/C) 75
♦Taken from the Standard In d u str ia l  C la s s i f ic a t io n  Manua1 1972 (U.S. GPO 
Stock No.041-001-00066-6).
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KEY WORD INDEX
A
aberrat io n (s )  15, 38, 66, 67, 68, 
69, 70, 79, 98, 99, 100, 101,
125, 154, 182, 186, 187 
abortions 45, 76, 77, 78, 79,
126, 130, 136, 145, 155, 183 
acetone 17, 25, 38, 56, 61, 75,
109, 161, 234, 235 
acne 74
a c r y lo n itr i le  42, 80, 135, 186, 
189, 233
a ery lo n itr i le -b u ta d ie n e -s ty rene 
18, 227 
acuity 22, 23
adenocarcinomas 107, 126, 127 
adenomas 107, 108, 109, 126, 127 
adipose ( t i s s u e )  86 
adrenocortical ( in su f f ic ie n c y )  16 
a g ita t io n  55, 210 
airway ( e f f e c t s )  41, 123, 153 
albumin 38, 51
alpha-methyl (styrene) 99, 179, 
183, 228, 233, 234 
a lveo lar  28, 29, 32, 33, 83, 84, 
85, 100, 106, 109, 125, 137, 142, 
143, 144, 178, 186 
amniotic ( f lu id )  101, 102 
anemia 31, 49, 74 
anencephaly 25, 26 
an esth etic  ( e f f e c t s )  111 
aneuploidy 67, 100 
an iso cy to s is  95 
a n iso ref lex ia  48 
anomaly(ies) 25, 103 
anorexia 49, 51, 55, 59 
anxiety 23, 176 
apathy 55 
appetite  64
asleep ( d i f f i c u l t i e s  in staying)
65
asthenia (weakness) 48, 49 
a sth en ic -vege ta tive  (syndrome) 48 
audiovisual (reaction  time te s t s )
31, 32, 151 
autonomic (nervous system) 23, 52, 
153
B
balance 1, 26, 28, 32, 35, 52,
121, 122, 130, 150, 153, 156,
177, 181, 190
behavioral 65, 75, 76, 94, 103, 
183, 185, 198 
benzene 17, 18, 19, 36, 38, 39,
40, 45, 79, 80, 93, 109, 117,
122, 127, 170, 172, 173, 176, 183 
benzoic (acid) 46, 97, 112, 116,
129
beta-n itrostyrene 108, 109, 127, 
188
b i l e  43, 44, 121
b il iru b in  38, 40, 45, 46, 51,
60
biopsy 23, 86
biotransformation 100, 124, 154, 
183, 185, 187, 190, 191 
b irth  (d e fec ts )  15, 25, 78, 155 
bladder 16, 36, 37, 45, 51, 74,
129
blind (spots  in both eyes) 23 
b li s te r in g  93, 168 
blood 21, 22, 23, 24, 25, 27, 28, 
29, 35, 39, 40, 44, 45, 48, 49,
50, 51, 54, 57, 60, 61, 66, 68,
69, 70, 72, 73, 74, 75, 76, 81,
83, 84, 85, 88, 93, 94, 95, 99,
1 0 1 , 1 0 2 , 1 1 0 , 1 1 1 , 1 1 2 , 1 2 0 ,
125, 129, 137, 142, 154, 155,
172, 176, 177, 178, 181, 190
b o il in g  (po int) 17, 162, 220
bone 24, 98, 100, 101, 105, 125, 
186, 187
Bourdon-Wiersman ( t e s t )  65, 75 
brain(s) 23, 94, 95, 110, 111, 119 
breath 28, 51, 58, 59, 72, 73,
75, 82, 83, 85, 87, 88, 123, 137, 
142, 143, 153, 177 
bronchiolar (adenomas) 109 
burning 21, 27
burns (o f the human cornea) 21,
123, 175
butadiene 16, 79, 80, 111, 134, 
135, 172, 201, 233, 234
C
calcium (d ep osits )  107 
cancer 79, 80, 81, 82, 108, 109, 
127, 128, 130, 136, 156, 188
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c a p i i la r y ( ie s )  16, 84, 137, 145, 
172
carcinogen, carcinogenic,
carcinogenicity  2, 15, 82, 96, 
98, 106, 109, 110, 126, 127, 128, 
146, 150, 156, 157, 183, 186,
187, 188 
carcinomas 107, 108, 109, 110 
cardiac ( t e s t s )  83 
cardiovascular 74, 79, 127 
catarrh (upper respiratory) 60 
CBC (complete blood count) 28,
29, 38, 66, 72 
cereb e llar  (nerve disturbances) 24 
cerebral 24, 26, 48, 79, 176 
chapped (skin) 61, 123 
chest 23, 38, 41, 51, 57, 58, 59,
69, 123, 153 
chicken (embryos) 101 
Cholinesterase ( a c t i v i t i e s )  94 
chromatid 1, 15, 68, 70, 79, 99,
100, 125, 154, 186, 187 
chromosomal 15, 66, 67, 68, 69,
70, 78, 79, 98, 100, 101, 125,
150, 154, 156, 182, 186, 187
chromosome(s) 1, 38, 66, 68, 69,
70, 99, 100, 101, 124, 177, 182, 
186, 187 
c lastogen ic  66, 100, 187 
CNS (cen tra l nervous system) 1,
2, 15, 25, 26, 29, 48, 62, 75,
91, 121, 122, 129, 145, 150, 151, 
153, 156 
c o l i t i s  74 
colon (cancers) 79 
confusion 56, 150 
congenital 25, 125
congestion 10, 22, 58, 91, 92,
95, 106, 108, 124 
conjunctival 22, 41, 58, 93, 153 
c o n ju n c t iv it is  49, 62 
consciousness ( lo s s  o f)  91 
convulsions (c lo n ic )  91 
coordination 27, 28, 74, 75, 121, 
122, 130, 150 
copolymer(s) 18, 19, 39, 41, 78, 
173, 179, 197, 227, 228, 233 
cornea(s) 21, 41, 93, 123, 175
cough 57, 58
creatin ine  28, 38, 39, 51, 67,
70, 76, 83, 85, 89, 143, 215
creatinuria  23
cytogenetic ,  cy togen ic ity  90, 99, 
105, 126, 130, 186
deaths 79, 80, 81, 91, 92, 93,
102, 103, 110, 127, 130, 156 
d efatting  61, 123, 156 
defects  15, 25, 78, 105, 125, 155, 
176
depression 1, 2, 15, 26, 29, 75, 
91, 94, 121, 122, 129, 150, 151, 
156, 189
dermal, derm atitis  22, 46, 61,
74, 123, 156, 164, 169, 200 
dermatosis 50 
d e to x if ica t io n  124, 154 
dexter ity  27, 28, 30, 31, 74,
121, 122, 130, 150 
diaphoresis 60 
d ig es t iv e  35, 79, 172 
dizz in ess  1, 22, 26, 34, 48, 55, 
56, 57, 59, 78, 85, 122, 150,
151, 156
DNA 15, 68, 70, 98, 121, 124,
125, 154, 183, 186 
drowsiness 1, 24, 26, 46, 51, 52, 
53, 55, 59, 61, 121, 150, 151, 156 
drunkenness (sense o f)  26
E. c o l i  97, 124, 154 
ear(s)  25, 35, 93, 167, 168 
eczema 53
edema 23, 25, 91, 92 
electrocardiogram (ECG) 35, 69 
electroencephalogram (EEG) 1, 
23, 24, 29, 52, 59, 60, 61, 62, 
63, 65, 69, 79, 85, 122, 130, 
150, 152, 156 
electromyogram (EMG) 22, 23, 30, 
59, 122 
electromyograph 63 
embryo(s) 101, 102, 103, 105, 
126, 187
embryotoxic, embryotoxicity 77, 
103, 104, 105, 126, 187
2 3 8
KEY WORD INDEX (CONTINUED)
emotional ( in su f f ic ie n c y )  24 
emotional (complaints) 26 
emotional ( in s t a b i l i t y )  48 
emphysema 23, 80
enzyme(s) 96, 97, 98, 99, 114,
116, 119, 120, 124, 128, 186, 201 
ep ig a s tr ic  (pains) 44 
equilibrium 29, 32, 91, 122, 150 
erythema 58, 93 
erythrocyte(s)  38, 95, 120, 190 
esophagus ( i r r i t a t io n  o f)  93 
ethylbenzene 18, 19, 36, 38, 39, 
40, 79, 80, 81, 99, 122, 133,
144, 170, 172, 179, 184, 192,
215, 233, 234, 235
e x c i t a b i l i t y  60, 153 
excreted 82, 83, 85, 87, 110,
112, 113, 114, 117, 129, 130,
137, 139, 142, 194
excretion  23, 26, 28, 60, 70, 73, 
85, 86, 87, 88, 89, 90, 112, 113, 
114, 115, 116, 117, 121, 128,
137, 138, 142, 144, 145, 183,
184, 188, 194, 195, 200, 216
e x fo l ia t io n  93
exhaled 28, 29, 30, 32, 73, 82, 
83, 87, 110, 137 
eye(s)  1, 2, 3, 4, 5, 6, 8, 12, 
15, 21, 22, 23, 26, 27, 28, 30,
34, 35, 50, 52, 55, 56, 57, 58,
59, 60, 64, 74, 78, 85, 91, 92,
93, 94, 122, 123, 130, 145, 147,
150, 151, 152, 153, 156, 160,
161, 169, 170, 198, 221
e y e l id ( s )  41, 93
F
face 6, 27, 91, 160, 161, 169
f a t  21, 32, 33, 39, 40, 86, 94,
112, 113, 178 
fa t ig u e ,  fatigued 1, 22, 24, 26, 
34, 35, 46, 48, 52, 53, 55, 56,
58, 61, 76, 121, 122, 129, 150,
151, 156 
feces  110, 112
FEF (forced expiratory flow) 74, 
154
f e r t i l i t y  26, 105
f e t a l  101, 102, 104, 105, 155
fe to to x ic i t y  126 
fe tu s (e s )  102, 103, 104, 105, 126 
FEVi (forced expiratory volume in 
1 second) 50, 58, 74, 123, 153, 
154
FEV1/FVC 30, 61, 74, 154 
fever 42
f ib r in o ly s i s  61, 181 
f in g er (s )  27, 48, 60, 62, 153 
Flanagan (Coordination Test) 27, 
28, 74, 75 
f l i e s  100, 101, 125 
forearm(s) 22, 55, 74, 87 
forestomach 108, 110 
forgetfu ln ess  59 
formaldehyde 45, 80, 233, 234 
fu g it iv e  (em issions) 19 
FVC (forced v i t a l  capacity) 30, 
58, 74, 154
G
gastra lg ia  33, 34, 35, 49,
129
g a str ic  55, 93, 201 
gastrocnemius (muscles) 23 
g a s tr o in te s t in a l  45, 129, 130 
gene 98, 125 
genetic  120, 129, 155 
genotoxic 70, 125, 154 
gesta tion  102, 103, 104, 105,
106, 107, 126 
GGTP ( gamma-
glutamyltranspeptidase) 38, 40, 
69
giddiness 62, 151
groggy ( f e e l in g )  55
guinea (p igs)  90, 91, 92, 93,
113, 118, 120, 124, 129 
gynecological 44, 45, 51
H
hair 93, 168 
h a l f - l iv e s  86, 90
hamster(s) 97, 98, 99, 100, 101,
104, 118, 120, 124, 125, 126,
154, 187
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hand( s ) 13, 19, 22, 23, 27, 46,
48, 49, 52, 53, 57, 60, 61, 63,
65, 71, 73, 74, 87, 88, 145, 155, 
163, 167, 169 
Hautant ( t e s t )  52 
headache(s) 1, 23, 24, 26, 28,
30, 34, 35, 44, 48, 49, 51, 52,
53, 55, 56, 57, 58, 59, 62, 78,
85, 121, 122, 129, 150, 151, 152, 
156
heart 30, 44, 48, 80, 84, 95,
118, 119, 120, 151 
h e e l- to - to e  ( t e s t )  29 
hematocrit 40
hematopoietic 81, 130, 148, 156, 
2 0 1
hemoglobin 40, 94, 95, 102, 103 
hemograms 96 
hemorrhage 91, 92 
hepatectomized (mice) 100 
hepatic 45, 95, 114, 118, 119, 
121, 124, 172, 187, 189, 190 
hepatobiliary 45 
hepatocellu lar  95, 107 
hepato toxic  124
hippuric (ac id ) 22, 23, 26, 27, 
28, 46, 60, 82, 90, 97, 112, 113, 
114, 115, 116, 117, 129, 137,
139, 142, 184, 195, 
hives 51
hounds (Beagle) 95 
hydrocephaly 25, 26 
hyperbilirubinemia 53 
hyperreflexia 59
hypertension 51 
hyporeflexia 52
imbalance 24 
incoordination 91 
inebriated , inebriat ion  28, 121, 
150
inflammation(s) 16, 35, 42, 74, 
92, 93, 107, 108, 129 
infrared (IR) 27, 95, 134, 135 
ingesting  130, 137, 145, 161, 215
inh alation , inhaled 1, 3, 4, 5, 
23, 26, 32, 82, 83, 84, 85, 91,
92, 93, 94, 95, 100, 102, 104,
105, 106, 111, 126, 128, 137,
169, 176, 185, 186, 187, 188, 189
insomnia 23
in tox icated , in to x ica tio n  21, 26, 
34, 62, 64, 65, 78, 93, 121, 129, 
150
i r r i t a b i l i t y  24 
i r r i t a n t ( s )  21, 50, 51, 57, 122, 
123, 130, 153, 198 
i r r i ta t in g  4, 5, 21, 92, 94
ir r i t a t io n  1, 2, 4 , 8, 12, 15,
21, 23, 26, 27, 28, 30, 34, 35,
41, 44, 50, 55, 56, 57, 58, 62,
64, 74, 78, 85, 91, 92, 93, 122,
123, 147, 150, 151, 152, 153,
156, 161, 168, 169, 170, 221
itch ing  22
jaundice 24
K
kidney(s) 21, 74, 79, 91, 92, 93, 
94, 95, 105, 108, 110, 111, 112, 
119, 120 
knee (r e f le x e s )  49, 59
lacrimation, lacrimator 23, 91, 
164 
larynx 42 
LC50 94, 110
LD50 93, 220
le g (s )  22, 23, 35 
le s io n s  24, 62, 96, 106, 108, 
110, 176
leukemia 80, 81, 106, 126, 127, 
130, 156 
leukocyte(s) 21, 107 
leukocytic 91 
leukopenia 46, 49 
limbs 22, 59 
l ip id ( s )  60, 111
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l i s t l e s s n e s s  26, 92, 121, 150 
l iv e r  1, 3, 15, 16, 21, 22, 23,
26, 36, 37, 43, 44, 45, 46, 50,
51, 53, 79, 91, 92, 93, 94, 95,
96, 97, 98, 100, 105, 106, 107,
108, 110, 111, 112, 118, 119,
120, 121, 124, 125, 130, 145,
150, 154, 157, 179, 181, 186,
190, 191
lung(s) 4, 5, 21, 41, 50, 74, 79, 
82, 83, 87, 88, 91, 92, 93, 95, 
106, 107, 108, 111, 119, 120,
123, 126, 127, 128, 130, 155, 179
lymph 21, 80
lymphatic 80, 81, 127, 130, 156, 
2 0 1
lymphocyte(s) 1, 38, 66, 67, 68, 
69, 70, 99, 120, 124, 125, 154, 
156, 182, 183, 186, 190 
lymphocytic 81 
lymphocytosis 49 
lymphoid 148
lymphoma(s) 80, 81, 107, 109,
127, 156 
lymphosarcoma 106, 126, 130
H
malaise 23, 34, 35, 121, 122,
129, 150
malformations, malformed 25, 101, 
104, 105, 126 
malignant 80, 81, 109, 156 
mandelic (acid) 3, 24, 33, 37,
39, 46, 51, 52, 53, 59, 60, 63,
64, 65, 66, 67, 69, 70, 72, 75,
82, 83, 84, 85, 86, 87, 88, 89,
90, 97, 112, 113, 114, 115,
116, 117, 122, 128, 129, 130,
137, 138, 139, 140, 142, 143,
144, 145, 152, 153, 154, 177,
179, 181, 184, 194, 195, 200,
214, 215, 216, 217, 218
marrow 24, 98, 100, 101, 105,
125, 186, 187 
maximal (mid-expiratory f low -rate)  
30, 58
metabolic 46, 86, 90, 97, 98, 99, 
100, 124
metabolism 70, 00 83, 110,
113, 114, 116, 117, 118, 121
125, 129, 144, 155, 170, 178
179, 181, 183, 184, 185, 186
188, 189, 190, 195
metabolite 3, 40, 85, 96 , 97
113, 116, 117, 120, 121, 128
137, 144, 178, 185, 186, 189
190, 214
m etabolites 82 , 86,
GO 90,
113, 114, 115, 116, 117, 118
128, 129, 143, 144, 178, 186
189, 190, 194
metabolized, metabolizing 90
101, 110, 120, 121, 191
methanol 17, 23, 59, 131, 233, 234 
mice 94, 98, 100, 104, 106, 107, 
108, 109, 110, 118, 120, 125,
126, 127, 128, 129, 187, 188
Mira ( t e s t )  65
miscarried 76 
MMEF (maximal med-expiratory 
f low -rate) 30, 58 
monkeys 90, 92, 93, 124
monomer 18, 19, 36, 48, 79, 147,
159, 160, 162, 175, 189, 195,
196, 197, 228, 233, 236
mononeuropathy 63, 153 
morbidity 36, 38, 43, 44, 177,
182
m ortality 37, 79, 80, 81, 91, 92, 
96, 102, 103, 105, 106, 107, 108, 
126, 127, 130, 156, 174, 177,
178, 201 
mouse 98, 107, 118, 120, 128 
mouth 4, 35, 58, 83, 210 
mucosal, mucous 26, 42, 44, 55,
152
muscle(s) 22, 23, 58, 62, 118 
mutagen 97, 120, 125, 185 
mutagenic 96, 97, 98, 101, 120, 
121, 124, 130, 154, 155, 183,
185, 190
mutagenicity 90, 96, 97, 98, 99, 
120, 121, 124, 125, 146, 154,
155, 157, 177, 185, 186 
mutations 96, 97, 98, 99, 100,
101, 120, 125, 129, 136, 155, 186
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narcosis 21, 32, 35 
nasal 23, 26, 27, 28, 42, 58, 83, 
91, 150, 170 
nasopharynx 50, 152 
nausea, nauseated 1, 28, 34, 35,
48, 49, 56, 58, 64, 78, 121, 129, 
150, 151, 156
n ecro s is ,  necrotic  93, 106, 107, 
108, 168
N eisser ( l e t t e r  search te s t )  74, 
75
neoplasms 80, 81, 108, 156 
nephropathy 45
nerve 22, 23, 24, 40, 41, 48, 52, 
63, 64, 95, 122, 153 
nervous 1, 3, 15, 22, 23, 32, 35, 
40, 48, 52, 55, 60, 63, 92, 95, 
121, 122, 145, 150, 153, 176,
179, 181, 182, 188 
neurasthenic (syndrome) 48, 52 
n e u r it is  22, 41, 129, 176 
neurogenic 108, 176 
neu ro log ic (a l)  22, 46, 47, 48,
49, 51, 52, 61, 69, 74, 153, 180 
neuropathy 1, 23, 62, 64, 122,
152, 153, 157 
neurophysiological 62, 63, 181 
neuropsychological 26 
neuroradiologic 26 
neurotic (trou b les) 60 
neutropenia 49 
nitrostyrene 108 
nodes 21
nose 4, 5, 21, 27, 30, 34, 35,
42, 51, 57, 58, 59, 64, 74, 83, 
91, 92, 93, 94, 123, 129, 147, 
150, 151, 152 
nosebleeds 42 
numbness 22, 23, 51 
nystagmus 35, 60, 153
0
ocular 93, 176
odor 16, 21, 28, 147, 172, 175, 
2 2 0
ophthalmologic(al) 22, 41, 59, 96 
optic  (n e u r it is )  41 
optokinetic  35, 122
N
pain 22, 44, 45, 48, 55, 57, 59, 
151, 221 
p a lp ita tio n  59 
pancreas 79, 112 
papillomas 109, 110
paresthesia  23, 62
PEFR (peak expiratory f low -rate)
30
percutaneous(ly) 87, 88, 145, 156, 
184, 215 
peribronchial ( t i s s u e )  95 
peripheral 1, 15, 22, 23, 63, 66, 
68, 69, 70, 95, 122, 150, 152,
153, 157
peroneal 22, 40, 41, 63, 122, 153 
pharyngeal (congestion) 22 
pharynx 42
phenylglyoxylic (ac id) 72, 75,
82, 83, 85, 86, 87, 88, 89, 90,
97, 112, 113, 114, 115, 117, 128, 
129, 130, 137, 138, 139, 140,
142, 143, 144, 177, 178, 181,
184, 194, 195, 200, 214 
placenta, p lacenta l 101, 125,
126, 155 
plethysmography 69 
pneumoencephalography 26 
pneumonia 92, 106, 126 
polyneuropathy 26, 62, 63, 64, 153 
polystyrene 16, 18, 19, 22,
36, 37, 38, 39, 41, 42, 43, 44,
45, 62, 79, 80, 122, 123, 124,
127, 133, 152, 153, 163, 164,
173, 174, 175, 176, 177, 179,
201, 205, 227, 228, 229, 233, 234
pregnancy(ies) 25, 45, 69, 76,
77, 78, 103, 104, 107, 108, ,
155, 126, 145 
pregnant 102, 103, 104, 105, 106, 
107
prenarcotic 7, 35, 40, 158 
prothrombin (r a t io )  61 
psychasthenia 129 
psychological 62, 63, 64, 65, 66, 
177, 182
psychomotor 30, 31, 64, 65, 72,
74, 75, 79, 150, 179 
pulmonary 1, 15, 23, 30, 58, 60, 
72, 74, 83, 84, 85, 123, 144,
150, 154, 157, 183
P
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pupillary 49 
pupils 60, 153
rab b lt(s )  90, 92, 93, 104, 105, 
113, 117, 119, 120, 124, 126,
129, 168, 169, 187, 189 
ra les  58
rash(es) 51, 57, 58, 74, 123 
r a t(s )  90, 91, 92, 93, 94, 95,
96, 97, 98, 100, 101, 102, 103,
104, 105, 106, 107, 108, 109,
110, 111, 112, 113, 114, 115,
116, 117, 118, 119, 120, 121,
124, 125, 126, 127, 128, 129,
130, 148, 155, 185, 186, 187,
188, 189, 190, 191
RBC (red blood c e l l  count) 24,
49, 94, 102, 103
re f lex e s  22, 23, 24, 40, 48, 49,
50, 52, 59, 60, 62, 153 
reproductive 4, 45, 74, 101, 104,
105, 125, 126, 150, 155 
resp ira tion  83, 136, 137
respiratory 1, 2, 3, 6, 7, 8, 10,
11, 15, 25, 41, 42, 43, 44, 51, 
56, 57, 60, 78, 79, 80, 83, 85, 
88, 102, 113, 123, 127, 128, 129, 
130, 145, 150, 152, 153, 156,
158, 163, 164, 168, 169, 170,
179, 181, 200 
retention  28, 32, 33, 39, 83, 86, 
88, 113, 119, 120, 128, 139, 183, 
209, 215 
re t icu lo cy te  28 
r e t in a l  24, 129 
retrobulbar (n e u r i t i s )  22, 41, 
129, 176 
roentgenogram(s) 23, 38 
Reraberg ( t e s t )  27, 28, 29, 32,
48, 50, 52 
Rorschach ( in k b lo t  t e s t )  64
sa l iv a t io n  91
salmonella ( typhimurium) 90, 96, 
97, 98, 124, 154, 186 
SAN (s ty r e n e -a c r y lo n i tr i le )  18, 
19, 41, 42, 227, 228, 233
SBR (styrene-butadiene rubber)
16, 18, 19, 36, 173, 227, 228,
229, 233, 234 
SCE ( s i s t e r  chromatid exhanges)
68, 69, 70, 99, 100, 101, 125, 154 
scratching 91 
sensory 62, 63, 122, 153 
serum 28, 38, 40, 45, 46, 51, 57, 
60, 61, 124, 145 
SG0T (serum glutam ic-oxaloacetic  
transaminase) 38, 40, 51 
SGPT (serum glutamic-pyruvic 
transaminase 28, 38, 40, 45,
46, 51
s i s t e r  (chromatid exchanges) 1,
15, 68, 79, 99, 125, 154, 182,
186, 187
skin 1, 3, 4 , 5, 6, 8, 12, 15,
19, 21, 23, 36, 49, 51, 57, 58,
60, 64, 74, 87, 88, 93, 123, 128, 
129, 130, 137, 144, 145, 147,
150, 156, 157, 161, 168, 169,
176, 179, 184, 191, 221 
s leep in ess  34, 35, 48, 121, 129, 
150, 151 
s o lu b i l i ty  17, 172, 220 
spinal (cord) 111 
spirometric 41, 123, 153 
spleen 16, 21, 79, 94, 95, 106, 
119, 120
s t i l l b i r t h s ,  s t i l lb o r n  25, 69, 102 
stomach(s) 51, 79, 93, 95, 106, 
108, 110, 116, 117, 118, 126, 128 
stupor 91
s ty r en e -a c r y lo n itr i le  (SAN) 18,
41, 227
styrene-butadiene 16, 18, 173,
183, 201, 227, 228, 233 
styrene oxide 69, 82, 96, 97, 98, 
99, 100, 101, 105, 109, 110, 111, 
112, 113 114, 115, 116, 117, 118, 
119, 120, 121, 124, 125, 128,
129, 136, 138, 145, 146, 155,
168, 185, 186, 187, 188, 189,
190, 191, 194, 195, 235
subcostal (pain) 44
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TA (s tr a in s  of S. typhimurium)
90, 96, 97, 98, 99, 124 
taste  21, 26 
tearflow 55
tendon 23, 24, 40, 48, 49, 59, 153 
tense, tension 30, 55, 122, 166 
terata 104, 126, 136 
teratogen esis ,  teratogenic ,  
tera togen ic ity  104, 105, 126,
130, 145, 155, 157, 157 
te s te s  95 
th ir s t  51
throat(s)  4, 26, 28, 30, 42, 43, 
50, 51, 57, 58, 59, 62, 74, 91, 
123, 150, 151, 152 
thrombocyte 38 
thrombosis 24, 129 
thyroid 58, 129
tired , tiredness 51, 59, 62, 64, 
65, 76, 151 
toluene 17, 23, 31, 38, 39, 56,
59, 79, 93, 116, 117, 122, 132, 
170, 172, 184, 189, 191, 195,
233, 234, 235 
tomography 26 
t o n s i l l i t i s  42 
trembling 60, 153 
tremors 48, 60, 65, 91 
taattors 45, 79, 96, 106, 107, 108, 
109, 110, 128, 129, 130, 148, 155
T urine 26, 27, 37, 39, 46, 53,
59, 60, 63, 67, 69, 70, 72, 75, 
82, 83, 85, 87, 89, 90, 110, 112, 
113, 114, 115, 116, 117, 120,
128, 129, 130, 137, 138, 139,
140, 142, 143, 144, 145, 177,
184, 194, 195, 204, 214, 215,
216, 217, 218
V
vert igo  49
v isu a l (evoked response) 29, 30, 
85, 121, 150
visuomotor 64, 65, 79
vomiting 49, 51, 58
U
WBC (white blood c e l l  count) 40, 
94, 102
weakness 26, 48, 49, 58, 61, 91, 
1 2 2
wheezing 41, 51, 58, 123, 153
X
X-rays 69
Y
y e a s t ( s )  97, 98, 117, 124, 125 
154
U
um bilical (cord) 24, 125, 155 
«•consciousness 66, 91 
unscheduled (DNA syn th es is )  15, 
70, 9«, 124, 125, 154, 183 
»«stead iness, unsteady 26, 48,
50, 91, 150
uric  (ac id ) 57, 124 
u r in a ly s is  29, 54, 96, 181 
urinary 3, 22, 28, 33, 39, 46,
51, 53, 59, 60, 63, 64, 65, 66, 
70, 75, 82, 83, 84, 85, 87, 88, 
89, 90, 114, 115, 116, 117, 122, 
130, 137, 138, 140, 142, 143, 
144, 152, 153, 154, 178, 179, 
184, 189, 194, 195, 214, 215
2 4 4
REFERENCE INDEX
Reference Page
I 16
2 16, 168
3 16
4 16
5 16, 17
6 16
7 16
8 16
9 16
10 16, 17
11 16
12 17
13 17
14 17
15 17
16 17, 21
17 17, 18
18 17
19 17
20 18
21 18
22 18
23 18, 227
24 18
25 18, 227
26 18
27 18
28 18
29 18
30 19
31 19, 80, 81,
127,
233
156, 228,
32 19, 134, 161,
165,
233
169, 228,
33 19, 233
34 19
35 19, 49, 50, 85
86, 123, 128,
131, 133, 135,
136, 137, 138,
152, 170, 230
36 19,
235
231, 234,
Reference Page
37 19
38 19
39 19
40 20
41 20
42 20
43 20
44 20
45 20
46 20
47 20
48 20
49 20
50 20
51 21
52 21
53 21, 90, 91, 92
93, 123, 124,
129, 147 , 148,
152, 169 , 170
54 21, 123, 147,
156, 165 , 168
55 21, 123
56 22, 123, 152,
156, 168, 170,
228, 233
57 22, 129
58 22, 38, 39, 41
79, 123, 152,
170
59 22, 59, 122,
123, 129 , 152,
170
60 23
61 23, 123, 152,
156, 168 , 170
62 24, 129
63 24, 122
64 24, 129
65 24, 125, 155
66 25,
155
125, 136,
67 26, 122
245
REFERENCE INDEX (CONTINUED)
Reference Page
68 26, 121, 122,
123, 129, 137,
147, 148, 150
69 26, 27, 28, 29
39, 121, 122,
123, 128, 134,
135, 137, 148,
150, 151, 156
70 29, 30, 85,
121, 122, 123,
137, 142, 143,
150, 151, 156
71 30, 31, 121,
122, 137, 150
72 31, 32, 33, 34
35, 121, 122,
123, 128, 129,
137, 150, 151,
156
73 35, 122
74 36, 37, 129
75 37, 38, 69, 79
137, 139, 228,
230, 231
76 37, 38, 69, 79
125, 154, 156
77 37,
228
38, 63, 79
78 37,
156
79, 127,
79 37, 63, 137,
138, 139, 140,
142, 143, 144,
214, 215, 216
80 37
81 38, 39, 40, 41
79, 122, 153,
156
82 38, 39, 40, 41
79, 122, 123,
124, 153, 154,
156
83 38, 39, 79, 80
127, 137, 156
84 38, 39, 40, 79
122, 127, 156,
228, 233
85 38, 39, 40, 79
Reference Page
86 38, 39, 79,
156
87 38, 39, 40, 79
88 39, 83, 84, 85
128, 136 , 137,
138, 214
89 39, 137, 139
90 39, 137, 139,
163
91 39, 71, 72, 73
74, 75, 123,
128, 143 , 153,
156, 168 , 214
92 39, 137, 139,
140, 214 , 215
93 41, 42, 43,
123, 129 , 152,
170, 223 , 233
94 43, 44, 122,
129, 151 , 152,
156, 228
95 44, 45
96 45, 46, 124,
154
97 46, 148
98 46, 131, 134
99 46, 135
100 46, 82
101 46, 48, 122,
129, 151
102 48, 49, 122,
129, 169 ,229
103 49, 50, 124,
154
104 50, 123, 129,
152, 153 , 156,
168, 170 , 231,
235
105 51, 122, 129,
151
106 52, 122, 151,
152, 153 , 156
107 52, 131, 136
108 52, 122, 152
109 52, 53, 122,
128, 129 , 137,
138, 151 , 156,
2 3 1
2 4 6
REFERENCE INDEX (CONTINUED)
R e f e r e n c e  P a g e  R e f e r e n c e  P a g e
110 53, 54, 55, 128 62, 63, 65, 129
122, 123, 129, 129 66, 67, 68,
151, 152, 156, 125, 154, 156
170, 230 130 68, 125, 154,
111 55, 56, 122, 156
152, 156 131 68, 125, 154,
112 56, 122, 151, 156
156, 230 132 68, 69, 125,
113 56, 57, 58, 154, 156
122, 123, 124, 133 69, 70
129, 151, 152, 134 69, 70, 125
153, 154, 156, 135 70
168, 170, 230, 136 70, 125
235 137 70, 125, 154
114 59, 60, 61, 138 75, 122, 151,
123, 152, 153, 152, 156
170 139 76, 77, 126, 155
115 59, 60, 112, 140 77, 78, 126, 155
124, 152, 153, 141 79
154, 156, 170 142 81, 82, 127, 156
116 59, 60, 61, 143 82, 83, 128,
112, 124, 154 137, 148
117 59, 60, 61 144 82, 83, 128,
118 59, 60, 61, 137, 138, 143,
122, 152, 156 144, 214
119 59, 60, 61 145 82
120 59, 60, 112, 146 83, 128, 137
124, 154, 156 147 83
121 59, 63, 85, 148 83, 214
135, 137, 138, 149 86
143, 144, 214 150 86
122 61, 123, 137, 151 87, 88, 128,
157, 168 137, 156, 161,
123 61, 62, 122, 169
123, 151, 152, 152 87, 137, 156,
153 161
124 62, 63, 65, 153 87, 137, 161
122, 152, 153, 154 87, 128, 169,
156 214, 215
125 62, 63, 65, 155 88
122, 128, 137, 156 88, 89, 137,
139, 140, 152, 144, 214
214 157 88
126 62, 63, 64, 65, 158 89, 137, 143,
122, 123, 152, 159 90, 115, 117,
157, 168, 170 128, 129, 137,
127 62, 63, 64, 65 138, 214, 229
160 90, 99
1 6 1  9 0
2 4 7
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
REFERENCE INDEX (CONTINUED)
93, 94, 148, 
169
94
94
94, 110, 111, 
128, 169
94, 95
95 
95
95, 124
96, 104, 105, 
126
96, 97, 124, 
154
97, 124, 154 
97, 124, 154 
97, 124, 154
97, 98, 124,
125, 154
98, 124, 125,
154
98, 124, 154
98, 124, 154
99, 124, 125 
99, 120
99, 125, 154 
99
100, 125 
100, 125
100, 125 
1 0 1
101, 125 
1 0 1
101, 102, 126,
155
102, 103, 104,
126, 155
103, 104, 126,
155
104, 126, 155 
104, 126, 155 
105
106, 126, 148,
156
106, 107, 108, 
126, 128, 155 
108, 126, 127, 
128, 155, 156 
108, 109, 126, 
127
Page Reference Page
199 109, 128
200 109, 128
201 109, 110, 128
202 109, 110, 128
203 110, 129
204 111, 112
205 112
206 112, 129
207 112, 129
208 112
209 113
210 113, 129
211 113, 129
212 113, 129
213 113,
129
114, 115
214 115, 129
215 116, 129
216 116,
144
120, 129
217 116, 129
218 116, 117, 170
219 117, 129
220 118, 128
221 118
222 118, 119
223 119
224 119, 129, 155
225 119, 129, 155
226 119, 129
227 120, 128, 129
228 120
229 120
230 120, 121
231 121
232 121
233 136, 145, 146
155, 168, 235
234 123, 156
235 128
236 131, 134
237 131, 134
238 131, 134
239 131, 134
240 131
241 131, 135
242 131, 134, 135
243 131,
136
134, 135
2 4 8
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
1
REFERENCE INDEX (CONTINUED)
P age R e fe r e n c e  P age
131, 134, 135, 285 146
136 286 147
131 287 147
131, 134 288 147
131, 133, 135 289 147
131, 134 290 147
131, 132, 133, 291 147
135, 136 292 147
131, 135 293 147
131, 132, 133, 294 148
135 295 148
131, 132, 133, 296 148
134, 136 297 148
131, 132, 133 298 148
131, 132, 133, 299 148
135, 136 300 148
131, 132, 133, 301 148
135, 208 302 148
131, 132, 135 303 148, 149
131, 132, 133 304 149
132, 133, 136 305 149
132, 135, 136 306 158, 219
208 307 158
134, 135 308 158, 160, 162
134, 135, 136 164, 165, 169
134 309 158, 159, 163
134 310 159
134 311 159
134 312 159
135 313 159
135 314 159, 162, 163
136 164, 166
136, 145, 146, 315 159, 160
155, 168, 235 316 160
137, 138, 139, 317 160, 162
144 318 162, 163, 169
137, 138 319 162
137, 138 320 164
137 321 164
137, 138 322 164
137, 139 323 164
137, 139, 140 324 164, 165
137, 139 325 166, 168
137, 140 326 166
137, 142 327 166, 167
139 328 167, 168
139, 215 329 167
142, 143, 214 330 168
143 331 168
144 332 168
2 4 9
REFERENCE INDEX (CONTINUED)
R e f e r e n c e R e f e r e n c e
333 168, 228, 233 363 229
334 168 364 229, 234
335 169 365 229, 234
336 169 366 229, 234
337 169 367 229, 234
338 170 368 229, 234
339 170 369 229
340 170 370 229
341 206 371 229, 234
342 208 372 229
343 214, 230 373 230
344 227 374 230
345 227 375 231, 235
346 228, 233 376 231, 235
347 228 377 231, 235
348 228 378 231, 235
349 228, 233 379 231, 235
350 228, 233 380 231, 235
351 228, 233 381 231
352 228 382 231
353 228, 233 383 231, 235
354 228, 233 384 231, 235
355 228, 233 385 231
356 228, 233 386 232, 235
357 229 387 232, 235
358 229, 234 388 232, 235
359 229 389 232, 235
360 229, 234 390 234
361 229, 234, 235 391 234
362 229, 231, 234 392 75, 122,
250
☆  U.S. GO VERNMENT PR INTING  OFFICE: 1983— 659-0%/1029
DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
C E N T E R S  F O R  D IS E A S E  C O N T R O L  
NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH 
ROBERT A. TA FT LABORATORIES 
4676 COLUMBIA PARKWAY, CINCINNATI, OHIO 45226
OFFICIAL BUSINESS
PENALTY FOR PRIVATE USE. *300
U&MAIL
S p ec ia l  Fourth C la s s - B o o k
POSTAGE AND FEES PAID 
U.S. DEPARTMENT OF HHS 
HHS 396
Redistribution using indicia is illegal. DHHS (NIOSH) Publication No. 83-119
